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THE BIOLOGY OF GENOMES 
Tuesday, May 11 – Saturday, May 15, 2010 
 
Tuesday 7:30 pm 1  Functional and Cancer Genomics 
   
Wednesday 9:00 am 2  Genetics of Complex Traits 
   
Wednesday 2:00 pm 3  Poster Session I 
   
Wednesday 4:30 pm Wine and Cheese Party * 
   
Wednesday 7:30 pm 4  High-Throughput Genomics and 
Genetics 
   
Thursday 9:00 am 5  Computational Genomics 
   
Thursday 2:00 pm 6  Poster Session II 
   
Thursday 4:30 pm 7  ELSI Panel Discussion 
   
Thursday 7:30 pm 8  Evolutionary Genomics 
   
Friday 9:00 am 9  Population Genomic Variation 
   
Friday 2:00 pm 10  Poster Session III   
   
Friday 4:30 pm GUEST SPEAKERS 
   
Friday 6:00 pm Banquet 
   
Saturday 9:00 am 11  Genetics and Genomics of Non-Human 
Species 
   
 
Poster sessions are located in Bush Lecture Hall 
* Airslie Lawn, weather permitting 
Mealtimes at Blackford Hall are as follows:   
Breakfast   7:30 am-9:00 am 
Lunch       11:30 am-1:30 pm 
Dinner       5:30 pm-7:00 pm 
 
Bar is open from 5:00 pm until late 
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Please note that recording of oral sessions by audio, video or still 
photography is strictly prohibited except with the advance permission of 
the author(s), the organizers, and Cold Spring Harbor Laboratory. 
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PROGRAM 
 
 
TUESDAY, May 11—7:30 PM 
 
 
SESSION 1 FUNCTIONAL AND CANCER GENOMICS 
 
Chairperson: L. Ding, Washington University School of Medicine,  
St. Louis, Missouri 
P. Farnham, University of California, Davis 
 
 
ZNF274 recruits the histone methyltransferase SETDB1 to the 
human genome 
Peggy Farnham. 
Presenter affiliation: University of California-Davis, Davis, California. 
 
 
 
1 
  
Transcription binding variation in eucaryotes 
M. Snyder, M. Kasowski, W. Zheng, F. Grubert, C. Heffelfinger, M. 
Hariharan, A. Asabere, S. Waszak, L. Habegger, J. Rozowsky, M. Shi, 
A. Urban, K. Karczewski, H. Zhao, E. Mancera, L. Steinmetz, M. 
Gerstein, J. Korbel. 
Presenter affiliation: Stanford University, Stanford, California. 
 
 
 
 
 
2 
  
Relapse-specific mutations in an AML genome discovered by 
whole genome sequencing 
Elaine Mardis, Li Ding, John Welch, David Larson, Ken Chen, Michael 
McLellan, Heather Schmidt, Ling Lin, Vince Magrini, Tammi Vickery, 
Richard Wilson, Timothy Ley. 
Presenter affiliation: Washington University School of Medicine, St. 
Louis, Missouri. 
 
 
 
 
 
 
3 
  
Tumor progression revealed by sequencing 100 single cells in a 
heterogeneous breast carcinoma 
Nicholas E. Navin, Jude Kendall, Kerry Cook, Jennifer Troge, James 
Hicks, Michael Wigler. 
Presenter affiliation: Cold Spring Harbor Laboratory, Cold Spring 
Harbor, New York; Stony Brook University, Stony Brook, New York. 
 
 
 
 
 
4 
  
Approaching a comprehensive view of cancer genomes 
Li Ding. 
Presenter affiliation: Washington University School of Medicine, St. 
Louis, Missouri. 
 
 
 
5 
  
 vi 
Evolution of the population of cancerous cells in a hepatocellular 
carcinoma patient 
Xuemei Lu, Weiwei Zhai, Jue Ruan, Yong Tao, Yu Wang, Jun Cai, 
Shaoping Ling, Shiou-Hwei Yeh, Pei-Jer Chen, Chung-I Wu. 
Presenter affiliation: Beijing Institute of Genomics, Beijing, China. 
 
 
 
 
6 
  
ChIP-Seq reveals evolutionarily hidden heart enhancers 
Axel Visel, Matthew J. Blow, Bing Ren, Brian L. Black, Edward M. 
Rubin, Len A. Pennacchio. 
Presenter affiliation: Lawrence Berkeley National Laboratory, Berkeley, 
California; U.S. Department of Energy Joint Genome Institute, Walnut 
Creek, California. 
 
 
 
 
 
7 
  
Characterization of 1000 breast cancer genomes and 
transcriptomes 
Christina Curtis, Suet-Feung Chin, Sohrab Shah, Simon Tavaré, 
Samuel Aparicio, Carlos Caldas, METABRIC Consortium. 
Presenter affiliation: University of Cambridge, Cambridge, United 
Kingdom; Cancer Research UK Cambridge, United Kingdom. 
 
 
 
 
 
8 
 
 
WEDNESDAY, May 12—9:00 AM 
 
 
SESSION 2 GENETICS OF COMPLEX TRAITS 
 
Chairperson: D. MacArthur, Wellcome Trust Sanger Institute, Hinxton,  
  United Kingdom 
C. Ober, University of Chicago, Illinois 
 
  
Loss-of-function mutations in healthy human genomes—
Implications for clinical genome sequencing 
Daniel G. MacArthur, Suganthi Balasubramanian, Ni Huang, Adam 
Frankish, Zhang Zhengdong, Lukas Habegger, Xinmeng Mu, Matthew 
Bainbridge, Bryndis Yngvadottir, 1000 Genomes Consortium, Jennifer 
Harrow, Richard A. Gibbs, Matthew E. Hurles, Mark B. Gerstein, Chris 
Tyler-Smith. 
Presenter affiliation: Wellcome Trust Sanger Institute, Hinxton, United 
Kingdom. 
 
 
 
 
 
 
 
 
9 
  
 vii 
High throughput RNA sequencing reveals genetic determinants 
and mechanisms regulating human expression quantitative traits 
loci 
Jacek A. Majewski, Zibo Wang, Amandine Bemmo, Kevin Ha, Emilie 
Lalonde, Tony Kwan, Tomi M. Pastinen. 
Presenter affiliation: McGill University, Montreal, Canada; Centre 
d’Innovation Montreal, Canada. 
 
 
 
 
 
 
10 
  
Synthetic associations are unlikely to account for most common 
disease genome-wide association signals 
Jeffrey C. Barrett, Carl A. Anderson, Nicole Soranzo, Eleftheria 
Zeggini. 
Presenter affiliation: Wellcome Trust Sanger Institute, Hinxton, United 
Kingdom. 
 
 
 
 
 
11 
  
A scalable class of multiple locus methods for genome-wide 
association studies 
Gabriel Hoffman, Benjamin Logsdon, Chuan Gao, Abra Brisbin, Jason 
Mezey. 
Presenter affiliation: Cornell University, Ithaca, New York; Weill Cornell 
Medical College, New York, New York. 
 
 
 
 
 
12 
  
Rare variants contribute to asthma susceptibility 
Carole Ober, Dara G. Torgerson, Daniel Capurso, Scott R. Weiss, 
Deborah A. Meyers, Kathleen C. Barnes, Eugene R. Bleecker, 
Benjamin A. Raby, Rasika A. Mathias, Penelope E. Graves, Fernando 
D. Martinez, Dan L. Nicolae. 
Presenter affiliation: University of Chicago, Chicago, Illinois. 
 
 
 
 
 
13 
  
A gene-based approach to joint analysis of multiple related 
phenotypes 
Katherine I. Morley, David G. Clayton, Jeffrey C. Barrett. 
Presenter affiliation: Wellcome Trust Sanger Institute, Cambridge, 
United Kingdom. 
 
 
 
 
14 
  
The Drosophila Genetic Reference Panel—Whole genome 
association mapping of quantitative traits, and a new tool for 
Drosophila genetics 
Stephen Richards, Dianhui Zhu, Yi Han, Julien Ayroles, Mary Anna 
Carbone, Trudy Mackay, Eric Stone, Richard A. Gibbs. 
Presenter affiliation: Baylor College of Medicine, Houston, Texas. 
 
 
 
 
 
15 
  
 viii 
Transcription factor polymorhpisms and complex traits—A 
thermodynamic model of genetic interactions 
Justin P. Gerke, Jason Gertz, Barak A. Cohen. 
Presenter affiliation: Washington University School of Medicine, St. 
Louis, Missouri. 
 
 
 
 
16 
 
 
WEDNESDAY, May 12—2:00 PM 
 
 
SESSION 3 POSTER SESSION I 
 
  
Direct effects of environmental perturbation on cis-regulation 
assessed by allelic expression 
V. Adoue, E. Grundberg, B. Ge, T. Kwan, K.L. Lam, V. Koka, O. 
Nilsson, Q.L. Duan, S.T. Weiss, B. Raby, K.G. Tantisira, T. Pastinen. 
Presenter affiliation: McGill University, Montreal, Canada. 
 
 
 
 
17 
  
Accuracy of Illumina Genome Analyzer and HiSeq 2000—What 
depth of coverage do you really need? 
Subramanian S. Ajay, Stephen C. Parker, Hatice Ozel Abaan, Jamie K. 
Teer, Praveen F. Cherukuri, Nancy F. Hansen, Pedro Cruz, William A. 
Gahl, James C. Mullikin, Elliott H. Margulies. 
Presenter affiliation: Genome Technology Branch, Bethesda, 
Maryland. 
 
 
 
 
 
 
18 
  
Genome-wide identification of small insertions and deletions in 
the 1000 Genomes pilot project 
Cornelis A. Albers, Gerton A. Lunter, Quang S. Le, Daniel MacArthur, 
Willem H. Ouwehand, Richard Durbin, 1000 Genomes Consortium. 
Presenter affiliation: University of Cambridge, Cambridge, United 
Kingdom; Sanger Institute, United Kingdom. 
 
 
 
 
 
19 
  
Studying animal domestication by brain transcriptome 
sequencing 
Frank W. Albert, Michel Halbwax, Jose A. Blanco Aguiar, Miguel 
Carneiro, Sylvia Kaiser, Irina Plyusnina, Lyudmila Trut, Rafael 
Villafuerte, Nuno Ferrand, Per Jensen, Svante Pääbo. 
Presenter affiliation: Max Planck Institute for Evolutionary 
Anthropology, Leipzig, Germany. 
 
 
 
 
 
 
20 
  
 ix 
Unbiased reconstruction of a mammalian transcriptional network 
mediating the differential response to pathogens 
Ido Amit, Manuel Garber, Nicolas Chevrier, Ana Paula Leite, Thomas 
Eisenhaure, Mitchell Guttman, Jen Grenier, Or Zuk, Alex Meissner, 
David E. Root, Nir Hacohen, Aviv Regev. 
Presenter affiliation: Broad Institute of MIT and Harvard, Cambridge, 
Massachusetts; MIT, Cambridge, Massachusetts. 
 
 
 
 
 
 
21 
  
Multivariate analysis of rate co-variation of different types of 
mutations in their genomic context 
Guruprasad Ananda, Anton Nekrutenko, Francesca Chiaromonte, 
Kateryna Makova. 
Presenter affiliation: Penn State University, University Park, 
Pennsylvania. 
 
 
 
 
 
22 
  
Virus metagenomics—Virus enrichment and deep sequencing 
reveals new human viruses and strains 
Fredrik Lysholm, Tobias Allander, Bengt Persson, Björn Andersson. 
Presenter affiliation: Karolinska Institutet, Stockholm, Sweden. 
 
 
 
23 
  
Whole genome resequencing reveals loci under selection during 
chicken domestication 
Carl-Johan Rubin, Michael C. Zody, Jonas Eriksson, Jennifer R. 
Meadows, Ellen Sherwood, Matthew T. Webster, Ted Sharpe, 
Francois Besnier, Örjan Carlborg, Paul Siegel, Kerstin Lindblad-Toh, 
Leif Andersson. 
Presenter affiliation: Uppsala University, Uppsala, Sweden; Swedish 
University of Agricultural Sciences, Uppsala, Sweden. 
 
 
 
 
 
 
 
24 
  
Population genetic inference using low coverage sequencing 
data 
Adam Auton, Ryan Hernandez, Gil McVean, The 1000 Genomes 
Project. 
Presenter affiliation: University of Oxford, Oxford, United Kingdom. 
 
 
 
 
25 
  
Capturing the rate of germ-line and somatic mutations in genome 
resequencing of childhood leukemia families using a “Quartet” 
design 
Philip Awadalla, Jon M. Keebler, Julie Hussin, Mathieu Lariviere, Diego 
Czul, Daniel Sinnett. 
Presenter affiliation: Universite de Montreal, Montreal, Canada. 
 
 
 
 
 
26 
  
 x 
A population genomics approach to explore the molecular basis 
for athletic performance traits in North Swedish trotters 
Jeanette Axelsson, Jennifer Meadows, Lisa Andersson, Hanna 
Smedstad, Aneta Ringholm, Knut Roed, Leif Andersson, Sofia Mikko, 
Gabriella Lindgren. 
Presenter affiliation: Swedish University of Agricultural Sciences, 
Uppsala, Sweden. 
 
 
 
 
 
 
27 
  
Gambit—A cross-platform, low-memory visualization and 
analysis toolkit for next-generation sequencing 
Derek Barnett, Gabor Marth. 
Presenter affiliation: Boston College, Chestnut Hill, Massachusetts. 
 
 
 
28 
  
Orangutan (P. pygmaeus) mobile elements—The extinction of Alu 
Miriam K. Konkel, Jerilyn A. Walker, Brygg Ullmer, Leona G. 
Chemnick, Oliver A. Ryder, Robert Hubley, Arian F A. Smit, Mark A. 
Batzer, for the Orangutan Genome Sequencing and Analysis 
Consortium. 
Presenter affiliation: Louisiana State University, Baton Rouge, 
Louisiana. 
 
 
 
 
 
 
29 
  
Genome sequencing and microRNA discovery in the basal 
flatwork M. lignano 
Daniil Simanov, Patrick van Zon, Ewart de Bruijn, Sam Linsen, Katrien 
de Mulder, Edwin Cuppen, Andres Canela, Gregory J. Hannon, Dita B. 
Vizoso, Lukas Scharer, Peter Ladurner, Eugene Berezikov. 
Presenter affiliation: Hubrecht Institute, Utrecht, Netherlands. 
 
 
 
 
 
30 
  
Assaying the distribution of sequence variants within a viral 
patient sample 
Henry R. Bigelow, Michael G. Ross, Filipe J. Ribeiro, Bruce D. Walker, 
Michael C. Zody, Todd M. Allen, Matthew R. Henn, David B. Jaffe. 
Presenter affiliation: Broad Institute, Cambridge, Massachusetts. 
 
 
 
 
31 
  
Metaphase spindle proteome reveals potential furrow initiation 
factors 
Mary Kate Bonner, Ali Sarkeshik, Dan S. Poole, John Yates III, Ahna 
R. Skop. 
Presenter affiliation: UW-Madison, Madison, Wisconsin. 
 
 
 
 
32 
 
 
 
 xi 
Exploring synthetic genetic interaction networks by high-
throughput RNAi 
Thomas Horn, Thomas Sandmann, Bernd Fischer, Wolfgang Huber, 
Michael Boutros. 
Presenter affiliation: German Cancer Research Center and University 
Heidelberg, Heidelberg, Germany. 
 
 
 
 
 
33 
  
Genomic analysis of global village dog populations reveals 
complex domestication history of domestic dogs from gray 
wolves 
Adam R. Boyko, Ryan H. Boyko, Corin M. Boyko, Elaine A. Ostrander, 
Robert K. Wayne, Carlos D. Bustamante. 
Presenter affiliation: Stanford University, Stanford, California. 
 
 
 
 
 
34 
  
Expressed, rare, deleterious genetic variants distinguish breast 
cancer sub types 
Christopher D. Brown, Thomas Stricker, Megan E. McNerney, Ralf 
Kittler, Subhradip Karmakar, Kevin P. White. 
Presenter affiliation: University of Chicago, Chicago, Illinois. 
 
 
 
 
35 
  
Genome-wide patterns of population structure and admixture 
among Hispanic/Latino populations 
Katarzyna Bryc, Christopher Velez, Tatiana Karafet, Andres Moreno-
Estrada, Andy Reynolds, Adam Auton, Michael Hammer, Carlos D. 
Bustamante, Harry Ostrer. 
Presenter affiliation: Cornell University, Ithaca, New York. 
 
 
 
 
 
36 
  
Tissue-specific rewiring of signaling pathways through 
alternatively spliced disordered segments 
Marija Buljan, Alex Bateman, Madan Babu. 
Presenter affiliation: Wellcome Trust Sanger Institute, Hinxton, 
Cambridge, United Kingdom. 
 
 
 
 
37 
  
Enriching for indels in complex disease by deep sequencing. 
Lara M. Bull-Otterson, Alex Coventry, Andrew G. Clark, Alan R. 
Templeton, Thomas J. Rea, Charles F. Sing, Jacy Crosby, Xiaoming 
Liu, Taylor Maxwell, Eric A. Boerwinkle, Richard A. Gibbs. 
Presenter affiliation: Baylor College of Medicine Houston, Texas. 
 
 
 
 
38 
  
Fitness and structure landscapes for pre-miRNA processing 
Ralf A. Bundschuh, Juliette de Meaux, Michael Lässig. 
Presenter affiliation: Ohio State University, Columbus, Ohio. 
 
 
39 
  
 xii 
Punctuated or gradual? Timing the acceleration of human 
accelerated regions with Neandertal DNA sequences 
Hernán A. Burbano, Richard E. Green, Tomislav Maricic, Marco de la 
Rasilla, Antonio Rosas, Michael Lachmann, Svante Pääbo. 
Presenter affiliation: Max Planck Institute for Evolutionary 
Anthropology, Leipzig, Germany. 
 
 
 
 
 
40 
  
A general method for assembling genomes from Illumina data 
Joshua N. Burton, Iain A. MacCallum, Sante Gnerre, Dariusz 
Przybylski, Filipe Ribeiro, Bruce Walker, Ted Sharpe, Giles Hall, 
Carsten Russ, Chad Nusbaum, David B. Jaffe. 
Presenter affiliation: Broad Institute, Cambridge, Massachusetts. 
 
 
 
 
41 
  
Comparative analysis of transcription in four yeast species using 
RNA-Seq 
Michele Busby, Jesse Gray, Michael Springer, Chip Stewart, Jeffrey 
Chuang, Michael Greenberg, Gabor Marth. 
Presenter affiliation: Boston College, Newton, Massachusetts. 
 
 
 
 
42 
  
Identifying the genetic determinants of transcription factor 
activity 
Eunjee Lee, Harmen J. Bussemaker. 
Presenter affiliation: Columbia University, New York, New York. 
 
 
 
43 
  
Improving the high-quality draft swine genome reference 
Mario Caccamo. 
Presenter affiliation: The Genome Analysis Centre, Norwich, United 
Kingdom. 
 
 
 
44 
  
Patterns of genetic change in Drosophila coding sequence reveal 
the generic modularity of proteins, and the ubiquity of epistasis. 
Benjamin J. Callahan, Richard A. Neher, Peter Andolfatto, Boris I. 
Shraiman. 
Presenter affiliation: Stanford University, Stanford, California. 
 
 
 
 
45 
  
Rapid integration of novel genes into cellular networks 
John A. Capra, Katherine S. Pollard, Mona Singh. 
Presenter affiliation: University of California, San Francisco, San 
Francisco, California; Princeton University, Princeton, New Jersey. 
 
 
 
46 
 
 
 
 xiii 
Next-generation targeted resequencing to investigate population 
history of gibbon species 
Lucia Carbone, Sung Kim, Alan R. Mootnick, David Li, Pieter J. 
deJong, Jeffrey D. Wall. 
Presenter affiliation: Children's Hospital Oakland Research Institute, 
Oakland, California. 
 
 
 
 
 
47 
  
Deciphering mammalian transcriptome complexity by deep-CAGE 
Piero Carninci, Timo Lassmann, Hazuki Takahashi, Charles Plessy, 
Nicolas Bertin, Geoffrey Faulkner, Nadine Hornig, Carrie Davis, Valerio 
Orlando, Thomas Gingeras, Yoshihide Hayashizaki. 
Presenter affiliation: RIKEN Yokohama, Kanagawa, Japan. 
 
 
 
 
48 
  
A population genetic approach to mapping neurological disorder 
genes using deep resequencing 
Ferran Casals, Rachel A. Myers, Julie Gauthier, Jonathan E. Keebler, 
Adam R. Boyko, Carlos D. Bustamante, Amelie M. Piton, Dan 
Spiegelman, Edouard Henrion, Martine M. Zilversmit, Julie Hussin, 
Jacki Quinlan, Yan Yang, Ron Lafrenière, Alexander Griffing, Eric A. 
Stone, Guy A. Rouleau, Philip Awadalla. 
Presenter affiliation: Université de Montréal, Montréal, Canada. 
 
 
 
 
 
 
 
49 
  
Sample sequencing the dynamic repeat structure of snake 
genomes 
Todd A. Castoe, Kathryn Hall, Marcel Guibotsy Mboulas, A. P. Jason 
de Koning, Cedric Feschotte, David D. Pollock. 
Presenter affiliation: University of Colorado School of Medicine, 
Aurora, Colorado. 
 
 
 
 
 
50 
  
Transcriptome characterization of planarian S. mediterranea by 
massive parallel sequencing 
Catherine Adamidi, Yongbo Wang, Xintian You, Christoph Dieterich, 
Nikolaus Rajewsky, Wei Chen. 
Presenter affiliation: Max-Delbrück-Center for Molecular Medicine, 
Berlin, Germany. 
 
 
 
 
 
51 
  
Integrated genome analysis of genetic networks regulated by 
eyeless during retinal development in Drosophila 
Yiyun Chen, Yumei Li, Keqing Wang, Rui Chen. 
Presenter affiliation: Baylor College of Medicine, Houston, Texas. 
 
 
 
52 
 
 
 
 xiv 
An integrative computational pipeline towards large-scale 
accurate discovery of genomic structural variation in cancer 
Ken Chen. 
Presenter affiliation: Washington University School of Medicine, St. 
Louis, Missouri. 
 
 
 
 
53 
  
MapSplice---Mapping RNA-seq reads for splice discovery 
Kai Wang, Darshan Singh, Zheng Zeng, Stephen J. Coleman, Xiaping 
He, Piotr Mieczkowski, Charles M. Perou, James N. MacLeod, Derek 
Y. Chiang, Jan F. Prins, Jinze Liu. 
Presenter affiliation: University of Kentucky, Lexington, Kentucky; 
University of North Carolina, Chapel Hill, North Carolina. 
 
 
 
 
 
54 
  
Rewired signal transduction pathways among S. cerevisiae 
strains 
Brian L. Chin, Gerald R. Fink. 
Presenter affiliation: Whitehead Institute for Biomedical Research, 
Cambridge, Massachusetts. 
 
 
 
 
55 
  
Identification and analysis of novel, functional variants by 
population-based deep re-sequencing in eight drug target genes 
Stephanie L. Chissoe, Matthew R. Nelson, Kijoung Song, Silviu-Alin 
Bacanu, Xiangyang Kong, Dana Fraser, Jennifer Aponte, Li Li, Xin 
Yuan, John Whittaker, Dawn Waterworth, Lon Cardon, Vincent 
Mooser. 
Presenter affiliation: GlaxoSmithKline, Research Triangle Park, North 
Carolina. 
 
 
 
 
 
 
 
56 
  
dbVar—NCBI's database of genomic structural variation 
D M. Church, T P. Sneddon, J Lopez, J Garner, A Mardanov, C 
Clausen, N Bouk, J Paschall, M Feolo, S T. Sherry, L Phan, D R. 
Maglott, J Ostell. 
Presenter affiliation: NCBI/NIH, Bethesda, Maryland. 
 
 
 
 
57 
  
A new high-resolution and ultra-dense Zebrafish meiotic map 
Matthew D. Clark, Carlos Torroja, John Postlethwait, Derek L. Stemple. 
Presenter affiliation: Wellcome Trust Sanger Institute, Hinxton, United 
Kingdom. 
 
 
 
58 
  
Browsing 1000 genomes data using EnsEMBL 
Laura Clarke, Holly Zheng Bradley, Richard Smith, Eugene Kuleshea, 
William McLaren, Paul Flicek, The 1000 genomes Project. 
Presenter affiliation: European Bioinformatics Institute, Cambridge, 
United Kingdom. 
 
 
 
 
59 
  
 xv 
Microbial and metagenomic research at the Washington 
University Genome Center 
Sandra Clifton. 
Presenter affiliation: Washington University School of Medicine, St. 
Louis, Missouri. 
 
 
 
 
60 
  
A framework for detection and interpretation of structural 
variation from matepair data 
Cristian Coarfa, Oliver A. Hampton, Petra Den Hollander, Martin M. 
Matzuk, Adrian V. Lee, Aleksandar Milosavljevic. 
Presenter affiliation: Baylor College of Medicine, Houston, Texas. 
 
 
 
 
61 
  
Identifying causal genetic variants with single-nucleotide 
evolutionary constraint scores 
Gregory M. Cooper, David L. Goode, Sarah B. Ng, Arend Sidow, 
Michael J. Bamshad, Jay Shendure, Deborah A. Nickerson. 
Presenter affiliation: University of Washington, Seattle, Washington. 
 
 
 
 
62 
  
The genetic architecture of immune-mediated disease 
Chris Cotsapas, Benjamin F. Voight, Kasper Lage, Elizabeth R. 
Rossin, Benjamin M. Neale, Mark J. Daly. 
Presenter affiliation: Massachusetts General Hospital, Boston, 
Massachusetts; Harvard Medical School, Boston, Massachusetts; 
Broad Institute of MIT and Harvard, Cambridge, Massachusetts. 
 
 
 
 
 
63 
  
Vast excess of rare variation revealed by resequencing 13,715 
individuals 
Alex Coventry, Lara M. Bull, Xiaoming Liu, Andrew G. Clark, Taylor J. 
Maxwell, Jacy Crosby, James E. Hixson, Thomas J. Rea, Alan R. 
Templeton, Eric Boerwinkle, Richard Gibbs, Charles F. Sing. 
Presenter affiliation: Cornell University, Ithaca, New York. 
 
 
 
 
 
64 
  
Human islets prepared for clinical transplantation exhibit an 
altered glycolytic profile 
Mark J. Cowley, Anita Weinberg, James Cantley, Warren Kaplan, 
Stacey N. Walters, Wayne J. Hawthorne, Philip J. O'Connell, Shane T. 
Grey. 
Presenter affiliation: Garvan Institute, Sydney, Australia. 
 
 
 
 
 
65 
  
Genome-wide DNaseI footprinting in a diverse set of human cell-
types 
Gregory E. Crawford, Alan P. Boyle, Lingyun Song, Bum-Kyu Lee, 
Damian Keefe, Ewan Birney, Vishwanath R. Iyer, Terrence S. Furey. 
Presenter affiliation: Duke University, Durham, North Carolina. 
 
 
 
 
66 
  
 xvi 
A high resolution map of the Drosophila transcriptome by paired-
end RNA-sequencing 
Bryce Daines, Liguo Wang, Hui Wang, Yumei Li, David Emmert, 
William Gelbart, Wei Li, Richard Gibbs, Rui Chen. 
Presenter affiliation: Baylor College of Medicine, Houston, Texas. 
 
 
 
 
67 
  
Determining evolutionary changes in glucocorticoid receptor 
binding sites using ChIP-seq 
Charles G. Danko, Lee W. Kraus, Adam Siepel. 
Presenter affiliation: Cornell University, Ithaca, New York. 
 
 
 
68 
  
Rapid evolutionary innovation during an Archean genetic 
expansion 
Lawrence A. David, Eric J. Alm. 
Presenter affiliation: Massachusetts Institute of Technology, 
Cambridge, Massachusetts. 
 
 
 
 
69 
  
Optimal study design for targeted re-sequencing in pooled DNA 
for disease association studies 
Aaron G. Day-Williams, Kirsten McLay, Eleanor Howard, Alison J. 
Coffey, Aarno Palotie, Eleftheria Zeggini. 
Presenter affiliation: Wellcome Trust Sanger Institute, Hinxton, United 
Kingdom. 
 
 
 
 
 
70 
  
High-throughput evolutionary genomic analysis on large 
phylogenies 
A.P. Jason.de Koning, Todd A. Castoe, David D. Pollock. 
Presenter affiliation: University of Colorado Denver, Aurora, Colorado. 
 
 
 
71 
  
Massively-parallel transcriptome sequencing analysis by Cloud 
Computing 
Francisco M. De La Vega, Jigntao Sun, Catalin Barbacioru, Adam 
Kraut, Bill Van Etten, Brian Tuch, Yongming Sun. 
Presenter affiliation: Life Technologies, Foster City, California. 
 
 
 
 
72 
  
Multiple regions of strong primate-specific noncoding constraints 
in the FOXP2 locus 
Ricardo C. del Rosario, Shyam Prabhakar. 
Presenter affiliation: Genome Institute of Singapore, Singapore. 
 
 
 
73 
  
 xvii 
The Genome Analysis Toolkit—A MapReduce framework for 
analyzing next-generation DNA sequencing data 
A. McKenna, M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. 
Kernytsky, K. Garimella, D. Altshuler, S. Gabriel, M A. DePristo. 
Presenter affiliation: The Broad Institute of Harvard and MIT, 
Cambridge, Massachusetts; Massachusetts General Hospital, Boston, 
Massachusetts. 
 
 
 
 
 
 
74 
  
De novo sequencing and assembly of the cucumber genome 
using exclusively next-generation sequencing methods 
Brian Desany, Jason Affourtit, Pascal Bouffard, Timothy Harkins, 
James Knight, Chinnappa Kodira, Jason Miller, Therese Mitros, 
Mohammed Mohiuddun, Daniel Rokhsar, Granger Sutton, Cynthia 
Turcotte, Yiqun Weng, Jack Staub. 
Presenter affiliation: 454 Life Sciences, Branford, Connecticut. 
 
 
 
 
 
 
75 
  
Natural genetic variation caused by endogenous human 
retrotransposons 
Rebecca C. Iskow, Micheal T. McCabe, Ryan E. Mills, Spencer 
Torene, Erwin G. Van Meir, Paula M. Vertino, Scott E. Devine. 
Presenter affiliation: Emory University School of Medicine, Atlanta, 
Georgia; University of Maryland School of Medicine, Baltimore, 
Maryland. 
 
 
 
 
 
 
76 
  
The genome of the Anolis lizard—A reptile in a mammalian world 
Federica Di Palma, Jessica E. Alfoldi, Manfred Grabherr, Lesheng 
Kong, Andreas Heager, Craig Lowe, Anolis Genome Sequencing 
Consortium, David Haussler, Chris Ponting, Kerstin Lindblad-Toh. 
Presenter affiliation: Broad Institute of MIT and Harvard, Cambridge, 
Massachusetts. 
 
 
 
 
 
77 
  
The Cichlid model system—Understanding how small RNAs 
regulate plastic and reversible changes in social behavior 
Rosa Alcazar, Karen Maruska, Federica Di Palma, Kerstin Lindblad-
Toh, Poornima Parameswaran, Russell D. Fernald. 
Presenter affiliation: Broad Institute of MIT and Harvard, Cambridge, 
Massachusetts. 
 
 
 
 
 
78 
  
The promoter of the IGF2 imprinted gene in the opossum, M. 
domestica, simultaneously exhibits mutually exclusive histone 
modifications 
Kory C. Douglas, Paul B. Samollow. 
Presenter affiliation: Texas A&M University, College of Veterinary 
Medicine, College Station, Texas. 
 
 
 
 
 
79 
  
 xviii 
Large-scale human genome sequencing and haplotyping for 
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SESSION 7 ELSI PANEL and DISCUSSION  
 
 
RETURNING RESEARCH RESULTS TO PARTICIPANTS 
IN LARGE-SCALE GENOMICS STUDIES 
 
Moderator: Susan M. Wolf, J.D., University of Minnesota 
 
Panelists: Yann Joly, DCL, McGill University 
  Kazuto Kato, Ph.D., Kyoto University 
  Jane Kaye, Ph.D., Oxford University 
  Isaac Kohane, M.D., Ph.D., Harvard Medical School 
 
As biobanks and large-scale genomics research projects proliferate around 
the globe, debate is growing about whether, when, and how to return 
individual research results and incidental findings to the people who donated 
their samples for study.  The topic raises difficult questions about the extent 
of the ethical and legal duties that may, or may not, be owed to research 
participants.  It also has important operational implications.   
 
The traditional approach—at least in most large-scale studies involving 
researchers who are not clinicians—has been not to return any research 
results.  In fact, individual identifiers in such studies are frequently removed, 
making the whole question of whether to return results essentially moot as it 
is impossible to associate the data to a named person when no identifiers 
are available.  At the opposite extreme, some have called for the return of all 
individual research results, or at least giving participants the option to choose 
what information they will receive; proponents of this approach argue that 
any withholding of data is unduly paternalistic.  A middle ground advocated 
by some is to strike a balance, returning results only in cases where the 
results are scientifically validated and clinically actionable.  The question of 
when, if ever, to return incidental research findings (findings beyond the aims 
of a study but which have potential clinical or reproductive significance) is an 
important part of the debate.  Whatever position is taken on these issues will 
have major implications for the operation of the study and for the burdens on 
both researchers and participants.  This panel will provide a range of 
perspectives on these questions from four parts of the world:  Canada, 
Japan, the United States, and the U.K 
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ZNF274 RECRUITS THE HISTONE METHYLTRANSFERASE SETDB1 
TO THE HUMAN GENOME 
 
Peggy J Farnham  
University of California-Davis, Genome Center, Davis, CA, 95616 
 
Only a small percentage of human transcription factors (e.g. those 
associated with a specific differentiation program) are expressed in a given 
cell type. Thus, cell fate is mainly determined by cell type-specific silencing 
of transcription factors that drive different cellular lineages. Several histone 
modifications have been associated with gene silencing, including 
H3K27me3 and H3K9me3. We have previously shown that the two largest 
classes of mammalian transcription factors are marked by distinct histone 
modifications; homeobox genes are marked by H3K27me3 and zinc finger 
genes are marked by H3K9me3. Several histone methyltransferases (e.g. 
G9a and SETDB1) may be involved in mediating the H3K9me3 silencing 
mark. We have used ChIP-chip and ChIP-seq to demonstrate that SETDB1, 
but not G9a, overlaps with H3me3K9. A current model is that SETDB1 is 
recruited to specific genomic locations via interaction with the corepressor 
TRIM28 (KAP1), which is in turn recruited to the genome via interaction 
with zinc finger transcription factors that contain a Kruppel-associated box 
(KRAB) domain. However, specific KRAB-ZNFs that recruit TRIM28 
(KAP1) and SETDB1 to the genome have not been identified. We have 
shown that ZNF274 (a KRAB-ZNF that contains 5 finger domains), can 
interact with KAP1 in vitro and, using genome-wide ChIP-seq, we show 
that ZNF274 binding sites co-localize with SETDB1, KAP1, and 
H3K9me3. Knockdown of ZNF274 with siRNAs reduces the levels of 
KAP1 and SETDB1 at target sites. Thus our studies provide in vivo support 
for the model that KRAB domain-containing ZNFs can recruit histone 
methyltransferases to specific sites in the human genome. 
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TRANSCRIPTION BINDING VARIATION IN EUCARYOTES 
 
M Snyder, M Kasowski, W Zheng, F Grubert, C Heffelfinger, M Hariharan, 
A Asabere, S Waszak, L Habegger, J Rozowsky, M Shi, A Urban, K 
Karczewski, H Zhao, E Mancera, L Steinmetz, M Gerstein, J Korbel 
 
Stanford University, Genetics, Stanford, CA 94305 
 
Variation in transcriptional regulation is thought to be a major cause of 
phenotypic diversity. Widespread differences in gene expression among 
individuals of a species have been observed, yet few studies have examined 
the variability of transcription factor (TF) binding, and thus the extent and 
underlying genetic basis of TF binding diversity is largely unknown. We 
mapped differences in transcription binding among individuals and 
elucidated the genetic basis of such variation on a genome-wide scale for 
both yeast and humans. For humans we mapped the binding sites of RNA 
Polymerase II (PolII) and a key regulator of immune responses, NFκB 
(p65), in ten lymphoblastoid cell lines and found that 25% and 7.5% of the 
respective binding regions differed between individuals. Binding 
differences were frequently associated with SNPs and genomic structural 
variants. 
To further understand the genetic basis of transcription factor binding 
variation, we mapped the binding sites of Ste12 in pheromone-treated cells 
of 43 segregants of a cross between 2 highly diverged yeast strains and their 
parental lines. We found that the majority of TF binding variation is cis-
linked and that many variations are associated with polymorphisms in the 
binding motifs of Ste12 as well as those of several proposed Ste12 
cofactors. We also identified trans factors that modulate Ste12 binding to 
specific promoters. Yeast and human transcription factor binding strongly 
correlates with gene expression showing that binding variation is functional. 
Overall these different studies identified genetic regulators of molecular 
diversity among individuals and provide novel insights into variation in 
eucaryotes and mechanisms of gene regulation.  
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RELAPSE-SPECIFIC MUTATIONS IN AN AML GENOME 
DISCOVERED BY WHOLE GENOME SEQUENCING 
 
Elaine Mardis 1, Li Ding1, John Welch2, David Larson1, Ken Chen1, Michael 
McLellan1, Heather Schmidt1, Ling Lin1, Vince Magrini1, Tammi Vickery1, 
Richard Wilson1, Timothy Ley2 
1Washington University School of Medicine, The Genome Center, 4444 Forest 
Park Blvd Campus Box 8501, St. Louis, MO, 63108, 2Washington University 
School of Medicine, Division of Oncology, 500 South Kingshighway SW 
Tower, St. Louis, MO, 63110 
 
Acute myeloid leukemia (AML) is a highly malignant hematopoietic disease 
that affects about 13,000 adults in the United States annually, causing ~9,000 
deaths. Whole-genome sequencing of two AML genomes have identified novel 
mutations that may be relevant for disease initiation, and (in the case of IDH1 
mutations) predictive of poor outcome. To better understand the mutations 
associated with AML progression and relapse, we sequenced the relapse 
genome of an AML patient obtained 11 months after initial diagnosis. The 
patient initially presented with FAB M1 AML with normal cytogenetics and 
100% blasts in the marrow. She was treated with standard induction 
chemotherapy, and consolidated with high dose AraC and an autologous stem 
cell transplant. She relapsed at 11 months with M1 AML, 78% blasts, and a 
novel t(10;12) in 100% of her metaphases. The ten somatic mutations present in 
this AML genome at initial presentation were previously reported (Ley et al 
Nature 2008). By sequencing the relapse tumor genome, we discovered two 
genic mutations that were missed in the de novo genome due to coverage issues 
(DNMT3A L723FS; LOC728896 F46L). Most importantly, we discovered four 
novel relapse-specific genic mutations, including a missense mutation in 
ETV6/TEL (R105P), an 11bp insertion in STK4 (at A461, predicted to cause 
loss of function due to a frameshift), and a missense mutation in MYO18B 
(A2317T). The ETV6/TEL gene is frequently involved in translocations in 
acute leukemias, and both STK4 and MYO18B are putative tumor suppressors. 
Although the mutations in STK4 and MYO18B were not detected in 21 
additional AML relapse genomes, a mutation at the same position in ETV6 was 
detected in an additional de novo AML genome (R105Q). Paired-end data 
revealed a novel WNK1-WAC fusion at base pair resolution, resolving the 
relapse-specific clonal cytogenetic abnormality, t(10;12)(p12;p13). The 
resulting fusion retains the full catalytic domain of WNK1 but truncates its C-
terminus; the fusion cDNA is expressed in the tumor. Functional analysis is in 
progress. Ultra deep read count analysis revealed that none of the relapse-
specific mutations could be detected in the de novo AML sample, or in 
subsequent bone marrow specimens obtained at 43, 121, or 170 days after 
presentation (relapse occurred at day 338); the sensitivity of the assay allowed 
us to accurately detect 1 cell in 1,000 carrying a mutation. Our study establishes 
whole-genome sequencing as an unbiased approach for discovering AML 
relapse-specific mutations. Comparison of the de novo and relapse samples 
revealed additional somatic mutations at relapse that were almost certainly 
relevant for the progression 
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TUMOR PROGRESSION REVEALED BY SEQUENCING 100 SINGLE 
CELLS IN A HETEROGENEOUS BREAST CARCINOMA 
 
Nicholas E Navin1,2, Jude Kendall1, Kerry Cook1, Jennifer Troge1, James 
Hicks1, Michael Wigler1  
 
1Cold Spring Harbor Laboratory, Wigler Laboratory, 1 Bungtown Road, 
Cold Spring Harbor, NY, 11724, 2Stony Brook University, Molecular 
Genetics & Microbiology, 100 Nicolls Road, Stony Brook, NY, 11733 
 
Genomic analysis by microarray, and more recently DNA sequencing, has 
provided important insights into the role of copy number variation in human 
cancer. However, these methods can yield only approximate results when 
applied to mixed populations of rapidly evolving cells. In such cases our 
understanding would be improved by dissecting genetic events at the single 
cell level. We have therefore developed a method of single nucleus 
sequencing (SNS) to quantify the genome copy number of individual nuclei. 
Using the Illumina GA2 platform we have shown that a single lane of 
sequence reads are sufficiently distributed across the genome to measure 
copy number at a resolution of about 50kb. We validated our method in a 
normal fibroblast cell line (SKN1) that has been deep-sequenced along with 
a genetically complex breast cancer cell line (SK-BR-3). We then used SNS 
to analyze 100 single cells isolated from a heterogeneous Basal-like breast 
carcinoma. From this data, we constructed a detailed phylogenetic lineage, 
showing that the majority of cells belong to one of five major clonal 
subpopulations. We compared these subpopulations to infer a step-wise 
progression in which much of the genome is deleted, followed by 
endoreduplication to generate a highly aneuploid genome that acquires 
many focal amplifications and deletions of cancer genes including KRAS, 
EFNA5 and COL4A5. Additionally, we observed a rare subpopulation of 
diploid cells that contain single random amplifications and deletions that are 
not present in the major aneuploid subpopulations and perhaps represent an 
unstable precursor. Our data strongly support the polyclonal evolution 
model for tumor progression, in which the majority of tumor cells continue 
proliferate and undergo clonal expansions to form the mass of the tumor. 
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APPROACHING A COMPREHENSIVE VIEW OF CANCER GENOMES  
 
Li Ding, Ken Chen, Michael D. McLellan, David E. Larson, Christopher C. 
Harris, Daniel Koboldt, Nathan Dees, Dong Shen, David Dooling, John 
Wallis, Sean McGrath, Todd Wylie, Kim Delehaunty, Lisa Cook, Vincent 
Magrini, Rachel M. Abbott, Lucinda L. Fulton, Robert S. Fulton, George 
Weinstock, Matthew J. Ellis, Timothy J. Ley, Elaine R. Mardis, and 
Richard K. Wilson 
 
The Genome Center at Washington University School of Medicine, 4444 
Forest Park Blvd., St. Louis MO 63108. 
 
Massively parallel DNA sequencing technologies provide an unprecedented 
ability to characterize entire genomes, in an unbiased manner, for genetic 
changes associated with tumor initiation, growth, and metastasis. Building 
upon our large collection of data from acute myeloid leukemia, 
glioblastoma multiforme, breast cancer, lung adenocarcinoma, and serous 
cystadenocarcinoma, we have developed a set of high throughput software 
solutions for discovering and analyzing a wide range of variation types, 
both in individual and in a population of cancer genomes. Algorithmic 
approaches we developed to perform structural variation analysis of paired 
end reads, coupled with a targeted capture-based validation strategy, have 
identified a multitude of such sites in these tumor genomes. This large data 
set also allowed us to perform a comparative analysis of different tumor 
types aimed at identifying cancer type-specific mutational profiles, rates, 
and spectra. Furthermore, the comparison between primary tumor and 
metastasis in breast cancer, as well as between de novo tumor and relapse in 
acute myeloid leukemia, identified genetic changes associated with tumor 
growth, relapse, and metastasis. The differential mutation frequencies and 
structural variation patterns between primary and metastatic breast tumors 
suggest that metastatic tumors may arise from minor subpopulations of cells 
within the primary. On the other hand, the comparison between de novo 
tumor and relapse revealed clonal characteristics of acute myeloid leukemia.  
 6 
EVOLUTION OF THE POPULATION OF CANCEROUS CELLS IN A 
HEPATOCELLULAR CARCINOMA PATIENT 
 
Xuemei Lu*1, Weiwei Zhai*1, Jue Ruan*1, Yong Tao1, Yu Wang1, Jun Cai1, 
Shaoping Ling1, Shiou-Hwei Yeh2, Pei-Jer Chen2, Chung-I Wu1  
 
1Beijing Institute of Genomics, Chinese Academy of Sciences, 7 
Beitucheng Xilu, Beijing, 100029, China, 2National Taiwan University 
Medical College, Graduate Institute, 1 Jen-Ai Rd., Taipei, 10617, Taiwan 
 
“... natural selection as a force for the good maintains the fittest in a species. 
But when we turn to the competition between the individual cells within a 
single animal, … natural selection has now become a liability. ” All cancers 
are caused by somatic mutations in the population of cells. The cancer-
causing mutations (the drivers) can be inferred by functionality or by the 
signature of natural selection. Here we adopted the approach of population 
genetics in searching for advantageous mutations in natural populations to 
identify the mutations that drive tumor cells to proliferate. We collected 
primary hepatocellular tumor (T0) and its six adjacent normal liver tissue 
(N1…N6), two recurrent tumors (RC1 and RC2) which emerged 15 months 
after the operation to the T0, and the RC1’s adjacent normal tissue (N0) 
from a hepatocellular carcinoma (HCC) patient . We have sequenced the 
genomes of N0 and RC1 with AB SOLiD and Illumina GAII to identify 
SNP, CNV and SV, providing the first whole genome analysis of somatic 
mutations, for HCC. Tumor and normal specific SNPs called from whole 
genomic short-read sequencing were genotyped for all those samples 
mentioned above with Sequenom and PCR sequencing. The patterns of 
somatic mutations indicate that tumors are highly clonal even with respect 
to aneuploidy generation, whereas normal tissues may generally lack 
clonality. RC2 is somewhat distinct. The two mutations and Δ5q occurred 
in T0 and RC1 after their separation from RC2, associating with the “faster” 
proliferation. It also suggests that metastasis happened during different 
phases of tumor evolution. Several cancer suppresser genes are in the region 
of Δ5q which is the more likely candidate for “driver mutation”. Most of 
SNVs exist in the region with partial ploidy. Partial aneuploidy contributes 
to genetic diversity, enabling natural selection. 
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CHIP-SEQ REVEALS EVOLUTIONARILY HIDDEN HEART 
ENHANCERS 
 
Axel Visel1,2, Matthew J Blow1,2, Bing Ren3, Brian L Black4, Edward M 
Rubin1,2, Len A Pennacchio1,2  
 
1Lawrence Berkeley National Laboratory, Genomics Division, 1 Cyclotron 
Road, Berkeley, CA, 94720, 2U.S. Department of Energy Joint Genome 
Institute, Genetic Analysis, 2800 Mitchell Drive, Walnut Creek, CA, 94598, 
3University of California San Diego School of Medicine, Ludwig Institute 
for Cancer Research, 9500 Gilman Drive, La Jolla, CA, 92093, 4 University 
of California San Francisco, Cardiovascular Research Institute and 
Department of Biochemistry and Biophysics, 600 16th Street, San 
Francisco, CA, 94158 
 
The success of enhancer prediction by extreme non-coding sequence 
conservation across vertebrate species varies depending upon the tissue 
being studied. Conservation-based screens of the human genome have 
identified a 20-fold larger number of developmental forebrain enhancers 
than developmental heart enhancers. This puzzling discrepancy suggests 
either a relative paucity of heart enhancers compared to other tissues, or the 
failure of evolutionary constraint to identify them. To explore this question, 
we used ChIP-seq with the enhancer-associated protein p300 from mouse 
embryonic heart and forebrain tissues. This conservation-independent 
strategy for discovery of in vivo enhancers identified several thousand 
candidate sequences for both heart and forebrain. In striking contrast to 
forebrain, candidate heart enhancers were under substantially relaxed 
evolutionary sequence constraint. Only 6% of predicted heart enhancers 
were highly constrained (phastCons scores >600) compared to 44% in 
forebrain. Conversely, a substantial proportion (24%) of predicted heart 
enhancers was under no detectable sequence constraint, compared to a 
seven-fold smaller fraction (3.5%) in forebrain. To test if these ChIP-seq 
predictions represent bona fide enhancers despite the absence of sequence 
constraint, we tested more than 130 heart candidate regions with high, 
moderate, weak or no sequence constraint in a transgenic mouse assay. 
More than 60% of candidate sequences were reproducible in vivo enhancers 
active in the heart and, importantly, no significant difference in success rate 
was observed between the four constraint bins. The large, previously 
concealed population of poorly conserved heart enhancers identified in this 
study highlights the strengths of epigenomic strategies for discovery of in 
vivo enhancers and provides evidence for marked global disparities in 
evolutionary constraint between enhancers involved in different biological 
processes. 
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CHARACTERIZATION OF 1000 BREAST CANCER GENOMES AND 
TRANSCRIPTOMES 
 
Christina Curtis*1,2, Suet-Feung Chin*1,2, Sohrab Shah*3, METABRIC 
Consortium1,2,3,4, Simon Tavaré1,2, Samuel Aparicio3, Carlos Caldas1,2  
 
1University of Cambridge, Oncology, Hills Road, Cambridge, CB2 2XZ, 
United Kingdom, 2Cancer Research UK, Cambridge Research Institute, 
Robinson Way, Cambridge, CB2 0RE, United Kingdom, 3British Columbia 
Cancer Research Agency, Molecular Oncology, 675 W10th Avenue, 
Vancouver, V5Z 1L3, Canada, 4 University of Nottingham, Histopathology, 
Hucknall Road, Nottingham, NG5 1PB, United Kingdom 
 
Breast cancer is driven by the acquisition of key genetic aberrations that 
confer clonal growth advantages. The identification of recurrent genomic 
alterations that impact gene expression can facilitate the elucidation of such 
‘driver’ events. Given the substantial inter-individual variability of 
clinicopathological characteristics amongst breast cancer patients, genome-
wide measurements of multiple data types combined with clinical variables 
provide an invaluable resource to dissect the complexity of this disease. 
Here we describe an integrated analysis of copy-number, allelic-ratios, and 
gene-expression for 1000 primary tumors aimed at further characterizing 
the genomic and transcriptional landscape of breast cancer. 
 
High-density Affymetrix SNP 6.0 arrays were employed to assay allele-
specific and total copy number on 1000 fresh frozen tumors with a 
minimum of 5 years clinical history. Matched RNA from 824 samples was 
hybridized to Illumina HT-12 arrays for gene-expression analysis. 
Additional orthogonal data includes deep sequencing of a subset of cases to 
survey the mutational spectrum of critical cancer loci. 
 
Through the joint analysis of diverse data types, which reflect alterations at 
both the DNA and mRNA level, we identified novel breast cancer subtypes 
with distinct clinical outcomes. We further characterized the genomic and 
transcriptional landscape of breast cancer in terms of focal alterations, 
preferential allelic amplification, and ploidy. By identifying both cis and 
trans-acting copy number alterations, we have generated a systematic 
overview of pathway disruption amongst subtypes suggesting novel targets 
for therapeutic agents in specific patient sub-populations. 
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LOSS-OF-FUNCTION MUTATIONS IN HEALTHY HUMAN 
GENOMES: IMPLICATIONS FOR CLINICAL GENOME 
SEQUENCING 
 
Daniel G MacArthur1, Suganthi Balasubramanian2, Ni Huang1, Adam 
Frankish1, Zhang Zhengdong2, Lukas Habegger2, Xinmeng Mu2, Matthew 
Bainbridge3, Bryndis Yngvadottir1, 1000 Genomes Consortium1, Jennifer 
Harrow1, Richard A Gibbs3, Matthew E Hurles1, Mark B Gerstein2, Chris 
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1Wellcome Trust Sanger Institute, various departments, Genome Campus, 
Hinxton, CB10 1SA, United Kingdom, 2Yale University, Gerstein Lab, 266 
Whitney Ave, New Haven, CT, 06520, 3Baylor College of Medicine, 
Molecular and Human Genetics, Baylor Plaza, Houston, TX, 77030 
 
For the clinical benefits of high-throughput sequencing technologies to be 
fully realised it must be possible to distinguish medically relevant genetic 
variants from benign polymorphisms in individual human genomes. 
 
Here we present a comprehensive analysis of common variants predicted to 
severely affect gene function, using data from all three pilots of the 1000 
Genomes Project (low-coverage sequencing of ~180 individuals, high-
coverage sequencing of six individuals and sequencing of ~1,000 genes in 
over 600 individuals), including all nonsense and splice site-disrupting 
SNPs, frame-shift-inducing indels and structural variants predicted to 
disrupt one or more protein-coding exons. 
 
We show that the number of predicted loss-of-function (LOF) variants in 
putatively healthy individuals is surprisingly high. These variants are highly 
enriched for artefacts - thus providing sensitive indicators of sequencing 
and annotation quality - but display a frequency spectrum suggesting many 
are mildly deleterious to human health. 
 
We present catalogues of LOF variants and LOF-tolerant genes for use in 
distinguishing between benign and pathogenic variants in clinical genome 
sequencing. We also demonstrate profound differences in functional, 
evolutionary, expression and interaction properties of LOF-containing 
genes and genes implicated in severe Mendelian disease, allowing 
prioritisation of novel variants for functional follow-up. 
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Expression levels of many human genes are under genetic control. Such 
genes, known us expression quantitative trait loci (eQTLs), have been 
identified by their association to cis-acting variants – in most cases single 
nucleotide polymorphisms. It is presumed that the associated genetic 
variants, or variants in linkage disequilibrium with the marker SNP, exert 
control over the expression levels of the gene. However, to date few actual 
causative variants have been identified. Two competing hypothesis 
postulate either control at the level of transcription, or post-transcriptionally 
at the level of mRNA stability. Here we use ultra-deep mRNA sequencing 
to investigate the mechanisms underlying eQTLs by focusing on deep 
coverage – over 200 million sequence tags - of two fully sequenced 
HapMap samples. Our RNA preparation method allows us to extract 
information from both exonic (mRNA) and intronic (pre-mRNA) 
sequences. For a set of highly confident eQTLs, we find that there is a very 
high correlation between the levels of mature and unprocessed RNA, 
implying that 80% of eQTL variance can be explained by genetic control at 
the level of transcription. To explain the remaining 20% of the variance, we 
focus on the outliers which exhibit discordant mRNA and pre-mRNA 
expression patterns. We find dozens of SNPs affecting splicing patterns 
within genes, many of which in turn affect the overall RNA levels. We 
observe three predominant mechanisms of action: 1) SNPs that affect the 
usage of existing splice sites leading to alternative splice site choices, likely 
resulting in non-sense mediated decay, 2) SNPs activating the usage of 
pseudoexons and resulting in premature stop codons, 3) SNPs altering 
splicing within the 5’UTRs, likely affecting the stability of the resulting 
mRNA. We focus in detail on four examples, OAS1, MRPL43, MMAB, 
and USMG5 to illustrate and dissect the exact downstream effects of the 
causative genetic variants. 
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Genome wide association studies have revealed hundreds of bona fide, 
replicable regions associated with dozens of complex diseases and traits. 
These studies are explicitly designed to discover associations to common 
polymorphisms, almost always of weak effect. Thus far they explain only a 
small fraction of the total heritability of complex disease. A great deal of 
recent attention has focused on explaining this "missing heritability", 
including a recent suggestion that "synthetic associations" generated by 
many rare variants of high penetrance within a few megabases of common 
alleles are actually responsible for the signals observed in GWAS. 
While this scenario is plausible, we believe it is likely to be uncommon for 
several reasons:  
 
a) Rare variants of large effect – those most likely to yield synthetic 
associations - can be readily detected by well-powered linkage scans. We 
substantiate this argument with power calculations and highlight an 
example from the literature: the NOD2 susceptibility locus for Crohn’s 
disease. This locus exemplifies the synthetic association hypothesis, at 
which three rare, highly penetrant mutations fully explain the observed 
association to nearby common variants; as our power calculations predict, it 
is one of the few complex disease genes mapped by linkage. 
 
b) We describe why the empirical evidence (sickle cell disease and 
syndromic hearing loss) provided in support of synthetic associations is not 
appropriate for common complex traits and highlight reasons why it is 
incorrect to extrapolate to traits with an underlying polygenic genetic 
architecture. Briefly, both these loci contain rare variants that explain a 
significant proportion of the phenotypic variance (100% and 50% 
respectively) and such loci do not exist in common complex traits 
(otherwise they would have been detected using linkage analysis, as indeed 
HBB and GJB2/GJB6 were).  
 
c) Finally, we discuss published resequencing efforts, in which very little 
evidence has been unearthed pointing toward rare variants explaining 
signals from GWAS. 
 
We believe the consideration of these wider lines of evidence support the 
conclusion that synthetic associations explain very few GWAS signals. 
 12 
A SCALABLE CLASS OF MULTIPLE LOCUS METHODS FOR 
GENOME-WIDE ASSOCIATION STUDIES 
 
Gabriel Hoffman1, Benjamin Logsdon1, Chuan Gao1, Abra Brisbin1, Jason 
Mezey1,2  
 
1Cornell University, Biological Statistics and Computational Biology, 
Biotechnology Building, Ithaca, NY, 14853, 2Weill Cornell Medical 
College, Genetic Medicine, 1305 York Ave, New York, NY, 10065 
 
All corroborated disease loci that have been discovered in genome-wide 
association studies (GWAS) were identified by independently analyzing 
each genetic marker in a study. While the success of individual marker 
analysis is unequivocal, it is well appreciated that multiple locus algorithms 
can have better performance, particularly in the identification of weaker 
associations due to small locus effects, weak linkage, or low minor allele 
frequencies. Yet, computational limitations and concerns about performance 
on large datasets have prevented widespread application of these methods 
by practitioners of GWAS. To address these concerns, we have developed a 
highly scalable class of multiple locus algorithms for simultaneous analysis 
of all markers in a GWAS, and we have undertaken an extensive simulation 
and data analysis assessment of algorithm performance. The foundation of 
our family of methods is a penalized generalized linear model (GLM) that 
provides great versatility for analyzing case/control and continuous 
phenotypes, and allows the incorporation of covariates. We have 
implemented a range of theoretically well-founded penalties, including 
standard (i.e. lasso, ridge, SCAD) and non-standard (i.e. mixture) 
approaches. We have also incorporated random covariate and related 
techniques to increase mapping power in the presence of missing latent 
covariates. In order to scale these methods to massive GWAS datasets we 
have implemented coordinate-wise gradient descent algorithms for 
likelihood analysis and variational Bayes algorithms for approximate 
Bayesian analysis. Our algorithms scale extremely well and are typically 
able to complete an analysis of a GWAS that included a thousand samples 
and one-million markers in less than 24 hours on a standard desktop (with 
large memory capacity). Through our simulations, we have identified broad 
conditions under which different penalties perform better. Through our 
analysis of available GWAS data for a number of diseases, we demonstrate 
that our algorithms identify additional high-confidence “hits” when 
compared to individual marker analysis. 
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Genome-wide association studies of asthma have identified only a small 
proportion of the heritability, similar to other common diseases. In this 
study we sequenced the coding exons and flanking sequences of 9 asthma 
candidate genes to assess the role of rare variants in asthma risk. We 
selected genes that were previously associated with asthma and showed 
signatures of purifying selection for resequencing studies in 513 asthma 
cases and 515 controls. In European Americans, individual rare (<5%) 
variants in 4 genes were enriched in asthma cases compared to controls, 
whereas no individual variants were enriched in African American cases. 
The largest number of associated variants was in the CFTR gene, in which 7 
alleles were significantly enriched in the cases compared to controls: 3 had 
frequencies of 3-6% in cases and were absent in controls (p= 0.0003 - 1.5 x 
10-7) and 4 had frequencies 4-5% in cases and <1% in controls (p= 0.0008 - 
1.9 x 10-5). One associated variant in CFTR as nonsynonymous and 6 were 
noncoding (intronic); odds ratios ranged from 8.8 to >12.7. None of the 
associated variants are known cystic fibrosis mutations, suggesting that 
highly penetrant, noncoding rare variation in the CFTR gene specifically 
affects asthma risk. Our study further supports the hypothesis that a 
significant proportion of the heritability of asthma is due to rare variation. 
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Genome-wide association studies have been very successful for 
autoimmune (AI) diseases such as type 1 diabetes (T1D) and Crohn's 
disease (CD), identifying over 80 associated loci. Some of these findings 
implicate novel biological pathways, generating hypotheses about how 
these may be shared by AI disorders.  
 
Joint association analysis of AI diseases using raw data may improve power 
to detect loci shared between diseases. However, any method must allow for 
heterogeneity in disease-variant associations at both the phenotypic and 
genotypic levels. Although a number of shared loci have been discovered, 
allelic heterogeneity exists. For example, the tryptophan variant of R602W 
in PTPN22 is associated with increased risk of T1D and rheumatoid arthritis 
(RA), but reduced risk of CD. Additionally a single locus may be associated 
with multiple AI phenotypes but the causal SNP may differ. For example, 
different SNPs at the IL2RA locus are associated with RA, multiple 
sclerosis and T1D.  
 
No method deals with all these issues. We address the problem using an 
elastic net within a multinomial logistic regression framework to conduct 
gene-based tests of association. This method selects SNPs within a region 
that jointly provide the strongest evidence for association to a set of 
diseases, but explicitly allows for heterogeneity on both sides of the 
disease-locus association.  
 
We compare our method to other strategies for gene-based association using 
binary or multinomial logistic regression models. In scenarios where a 
single causal SNP is associated with two diseases the power of this method 
is very close to that of multinomial logistic regression analyses of each 
SNP, adjusting for multiple testing (generally the most powerful strategy). 
With more than one causal SNP, the multinomial elastic net is more 
powerful than any other analytical strategy, even if each causal SNP is only 
associated with a single disease. This new method thus utilises the increase 
in power provided by combining disease samples without compromising the 
ability to identify variants that are only associated with some traits, or 
which show opposite directions of association with different diseases. 
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The Drosophila Genetic Reference Panel is a community resource of 192 
sequenced inbred Drosophila melanogaster lines with measured 
quantitative traits. Forty lines have been sequenced to a minimum of 12X 
coverage using both 454 and Illumina sequencing platforms. The remaining 
152 lines are being sequenced using the Illumina platform. Alignments have 
been generated using BWA, and polymorphisms identified using Atlas 
SNP2. We find approximately 500,000 SNPs, and 50,000 indels per inbred 
line, relative to the reference sequence. Extensive quality control 
genotyping has ensured both sequence and strain sample integrity, matching 
and true homozygosity for all of the lines. Lines with excess heterozygosity 
have been replaced to optimize the power of association studies. 
 
Initial whole genome association analyses have identified between 20-100 
polymorphisms associated with complex traits with p-values of 10-5 or less. 
Interestingly, most of these genes are novel, and many have pleiotropic 
effects on multiple traits. Thus, we believe this tool will provide a new 
understanding of Drosophila genetics, complementary to the large body of 
work based on induced mutational screens. We also present multiple 
methods for the validation of associations. 
 
As a community resource we are working to facilitate the use of the 
reference panel in as many settings as possible. The fly stocks are currently 
available from the Bloomington Drosophila Stock Center. We are also 
preparing a website for genome wide associations allowing input of 
phenotypes measured on the lines, and outputting associated 
polymorphisms and p-values. We hope this web tool will allow any 
Drosophila geneticist with the ability to work on flies to utilize the 
reference panel – even high school students counting bristles. 
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Understanding the molecular basis of complex traits is a major challenge 
facing modern geneticists. By mapping Quantitative Trait Loci (QTL) much 
progress has been made in understanding the genetic basis of complex 
traits. In contrast, our understanding of the molecular basis of these traits 
lags far behind. Advancing this field requires understanding the molecular 
mechanisms through which causal polymorphisms exert their effects on 
phenotype. Using the yeast S. cerevisiae as a model system, we showed that 
variation in sporulation efficiency between two natural isolates is due, 
almost entirely, to four polymorphisms that reside in three transcription 
factors (TFs), IME1, RME1, and RSF1. The causative variants are both 
coding (in IME1 and RSF1) and non-coding (in the promoters of IME1 and 
RME1). Genetic interactions (epistasis) between these TF loci explain 87% 
of the phenotypic variation in this trait. To better understand the molecular 
mechanisms that underlie these genetic interactions we constructed a 
thermodynamic model of natural variation in sporulation efficiency. The 
model, which incorporates the non-linear biochemical reactions that 
underlie genetic interactions, suggests a general molecular mechanism that 
generates epistasis between polymorphisms. The model produces testable 
hypotheses about the concentrations and affinities of specific molecular 
species in different genetic backgrounds. Our first experimental test of this 
model suggests that we are indeed capturing many of the salient features 
that underlie genetic interactions. We anticipate that this biophysical 
framework for modeling genetic variation will be a useful tool for 
understanding the molecular basis of complex traits. Our results also point 
to variation in transcription factors as a major source of phenotypic 
diversity within species. 
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The effects of environmental perturbation on cis-eQTLs are unknown. 
Using 100 primary human osteoblasts from Swedish donors and following 
culture in either standard conditions or after induction with BMP-2, 
dexamethasone (DEX), and PGE2 we collected expression data (Illumina 
Ref-8) and correlated expression levels to SNP data. Only ~1.4% of the cis-
eQTLs showed treatment-specificity at high confidence. However, in 
follow-up analysis by direct measurement of cis-variation using genome-
wide allelic expression (AE) tests (NG 2009;41:1216) most treatment-
specific effects failed to validate. DEX-specific cis-variants in the MYO6 
and TNC loci could be fine-mapped to putative distal regulatory elements. 
Strong interaction between treatment and cis-variation appear rare and 
detection of such requires allelic expression studies.  
We are now applying the genome-wide AE test for specific discovery of 
functional variants underlying differences in drug response using resting 
and stimulated Lymphoblastoid Cell Lines (LCL) from asthmatic children 
included in the Childhood Asthma Management Program (CAMP). CAMP 
includes children who demonstrate variability in clinical response to 
corticosteroids. We analyzed LCLs from patients representing extremes of 
response and observed allelic variation at different doses and timepoints 
upon DEX stimulation. Preliminary data analysis indicates up to 30 
transcripts with DEX-specific allelic cis-regulation. Most effects are 
detected at 4h timepoint and some show dose response, suggesting direct 
treatment-specific interactions. We focus now on comparing differences in 
DEX-specific cis-regulation among cell lines derived from patients with 
varying clinical response and mapping cis-regulatory variants underlying 
DEX-specificity. Our approach can be generically applied for isolation of 
pharmacogenetic variants. 
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The development of high-throughput sequencing technologies has made it 
feasible to sequence whole human genomes at a fraction of the cost and 
time than was previously possible. This ability can be leveraged to routinely 
use whole-genome sequencing as a clinical diagnosis tool. With this 
objective, we present here results from analysis of a clinical sample that was 
sequenced using both the Illumina GAIIx and HiSeq 2000 instruments.  
 
With 100bp paired-end reads aligned to the reference genome, we were able 
achieve more than 75x coverage from two flowcells on the HiSeq 2000 
platform and 35x coverage from two flowcells on the GAIIx platform, 
giving us a total coverage of more than 100x. Using bioinformatics 
algorithms, genotype calls were made to detect single nucleotide variants 
(SNVs) across the whole genome. We compared calls made from the two 
different datasets to genotype calls made on an array-based technology. In 
addition, we used these datasets to address what coverage is required to 
attain a certain level of comprehensiveness and accuracy, allowing us to 
make an informative decision about the depth of coverage needed for future 
whole-genome sequencing endeavors. 
 
To tackle biological questions, SNVs were subjected to further analysis, 
including identification of synonymous and non-synonymous base changes. 
In addition, positions identified as variants were evaluated for their potential 
to dramatically change DNA structure and for their overlap with 
evolutionarily constrained regions. This helps us prioritize non-coding 
variants for their potential to be biologically important. Finally, 
identification of copy number variations and gross rearrangements of the 
genome are also providing insights into the nature of disease. 
 
These results will help better develop methodologies to provide a confident 
approach in solving clinical cases where the underlying disease mechanism 
remains unknown. 
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We compiled a genome-wide set of over a million insertions and deletions 
ranging from 1 to 50 nucleotides in the 1000 Genomes Project pilot 1 data 
set using the novel Bayesian method Dindel. The main idea is to consider 
candidate indels and other sequence variants obtained from different 
approaches such as read-mappers and assembly-based methods, and then 
evaluate support for these candidates by performing a Bayesian gapped 
realignment of reads to a set of haplotypes potentially segregating in the 
population. We use a Bayesian EM caller to estimate allele frequencies and 
posteriors. 
 
We observed that the rate of indels due to sequencing errors is as high as 
1% in long homonucleotide runs, and that ~10 % of the called indels 
occurred in these. We explicitly account for these context-specific error 
rates in the realignment. 
 
The method successfully identified all capillary-validated indels in a 3.8 kb 
region from a candidate gene study in 96 individuals without false-positives 
on artificially downsampled coverage ranging from 10X to 100X. 
 
We identified in total 1.03 M indels in 170 individuals using candidate 
indels generated by various methods. Deletions were more common than 
insertions, noting that there is better power to detect deletions. The length 
distribution of indels did not differ between populations. YRI had ~3 times 
more private indels than CEU and JPT/CHB. We called ~1400 indels in 
CCDS coding regions; 60% resulted in a frame shift, although 3n-indels 
were strongly overrepresented relative to non-coding regions. In each 
population the non-reference allele frequency distribution of frame-shift 
indels was shifted towards zero compared to that of in-frame indels. 
 
Genotypes appear to be highly consistent with the local genealogy 
independently estimated from HapMap3 haplotypes. This suggests that 
most indels are amenable to imputation for disease association testing. 
Validation of a subset of the predicted indels is currently in progress. 
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The genetic basis of animal domestication is currently not well understood. 
Which genes were important when humans converted wild into domestic 
animals, and which genes differ today in their structure or expression 
between domestic animals and their wild relatives? A promising approach is 
to study gene expression differences between domestic and wild animals. 
Current next-generation sequencing technologies allow transcriptome 
analyses in non-model species that are difficult to study with microarray-
based gene expression measurements. 
To learn more about functional genetic differences between domestic and 
wild animals, we have used Illumina sequencing to analyze mRNA from the 
brains of several pairs of domestic and wild species: pigs, rabbits, Guinea 
pigs and dogs/wolves. We compare these data to those from a long-running 
selection experiment for tameness and aggression in rats. Analyses are 
underway to study the impact of domestication and artificial selection on 
gene expression levels, transcript structure and sequence polymorphism in 
expressed transcripts. 
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Models of mammalian regulatory networks controlling gene expression 
have been inferred from genomic data, yet have largely not been validated. 
We present an unbiased strategy to systematically perturb candidate 
regulators and monitor cellular transcriptional responses. We apply this 
approach to derive regulatory networks that control the transcriptional 
response of mouse primary dendritic cells (DCs) to pathogens. Our 
approach revealed the regulatory functions of 125 transcription factors, 
chromatin modifiers, and RNA binding proteins and constructed a network 
model consisting of two dozen core regulators and 76 fine-tuners that help 
explain how pathogen-sensing pathways achieve specificity. This study 
establishes a broadly-applicable, comprehensive and unbiased approach to 
reveal the wiring and functions of a regulatory network controlling a major 
transcriptional response in primary mammalian cells. 
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While the abundance of completely sequenced genomes has greatly 
facilitated our understanding of regional heterogeneity in rates of individual 
mutation types, the co-variation in rates of multiple mutation types has 
remained largely unexplored, hindering a deeper understanding of 
mutagenesis. In this study, we used linear and non-linear multivariate 
analysis tools to explore rate co-variation among four mutation types, and 
associate it to multiple genomic features simultaneously. We observed a 
concordant and largely linear co-variation among rates of nucleotide 
substitutions, small insertions and small deletions. In contrast, microsatellite 
mutability did not display co-variation with any of the other three rates 
studied. GC content, distance to telomere, and local recombination rates 
were found to be significant predictors of mutation rate co-variation, 
corroborating the role of these features as predictors of mutagenesis. Our 
analysis also uncovered the significance of novel genomic predictors of 
mutation rate co-variation; namely, nuclear lamina binding regions and 
methylated non-CpG sites. Thus, co-variation in the rates of different 
mutation rates might be explained by shared local genomic landscapes. 
Interestingly, we observed strong non-linearities among the genomic 
predictors explaining co-variation in mutation rates. The genomic loci 
driving these non-linear behaviors are located either on chromosome X or at 
a certain distance to telomeres, suggesting unique environments in these 
portions of the genome. Based on the role of various genomic predictors, 
we speculate about the importance of different molecular mechanisms (e.g., 
replication and recombination) in generating mutations. Importantly, our 
multivariate analysis approach can provide improved background 
corrections for computational methods that identify potentially functional 
regions of a genome – these corrections would employ composite scores, 
encompassing rates of multiple mutation types simultaneously. 
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Virus infections cause many of the largest health problems in the world. It 
is likely that there is a multitude of unknown viruses that infect humans and 
it is has been suggested that viruses are involved in causing many common 
diseases, such as diabetes and MS. The discovery rate of new viruses has 
until now been slow. Deep sequencing methods have made it possible to 
more efficiently characterize human viruses. Our strategy includes 
enrichment of virus particles, 454 shotgun sequencing and bioinformatics 
analyses. We have sequenced pooled samples from the respiratory tract, 
serum, feces and other body fluids, from different patient groups, including 
people with common infection symptoms, different autoimmune disorders, 
and other diseases. In addition, several tumor samples have been sequenced. 
The results have revealed the presence of a multitude of known viruses, new 
virus strains and new virus species. Two new human viruses, Human 
Bocavirus and KI Polyomavirus have been published.  
I will present the analysis of the sequence data accumulated thus far (10 
libraries sequenced by 454)and a broader description of the known and 
novel viruses, bacterial, phage and human sequences found. The results of 
deeper analyses of variable virus families, including TTV and 
picornaviruses, where a multitude of new variants have been found, will be 
shown, as well as descriptions of which viruses are present in specific 
patient groups. 
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Domestic animals are excellent models for genetic studies of phenotypic 
evolution. They have evolved genetic adaptations to a new environment, the 
farm, and have been subjected to strong human-driven selection leading to 
remarkable phenotypic changes in morphology, physiology and behaviour. 
Here we have used massively parallel sequencing to identify selective 
sweeps of favourable alleles as well as candidate mutations that have played 
a prominent role during chicken domestication and subsequent 
specialization into broiler (meat-producing) and layer (egg-producing) 
chickens. We have generated 44.5x coverage of the chicken genome using 
pools of genomic DNA representing eight different populations of domestic 
chickens as well as red junglefowl, the major wild ancestor. We report more 
than seven million SNPs, about 1,300 deletions and a number of putative 
selective sweeps. One of the most striking selective sweeps found in all 
domestic chickens occurred at the locus for thyroid stimulating hormone 
receptor (TSHR), which has a pivotal role for metabolic regulation and 
photoperiod control of reproduction in vertebrates. Several of the selective 
sweeps detected in broilers overlapped genes associated with growth, 
appetite and metabolic regulation. We found little evidence that selection 
for loss-of-function mutations played a prominent role during chicken 
domestication, but we detected two deletions in coding sequences that we 
suggest are functionally important. This study has direct application to 
animal breeding and enhances the importance of the domestic chicken as a 
model organism for biomedical research. 
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In population-scale genome sequencing a common experimental design is to 
sequence a large number of individuals at low coverage (4-6X). Such a 
design is powerful for discovery of novel genetic variants in the population, 
but can be problematic for population genetic studies as accurate genotypes 
cannot be obtained without the use of LD and imputation, which has the 
potential to bias results and which typically requires populations to be 
analyzed independently. 
 
For these reasons, we have developed methodology for estimating 
population genetic parameters, including the level of diversity, the site-
frequency spectrum and the degree of differentiation between populations 
that analyses multiple populations simultaneously, incorporates uncertainty 
arising from sequence data and does not rely on imputation. Specifically, 
the method integrates over the uncertainty in the data at each site in the 
sample, combining population genetics modeling with machine-generated 
estimates of base quality to calculate the likelihood of key parameters. The 
method is validated through analysis of sequence data from the 1000 
Genomes Project where independent genotypes are available from the 
HapMap project. We compare the method to estimates from genotypes 
inferred through imputation and describe the results of applying the 
methodology to population-scale genome-sequencing data sets in humans 
and other species. 
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Although acute lymphoblastic leukemia (ALL) is the most common 
childhood cancer, factors governing susceptibility to this disease have not 
yet been identified. Little is known about the molecular basis of childhood 
ALL, although the clinical, pathological, and immunophenotypic features 
have been well documented. Here we sequenced the entire exomes of tumor 
(malignant) tissue, healthy tissue from the same individual, and from 
parents (quartet) from sets of leukemia patients/families (n=30) which either 
1) carry a translocation, 2) the disease phenotype is associated with 
hyperdiploidy or 3) that do not have known genomic alterations. We also 
sequenced the full genome of tumor tissue and healthy tissue of an ALL 
family with two siblings having ALL with different ages of onset. A set of 
controls includes sequencing a set of twin families to obtain a background 
rate of de novo somatic and germ-line mutations where we demonstrate a 
clear excess of somatic mutations in our ALL families. Our approach 
involves making de novo mutation calls with a probabilistic framework that 
makes use of the relatedness between the individuals, including different 
tissue types, and produces a joint probability for the entire pedigree for each 
site. By dependently rather than independently determining the family 
members’ genotypes, we take full advantage of the information contained 
within the pedigree. Our framework includes the implementation of an 
Expectation-Maximization algorithm to simultaneously produce direct 
estimates for the de novo point mutation rate, the population mutation rate 
(μ), and the sequencing error rate. We obtained a full catalogue of both 
germ-line and somatic de novo mutations many of which occur in coding 
regions of known genes associated with various cancers, indicating 
potential driver mutations of cancer. We have also catalogued a number of 
driver and passenger mutations with high predictive phenotypic impact. 
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We have compared the genetic makeup of North Swedish trotters (NST), 
North Swedish horses (NS) and Standardbreds (S) by performing a genome 
scan using 144 microsatellite markers (10 individuals/breed) and the 
Illumina EquineSNP50 BeadChip (12 individuals/breed). The total 
genotyping rate in individuals analyzed on the BeadChip was 0.982. 17 887 
SNPs had a MAF < 0.1 and 1331 SNPs failed the missingness test (>0.1). In 
total 36 415 SNPs remained after frequency and genotype pruning. The 
three breeds separated into three distinct clusters in the identity by state 
(IBS) cluster analysis. All analyses above were preformed in the software 
PLINK.  
 
In the microsatellite data set, the average number of alleles per locus was 
highest for the NS, 4.75, which also showed the highest expected 
heterozygosity, He, 0.666. The S showed the lowest He, 0.627, and also the 
lowest average number of alleles per locus, 4.40. The NST had a He of 
0.649 and 4.53 as average number of alleles per locus. Following this the 
NS also showed the highest observed heterozygosity, Ho, 0.709. Contrary 
to He, however, the S showed the second highest Ho, 0.699, and the NST 
showed the lowest Ho, 0.692. The rarefied allelic richness average over loci 
was highest for the NS (3.23), and NST (3.17) and lowest for the S (3.02). 
The private allelic richness was highest for the S (0.96) and was 0.89 and 
0.86 for the NS and the NST respectively.  
 
The genetic distance between the NST and the S (0.503) is smaller than 
between the NS and the S (0.524). The genetic distance between the NST 
and the NS was estimated at 0.367. These results support that crossbreeding 
has occurred between the Standardbred and the North Swedish trotter.  
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Next-generation sequencing is now a mainstay for polymorphism/mutation 
discovery, detecting structural or copy number variations, novel transcript 
discovery and counting-based expression analysis, etc. Although pipelines 
for automated analysis exist, manual data review remains essential for 
sequencing software developers (to check program performance), data 
analysts (for spot-checking), and scientists (for hypothesis generation).  
Visualization requires considerable flexibility from viewer software. A 
fully-featured viewer application must support the visualization of 
organismal reference sequence, multiple resequenced samples, and deep-
coverage sequence alignments. Sequences are best evaluated in the context 
of genome annotations such as gene models, regulatory units, repeat 
elements, and genetic variation features. Such annotations must therefore be 
integrated into the viewer.  
Analysis of a growing amount of sequence data currently requires 
specialized expertise and is rapidly becoming a nontrivial bottleneck. The 
needs of smaller biology laboratories can be served if the visualization 
software integrates essential analytical functionality such as PCR primer 
design (e.g. for SNP validation experiments), importing custom annotations, 
and exporting data from specific regions for detailed and focused analysis.  
Gambit is a cross-platform, low-memory, graphical program for sequence 
visualization and analysis. A researcher is able to upload an alignment file 
showing the sequencing data from samples of interest. An overall view of 
the alignment depth along chromosomes is provided. Essential properties of 
sequencing reads (e.g. sample identity, alignment orientation, mismatches 
& indels) are displayed as graphical cues. Views are customizable to 
hide/highlight certain alignment types. 
Gambit takes advantage of the indexing features of the BAM sequence 
alignment format that allows rapid panning and zooming across 
chromosomes, with only minimal startup time, and re-rendering delay. 
Gambit is multi-threaded, handling time-intensive steps “behind the 
scenes”, which keeps the interface responsive. The application is also 
plugin-aware, so that anyone with programming skills can readily include 
their own custom features: support for new file formats, additional metrics, 
or even custom views. A beta version of Gambit is available for download 
at http://code.google.com/p/gambit-viewer . 
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Orangutans (Pongo pygmaeus) are the only living Asian ape and are highly 
endangered. We investigated the mobile DNA composition (mobilome) of 
the orangutan draft genome sequence derived from a female of Sumatran 
origin (Pongo pygmaeus abelii). Similar to other primate genomes, about 
half of the orangutan draft genome sequence is comprised of repetitive 
sequences. As expected, no DNA transposon activity was detected in the 
orangutan lineage. L1 (long interspersed element 1, LINE1) is the only 
active autonomous non-LTR retrotransposon in the orangutan lineage and 
shows a mostly linear evolution. The orangutan-specific L1 lineage appears 
to be derived from L1PA3. SVA elements have been active throughout the 
evolution of orangutans and appear to be currently undergoing 
retrotransposition. Similar to L1, the orangutan-specific SVA subfamilies 
show a mostly linear evolution. We found evidence of expansion of SVA 
and L1, with ~1800 and ~4700 orangutan lineage-specific insertions, 
respectively. This translates to a retrotransposition rate comparable to other 
sequenced primates. In contrast, Alu elements appear to have propagated at 
a very low rate in orangutans. On the basis of computational and wet bench 
analyses, we estimate that the draft genome sequence contains only ~250 
lineage-specific insertions. The identification of polymorphic and 
population-specific Alu insertions indicates that Alu retrotransposition is 
ongoing albeit at an extremely low rate. The quiescence of Alu 
retrotransposition in the orangutan-lineage is particularly surprising, as all 
other primate species studied to date show evidence of an appreciable Alu 
retrotransposition rate. 
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Macrostomum lignano is a free-living flatworm with high regeneration 
capacity facilitated by neoblasts, the stem cell system of the worm. Due to 
its small size, short generation time, amenability to genetic manipulation 
and easy maintenance in laboratory conditions, M. lignano is a promising 
invertebrate experimental model for stem cell research. We have initiated de 
novo genome sequencing of this organism using hybrid 454 and 
Solexa/Illumina approach. The estimated genome size of M. lignano is 600 
Mb. Initial 5x coverage of the genome produced ~300Mb of assembled 
contigs with N50 size of 1.7 kb. While this low-coverage assembly is not 
productive for annotation of protein-coding genes, it is already efficient for 
discovery of microRNAs – small RNAs that regulate gene expression at the 
posttranscriptional level and are involved in various cellular processes, 
including maintenance and differentiation of stem cells. More than 40% of 
the 5.4 million small RNA reads generated by SOLiD technology from 
irradiated (=neoblast-depleted) and non-irradiated worms mapped to the 
assembly and allowed annotation of more than 50 miRNA genes. Levels of 
several miRNAs are significantly decreased in the irradiated worms, 
suggesting neoblast-specific expression of these miRNAs. The progress on 
the genome sequencing and small RNA analysis in M. lignano will be 
presented. 
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Over the course of infection, single stranded RNA viruses such as HIV 
rapidly replicate, mutate, and are selected against by the patient's immune 
system. This process leads to a highly diverse and dynamic viral population, 
and for both clinical and theoretical reasons it is important to be able to 
assay this population accurately. Such an assay would need to be sensitive 
to rare variants that could evade the patient’s immune system and in a short 
period of time become common. 
 
Deep sequencing of patient samples could provide such an assay. Here we 
address a key technical challenge: bona fide rare variation tends to be 
swamped by sequencing error. To maximize the potential to distinguish 
between these two, we developed the appropriate computational model, 
which takes as input base calls along with quality scores, and has no prior 
on the distribution of variants at a given locus. While this model is 
computationally intractable to direct analysis, it can be interrogated using 
sampling, which we do using a Markov Chain Monte Carlo method. 
 
In this way we estimate the abundance of each variant within a given 
sample and provide a confidence interval for each such estimate. We tested 
our method using Illumina sequence from 24 HIV patient samples, and 
assessed the methods using clonal control samples and also by sequencing 
the same samples using a different sequencing technology (454). 
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Cytokinesis is an important and fundamental process in the development of 
all organisms. The factors that establish the cleavage furrow have remained 
mysterious and have eluded many for over 130 years. In order to identify 
factors required for early steps in cytokinesis, mitotic spindles from 
synchronized Chinese Hamster Ovary (CHO) cells were isolated. Proteins 
enriched from isolated metaphase-enriched spindles were identified by 
multidimensional protein identification technology (MudPIT) in 
collaboration with the Yates Lab at Scripps. A comparative genomics 
analysis between the spindle and the midbody proteome (Skop et al., 2004), 
identified potential candidates. 
 
Results from multiple MudPIT data sets identified ~1500 proteins with two 
or more peptide hits. We compiled the spindle proteome by averaging four 
MudPIT data sets. Comparison to the midbody proteome has yielded a list 
of proteins unique to the metaphase spindle. We prioritized our list of 
candidates by sorting metaphase specific proteins, using Babelomics 
(http://babelomics.bioinfo.cipf.es/) and Microsoft Access. We are 
particularly interested in membrane-cytoskeleton remodeling proteins, as 
these factors are likely involved in establishing and regulating the acto-
myosin contractile ring. We are currently screening several homologs of the 
identified mammalian candidates in C. elegans using RNAi. Potential 
candidates include factors that function in furrow formation. We are further 
characterizing candidates using in vivo microscopy, genetics and cell 
biological techniques.  
 
MKB is supported by an NHGRI training grant to the Genomic Sciences 
Training Program (5T32HG002760). The work from the Yates lab is 
supported by the National Center for Research Resources of the National 
Institutes of Health by a grant to T.N.D. entitled 'Comprehensive Biology: 
Exploiting the Yeast Genome,' P41RR11823. A.R.S. is funded by an NSF 
CAREER Award (MCB-0546398). 
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Synthetic genetic interaction analysis has provided key insights by 
highlighting functional relationships between genes on a genome-wide 
scale. Genetic interactions can identify components that are otherwise 
masked due to buffering, dissect complex phenotypes, and circumvent early 
lethality in metazoans. The profile of genetic interactions of a gene with all 
other genes is a sensitive assay for a comprehensive view on its molecular 
functions. We employ high-throughput RNAi approaches to systematically 
identify genetic interactions in cell-based assays using Drosophila as a 
model system.  
 
We developed methods to quantitatively perform, validate and analyze 
double RNAi experiments in a high-throughput format. Phenotypes were 
assessed using automated imaging to simultaneously record cell number and 
evaluate multi-parametric changes. Novel computational approaches, 
including methods for the exclusion of off-target effects, experimental 
fluctuations and robust error estimation were developed in order to build 
multi-dimensional and quantitative maps of genetic interactions based on 
RNAi phenotypes. 
 
We have applied these technologies to construct a genetic interaction map 
of several signal transduction pathways using a matrix of combinatorial 
RNAi experiments in cultured cells. Mathematical modelling of the 
combinatorial perturbations allowed us to reconstruct known molecular 
pathways, to predict novel molecular interactions, and to predict new 
functions of genes that were confirmed by independent biochemical 
experiments. 
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Written into the genome of modern domestic dogs are the genetic footprints 
of the demographic and selective forces underlying their transition from 
gray wolves. However, mtDNA sequencing and SNP genotyping of wolves 
and dog breeds have thus far yielded conflicting accounts of dog origins. 
Village dogs are potentially highly informative for domestication history 
because of their high genetic diversity, their geographic population 
structure, and the small amount of genetic drift since domestication relative 
to breed dogs. We present a novel dataset comprised of 58,000 SNPs in 260 
village dogs, 150 gray wolves, and hundreds of modern and ancient breed 
dogs that reveals strong evidence for a complex domestication history in 
dogs that differs substantially from current theories of a single, recent East 
Asian origin of domestic dogs. 
Principal component analysis uncovers at least four radiations of dogs from 
a central Middle Eastern cluster, including a radiation into sub-Saharan 
Africa, northern Africa, East Asia and the Pacific, and Europe. PCA and 
haplotype sharing patterns between village dogs and wolves show both a 
primary domestication origin in the Middle East and regional introgression 
with sympatric wolf populations. Wolves have significantly less linkage 
disequilibrium than village dogs, consistent with a domestication bottleneck 
shared by breed and village dogs. In contrast, wolves have more IBD tracts 
than village dogs, implying village dogs have subsequently maintained 
higher effective population sizes than wolves. 
Several traits associated with domestication---including body size, fur type 
and floppy ears---show significant variation within or between village dog 
populations. Analysis of known QTLs for these traits in breed dogs reveals 
they account for much of the phenotypic variation of village dogs as well. 
Tracing allele and haplotype sharing patterns between village dog and wolf 
populations around these loci reveals a rich picture of the genetic and 
phenotypic evolution of domestic dogs. 
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Breast cancer is a heterogenous disease, representing a mix of tumors with 
different histologies, expression of biomarkers and gene expression profiles. 
Importantly, expression of biomarkers such as Estrogen Receptor (ER), the 
Progesterone Receptor (PR), or the Human Epidermal Growth Factor 
Receptor 2 (HER2) can determine choices in therapy. Indeed, one of the 
most aggressive classes of breast cancer is defined by the absence of these 
biomarkers; so-called triple negative breast cancer (TNBC) cannot be 
treated by inhibiting hormone receptors or by targeting HER2. To examine 
the genetic basis underlying the different subtypes of breast cancer, we 
sequenced the transcriptomes of eleven ER positive (ER+) breast cancers 
and fifteen TNBCs. In total, we identified over 70,000 allelic variants, many 
of which are presumed to be of germline origin as they commonly occur in 
the human population. However, a smaller fraction of allelic variants we 
identified are not common alleles and are predicted to be deleterious to 
protein function. Genotyping of adjacent normal tissue demonstrate that a 
small fraction of these variants have a somatic origin. These rare, 
deleterious alleles deifferentiate less aggressive ER+ tumors from more 
aggressive triple negative tumors. In contrast, common variants fail to 
segregate the tumor types. Thus, the previously defined clinicopathologic 
subtypes of breast cancer have a common genetic basis that is unique from 
the other subtypes. Dozens of rare, deleterious alleles contribute to each 
genetic subtype we observed, indicating that these subtypes are may be by 
many loci acting in combination. Furthermore, these combinations of alleles 
often occur in multiple components of the same molecular pathways. 
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Hispanic/Latino populations possess a complex genetic structure that 
reflects recent admixture among and potentially ancient substructure within 
Native American, European, and West African source populations. We 
quantify genome-wide patterns of SNP and haplotype variation among 100 
individuals with ancestry from Ecuador, Colombia, Puerto Rico, and the 
Dominican Republic genotyped on the Illumina 650K SNP panels as well as 
112 Mexicans genotyped on the Affymetrix 500K platform. Intersecting 
these data with previously collected high-density SNP data from 4,305 
individuals, we use principal component analysis and clustering methods to 
investigate genome-wide patterns of African, European, and Native 
American population structure within and among Hispanic/Latino 
populations. Comparing autosomal, X and Y chromosome, and mtDNA 
variation, we find evidence of a significant sex bias in admixture 
proportions consistent with disproportionate contribution of European male 
and Native American female ancestry to present day populations. We also 
find that patterns of linkage-disequilibria in admixed Hispanic/Latino 
populations are largely impacted by the admixture dynamics of the 
populations with faster decay of LD in populations of higher African 
ancestry. Finally, we reconstruct fine-scale chromosomal patterns of 
admixture and estimate time since admixture from the lengths of ancestry 
tracts for each of the admixed populations. 
 
* These authors contributed equally. 
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It is a frequent phenomenon that the same gene takes part in signaling 
pathways that have different, sometimes even opposing, outcomes. 
Intriguingly, mechanisms that ensure the specificity of the transmitted 
signals are still unclear. In this study we present the argument for the 
importance of finely regulated alternative splicing of disordered protein 
segments in attaining this specificity. We observe that tissue-specific exons 
encode protein segments enriched in intrinsically disordered regions with 
overrepresented binding peptides and post-translationally modified sites. 
Functional relevance of the observed phenomenon is further indicated with 
significant evolutionary conservation of the tissue-specific disordered 
regions and predicted binding peptides. By alternatively splicing functional 
disordered segments, an individual gene can achieve functional versatility 
without compromising the structural stability of its protein products. Since 
the mechanisms for regulation of signaling specificity are frequently 
disrupted in cancer and other diseases, it is important to understand the role 
of proteins’ functional disordered residues in the regulation of signaling 
cascades. 
 38 
ENRICHING FOR INDELS IN COMPLEX DISEASE BY DEEP 
SEQUENCING. 
 
Lara M Bull-Otterson*1, Alex Coventy*2, Andrew G Clark2, Alan R 
Templeton3, Thomas J Rea4, Charles F Sing4, Jacy Crosby4, Xiaoming Liu5, 
Taylor Maxwell5, Eric A Boerwinkle5, Richard A Gibbs1  
 
1Baylor College of Medicine, Human Genome Sequencing Center, 
Molecular & Human Genetics, 1BaylorPlaza, Houston, TX, 77030, 2Cornell 
University, Molecular Biology and Genetics, TowerRd, Ithaca, NY, 14853, 
3Washington University, Biology and Genetics, Monsanto419, St.Louis, 
MO, 63130, 4 University of Michigan, Human Genetics, 1241ECatherine, 
AnnArbor, MI, 48109, 5University of Texas HSC-H, Div of Epidemiology, 
1200HermanPressler, Houston, TX, 77030 
 
* Authors contributed equally 
 
Genetic association studies of complex disease commonly focus on 
variations caused by single base-pair substitutions while few studies 
consider the large assortment of insertions and deletions (INDELs) that also 
make up natural genetic variation in the face of disease. In a large 
population-based cohort of 13,715 individuals from the Atherosclerosis 
Risk in Communities (ARIC) study, we examined the rare and common 
INDELs in HHEX and KCNJ11, genes historically associated with diabetes. 
Our analysis focuses on these genes in relation to the population genetics of 
INDELs and the impact of INDEL variations on metabolic risk factors for 
diabetes and coronary heart disease. Using Sanger sequencing of the full 
gene regions, we detected significantly associated INDELs for multiple 
metabolic phenotypes that were internally replicable. From the initial 76 
INDELs, 44 were validated by 454FLX sequencing and ranged in size from 
1-9bp. We examined the INDELs in context with the surrounding haplotype 
background and the linkage disequilibrium between putative functional 
mutations and the INDELs. We then examined the correlation between 
phenotypic variation and regions of conservation in orthologous sequences. 
Finally, we compared the INDELs in the extreme phenotypic deciles to 
those found in the full distribution to examine the consequence of a 
common sampling strategy in wide use today. These data provide the first 
glimpse at the population genetic dynamics of INDEL variations in a 
population-based sample.  
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The processing from pre-miRNA to mature miRNA in plants involves a 
mechanism, which depends on an extended stem in the secondary structure 
of the pre-miRNA. Here, we show how natural selection acts on this 
secondary structure to produce evolutionary conservation of the processing 
mechanism together with modularity of the pre-miRNA molecules, making 
this molecular function independent of others. Our main results are: 
 
1. Selection on miRNA processing can be described by a fitness landscape 
which depends on the free energy ΔG of the processing stem as quantitative 
molecular phenotype. Stem structures with ΔG>17kcal/mol have a constant 
fitness value; less stable stems incur a relative fitness cost. We infer this 
fitness landscape by a genome-wide analysis of Arabidopsis thaliana, 
comparing the stem free energy distribution of 130 functional pre-miRNAs 
with a background ensemble of random RNA molecules.  
 
2. This fitness landscape (together with the overall sequence divergence) 
predicts the divergence of the free energy phenotype, as well as the 
selection coefficients of pre-miRNA sequence changes. These predictions 
are in excellent quantitative agreement with the results of a genome-wide 
cross-species comparison of orthologous pre-miRNAs between A. thaliana 
and A. lyrata. We conclude that there is a strong evolutionary constraint on 
processing phenotype and function, although individual sequence changes 
are only under weak selection. Our analysis shows how natural selection 
interacts with the complex genotype-phenotype mapping induced by RNA 
folding. 
 
3. Actual pre-miRNA structures are modular: their stem free energy is 
significantly less affected by deleterious mutations in the remainder of the 
molecule than for random RNA molecules. This modularity is driven by 
mutational load favoring structures with more stable stems. This suggests a 
general evolutionary mechanism by which selection, mutations, and genetic 
drift generate modularity, a feature that is important for the independence of 
molecular functions in RNA, proteins, and extended molecular networks. 
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Recent comparative genomics analyses have identified regions that are both 
highly conserved in vertebrate evolution yet fast-evolving on the human 
lineage. One intriguing possibility is that these human accelerated regions 
(HARs) are spots of adaptive evolution in human ancestors. Alternatively, 
however, the biased substitution spectrum of these elements, and their 
proximity to recombination hotspots, suggest that biased gene conversion 
could have caused the observed acceleration. 
One limitation in investigating the forces shaping HARs is that it is 
unknown exactly when, in the last 5-7 million years since the last human-
chimpanzee common ancestor, the human substitutions occurred. To get 
temporal resolution on the evolution of HARs, we are using DNA 
sequences from Neandertals, the closest extinct relative of current human 
populations, to determine which substitutions in HARs pre- and postdate the 
divergence to Neandertals.  
Using targeted sequence capture on glass microarrays, we captured 
Neandertal DNA sequences of previously identified HARs from a ~43,000-
year-old Neandertal specimen from El Sidrón, Spain, attaining multifold 
coverage. To generate a picture of which substitutions in HARs are fixed 
versus polymorphic in present-day humans, we also sequenced the same 
regions in 50 individuals from the Human Diversity Panel. We will present 
the substitutions in HARs and compare them with genome-wide average 
rates of substitutions.  
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Over the past decade, DNA sequencing costs have dropped about 10,000-
fold. The lowest-cost reads from current technologies are short, have a high 
error rate, and land unevenly on the genome. They are ideally suited to 
‘resequencing’ applications in which a preexisting reference sequence is 
available; but for de novo genome assembly, they are challenging to work 
with, and results have generally been inferior to those obtained from the old 
(Sanger method) technology. 
 
Here we demonstrate a practical and general laboratory/computational 
method for generating high-quality de novo assemblies of genomes at the 
lowest possible cost. Our method starts with 100-base Illumina paired reads 
from two libraries: one from fragments of size 180 bp (slightly less than 
twice the read length), and one from fragments of size 3000 bp, via a 
‘jumping’ construction. These two libraries use off-the-shelf methods and 
provide power that could not be obtained from a single library. We also 
demonstrate experimental methods for jumping longer fragments to yield a 
third library, providing even greater potential for long-range connectivity. 
 
We assembled these data using our new version of the ALLPATHS 
algorithm. This algorithm has been scaled up to work on large genomes and 
made robust to idiosyncrasies in library construction, variation in coverage, 
and run-to-run variability in sequence quality, all of which have been 
critical problems for genome assembly. 
 
We tested our method using a suite of 16 genomes, including 9 for which a 
reference sequence was available and 7 from completely new samples. 
These genomes range in size from 2 to 2600 Mb, and in GC content from 
19% to 71%. Using the preexisting reference sequences, we assess the 
completeness, continuity, and accuracy of these assemblies, finding that in 
most cases their quality exceeds the general quality level of draft assemblies 
that had been achieved using Sanger sequencing. 
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Comparative gene expression studies can be used to see which genes are 
diverged across species, not just in terms of sequence, but also in terms of 
function. RNA-Seq provides a method of measuring gene expression that is 
independent of probe design and therefore ideally suited for cross-species 
comparisons. We used this approach to compare the transcription level of 
orthologous genes in four Saccharomyces species.  
 
We found that the transcription level of single-copy orthologous genes was 
well-correlated between species, and genes which are known to have 
diverged in expression during evolution were easily identified. For example, 
genes involved in the nitrogen catabolite repression pathway were clearly 
expressed differently in cerevisiae versus the other three yeast species.  
 
We also looked at gene transcription in evolutionary lineages after a gene 
duplication event. We found several examples where the syntenic gene 
maintained a transcription level consistent with the orthologous genes in the 
other species, while the paralog, located in a different genomic context, had 
a markedly decreased level of transcription.  
 
In the course of this study, we developed a simple and statistically robust 
method for measuring differential gene expression in RNA-Seq (shotgun) 
reads. To develop this method, we relied on biological replicates as a null 
model. We found that our best results were achieved when we used the raw 
count of reads which uniquely mapped to the region of the genome where 
the gene is located as our primary measurement of gene expression, and we 
did not normalize by transcript length. We observed that variations in the 
measurement of gene expression across replicates was greater than is 
predicted by Poisson variation. We quantified the magnitude of this 
variation based on the replicates and modified the conventional Χ2 test to 
allow for calibration based on these fluctuations. We then use this test to 
identify statistically significant, and therefore likely biologically 
meaningful, differences in gene expression.  
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Understanding how phenotype relates to genotype is one of the central goals 
of biology. Analysis of parallel genotyping and expression profiling data 
has shown that mRNA expression level is highly heritable. While the 
molecular mechanisms underlying the heritability of gene expression levels 
are poorly understood, they are expected to often involve mediation by 
transcription factors (TFs). We here present a transcription-factor-centric 
and sequence-based method for dissecting the transcriptional response to 
genetic perturbations. In our approach, we first predict the affinity with 
which each TF binds to the promoter region of each gene using quantitative 
prior information about the DNA binding specificity. Next, we perform 
genomewide linear regression of differential mRNA expression on 
predicted promoter affinity to estimate segregant-specific TF activity as a 
quantitative phenotype. Genetic mapping of the TF activity trait allows us 
to identify the activity quantitative trait loci (“aQTLs”) whose inheritance 
modulates the regulatory activity of each specific TF. Our method has a 
greatly improved statistical power to detect regulatory mechanisms 
underlying the heritability of genomewide mRNA expression. Specifically, 
it identifies seven times as many locus-TF associations and more than twice 
as many trans-acting loci from a genetic cross between two haploid yeast 
strains as all existing methods combined. We validated our ability to predict 
locus-TF associations in yeast using gene expression profiles for allele 
replacement strains. Furthermore, application to mouse data from an F2 
intercross identified an aQTL on chromosome VII modulating the activity 
of Zscan4 in liver cells, demonstrating that our method also works in higher 
eukaryotes. 
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The availability of a high-quality genome reference sequence is a key 
resource to drive scientific discoveries in molecular biology. Whilst the 
recent developments of high-throughput sequencing technology have 
accelerated and reduced the cost of generating genomic data it remains a 
challenge to assemble high-quality contiguous sequences that can reliably 
represent the genome of the organism under study. Here we present the 
quality improvement work being undertaken by the Swine Genome 
Sequencing Consortium to generate a high-quality draft reference genome 
sequence for the pig. The development of the pig sequence exploits the 
availability of a physical map that integrates fingerprinted clones from 4 
different BAC libraries as well as a dense panel of radiation-hybrid 
markers. A minimal tile path of BAC clones representing 98.3% of the 
physical map was subjected to hierarchical shotgun Sanger sequencing, 
with preference given to clones from the CHORI-242 library, which was 
constructed from a single Duroc sow (TJ Tabasco). Sequence coverage for 
each BAC clone was supplemented using automated primer walking from 
the ends of assembled sequence contigs to obtain an equivalent to 6x 
shotgun coverage of each BAC clone. A number of genomic regions of 
specific interest to the pig research community and the ENCODE regions 
have been sequenced to finished quality. In the latest release of the pig 
genome (Sscrofa9), 114Mb of the 2.97 Gbp represented in sequence contigs 
have been finished. To further improve the quality of the genome, we are 
now integrating whole genome shotgun (WGS) Illumina sequences from the 
same Duroc sow generated by the Beijing Genomics Institute (China) and 
the Wellcome Trust Sanger Institute (UK) into the assembly. These reads 
were assembled using a stringent algorithm to ensure that the resulting 
contigs were free of misassemblies. Although short, the these contigs 
provided an invaluable resource to reliably close or reduced the size of 20% 
of the gaps. This approach is complemented by the alignment of WGS 
Sanger reads generated by the National Livestock Research Institute 
(Korea) and full-length cDNAs to correct the orientation and order of 
contigs. This strategy preserves the underlying sequence architecture 
defined by the physical map and minimizes the confounding effect of 
repeats. This information will be integrated in future releases of the pig 
genome reference sequence. 
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Protein structure is generically modular, a property which extends to protein 
sequence and results in characteristic patterns in the distribution of changes 
along protein coding sequence. We consider this effect in the Drosophila 
genome by use of correlation functions between divergences and 
polymorphisms as a function of sequence separation. Amino acid evolution 
is significantly correlated on a length scale of O(20) amino acids, the 
characteristic length scale of protein sequence modules. We call this 
phenomenon local clustering and its cause is two-fold: the character of 
selection (e.g. level of constraint) is correlated within a module, and 
epistasis is more likely within a module. Epistasis is revealed in the 
increased probability that nearby divergences occur on the same lineage, 
and by a significant tendency for nearby same-lineage divergences to 
conserve the total local charge. Overrepresentation of the doubly mutant 
haplotype at nearby polymorphic sites also suggests epistasis. While 
heterogeneity in constraint contributes greatly to clustering, we conclude 
that epistasis is essential to at least 10% of amino acid changes. 
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Gene duplication has long been appreciated as a source of raw material for 
genetic and functional innovation. More recently, attention has focused on other 
mechanisms that generate new genes. For example, de novo gene creation from 
previously non-coding sequence has been found in fungi, flies, and mammals---
with estimates that as many as 12% of new genes in fly and 6% in human were 
created via this mechanism. Processes such as exon shuffling, incorporation of 
mobile elements, and gene fission and fusion can also create new genes with 
sequence and structure combinations that are novel to a genome. Despite the 
prevalence of new gene creation, very little is known about the functions of 
recently evolved genes and how these functions change over time.  
 
To investigate these processes, we classified all genes in Saccharomyces 
cerevisiae according to their age and mechanism of creation. This enabled us to 
analyze the relationship between how and when a gene was created and the 
roles it plays in the cell. We observed significant differences in genes’ 
annotation, essentiality, interactions, and specific functions based on their 
evolutionary histories.  
 
Our primary finding is that new genes become more functionally integrated into 
the cell with time, but that the dynamics of this process differ significantly 
between duplicated and totally novel genes. For example, new proteins are 
generally less connected in physical interaction networks than older proteins, 
but duplicate proteins are more integrated than novel proteins of similar age. 
Similarly, older proteins are more likely to be essential and to play roles in well-
characterized cellular processes than new proteins, especially those created by 
mechanisms other than duplication. Furthermore, recently created duplicated 
genes show evidence of being involved in adapting existing functions to 
environmental changes, while no significant functional enrichment was found 
among new genes created by other mechanisms. Thus, genes with novel 
sequences are initially less integrated into cellular networks than duplicated 
genes, but they are more likely to experience a dramatic gain in function after 
creation.  
 
This study shed light on several other aspects of gene evolution. First, we found 
a significant preference among all proteins to interact with other proteins that 
share both the same age and mechanism of creation. Second, the regulation of 
genes differs based on their age and origin, with novel genes being significantly 
less regulated than other groups. Finally, analysis of new proteins in the context 
of the interaction network identified areas of potential recent adaptation. 
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Gibbons are small apes that inhabit South East Asia and shared a common 
ancestor with the other hominoids about 18 million years ago. Gibbon 
species display an extremely high rate of chromosomal rearrangements, 20 
fold higher than most of the other mammals. Moreover, with 15 recognized 
species they show a taxonomic diversity greater than the other hominoids. 
We have already shown that the increase frequency of chromosomal 
rearrangements in gibbons can be explained by lower epigenetic repression 
of transposable elements (Carbone et al. 2009). We are now investigating 
factors that might explain the high fixation rate of chromosomal 
rearrangements in this species group. In particular we are speculating that 
population dynamics and other aspects of gibbon population history might 
have played a role. 
To address this problem we have been gathering sequence data using 
targeted next-generation sequencing (Illumina GAII) in non-exonic 
sequences. For this study we used our collection of genomic DNA of more 
than 20 unrelated individuals from 9 different gibbon species. We are 
currently examining this unique dataset and we will discuss the results of 
this analysis, including the possible implications with the rapid karyotype 
evolution observed in gibbon species. 
 
Carbone, L. et al. Evolutionary breakpoints in the gibbon suggest 
association between cytosine methylation and karyotype evolution. PLoS 
Genet 5, e1000538 (2009). 
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The next generation sequencing technologies are profoundly influencing 
our way to study biology. We have previously developed cap-analysis gene 
expression (CAGE) to simultaneously mRNA/noncoding RNA starting sites 
and simultaneously detect their expression and transcriptional networks. We 
also adapted CAGE to few nanogram of RNA (nanoCAGE). CAGE 
technology was coupled to deep sequencing (DeepCAGE) to achieve 
comprehensive coverage of transcription starting site, and more recently 
also miniaturized for use with small amount of material (nanoCAGE) and to 
assign newly discovered promoters/5’ ends to the remaining part of the 
RNA sequence (CAGEscan). We have adapted several of these technologies 
for multiple sequencers, including the 454 Life Sciences, Illumina, SOLiD 
and Heliscope.  
 
DeepCAGE is being also used on subcellular fractionation as a part of the 
ENCODE project. We have detected clear patters of expression of 
retrotransposon elements (RE) in a panel of human and mouse tissues, 
which have a regulatory role. Now, we have clearly identified specific 
patterns of RE-derived RNA in different cell compartments. For instance, 
Line derived RNAs are preferentially bound to chromatin, while other 
specific patterns have been identified also for nucleoplasm, nucleolus, 
cytoplasmic, nuclear and polysomal RNA fractions. Altogether, these data 
are pointing at a potential function of these elements. In the C2C12 muscle 
cells, perturbation of the expression of Line elements can either accelerate 
or repress differentiation of myoblasts into myotubes. 
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Deep re-sequencing of coding regions in human genomes coupled with 
parametric and non-parametric statistical approaches are necessary to 
identify potentially causal rare variants for complex disorders. We present 
the results of a study to identify rare variants associated with ASD and 
Schizophrenia, the first to use population genetic methods. Nonparametric 
approaches identified three genes (MAP1A, GRIN2B and CACNA1F) with 
significant excesses of rare missense mutations in either one or both disease 
cohorts. In a broader context, we also find the variation in cases is best 
explained by population models including selection and complex 
demography over either neutral models or models including only complex 
demography. Mutations in disease associated genes explain much of the 
difference in the overall site frequency spectrum among the cases versus 
controls. This study demonstrates that genes associated with complex 
disorders can be mapped using resequencing and analytical methods, using 
sample sizes far smaller than those required by GWA studies. Additionally, 
our findings support the hypothesis that rare mutations are required to 
explain the etiology of these complex disorders.  
*equal contribution  
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Genomic sequencing efforts have mostly focused on creating nearly 
complete and highly annotated genome sequences, but target species are 
chosen based on limited prior genome information. This strategy has 
provided only a limited diversity of complete genomes among vertebrates 
and great gaps in our understanding of genome diversity and dynamics 
across vertebrates. Modest sequencing of random samples from vertebrate 
species using next-generation sequencing methods is a promising cost-
effective alternative for amassing comparative data for understanding 
vertebrate genome evolution and diversity. To test this approach, we 
sampled moderate fractions (2-4.5%) of the genome of two snake species, 
the copperhead (Agkistrodon contortrix) and the Burmese Python (Python 
molurus). This modest sampling allowed a fairly comprehensive perspective 
on the transposable element and simple sequence repeat structure of these 
two snake species, and provides novel insight into the repeat structure of 
snake genomes. Our results demonstrate the utility of such sample 
sequencing across a diversity of vertebrates for great resolution of 
vertebrate genome evolution, and the great genome diversity present within 
snakes. 
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Planarian Schmidtea mediterranea has extraordinary regenerative capacities 
and is becoming a model organism for the study of regeneration, tissue 
homeostasis and stem cell biology. Although the genome annotation 
endeavors are rapidly ongoing, until now its transcriptome characterization 
has not been completed and is still largely dependent on computational 
prediction . Here, by integrating 454 and Solexa sequencing technology, we 
sequenced the poly A+ transcripts from the whole worm of S. mediterranea 
at an unprecedented depth and do novo assembled the transcriptome. In 
total, 26,669 candidate transcripts with mean length 1,300 bp were 
obtained, out of which over 99% can be aligned to the current genome 
reference sequence. The transcribed regions and the exons covered 35.3% 
and 7.4% of the genome, respectively. Our results provide the most 
comprehensive transcriptome reference resources for further functional 
research. In addition, the robust transcriptome characterization pipeline 
established in this study could be widely applied to the study in other non-
model organisms whose genome sequence has not been determined yet. 
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As a key regulator of retinal development in metazoan, eyeless (ey) 
functions at the top of the genetic hierarchy and is sufficient to initiate the 
entire genetic cascade controlling retinal cell specification, determination, 
and differentiation. To gain comprehensive understanding of the genetic 
network controlled by ey during retinal development, we have first 
performed comprehensive gene expression profiling using microarray. Gene 
expression profiles have been generated for 19 tissue and genotype 
combinations, which allow us to identify and group of genes regulated by ey 
during retinal development. In parallel, genome wide Ey occupancy has 
been profiled by ChIP-Seq in developing eye imaginal discs. A total of 
more than 20 million uniquely mapped reads have been obtained from Ey 
ChIP and more than 3000 potential Ey binding regions have been identified. 
By comparing with the profile of PolII and Histon H3K4Me3 for the same 
tissue, we are able to classify these 3000 regions into promoters and 
enhancers. Combining with gene expression and Ey binding profile, 
downstream targets and pathways that are directly regulated by Ey in the 
Drosophila genome have been identified. To our surprise, ey appears to 
directly regulate genes from virtually all major known genetic pathways 
involved in retinal development, including the hh, dpp, wg, Notch, EGFR, 
and cell cycle control pathway. Furthermore, ey frequently regulates 
multiple members in the same pathway, presumably allowing more 
complex and fine-tuned control. In addition, we have found evidence that ey 
can function as both an activator and a repressor in terms of regulating 
downstream gene expression. Finally, in addition to known genes and 
pathways, a large set of novel ey targets have been identified. Functional 
analysis of these candidate genes is currently underway and several novel 
genes have been found to cause retinal developmental defects when 
mutated. Further studies of these genes will provide important insights of 
Ey function. 
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Recent progress on next generation sequencing of whole genomes has 
greatly expanded the scope and the resolution of structural variant (SV) 
analysis. To facilitate the systematic discovery of somatic SVs in hundreds 
of cancer genomes with a reasonable validation rate, we developed an 
integrative SV discovery pipeline that includes a suite of algorithms for 
variant detection, read re-mapping, and localized assembly. Among the 
components in this pipeline, the BreakDancer algorithm and the iterative 
graph routing assembler (TIGRA) are our key innovations. Our pipeline 
was able to ascertain twice as many nucleotide resolution SVs in a personal 
genome (NA18507) than a whole genome assembly approach reported 
recently. Meanwhile, it can accurately pinpoint somatic SVs in cancer 
genomes, as demonstrated by numerous validated novel somatic SVs 
discovered in various cancer genomes. The breakpoint sequences produced 
by targeted assembly have allowed us to further examine the genotypes and 
to predict the putative formation mechanisms of each SV in a large number 
of cancer genomes. We will present these results as well as recent 
improvements to our procedures that lower the false positive rate in this 
most challenging of discovery processes. 
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The vast majority of genes can undergo alternative splicing among multiple 
transcript isoforms. Deep sequencing of cDNA libraries provides 
quantitative snapshots on the diversity of alternative splicing. In particular, 
the counts of sequence reads spanning multiple exons can be used to infer 
the relative proportion of transcript isoforms. Thus, algorithms that reliably 
map sequence reads to splice junctions are critical for bioinformatics 
analyses of alternative splicing. While many computational approaches 
align short sequence reads to splice junction databases, these databases are 
incomplete and must be custom-built for different read lengths. We present 
a new algorithm, called MapSplice, to discover splice junctions from the 
alignment of mRNA-seq reads to any reference genome. MapSplice 
combines global and local search to find optimal spliced alignments in a 
memory-efficient implementation. Our method tolerates read errors relative 
to the reference genome (due to SNP variation or incorrect base calls) and 
utilizes base-call quality scores to maximize the probability of an alignment. 
A classification strategy predicts canonical as well as non-canonical splice 
junctions, based on the quality of read alignments and the distribution of 
aligned reads that include the given junction. We will present MapSplice 
analyses of 75bp mRNA-seq datasets to identify alternative splicing 
differences between basal and luminal classes of breast cancers. 
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What is the phenotypic consequence of individual genetic variation? The 
Saccharomyces cerevisiae S288C deletion collection provides phenotypes 
for every ORF in this reference strain, but it does not address the question 
of individual strain variability. Here, we use identical deletion libraries 
made in two closely related S. cerevisiae strains, S288C and Σ1278b, to 
examine control of agar adhesion. Both strains have about 300 genes that 
affect agar adhesion, but few of these genes affect adhesion in both strains. 
In other words, a gene required for adhesion in S288c will likely not be 
required for adhesion in Σ1278b, and vice versa. The MAP kinase pathways 
are a striking example of this. They have been rewired such that the 
filamentation MAPK, needed for adhesion in Σ1278b, is dispensable for 
adhesion in S288C. Instead, we find that S288C utilizes signals from other 
pathways thereby bypassing the filamenation MAPK pathway. The genes 
that bypass the requirement for the filamentation MAPK for adhesion in 
S288C are polymorphic in Σ1278b. This shows that the genetic variation 
between these strains can significantly impact what mutations will have a 
phenotype, to the extent that a well characterized signaling pathway can 
have no effect in one strain but a significant effect in another. 
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We conducted a re-sequencing study to explore the genetic variation within 
eight genes encoding drug targets and assess the phenotypic effects of those 
variants. This knowledge may increase our confidence in target choice and 
point to new indications for these drugs.  
 
Re-sequencing was performed on 2000 subjects from the CoLaus 
population study, which measured a range of cardiovascular, metabolic and 
psychiatric traits. The sequencing strategy targeted exons and exon-intron 
boundaries, including 10,248 coding bases, and identified 515 variants. The 
vast majority, 437 (85%), were rare (<0.5% minor allele frequency [MAF]) 
and 292 (56%) were observed in one heterozygous individual, and only 41 
(8%) had MAF>5%. The coding, UTR and intronic frequency spectra were 
similar with a small decrease in common variants within coding regions.  
 
Genotype data was available for 25 of the 515 variants including 14 with 
MAF<5%. The overall heterozygous error rate was 6.78%, with the 
sequence data calling fewer heterozygotes. Further genotyping was 
conducted to confirm the new variants. Although the concordance was very 
high, genotyping very rare variants was challenging. Two methods were 
used to conduct genotype–phenotype analyses. Variants with MAF>0.5% 
were analyzed individually and those with MAF<0.5% were analyzed in 
aggregate within genes.  
 
Results will be presented on the analysis and characterization of variants 
identified. This experiment has several implications for the design of future 
re-sequence-based studies. Because so many of the observed variants are 
private, follow up studies may need to be based on sequencing rather than 
genotyping.  
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Structural variants in the human genome, those segregating in the 
population as well as de novo events, have profound impact on human 
health. The current challenge lies in translating these discoveries into 
understanding of phenotypic consequences. To help address this challenge, 
we are providing a new resource called dbVar that is focused on collecting 
and adding value to large scale variation data.  
dbVar currently includes data for several species. While data is available for 
multiple organisms, human is by far the most data rich. In addition to data 
surveying normal populations, such as HapMap, dbVar maintains data from 
studies making genotype-phenotype correlations for a range of diseases, 
including autism and cancer. In cases where sample level data are not 
consented for public release, the individual level data is first submitted to 
dbGaP (the database of Genotype and Phenotype) and summary level data 
are submitted to dbVar. The data are presented such that asserted variants, 
supporting data and experimental data are available for download. 
One challenge of maintaining these data is that the submissions are typically 
tied to a particular genome assembly. However, meta-analysis across 
multiple datasets requires the placement of variants into a common 
coordinate system; dbVar performs this critical mapping process on 
submission and updates for subsequent assemblies. Variants with a genome 
location may be mapped to a new assembly via assembly-assembly 
alignment; however, the complex structure of many of these regions makes 
them difficult to align and data may be lost. Additionally, some of the 
structural variants have been identified based on misassembly in a previous 
version of a genome. We will discuss our efforts to improve mapping of 
these variants to a common coordinate system as well as our approach to 
correlating these events with curation being performed by the Genome 
Reference Consortium (GRC).  
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The Sanger Institute’s zebrafish genome sequencing project is based on the 
Tübingen strain, the other widely used strain is AB. The current assembly 
(Zv8) is clone by clone sequence supplemented by whole genome shotgun. 
Zebrafish lacks homozygous strains, and has a 1.45Gb genome with large 
arrays of repeat, duplicated and AT-rich regions. By fertilizing eggs with 
inactivated sperm, and heat shock suppression of the first mitotic division 
we generated doubled haploid (DH) Tübingen and AB individuals. Using 
Illumina GA technology we generated 40x base coverage of a DH AB male 
and DH Tübingen female. We mapped these reads to Zv8, finding over 10 
million single nucleotide polymorphisms (SNPs), and 700,000 small 
insertion/deletions between these completely homozygous fish. We crossed 
the sequenced fish to generate genetically identical heterozygous F1 
hybrids, and F1s to generate F2s. Since F2s can only have the sequenced 
alleles at any location, and exhibit hydrid vigor, we are distributing them to 
the community under the name SAT (Sanger AB x Tübingen). 
We selected 200,000 SNPs across Zv8 for a SNP array, and genotyped 459 
F2 fish. After SNP calling with homozygous and heterozygous hint tables, 
and genetic filters, we made a de novo map of 141,675 SNPs with MSTmap 
(Wu, Bhat, Close and Lonardi. 2008). The new map has ~1SNP/10kb 
mapped at a resolution of 0.1cM (~60kb). The Illumina data also contain 
sequences not present in the clone based Zv8. The next assembly, Zv9, will 
contain merged clone, shotgun and Illumina data, and be confirmed not just 
by sequence and clone overlaps but also extensive genetic mapping. The 
new markers place previously unattached scaffolds and, in combination 
with read depth, help identify haplotypic and duplicated regions.  
We believe the combination of next generation sequencing and a dense 
genetic map could be used in other genome projects to improve assembly 
and usefulness of the genome sequence. As the technology matures, dense 
meiotic or linkage disequilibrium maps are feasible to construct and resolve 
assembly problems that can not be solved by more sequence alone and 
which were previously addressed using detailed physical maps. 
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The 1000 Genomes Project is producing a deep catalogue of human 
variation, to provide a better baseline to underpin human genetics.  
 
In order to make this data useful to the wider community the project will be 
submitting its variant calls to the appropriate archives such as dbSNP. An 
Ensembl style browser is also provided to enable users to see the variant 
calls in the context of other annotation at 
http://browser.1000genomes.org.This browser allows users to view the SNP 
sets both for high coverage individuals and for the low coverage population 
in genomic context and see the consequences of the snps on the gene 
structures. 
 
Recent developments in both the Ensembl variation code and the Ensembl 
web code are enabling us to show a greater variety of variation data and 
make alignment data easier to visualise. Ensembl is now working with 
emerging structural variation archives to display this data as tracks within 
the genome browser. As structural variants are released based on 1000 
Genomes data we hope to be able to display them on the genome in the 
same way. 
 
The 1000 Genomes project provides a vast amount of alignment data in the 
SAM format. These files represent the alignment of all the sequence data 
for available for an individual to the reference genome. We can now view 
these files using the Ensembl system which should allow users to see how 
the genomic sequencing supports the variant calls the project is making. 
This large volume of data will hopefully help drive Ensembl variation 
visualization forward as more people need help to see the data in both the 
gene and genomic context. 
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Microbial genomics at the Genome Center at Washington University 
includes studies of both individual genomes as well as communities, and of 
prokaryotes, eukaryotes, and viruses. Sequencing of individual bacteria 
employs Illumina as well as the 454 platform. Bacteria are bar-coded, 
pooled, twelve to an Illumina lane, sequenced and deconvoluted, with over 
90% of the genomes passing the criteria for a high quality draft sequence. 
Sanger, 454, and Illumina platforms are employed for metagenomic 
sequencing of communities focusing on 16S rRNA or shotgun sequencing. 
These methods are being used to characterize the microbiome of healthy 
individuals, as well as diseased tissues in acne, necrotizing enterocolitis, 
Crohn’s disease, urethritis, HIV infection, periodontitis, as well as dietary 
effects measured in primates. Virus sequencing, to characterize the healthy 
virome or agents of febrile pediatric cases, employs either 454 or Illumina 
sequencing. Eukaryotic microbes are being studied both as reference 
sequencing projects as well as ocean metagenomics.  
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The availability of long insert mate pairs for next generation technology 
sequencing offers opportunities to analyze structural variants at an 
unprecedented scale. Compared to the the initially available short inserts in 
the 200-500 base pair range, currently available inserts in the 4000-6000 
basepair range enable a more sensitive detection of structural variants. The 
increasing size of inserts and volume of reads pose a series of challenges: 1) 
it is imperative to have computational methods that scale well with the 
increasing volume of reads and can make use of existing parallel 
infrastructures; 2) Interpretation of the obtained structural variants requires 
integrative data analysis, both with respect to previous studies and with 
respect to genomic features of interest. To answer these challenges we have 
developed the Breakout software package which performs multiple 
functions. Given a matepair dataset, Breakout fist decomposes the input into 
balanced subsets, to enable good load balancing on a multi-node cluster or a 
multicore desktop. Next, it infers automatically the lower and upper bounds 
for the observed insert size, and clusters efficiently aberrant matepairs 
indicating breakpoints using a parallel grid iterative strategy. Resulting 
matepairs are filtered for redundant clones and annotated with p-values 
using a Poisson distribution. Breakout enables their interpretation against 
reference genomic features, such as gene promoters, user-specified targets, 
and against published structural variant datasets. We show applications of 
this method on cancer cell lines, with PCR validation. These pipelines are 
made available to the community via a Galaxy server. We showcase the use 
of the Genboree Discovery System for structural variants intuitive 
visualization, via genome browser extensions and specialized graphing tools 
such as Circos. 
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Massively parallel sequencing is becoming routine in human genetics, but 
identifying disease-causing genetic variants in individual genomes is a difficult 
problem. Noncoding regions (>98% of the genome) are particularly challenging 
to study, but isolation of causal variants is difficult even within the best-
characterized subset of the genome that encodes proteins (i.e. the ‘exome’). 
Analyses of nucleotide-level sequence conservation hold potential to address 
this challenge, on the assumption that purifying selection ‘constrains’ 
evolutionary divergence at phenotypically important nucleotides. Constraint 
scores are quantitative, do not require functional annotations (e.g. non-
synonymous), and are applicable genome-wide, offering substantial advantages, 
in principle, over other approaches to identify causal variants. However, it 
remains unclear if constraint scores hold practical utility for the analysis of 
resequenced individuals. We therefore assessed the ability of a nucleotide-level 
evolutionary metric to identify causal variants in 16 published exomes, derived 
from 4 individuals with Freeman-Sheldon syndrome (FSS; OMIM #193700), a 
dominant disease caused by rare variants in MYH3; 4 individuals with Miller 
syndrome (OMIM #263750), a recessive disease caused by rare variants in 
DHODH; and 8 HapMap samples. We estimated constraints on each nucleotide 
of the human genome using Genomic Evolutionary Rate Profiling (GERP) in 
sequence alignments of 34 mammalian species that capture ~5.8 substitutions 
per neutral site. We found that single-nucleotide constraint scores enrich 
strongly and site-specifically for deleterious variants within these exomes. 
GERP scores were, in fact, more effective than functional definitions (i.e. non-
synonymous) at enriching for the known causal variants for both diseases, and 
also more effective than other, more complex, methods like SIFT and PolyPhen 
that only consider non-synonymous variants. Since they are quantitative, 
constraint scores also facilitate relative comparisons that are unavailable with 
discrete annotations, and ranked the known causal genes highly even under 
disease models that allow for genetic heterogeneity. Assuming a monogenic 
mode of inheritance, GERP scores ranked the known causal gene as the top 
candidate for both diseases. We conclude that single-nucleotide evolutionary 
constraint scores offer clear utility for analyzing exomes. Given this proof of 
principle and considering that constraint scores are readily defined genome-
wide, they hold exciting potential for the discovery of causal variation in 
arbitrary genomic segments (e.g. linkage peaks) and ultimately re-sequenced 
genomes. 
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Recent genome-wide association (GWA) studies have identified numerous 
replicable genetic associations influencing risk of common autoimmune and 
inflammatory (immune-mediated) diseases. Moreover, several loci have 
been independently shown to influence risk to more than one such disease. 
This observation suggests commonality in the processes underlying disease 
progression and is echoed in epidemiological observations, which 
nonetheless have as yet been unable to propose common molecular 
mechanisms of pathogenesis. Here, we compare 140 loci associated to 
immune-mediated disease across GWA studies of six such diseases and find 
that ~50% of these regions are convincingly associated to multiple immune-
mediated diseases. We further show that patterns of disease association 
group loci into clusters which encode interacting proteins, suggestive of 
distinct molecular mechanisms. Finally, we examine the genetic overlap 
between MS and Crohn Disease in more detail by comparing genome-wide 
meta-analyses of the two diseases across 629,000 SNPs and find association 
to components of the interleukin 23 receptor- and prostaglandin receptor-
mediated signaling pathways in MS, suggesting a role for variation in the 
cell functions they control in both diseases. 
This work demonstrates how functional information may be systematically 
retrieved from GWA data to make inferences about the molecular 
underpinnings of pathogenesis and provide medically relevant cellular 
targets for drug discovery and disease prediction efforts. We note that these 
approaches are relevant to any group of related traits and are likely useful in 
psychiatric, metabolic and pharmacological genetic research. 
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Targeted resequencing in an exceptionally large sample is the only way to 
(1) obtain an unbiased sample of rare human genetic variants, (2) determine 
how human demographic shifts have shaped their abundance and 
distribution, and (3) begin to understand the role of rare variants in risk for 
complex disease. Using Sanger sequencing of genomic PCR amplicons, we 
resequenced the diabetes-associated genes KCNJ11 and HHEX in 13,715 
individuals from the Atherosclerosis Risk in Communities (ARIC) study, 
then validated amplicons harboring rare variants using 454 pyrosequencing. 
The expected number of segregating sites in these two genes is far higher 
than previous polymorphism surveys would have predicted: over 740 and 
comprised mostly of rare variants, including an enriched set of damaging 
and loss-of-function variants. Variants which arose over the last 8,000 years 
would primarily appear as singletons in our dataset, so we had a unique 
opportunity to estimate human demography in Europe after the widespread 
adoption of agriculture there. We found a clear signature of a much higher 
population growth rate than has been estimated in earlier studies based on 
higher-frequency variants. Because higher-frequency variants arose earlier 
in human history, we conclude that, consistent with historical and 
archaeological data, there was an acceleration in the growth rate over the 
last 8,000 years. In fact, rapid population growth explains the huge number 
of rare variants we identified, and suggests that there are hundreds of 
distinct, rare loss-of-function mutations in every human gene. We also used 
our demographic estimates to estimate the mutation rates in the two genes 
directly from the site-frequency spectra (SFS) we obtained. 
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Type I diabetes (T1D) is characterized by the destruction of pancreatic beta 
cells, leading to inadequate insulin production and poor control of blood 
sugar levels. Islet cell transplantation can potentially reverse the harmful 
effects of T1D, however there is a decline in graft success rate from ~70% 
(1 yr) to ~10% (after 5 yrs). We reasoned that some islet preparations were 
more capable of restoring euglycemia than others, controlled in part at the 
level of gene expression. 
 
We used HGU133+2 microarrays to characterize 9 transplant grade human 
islet preparations. In the absence of patient outcome data, we used gene 
expression heterogeneity to identify perturbed molecular processes: 153 
(0.28%) genes had MAD>1.5. We adapted GSEA to assess variability at the 
level of genesets; 5 genesets relating to hypoxia were enriched 
(FDR<0.001). Animal studies show that stabilization of hypoxia inducible 
factor 1α (HIF-1α) represents a molecular switch towards anaerobic 
glycolysis ablating glucose sensing and insulin secretion in islets. 
 
Compared to laser captured microdissected human islets, key glycolytic 
enzymes PDK1, LDHA, and MCT4 were up-, and GCK down-regulated, 
indicating a switch to anaerobic glycolysis. These results were confirmed 
using mouse islets cultured in normoxic and hypoxic conditions, which was 
reversed using a HIF-1α inhibitor. We transplanted hypoxic mouse islets 
into immunodeficient RAG-/- mice, and 4 weeks after transplantation the 
same glycolytic profile was observed as seen in human islets. 
 
The permanence of this molecular signature may explain poor islet function 
post transplantation and suggests early intervention in reversing the hypoxic 
changes may be important. 
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Regulation of gene transcription is largely determined by cis-elements 
where trans-acting factors bind. In diverse cell types, gene transcription 
levels are modulated by utilizing varied sets of cis-elements. Here we 
demonstrate that data from high-throughput DNaseI hypersensitivity (HS) 
assays (DNase-seq) can delineate base-pair resolution 'footprints' that 
precisely mark individual protein-DNA interaction sites within DNaseI HS 
sites across the genome. We find that footprints for specific transcription 
factors correlate well with ChIP-seq enrichment and correctly identify 
functional vs. non-functional sites computationally predicted using motifs. 
By analyzing 6 cell types, we have identified many footprints for various 
factors that are cell-type specific and many others that co-localize together. 
We also find that footprints reveal a unique evolutionary conservation 
pattern that differentiates footprinted bases from surrounding DNA. These 
footprints can be used in addition to ChIP-seq data to more 
comprehensively elucidate genomic regulatory systems. 
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We have applied RNA-Sequencing to generate a comprehensive map of the 
Drosophila melanogaster transcriptome by broad sampling of 12 distinct 
developmental stages. In total, 272 million 64-75bp paired-end reads were 
generated on the Illumina GA II yielding 690x sequencing coverage. Direct 
supporting evidence for more than 95% of annotated FlyBase genes and 
90% of splicing junctions was observed. Furthermore, improvements were 
made to 34% of the current annotated gene models by extension of UTRs, 
inclusion of novel exons, and identification of novel splicing events. A total 
of 479 novel transcripts were identified, representing a 3.4% increase over 
the current Drosophila gene set. These data suggests that alternate splicing 
occurs in 36% of Drosophila genes, significantly less than mammals, but a 
61% increase over previous estimations. Much of the increase is attributable 
to subtle alternate splicing forms such as tandem alternate splice sites 
(TASS). For one form of TASS, the NAGNAG alternate acceptor site, 241 
novel cases were observed, a 4-fold increase over annotations. To make this 
massive dataset readily accessible multiple data tiers have been designed 
and made available through FlyBase providing a valuable resource to the 
Drosophila research community. 
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Changes in gene expression play an important role in the diversification of 
primate species. This effect is mediated partially by changes in the binding 
locations of DNA sequence-specific transcription factors. The 
glucocorticoid receptor (GR) is a steroid hormone-dependent transcription 
factor that affects the expression of hundreds of genes in the presence of 
corticosteroid hormones such as cortisol and dexamethasone (DEX). GR 
plays an important role in regulating innate and acquired immunity, and is 
involved in mediating a response to both stress and anxiety in nearly all 
tissues, including the brain. Moreover, several aspects of GR physiology 
and ligand sensitivity are known to have changed during the course of 
primate evolution. 
 
Here, we examine changes in GR binding sites during primate evolution. 
Our strategy is to systematically determine the location of GR binding sites 
in human, chimpanzee, and rhesus macaque using chromatin-
immunoprecipitation coupled with massive parallel sequencing (ChIP-seq). 
We focus on CD4+ T-cells, a peripheral blood cell that plays an important 
role in adaptive immune response. CD4+ T-cells are isolated from human 
and non-human primate peripheral blood samples using magnetic 
separation. Samples are treated using the synthetic GR agonist DEX to 
separate true species-specific differences in binding from those caused by 
differences in environment and ligand sensitivity. Using this system, we are 
in the process of constructing a deep and robust dataset of GR binding in 
human, chimpanzee, and rhesus macaque. This dataset will represent a 
wealth of information useful in understanding how changes in GR binding 
play a role in primate evolution. 
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A natural history of Precambrian life remains elusive because of the rarity 
of microbial fossils and biomarkers.  We have employed an explicit model 
of macroevolution including gene birth, transfer, duplication and loss to 
map the evolutionary history of 3,968 gene families across the three 
domains of life. This model uses the topology of the gene family tree rather 
than just gene copy presence/absence across genomes and accounts for 
uncertainty in gene trees. We observe that gene transfer is the primary 
source of gene gain in prokaryotes, while duplication dominates in 
Eukaryotes. Inter-domain gene transfer is rare compared to intra-domain 
transfer with the notable exception of a statistically significant enrichment 
for Bacteria-Eukarya transfer events that corresponds to the endosymbioses 
of the mitochondria and chloroplasts. Surprisingly, we find that a brief 
period of genetic innovation during the Archean eon gave rise to 27% of 
major modern gene families. Genes born during this period are especially 
likely to be involved in electron transport, while later genes exhibit a 
gradually increasing usage of molecular oxygen.  Our results demonstrate 
that reconstructing the complex interplay between organismal and 
geochemical evolution over Earth history is becoming a tractable goal. 
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Genome-wide association studies have yielded an unprecedented number of 
associations between common genetic variants and complex traits. But the 
loci identified only explain a small proportion of the heritability of the 
analyzed traits. Rare variants have been postulated to harbor some of the 
missing heritability. This has generated a huge interest in the re-sequencing 
of large numbers of cases and controls to find rare variants associated with 
disease. Although next-generation sequencing technologies have drastically 
reduced the costs of sequencing, it is still prohibitively expensive to 
sequence thousands of individuals. This has lead to the development of 
numerous methods for targeted sequence enrichment. To further reduce cost 
and increase the number of genomes sampled many groups propose to 
perform the capture and sequencing in DNA pools. There are many 
questions that need investigation in order to optimally design a targeted re-
sequencing experiment in pooled DNA including choice of sequence 
enrichment technology and number of individuals to pool.  
We evaluate long-range PCR, array based pull down, and in-solution based 
pull down enrichment methods for 6 genomic regions composing 1.6Mb. 
The enriched regions are sequenced in DNA pools of 1, 2, 10, 20, and 50 
individuals with an Illumina GA II. The 50 individuals assayed are 
composed of 31 HapMap individuals and 19 control individuals from the 
WTCCC. In addition to the extensive genotype data on these individuals, 25 
of the individuals are sequenced in the ExoSeq project and 22 individuals 
are sequenced in Pilot 1 of the 1000 Genomes project (19 individual 
overlap). Utilizing all the available genotyping and sequencing data on our 
subjects we will present an analysis of the estimated false positive and 
negative rates of variant discovery and accuracy of allele frequency 
estimation in all 15 study designs as well as recommendations on the 
optimal design including which capture technologies are the best in terms of 
enrichment of target regions and sequencing coverage, which is the most 
cost-effective, and the optimal number of individuals to include in the 
pools. 
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The informativeness of comparative data for making functional inferences 
can depend strongly on taxonomic sampling.  In particular, densely-sampled 
comparative data is expected to be highly informative on patterns of site- 
and lineage-specific variability, including on coevolutionary interactions 
among sites and on functional and adaptive shifts. We are approaching an 
exciting time for evolutionary genomics, in that the number of sequenced 
metazoan genomes is expected to increase remarkably to 500-10,000 over 
the next 2-10 years. Unfortunately, making effective use of this incoming 
flood of data poses significant computational challenges, particularly 
because the computational burden of rigorous evolutionary analysis 
explodes with increasing data size and model complexity.  We have 
therefore been working on ways to alleviate the poor scaling of likelihood-
based phylogenetic approaches, to facilitate rapid, large-scale comparative 
genomic analysis using more realistic models. We present a variety of 
results showing how likelihood analysis can be rapidly performed on large 
comparative genomic data sets with nearly as little computational burden as 
required by parsimony-based analysis, but without appreciably sacrificing 
rigor.  We show how these approaches can be applied in a Bayesian context 
to a number of important problems in comparative genomics and molecular 
evolution. In particular, we will present novel results on genome-wide 
inference of variation in selective constraint, variation of evolutionary 
pattern across sites in proteins, and coevolutionary interaction among sites. 
In each application, data analysis can be performed in merely minutes on a 
desktop computer, even for data sets including hundreds or thousands of 
species. 
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Due to growing throughput and shrinking cost, massively parallel 
sequencing is rapidly becoming an attractive alternative to microarrays for 
the genome-wide study of gene expression. The sequencing of transcripts 
(RNA-Seq) offers several advantages over microarray-based methods, 
including the ability to detect somatic mutations and accurately measure 
allele-specific expression. The Applied Biosystems SOLiD System can 
produce over a billion 50bp reads per run, enabling deep sequencing 
analysis of transcriptomes. Nevertheless, one of the challenges of the 
technology is that analyzing such ever growing volumes of data requires the 
implementation of commodity computer clusters that could be expensive in 
their high-end configurations, need dedicated facilities and incur associated 
maintenance and environmental costs. As an alternative to the computer 
cluster configuration, we explored implementing the SOLiD Whole 
Transcriptome Analysis pipeline on a Utility Computing environment and 
on the Amazon Elastic Compute Cloud (EC2). As a feasibility study, we 
analyzed a RNA-Seq dataset of over 700 million reads coming from a 
single slide from a SOLiD instrument. We compare both environments in 
terms of ease of deployment of applications, use, performance, and cost. 
The EC2 environment offers the maximum flexibility and two execution 
modes: virtual clusters and Map-Reduce jobs. The former is easier to 
deploy, although still with some effort, but not as scalable, and the later 
requires rewriting the algorithm code to accommodate the distribution 
system, which could be initially expensive and time consuming. On the 
other hand, the Utility Computing paradigm offers complete transparency 
and is highly efficient. We conclude that the analysis of sequencing data 
through cloud computing environments is efficient and cost effective, and 
could supplement or become the main IT infrastructure for large and small 
LABS. 
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Recent studies have provided significant examples of cis-regulatory 
sequence changes that drove morphological evolution in model organisms. 
However, regulatory elements that evolved uniquely among primates and 
contributed to primate-specific morphology have yet to be identified. The 
transcription factor FOXP2, which is associated with motor coordination, 
motor learning, and speech and language development, is well known for 
two human-specific amino acid substitutions that affect neuronal 
morphology and verbal phenotypes when introduced into mice. 
Intriguingly, the FOXP2 locus is extremely rich in non-coding conservation, 
raising the possibility that it may also have contributed to the evolution of 
motor phenotypes through alterations in its pattern of expression. 
Specifically, we hypothesized that primate-specific regulatory sequences in 
the FOXP2 locus might have contributed to the evolution of unique motor 
control phenotypes required for prehensile hands and feet and the arboreal 
lifestyle of primates. To test this hypothesis, we sought to identify genomic 
segments that evinced statistically significant evolutionary constraint among 
anthropoid primates, but little or no constraint among non-primate 
mammals. We scanned for primate conserved elements (human, orangutan, 
rhesus macaque, marmoset) using Gumby with parameters R-ratio=2 and 5 
in the 800-kb FOXP2 locus. To obtain conserved elements specific to 
primates, we contrasted these primate-conserved sequences with elements 
conserved in 24 mammals, ascertained by running Gumby with the same 
parameters on the 24-way non-primate mammal Multiz alignment. At a 
Pvalue threshold of 0.001, we identified 134 primate-conserved elements in 
the locus. Using a loose Pvalue threshold of 0.5 in order to rule out any 
possibility of mammalian conservation, we identified 836 mammal-
conserved elements covering 16.1% of the 800-kb. Surprisingly, in spite of 
these stringent criteria, we identified 5 primate-specific conserved elements 
in the locus (all noncoding), the strongest of which had a Pvalue of 5.0e-13. 
This result suggests that multiple noncoding elements in the FOXP2 locus 
potentially evolved primate-specific gain of function and provides the basis 
for the experimental exploration of gene expression changes that may have 
contributed to primate-specific motor phenotypes. 
 74 
THE GENOME ANALYSIS TOOLKIT: A MAPREDUCE 
FRAMEWORK FOR ANALYZING NEXT-GENERATION DNA 
SEQUENCING DATA 
 
A McKenna1, M Hanna1, E Banks1, A Sivachenko1, K Cibulskis1, A 
Kernytsky1, K Garimella1, D Altshuler1,2, S Gabriel1, M A DePristo1  
 
1The Broad Institute of Harvard and MIT, Program in Medical and 
Population Genetics, Five Cambridge Center, Cambridge, MA, 02142, 
2Massachusetts General Hospital, Center for Human Genetic Research, 
Massachusetts General Hospital, Richard B. Simches Research Center, 
Boston, MA, 02114 
 
Next-generation DNA sequencing (NGS) projects, such as the 1000 
Genomes Project, are already revolutionizing our understanding of genetic 
variation among individuals. However, the massive data sets generated by 
NGS—the 1000 Genome pilot alone includes nearly five terabases—make 
writing feature-rich, efficient and robust analysis tools difficult for even 
computationally sophisticated individuals. Indeed, many professionals are 
limited in the scope and the ease with which they can answer scientific 
questions by the complexity of accessing and manipulating the data 
produced by these machines. Here we discuss our Genome Analysis Toolkit 
(GATK), a structured programming framework designed to ease the 
development of efficient and robust analysis tools for next-generation DNA 
sequencers using the functional programming philosophy of MapReduce. 
The GATK provides a small but rich set of data access patterns that 
encompass the majority of analysis tool needs. Separating specific analysis 
calculations from common data management infrastructure enables us to 
optimize the GATK framework for correctness, stability, CPU and memory 
efficiency, and to enable distributed and shared memory parallelization. We 
highlight the capabilities of the GATK by describing the implementation 
and application of robust, scale-tolerant tools like coverage calculators and 
SNP calling. We conclude that the GATK programming framework enables 
developers and analysts to quickly and easily write efficient and robust 
NGS tools, many of which have already been incorporated into large-scale 
sequencing projects like the 1000 Genomes Project and The Cancer 
Genome Atlas. 
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De novo reconstruction of complex genomes by random shotgun methods is 
made difficult by the presence of genomic repeats. However, if individual 
sequence reads are long enough, they can span isolated repetitive sequences 
and reduce the magnitude of the problem. For this reason, sequencing of 
complex genomes longer than 100 Mb has to date been limited to Sanger 
methods or combinations of Sanger and next-generation methods. Here we 
describe the de novo sequencing, assembly, and annotation of the cucumber 
genome (Cucumis sativus) exclusively using the next-generation FLX 
Titanium technology from 454 Life Sciences. A high quality draft was 
generated using shotgun reads along with paired-end reads with span 
distances of 3 kb and 20 kb to allow scaffolding over longer repeats. Near-
complete assembly of the euchromatic portion of the genome is 
demonstrated by the extremely high mappability (>98%) of over 2 million 
ESTs, also generated using FLX Titanium. Comparable results were 
obtained between Celera Assembler and gsAssembler (newbler). The ease 
of generating a near-complete reference genome reconstruction has the 
potential to be very useful for ongoing crop improvement breeding 
programs for cucumber and other cucurbits with similar genomes. 
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Two abundant classes of mobile elements, namely Alu and L1 elements, 
continue to generate new retrotransposon insertions in human genomes. In 
fact, some estimates suggest that these elements have generated millions of 
new germline insertions in personal human genomes worldwide. 
Unfortunately, current technologies are not capable of detecting most of 
these young insertions, and the true extent of germline mutagenesis by 
endogenous human retrotransposons has been difficult to examine. Here, we 
describe new technologies for detecting these young retrotransposon 
insertions and demonstrate that such insertions indeed are abundant in 
human populations. We also found that new somatic L1 insertions occur at 
high frequencies in human lung cancer genomes. Genome-wide methylation 
analysis suggests that altered DNA methylation may be responsible for the 
high levels of L1 mobilization observed in these tumors. Overall, our data 
indicate that transposon-mediated mutagenesis is extensive in human 
genomes, and is likely to have a major impact on human biology and 
diseases. 
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Anolis carolinensis, the green anole lizard, is the first non-avian reptile to 
have its genome sequenced. Now that two avian genomes have also been 
sequenced (chicken and zebra finch), we have a great opportunity to 
understand both reptilian and mammalian evolution via synteny and gene-
based comparisons of these sequenced genomes. The 250 million-years 
between Anolis and birds, and the 310 million-years between Anolis and 
mammals add an extra challenge to our analysis, for which we have 
developed new sensitive genome comparison tools. Especially interesting is 
the comparison of bird and lizard microchromosomes. Even though lizard 
microchromosomes do not share the distinguishing characteristics of bird 
microchromosomes, their syntenic relationships have revealed a great deal 
about reptilian genome evolution and the nature of these remarkable tiny 
chromosomes.  
 
Here, we present our analysis of the genome of Anolis carolinensis, 
including our studies of microchromosomes, gene orthology and the 
amniote evolution of the immunologically-significant MHC region. We 
highlight several areas in which the Anolis genome structure is more 
reminiscent of mammalian genome structure than that of the more compact 
avian genomes. Finally, we also thoroughly examine the multitude of Anolis 
repeats that have been exapted as conserved non-coding and sometimes as 
exons in mammalian genomes.  
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Natural populations of Astatotilapia burtoni live in the river estuary system 
of Lake Tanganyika in east Africa. In this lake-like social system, only a 
few males in a given population have access to critical resources of food, 
spawning sites, and consequently, females. Males have evolved two 
distinct, reversible phenotypes in adapting to their dynamic social 
environment: dominant, reproductively competent territorial (T) males and 
submissive, reproductively suppressed non-territorial (NT) males. T males 
display bright coloration, aggressively defend territories, and court females, 
while NT males display dull coloration, mimic females, and limit their 
behavior to schooling and fleeing.  
The transition between social states regulates multiple changes in the brain-
pituitary-gonadal (BPG) axis including dramatic changes in GnRH-
containing cell size as well as testis size and cell composition, but little is 
known about how spermatogenic plasticity is controlled in adult vertebrates. 
In collaboration with the Broad Institute, as part of the ongoing cichlid 
genome sequencing efforts, we have sequenced small RNA libraries 
(Illumina) from A. burtoni testes of both aggressive territorial and 
submissive non-territorial males. Here we identify and characterize 
differentially expressed small RNAs which may modulate changes in 
spermatogenic activity during social transition. 
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Genomic imprinting, or parent-of-origin-specific gene expression, is an 
epigenetic phenomenon that occurs in therian mammals, flowering plants, 
and arguably in some insects, but has not been found in prototherian 
mammals or other vertebrates. Its failure in humans can result in 
developmental diseases including Beckwith-Wiedemann syndrome, Prader-
Willi/Angelman syndrome, and others. Analyses of fundamental epigenetic 
signals of imprinting in mammals, such as differential DNA methylation, 
histone modification, and the presence of certain characteristic genomic 
elements have been limited primarily to a small number of eutherian 
(placental) mammals and have not been conducted extensively in non-
eutherian species. To further elucidate the evolution and molecular 
mechanisms of genomic imprinting, it is also vital to examine this 
phenomenon in metatherian (marsupial) mammals, the only non-eutherian 
vertebrates in which imprinting is known to occur. 
It has been shown that certain post-translational modifications of histone 
proteins differentially mark the promoter regions of paternally and 
maternally derived copies of imprinted genes in eutherians and are 
correlated with active and inactive transcriptional states. More specifically, 
histone 3 lysine 4 trimethylation (H3K4me3) and histone 3 lysine 9 
trimethylation (H3K9me3) have been shown to be mutually exclusive 
marks for the active and inactive states, respectively, at imprinted gene loci. 
However, the enrichment of these marks at imprinted genes in metatherians 
has not been characterized. Utilizing chromatin immunoprecipitation 
(ChIP), we show the localization and concurrence of H3K4me3 and 
H3K9me3 epigenetic marks at the promoter of the IGF2 imprinted gene in 
Monodelphis domestica. We also analyze the correlation of specific 
genomic elements with these modifications. This study is the first to show 
that specific histone modifications mark an imprinted gene in a metatherian 
mammal and furnishes the basis for designing genome-wide scans for 
undiscovered, as well as marsupial-specific, imprinted genes. 
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We have developed a novel DNA nanoarray-based complete human 
genome sequencing technology providing high accuracy (99.999%) at a 
cost of less than $1500 in reagents-- Science 327, 78 (2010). In 2009 we 
sequenced over 50 high quality (40x) human genomes using this 
technology. Multiple disease genes and many novel cancer mutations were 
discovered in these genomes, including rare disease variants from a four-
member family. Based on further nanoarray and instrument improvements 
that allow for an average throughput of over 1,000 Gb per run, resulting in 1 
genome per instrument-day, we are building a human genome sequencing 
center with the capacity to analyze thousands of genomes per year. We have 
also successfully sequenced multiple human genomes using only 10-20 
cells (66-120 pg of DNA) by employing a novel sample preparation process 
allowing separate sequence assembly for each parental chromosome. The 
Mb-sized haplotype contigs obtained were confirmed by sequencing 
personal BACs and parental genomes, and compared to HapMap data. Over 
two million heterozygote SNPs (several times more than found in the 
HapMap) were haplotyped in the NA19240 genome. Our large-scale human 
genome sequencing center and these new genome analysis capabilities will 
allow for advanced molecular studies of both common and rare human 
diseases by complete sequencing and haplotyping of a large number of 
patient and control genomes. 
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Ultra high throughput sequencing methods have been rapidly adopted for 
analysis of the chromatin state and transcriptome of cells. A number of 
large- scale initiatives are now under way to produce systematic profiles of 
chromatin state in a variety of normal and diseased cells and cell lines. In 
particular, the ENCODE consortium has generated data by ChIP-seq, 
DNase-seq, RNA-seq, methyl-seq and other high-throughput methods for a 
broad range of representative human cell lines. Key tasks in maximising the 
utility of these data include methods for handling large and diverse datasets, 
strategies for data integration and analysis, and developing appropriate 
mechanisms for data presentation. We will present the approaches that we 
have adopted within the ENCODE consortium and in Ensembl.  
 
As part of the ENCODE Data Analysis Centre, we have been involved in 
both data summarising and integration. Following an ENCODE data freeze 
in January, we have analysed the status of ENCODE data production as part 
of a progress review process. In particular, we have developed approaches 
for assessing the status towards completion of the project with respect to its 
stated goals. This has included summarising ENCODE productivity, 
analyses of the diversity of ENCODE cell lines within transcriptome space, 
and analysis of coverage of the universe of regulatory elements, either 
within an individual cell line or across all cell lines, to estimate 
“saturation”.  
 
Within the context of the Ensembl Functional Genomics database, we are 
developing methods to provide access to functional genomics data across 
multiple species. This has been initiated with incorporation of key datasets 
form both large-scale consortium projects and smaller laboratory based 
analyses. We are aiming to provide access to these data, both in their raw 
form with innovative data visualisations, but also by novel processing that 
aims to present a unified view of chromatin state by cell type. One approach 
is the Regulatory Build that provides a set of functional elements across the 
genome and categorises these elements by their chromatin marks and 
transcription factor occupancy, either by cell type or as a union set.  
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One of the earliest epigenetic abnormalities observed in cancer was 
extensive genomic hypomethylation. This phenomenon has been implicated 
in genomic instability and possibly the reactivation of oncogenes; however, 
studying hypomethylation has been difficult since many of these changes 
are concentrated in interspersed repeats. The agouti and axin loci in mouse 
provide clear evidence that demethylation of retrotransposons can lead to 
ectopic expression of nearby genes, but a systematic screen for such events 
in cancer genomes has not been performed. To better understand the 
consequences of wide spread demethylation in repeat regions, we have 
employed Methyl-MAPS (Methylation Mapping Analysis by Paired-end 
Sequencing). In this method, genomic DNA is digested with methylation-
sensitive and –dependent enzymes, and Next-Gen sequencing is used to 
map the locations of digested and undigested CpG sites and, thus, map their 
methylation state. This technique detects methylation status at not only 
promoter and other single copy regions of the genome, but also at 
interspersed repeats. A new computational pipeline has been developed to 
quickly detect differentially methylated features genome-wide. Using this 
method, we have assessed methylation status of nearly the entire genome in 
several breast cancers and adjacent normal breast tissues and ER+ and ER- 
breast cancer cell lines. Combining whole-transcriptome and genome-wide 
methylation data is allowing us to better understand how hypomethylation 
events can lead to transcriptional abnormalities in cancer. In particular, we 
are beginning to understand the effects of repeat hypomethylation on 
transcription. 
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Genome-wide association studies (GWAS) have identified genetic variants 
that influence the risk of coronary heart disease (CHD) or myocardial 
infarction (MI). However, most of these studies have been performed in 
European populations. While some of the discovered variants may be 
universal in their effect, we believe that others will have different effects in 
different ethnicities. This can be due to differing gene-gene and gene-
environment interactions. In the present study, we performed a GWAS in 
South Asians from the INTERHEART study. In order to increase the 
chances to identify novel genetic regions, we compared early onset MI with 
older controls. We believe that this may also increase the chances for 
identifying less common variants. In order to assess the association of less 
common variants we used extended haplotype sharing comparisons as 
implemented in the software plink to identify regions and loci that contain 
multiple independent haplotypes that are shared identical by descent (IBD) 
between unrelated individuals. A single locus with multiple rare variants 
can be identified by demonstrating increased sharing among case pairs as 
compared to control pairs or case/control pairs. We have assessed and 
prioritized regions identified with this method by looking for overlapping 
signals from homozygosity mapping as well as Hardy Weinberg 
disequilibrium. We note one region in particular on chromosome 8p22 that 
showed the greatest signal of association. This region has been previously 
identified in a genome-wide linkage study of heart disease in the Quebec 
population. 
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Huntington disease (HD) is a neurodegenerative disorder that 
predominantly affects neurons of the forebrain. We have applied the 
Illumina massive parallel sequencing to deeply analyze the small RNA 
populations of two different forebrain areas, the frontal cortex (FC) and the 
striatum (ST) of healthy individuals and individuals with HD. More than 
80% of the small-RNAs were annotated as miRNAs in all samples. Deep 
sequencing revealed length and sequence heterogeneity (IsomiRs) for the 
vast majority of miRNAs. Around 80-90% of the miRNAs presented 
modifications in the 3'-terminus mainly in the form of trimming and/or as 
nucleotide addition variants, while the 5'-terminus of the miRNAs was 
specially protected from changes. Expression profiling showed strong 
miRNA and isomiR expression deregulation in HD, most being common to 
both FC and ST. The putative targets of the seed-region of deregulated 
miRNAs/isomiRs strongly suggest that their altered expression contribute to 
the aberrant gene expression of HD. Many REST (RE1-Silencing 
Transcription Factor) modulated miRNAs were downregulated in HD, 
suggesting that repressed REST target miRNAs play a role in aberrant gene 
expression in HD. Our results show that miRNA variability is a ubiquitous 
phenomenon in the adult human brain, which may influence the mechanism 
of gene expression modulation in physiological and pathological conditions. 
The charcaterization of different brain regions in other neurodegenerative 
disorders should uncover a myriad of IsomiRs involved in regulation of 
brain genes. 
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The most effective way to identify genes involved in a specific biological 
process is to create mutant strains that express the desired phenotype and 
identify the disabling mutation. Traditionally, this is accomplished using 
molecular techniques (e.g. complementation) or by linkage mapping. Such 
methods can be extremely time consuming, expensive, and are often not 
successful. High-throughput sequencing now provides a promising 
alternative: relatively inexpensive, complete re-sequencing of the entire 
mutant genome can quickly reveal the genes in which the mutations 
occurred. 
 
We have successfully applied this approach to the Toxoplasma gondii 
mutant strain F-P2, which exhibits a temperature-sensitive egress defect 
phenotype. The F-P2 mutant was originally isolated in 2001 and traditional 
attempts to identify the mutation since then have failed.  We shotgun 
sequenced both the parent and the F-P2 mutant using Illumina sequencers, 
at the Broad Institute, with 75 bp paired end reads. We aligned the reads to 
the reference using the Mosaik aligner.  Our alignment covered 97% of the 
genome at 5x coverage or greater, with an average coverage of 48x in the F-
P2 mutant and 38x in the parent. Using our Bayesian SNP caller program, 
GigaBayes, we identified 35 SNPs.  Using Sanger sequencing to verify the 
SNPs 25 have confirmed, 4 did not, and 6 are still in the processes of being 
sequenced. The SNPs were prioritized by possible biological significance 
and attempts to complement the mutation using wild type cosmids were 
begun. On our first attempt we identified a gene encoding a C2 domain-
containing protein that successfully complemented the mutation, confirming 
that this gene is responsible for the phenotype.   
 
Our study demonstrates the power of whole-genome sequencing for the 
identification of phenotypically important mutations that cannot be isolated 
with traditional genetic methods. Our pipeline is readily applicable for 
whole-genome mutational profiling for a range of genetically inaccessible 
organisms including many human parasites.  
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Rhesus macaques (Macaca mulatta) are the most widely used non-human 
primate in biomedical research. While the existing rhesus genome assembly 
is remarkably useful, the identification and validation of polymorphisms 
within this species, especially SNPs, will add significantly to its utility. 
Furthermore, it is advantageous to develop efficient strategies for 
identifying SNPs in draft genomes of additional species. More than 4.3 
million heterozygous nucleotide positions were identified as potential 
polymorphisms in the original reference assembly of the rhesus genome. 
We validated rhesus SNPs by re-sequencing the original reference animal 
and additional unrelated individuals using Next-Gen methods. Two 
strategies were used to bioinformatically validate SNPs: comparison of 
potential SNPs found in the same individual using two different sequencing 
chemistries and comparison of potential SNPs in different individuals 
regardless of chemistry. We validated ~1.3 million SNPs by comparing the 
assembly reference sequence (Sanger data) either to SNPs called by 
corona_lite from SOLiD re-sequencing of the reference animal or to the raw 
SOLiD reads analyzed using e-genotype (http://e-genotype.com/). We 
validated ~0.7 million additional SNPs by comparing SOLiD data from 
unrelated animals to the Sanger and SOLiD reference data. Approximately 
500,000 novel polymorphisms not observed in the reference animal were 
validated by comparing the SOLiD data from the two resequenced non-
reference animals. Altogether, we validated about 2.5 million SNPs in this 
genome, whereas previous work had validated fewer than 800 SNPs for this 
species. These data will be valuable for genetic analyses of complex 
phenotypes, population genetics, and management of captive breeding 
colonies and are being made available through appropriate on-line 
databases. Future work will investigate other forms of genomic variation in 
rhesus macaques, and apply this SNP identification methodology to new on-
human primate sequences (e.g. baboons, Papio hamadryas). 
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One of the key objectives of comparative genomics is the characterization 
of the forces that shape genomes over the course of evolution. In the last 
decades evidence has been accumulated that for vertebrate genomes also 
epigenetic modifications have to be considered in this context. Especially, 
the elevated mutation frequency of 5-methylcytosine (5mC) is assumed to 
facilitate the depletion of CpG dinucleotides in species that exhibit global 
DNA methylation. For instance, the underrepresentation of CpG 
dinucleotides in many mammalian genomes is attributed to this effect, 
which is only neutralized in so called CpG islands that are preferentially 
unmethylated and thus partially protected from rapid CpG decay. 
It has been shown that CpG decay is 10-fold stronger than any other 
genomic point substitution processes. Still, the number of evolutionary 
models that consider the methylation state of CpG dinucleotides is limited 
and substitution rates of 5mCpG and CpG dinucleotides are usually 
convoluted in the models.  
To bridge this gap, we here propose a comparative epigenomics approach 
that applies Markov models to the prediction of the germline methylation 
state of homologous genome regions from their multiple alignments. In a 
simulation study, we show that under the assumption of bimodal 
methylation states the model produces reliable predictions for homologous 
regions with divergence times up to 140 mya. Preliminary results on 
genomic DNA indicate that the model is applicable to comparative studies 
of closely related mammalian genomes. 
 
Key words: DNA methylation, CpG islands, comparative epigenomics, 
CpG depletion, germline, mammalian genome evolution, deamination 
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Confinement of genomic sequences plays a crucial role in biological 
processes. However, this presents a conundrum: dsDNA is a semiflexible 
polyelectrolyte with a persistence length on the same order of magnitude as 
the dimensions into which it is routinely confined. The result is a 1000-fold 
reduction in the volume occupied by the genome within the capsid relative 
to that of the unconfined genome. Bacteriophage have been shown to 
package their genome to such extremely high densities (as high as 55 
volume percent in many cases) through an active packaging "motor" that 
translocates dsDNA into the viral capsid. However, the mechanism by 
which the motor accomplishes this translocation has not been elucidated. 
Additionally, the conformations dsDNA takes on within the viral capsid are 
poorly understood at best. The present work employs a coarse-grained 
model for DNA (the so-called "Three Sites Per Nucleotide" Model) and 
molecular simulation techniques to probe the role played by the motor in 
the confinement of phage dsDNA. Specifically, the role that twisting of the 
genome during active packaging plays in the confinement process is 
interrogated over a range of twisting rates. Additionally, we use our model 
to study the response of dsDNA to the high curvatures and associated 
stresses encountered within the viral capsid. Local dehybridization is 
observed in regions with the highest curvature leading to a reduction in the 
local stresses encountered in those regions thus providing a viable 
mechanism for the extreme confinement of dsDNA observed in 
bacteriophage. 
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Non human primates (NHPs) are ideal animal models for systems biology, 
where the distinctions between human and rodent biology are particularly 
apparent. Systems approaches in humans – in contrast to NHPs – are limited 
by the difficulties of large-scale longitudinal investigations of multiple 
phenotypes and of collecting various tissues. The development of reagents 
for genome-level NHP investigations is now removing the major obstacle to 
NHP systems biology. I will discuss progress in establishing the vervet 
monkey as a model for genomic investigation, as well as planned projects of 
the newly formed Vervet Systems Biology Consortium (VSBC).  
Vervets, the most abundant natural hosts of Simian Immunodeficiency 
Virus (SIV), range throughout Sub-Saharan Africa, and their unusual 
population history makes them ideal for genetic investigations. Europeans 
brought small numbers of West African vervets to three Caribbean islands 
in the 17th-18th Century, where feral populations are now estimated to 
include ~105 monkeys. The Vervet Research Colony (VRC) was initiated in 
the 1970s with a few dozen Caribbean vervets, has since been maintained as 
a single extended pedigree, and now includes ~ 500 members. The 
development of a first generation vervet genetic map has stimulated genetic 
investigation of neurobehavioral and metabolic quantitative traits, and the 
establishment of the VRC Tissue Repository has facilitated large scale gene 
expression profiling studies, including pedigree-wide genetic mapping of 
expression quantitative trait loci (eQTL). Among the samples collected by 
the Repository are brain and peripheral tissues representing multiple 
developmental time points between birth and adulthood.  
Several coordinated initiatives are now increasing the scale of genome-level 
investigations in vervets. The vervet genome sequencing project is now 
generating a genome assembly and identifying genetic variants which can 
be assayed for genome-wide mapping of vervet phenotypes. To this end, 
NCRR has funded the collection of >2500 phenotyped samples from wild 
vervet populations in the Caribbean and Africa. These samples may be 
particularly informative for identifying host variants that protect against 
SIV-disease. Systems biology programs face the challenge of assembling 
diverse expertise and coordinating the multiple phenotyping and genomics 
efforts that provide their data. I will discuss our attempt to address this 
challenge in the VSBC.  
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Since the completion of the initial finished human genome sequencing, we 
have been trying to fill-in existing gaps or unmapped regions in the human 
genome reference sequence. Our major target chromosomes are Chr11, 
Chr18, Chr19, Chr21 and ChrY those we contributed in 
sequencing/finishing or have special biological interest. During the Human 
Genome Project, we constructed chromosome-enriched sheared fosmid 
libraries to each or set of chromosomes those isolated through chromosome 
sorting technology. In addition to screening of those libraries using 
traditional chromosome walking, we are also using short-read shotgun 
sequences obtained from whole genome or isolated chromosomes to design 
primers to fish out candidate clones that might fill or extend those gaps. The 
latter screening pipeline includes purification and mapping of 
IlluminaGAIIx reads onto the reference sequence; assembly then mapping 
onto other human genomes, characterization of hits against known 
annotations, screening of BAC and/or fosmid libraries if possible to isolate 
candidate clones for the gaps.  
Although our contribution might be small, we believe that continuing effort 
to improve the human genome reference sequence is very important and we 
wish to add genomic information and resources especially on sub-telomeric 
regions and un-cloned short arm regions of our target chromosomes. The 
progress of our effort will be presented. 
 91 
VARIANT VALIDATION AND SCREENING AT THE GENOME 
CENTER AT WASHINGTON UNIVERSITY SCHOOL OF MEDICINE 
 
Robert S Fulton1, Li Ding1, Vincent Magrini1, Michael D McLellan1, Daniel 
Koboldt1, Heather Schmidt1, Michelle O'Laughlin1, Rachel M Abbott1, 
Timothy J Ley2, Elaine R Mardis1, Richard K Wilson1  
 
1Washington University School of Medicine, The Genome Center, 4444 
Forest Park Avenue, St. Louis, MO, 63108, 2Washington University School 
of Medicine, Department of Medicine, Division of Oncology, 660 South 
Euclid Avenue, St. Louis, MO, 63110 
 
The emergence of next generation sequencing technologies has resulted in 
an explosion of data production capabilities and the capability to study 
entire human genomes on a daily basis. With this massive sequencing 
capacity expansion, the ability to call, validate, and screen additional 
samples for putative variants is essential. Although variant detection 
methods are ever improving, with greater sensitivity and specificity, the 
investment in generating the primary data, as well as the need to understand 
each genome’s exact mutation spectrum, means that validation of putative 
variants is still a necessary component. The Genome Center at Washington 
University has developed a robust, multi-platform, cost-effective validation 
platform, with the capability of validating variants at a comparable pace as 
the raw data production capabilities. The validation process is capable of 
leveraging Illumina, Roche 454, and ABI 3730 sequencing instruments. 
Template targeting is provided by either PCR or hybrid-capture. Both 
platform selection and template generation methods are determined based 
on scale, timeline, and data output requirements. The composition of the 
variant lists can include single nucleotide variants (SNV), small (< 20-30bp) 
insertion or deletion events, as well as structural variations including large 
(> 20-30bp), insertions or deletions, translocations, and inversions. 
Validation can be performed on single samples, panels of individuals that 
maintain individual genotypes, or pools of individuals providing pooled 
genotypes. Pooling strategies and sample barcodes are particularly useful 
when working with sample pools or panels, although they also can be 
applied for small sample sets such as tumor and normal samples. By 
enabling sample specificity using barcodes, more efficient use of the 
immense sequence throughput per run can be realized. In addition to current 
technologies, new methods and instrumentation are in development with 
new validation and screening procedures coming soon. Without these 
developments and continued confirmation of the detection methods, 
improvements and significant findings will not likely be produced as 
quickly, accurately, or effectively. This presentation will highlight many of 
the current methods and ongoing work to improve these processes. 
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In Hong Kong, foodborne infectious disease is a common public health 
issue and cases of foodborne disease outbreaks due to bacterial causative 
agents are frequent. There are 500 to 800 cases of food poisoning reported 
annually due to bacterial infection, with thousands of people affected. 
Therefore it is essential to have an effective surveillance system to screen 
for foodborne pathogens and to ensure safe food consumption. Salmonella 
enterica Typhimurium (ST) is a common causative agent of food poisoning 
in Hong Kong. Although symptoms (vomiting, diarrhea, abdominal pain, 
occasional fever) are self-limiting, death could occur from serious 
complications such as dehydration and septicemia. Traditional routine tests 
currently used for detecting ST take at least two days and rapid detection 
methods such as PCR- and microarray-based methods require prior 
knowledge of the ST genome sequence. Therefore this study aims at 
obtaining whole genome sequence information to identify ST isolates found 
locally in Hong Kong. The whole genome sequences from local isolates 
will provide tools for rapid and accurate identification of pathogens and 
allow the development of markers for identification. The study will also 
assist the epidemiological investigations of ST strains relevant to Hong 
Kong. The genome sequencing of a few Hong Kong ST isolates has been 
completed using the 454 pyrosequencing technology. The draft sequence 
will be used as a blueprint for the development of markers for rapid 
identification. The long-term aim is to use the genome sequence 
information to monitor the trend of foodborne diseases and to ensure that 
foods available in the community are safe for human consumption. 
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Expression QTL mapping is a potentially powerful means of dissecting the 
genetic basis of gene regulation. The availability of full genotype 
information suggests that we can now localize the true causal variants 
which drive differences in gene expression between individuals. However, 
even with full genotype data it is often difficult to distinguish true from 
closely linked variants by the strength of association with expression alone. 
We present an approach which integrates information from multiple 
different sources, such as DNase accessibility, histone modification state, 
predicted transcription factor binding sites, ChIP-seq and evolutionary 
conservation, to identify the most likely regulatory SNP for all human genes 
simultaneously. Our approach also provides an unbiased assessment of the 
ability of a large variety of methods to identify gene regulatory regions. By 
integrating information from a large variety of regulatory annotations, we 
identify almost 1400 variants with high posterior probability of being the 
causal regulatory SNP in the HapMap lymphoblastoid cell lines (LCLs). 
Our results demonstrate that DNase accessibility, some histone marks of 
gene activation and, to a lesser extent, certain computationally-predicted 
sites are useful predictors of eQTL location. Interestingly, binding sites for 
a number of key viral-response transcription factors identified using both 
ChIP-seq and DNase foot-printing are among the most highly eQTL-
enriched regions in the genome, suggesting that challenge with Epstein-Barr 
virus may be a key factor in determining the landscape of expression in 
LCLs. We suggest that our approach is a promising step towards dissecting 
the biology underlying human gene expression variation. 
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Transcription antisense to coding genes represents the majority of the stable 
unannotated transcripts in yeast and is prevalent also in humans. However, 
the genome-wide regulatory effects of antisense expression remain to be 
elucidated. We have performed a systematic analysis of sense-antisense 
expression in response to genetic and environmental variations in yeast. 
Antisense expression appears as an amplifier of gene expression response 
resulting in larger expression variability between cells in a clonal 
population, across genetic and environmental variations, and across species. 
Our results suggest pervasive antisense expression as a possible ancient 
mechanism for short-term and long-term adaptation by enhancing gene 
expression response to changes for genes with condition-specific functions. 
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Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease. 
SLE has a complex polygenic inheritance and susceptibility genes are 
shared with other autoimmune diseases. A GWAS for type 1 diabetes 
identified a nsSNP rs763361 in CD226 and the finding was replicated in 
other autoimmune diseases. We aimed to test if CD266 is associated with 
SLE and to dissect the mechanisms underlying the putative association. 
Twelve SNPs spanning CD226 were genotyped in 1194 SLE patients and 
1454 controls from Europe. A risk haplotype (P=1.69 x10-7) tagged by the 
rs727088-C allele and including rs763361 was detected in the 3’-UTR 
region. It was correlated with decreased levels of CD226 transcripts and 
protein levels. Reporter plasmids containing different risk alleles were 
employed to narrow the risk haplotype. Together, our data strongly support 
rs727088 as the functional variant responsible for the association with SLE. 
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RNA editing, the conversion of one base pair to another, has been found to 
play an important role in increasing transcriptome diversity. Several forms 
of editing have been discovered, such as adenosine-to-inosine (A-to-I) and 
cytosine-to-uracil (C-to-U) editing. Unlike many genomic scans for RNA 
editing sites, which rely on sequence from a single species, we used a 
Bayesian graphical model to search for conserved amino acid changing 
edits in multiple species. The model evaluates the probability of observing a 
conserved edit site in human, mouse, rat, dog, cow, and chicken given all 
available mRNA and EST data in GenBank. We did not limit our search to 
A-to-I and C-to-U candidates, but rather, looked for all possible types of 
base-pair substitutions in coding sequences.  
 
The top 13 A-to-I edits are all known, classical amino acid changing RNA 
editing sites. The only known C-to-U amino acid changing editing site 
ranked fourth in our list of predicted C-to-U sites. Consistent with the 
classically known cases of A-to-I editing, among the novel candidates there 
is a Gene Ontology (GO) enrichment for those genes that play a role in the 
plasma membrane and ion channel formation.  
 
Among our list of 214 predicted editing sites, there are 22 sites that are in 
the major histocompatability complex (MHC). Indeed, there is also a GO 
enrichment for the MHC class of genes. Most of the candidates in the MHC 
are recurrent single nucleotide polymorphisms in human and at least one 
other species. The MHC is well known for its high level of recurrent 
polymorphic sites in multiple species. Given the high number of MHC 
candidates, some of the other sites in our list may potentially be recurrent 
polymorphisms too.  
 
Identification of new RNA editing sites and novel forms of RNA editing 
will contribute to our understanding of the mechanisms of post-
transcriptional modifications. Furthermore, the discovery of new candidates 
of recurrent polymorphisms among highly divergent species potentially 
identifies sites under balancing selection and cases of trans-species 
polymorphisms.  
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Gene regulatory networks have been shown to share some common aspects 
with commonplace social governance structures. Thus, we can get some 
intuition into their organization by arranging them into well-known 
hierarchical layouts. Furthermore, these hierarchies can be placed between 
the extremes of autocratic ones, with well-defined levels and a clear chain 
of command, and democratic ones, without such well-defined levels and 
with more co-regulatory partnerships between regulators. In general, the 
presence of these partnerships decreases the variation in information flow 
amongst nodes within a level, more evenly distributing ‘stress’ across the 
network. Here we study a wide range of regulatory networks 
(transcriptional, modification and phosphorylation) in a hierarchical context 
for five evolutionarily diverse species, E. coli to Human. We specify three 
levels of regulators -- top, middle and bottom -- which collectively regulate 
the non-regulator targets lying in the lowest fourth level, and we define 
quantities for nodes, levels and entire networks that measure their degree of 
collaboration and autocratic or democratic character. We show that 
individual regulators have a range of partnership tendencies: some regulate 
their target genes in combination with other regulators in local instantiations 
of a democratic structure whereas others regulate mostly in isolation, in a 
more autocratic fashion. Overall we show that in all the networks studied, 
the middle level has the highest collaborative propensity and that co-
regulatory partnerships occur most frequently amongst mid-level regulators, 
an observation that has parallels in efficient corporate settings where middle 
managers need to interact most to ensure organizational effectiveness. There 
is, however, one notable difference between networks in different species: 
the amount of collaborative regulation and democratic character increases 
markedly with overall genomic complexity. 
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In a genomic screen investigating structural variation in Autism Spectrum 
Disorder (ASD) we detected a heterozygous deletion on chromosome 
10p12.1 at a frequency of ~1.4 % (6/427) spanning Patched-domain 
containing 3 (PTCHD3). Screening of another 177 autism probands yielded 
two additional deletions bringing the total to 8/604 (1.3%) in our ASD 
cohort. The deletion was found at a frequency of ~0.73% (27/3695) in 
combined controls from North America and Northern Europe 
predominately of European ancestry. Screening of the human genome 
diversity panel (HGDP-CEPH) yielded deletions in 7 (of 1043) unrelated 
individuals that were confined to those of European/Mediterranean/Middle 
Eastern ancestry. Breakpoint mapping yielded an identical 102,624 bp 
(chr10:27,643,753; 27,746,377; NCBI Build 35) deletion in all carriers 
tested suggesting a single ancestral event. RT-PCR and Northern blot 
analyses detected PTCHD3 expression in several tissues, with high level of 
expression in lymph node, testes and tongue. A novel shorter isoform for 
PTCHD3 was also characterized. Expression in transfected COS-7 cells 
showed PTCHD3 isoforms colocalize with calnexin in the endoplasmic 
reticulum. The presence of a patched (Ptc) domain suggests a role for 
PTCHD3 in various biological processes mediated through the Hedgehog 
(Hh) signaling pathway. However, further investigation yielded one 
individual with no obvious abnormal phenotype harbouring a homozygous 
deletion (PTCHD3 null). Exon sequencing of PTCHD3 in families with 
deletions showed compound point mutations also resulting in a null state. 
Taken together, these data indicate that PTCHD3 is a non-essential gene in 
humans. 
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Although Illumina shot-gun reads cover most genomes almost completely, 
sequences with extreme base compositions and idiosyncratic motifs (e.g., 
runs of G’s or C’s and AT dinucleotides) are often under-represented or 
missing. This unevenness in coverage hampers re-sequencing and de novo 
genome sequencing projects alike. 
 
To dissect the laboratory process and find the root cause of biases we 
developed qPCR assays for several categories of troublesome sequences in 
the human genome and tracked their abundance relative to well-behaved 
control sequences throughout the Illumina library preparation protocol. We 
also developed a panel of 36 qPCR assays for loci ranging from 6% to 90% 
GC that work well in a pool of three DNA samples of different base 
composition: P. falciparum (19% GC), E. coli (51% GC) and R. 
sphaeroides (69% GC). 
 
Following the standard protocol, we saw no significant GC bias up to and 
including the size-selection. However, GC-rich sequences were 
dramatically depleted during the subsequent PCR-enrichment when we 
applied the recommended conditions (Phusion DNA polymerase, 10s 
denaturation at each cycle). Simply prolonging the denaturation step (to 
80s) and/or adding betaine (2M) or using different polymerases (e.g., 
Accuprime Taq HiFi) significantly improved the representation of GC-rich 
sequences with little adverse effect on AT-rich loci. We found that PCR-
amplified Illumina libraries can be made that display essentially no 
systematic bias between 15% and 80% GC. 
 
The optimized PCR-amplified libraries are still somewhat more biased than 
PCR-free library preparations (especially at the very extreme ends of the 
%GC spectrum). Nonetheless, we chose the PCR protocol as our default 
process. In our experience, it is more robust and less wasteful than PCR-
free protocols and therefore a reasonable choice for high throughput 
processes handling a wide range of genomic DNA samples that vary in 
quality and purity and are often limited in quantity. 
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small RNAs (smRNAs) are established regulators of gene expression. These 
tiny molecules, once exclusively believed to affect post-transcriptional 
regulation, are emerging as important modulators of transcriptional rates as 
well. However, the mechanisms by which smRNAs regulate transcription of 
target genes remain unclear. We propose that smRNAs direct the action of 
histone-modifying enzymes, modulating interactions with promoters and/or 
non-coding RNAs present in promoter-proximal regions inducing long-term 
effects on gene expression. This is a novel model that would tie together 
endogenous smRNAs, noncoding RNAs, and the regulation of histone 
modifications, leading to long-term stabilization of gene expression. We 
have begun to define the relationship between small, non-coding RNA 
sequences and histone modifications through genome-wide analyses, and to 
explore the mechanisms by which epigenome-modifying complexes may be 
recruited by smRNAs to their target DNA sequences. Comparison of 
smRNAs identified in hESC by deep sequencing to previously published 
epigenomic data has identified a striking association between these two 
previously independent pathways. We have identified and characterized 
classes of smRNA sequences associated with specific chromatin 
modifications in human ES cells during neural differentiation. Using this 
characterization, we can begin to predict as yet unobserved smRNA-
mediated epigenetic effects, and experimentally confirm the functional 
interactions between smRNAs and histone modifications in hESC. RNA 
immunoprecipitation of known histone-modifying complexes has identified 
a subset of smRNAs that may be bound in complex. We are currently 
exploring the physical interaction between these smRNAs and chromatin. 
smRNA-directed epigenetic modifications represent a novel mechanism by 
which cells are capable of managing patterns of transcriptional regulation 
and these modifications are predicted to drive the stabilization of cell 
phenotypes during differentiation. 
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While SNVs and large structural variants in the human genome have been 
extensively studied, little is known about the functional impact of short 
insertions and deletions in the human genome, particularly at the individual 
genome level. Using evolutionary constraint as a proxy for function, we 
assessed the potential functional impact of the short (<11 bp) indels 
ascertained from four individual genomes (a Chinese, a Korean, a Yoruba 
and a Caucasian American). Our analysis reveals that there are as many as 
25,000 functional small indels in a single human genome. Despite 
differences between individuals in indel ascertainment, we observe 
consistent and strong selection against small indels in constrained sequences 
within each individual, demonstrating their functional importance. We use 
this signature of selection to investigate the evolutionary processes 
influencing selection on derived small human indels. We find that, 
collectively, putatively functional small indels could have a significant 
impact genome-wide on regulation of transcription and transcript 
processing. Our results provide insights into an important component of an 
individual’s genetic variation and suggest that the functional impacts of 
small indels deserve consideration during human genome sequencing 
studies. 
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We recently completed one-fold coverage sequencing of the genome of 
Neandertals, the closest extinct relative of modern humans. These data open 
a new avenue for revealing the instances of positive selection that have 
acted on our ancestors since they diverged from Neandertals approximately 
300,000 years ago. 
 
We have developed and implemented a new method for detecting instances 
of positive selection in ancient modern humans using present-day human 
polymorphism and Neandertal sequence data. This method relies on the 
convenient fact that much of the genetic variation within humans today was 
present at the time Neandertals diverged. Therefore, in most regions of our 
genome, we expect and find that Neandertals sometimes have derived 
alleles at human polymorphisms. However, in regions that have been 
subjected to positive selection, the variation within humans is not expected 
to be shared with Neandertals. By scanning the human genome for such 
regions we have identified several strong candidates for positive selection in 
genes involved in diet, cognitive traits, and skeletal morphology.  
 
We show, by simulating sequence evolution under both positive selection 
and neutral evolution scenarios, that our method can reliably detect 
instances of positive selection. The resulting signal can be further 
interpreted to indicate both the timing and intensity of selection. In contrast 
to previous scans for selection in humans, the Neandertal-based method has 
power to detect the occurrence of sweeps all the way back to the 
Neandertal-modern human population divergence. Thus, it offers an 
unparalleled opportunity to identify the last adaptive changes shared by all 
current humans. Finally, we demonstrate how Neandertal sequence data can 
be used in a secondary analysis to identify candidate causal genetic changes 
for driving these selective sweeps.  
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Whole-genome sequence data is a promising source of information about 
population history, yet it poses a serious computational challenge. 
MCMCcoal (Rannala and Yang, Genetics, 2003) is a Bayesian Markov 
chain Monte Carlo algorithm for inferring ancestral population sizes and 
split times, which is efficient enough for use with complete genomes. A 
major drawback of this algorithm, however, is its strict assumption of no 
gene flow between populations -– an assumption that can lead to biased 
estimates of the parameters of interest. We present a modification of this 
algorithm, called MCMCcoal-mig, that explicitly models inter-species 
migration in a general and flexible manner. Unlike existing tools that 
accommodate migration, our algorithm maintains the efficiency of 
MCMCcoal, allowing tens of thousands of loci to be analyzed. We present 
preliminary results based on simulated data that demonstrate the ability of 
MCMCcoal-mig to produce accurate parameter estimates in the presence of 
gene flow. 
 
MCMCcoal samples values for all model parameters (effective population 
sizes and split-times) together with a specific gene tree for each locus, under 
the assumption of no inter-population gene flow. In MCMCcoal-mig, gene 
flow is allowed by introducing migration into the coalescent model. In 
particular, we adapt the sampling procedure of MCMCcoal by introducing, 
removing, and perturbing migration events along each gene tree. These 
migration events draw complex dependencies between populations (which 
were otherwise assumed to be independent), necessitating a major revision 
in the way the likelihoods of gene trees are computed. The changes we 
implemented in the likelihood computation method actually ended up 
improving the efficiency of MCMCcoal. We performed several tests of 
MCMCcoal-mig on simulated datasets, demonstrating both an ability to 
detect inter-species migration, and an improved accuracy in parameter 
estimation in the presence of inter-species migration. We also examine the 
effect of allowing for migration in an analysis of the early history of human 
population evolution based on several individual human genomes, including 
the recently published Khoisan and Bantu genomes.  
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Integrative approaches are needed to disentangle the genetic and 
environmental contributions to complex trait susceptibility and to identify 
the underlying molecular mechanisms. To this end we have initiated the 
MuTHER project (www.muther.ac.uk) which aims to develop a resource of 
detailed genomic (SNP-genotyping, re-sequencing), transcriptomic 
(expression profiling), epigenomic (methylation) and metabolomic 
(metabolite profiling) data from a range of tissues (fat, skin, muscle, 
lymphocytes and LCL) collected from up to ~900 (1/3 MZ and 2/3 DZ) 
deeply-phenotyped twins from the TwinsUK resource. We find from initial 
analysis of the 826 fat biopsies analyzed that ~30% of expressed adipose 
transcripts have a heritability (h2) greater than 0.3, and that the most highly 
heritable subset (h2 > 0.6) show a significant enrichment for gene functions 
related to lipid metabolism. In addition, we find clear correlations of 
adipose gene expression traits with clinically relevant phenotypes such as 
DXA-derived fat mass (whole-body and abdominal), r= -0.59–0.62. 
Preliminary results from cis-eQTL analysis of a subset of heritable (h2 > 
0.3), fat mass-correlated transcripts (r>|0.4|) highlight strong cis-regulatory 
effects of numerous genes, including several genes known to play a role in 
adiposity. These will shortly be tested for association with obesity-related 
traits in the complete TwinsUK study. On-going efforts include extending 
the analyses to include transcriptomic/eQTL data from the additional tissues 
in combination with related clinical phenotypes as well as utilizing the twin 
design for accurate estimate of the genetic contributions to both gene 
expression and clinical phenotypes. This together with epigenomic and 
metabolomic data gathered within the project will greatly facilitate mapping 
the genetic architecture of complex traits. 
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Millions of Formalin Fixed Paraffin Embedded (FFPE) cancer tissue 
samples currently present in the US and worldwide provide an enormous, 
invaluable repository to the discovery of biomarkers in cancer research, 
drug development, diagnosis and treatment of diseases. However, the 
processes of fixation and storage of FFPE samples lead to degradation and 
base modification with chemical residues. This degraded FFPE DNA is 
inefficiently amplified in the Infinium® whole genome amplification 
(WGA) step leading to poor performance in the Infinium® assay. In this 
study, FFPE DNA (100 ng input) was restored through a treatment with 
DNA polymerase, DNA repair enzyme, ligase, and modified Infinium® 
WGA reaction conditions. Canonical genotype cluster files optimized for 
analysis of FFPE samples were generated from Covaris sheared Coriell 
DNA samples subjected to the restoration process and Infinium® assay. 
Results of genotyping on high density HumanCytoSNP-12 BeadChip®, 
featuring approximately 300k SNPs indicated that even moderately 
degraded FFPE samples with initial call rates of 40-70% prior to restoration 
can be successfully restored to a state with call rates greater than 90%, and 
concordance greater than 99.0%. In general, over 80% of FFPE samples, 
which passed a real time QC assay metric, were successfully restored and 
genotyped. Infinium® genotyping of restored DNA from a collection of 
tumor FFPE samples confirmed the presence of genomic aberrations around 
known cancer genes. Finally, we further demonstrated that paired sample 
analysis between normal and tumor samples provided improved precision in 
CNV and LOH analysis compared to single sample analysis.  
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The use of next-generation RNA sequencing (RNA-Seq) has facilitated the 
global expression profiling of cancer transcriptomes at a resolution 
previously unattainable by other methods. In particular, RNA-Seq is able to 
reveal gene fusion transcripts arising from genomic rearrangements, and 
novel transcript isoform variants arising from alternative splicing, both of 
which have been implicated in cancer pathogenesis. Here, we sought to 
identify gene fusion and isoform transcripts expressed in BRCA1-mutated 
breast cancers which may contribute to the observed phenotype. Mutations 
in BRCA1 are known to contribute to early onset breast and ovarian cancers. 
Using RNA-Seq on the Illumina Genome Analyzer platform, we have 
characterized and compared the transcriptomes of four breast cancer cell 
lines and one primary tumour with known BRCA1 mutations. Applying 
previously described as well as novel strategies, we were able to identify 
several candidate gene fusions, including the known NFIA-EHF fusion in 
the HCC1937 cell line identified by Stephens et al. (Nature, 2009). EHF is 
a member of the ETS transcription factor family that is frequently 
rearranged in cancers such as the prostate. We have also identified novel 
splicing events that are present in more than one sample. We will present 
findings from our comparative analysis thus far and demonstrate the utility 
of RNA-Seq for investigating cancer transcriptomes. 
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Bacteria of the genus Streptomyces are known as producers of natural 
products, including clinically used antibiotics, antifungals, anticancer 
agents, antiparasitics, immunosuppressants, and anti-obesity drugs. We 
have generated high-quality draft sequences of twenty new actinomycete 
genomes, of which 16 are Streptomyces species. Comparisons between the 
Streptomyces linear genomes revealed that they are partitioned into a central 
region enriched in core functions flanked by chromosome arms enriched in 
auxillary functions, including natural product biosynthetic genes, which 
vary greatly in type and size between strains. The core genome is well 
conserved, with localized gene order conserved across the most distantly 
related species.  
 
Our pan-genomic survey of Streptomyces allowed for genus-level 
comparisons with alternate pan genomes, allowing insights into properties 
that are characteristic of this genus. For comparative analysis, we selected 
nine comparator Eubacterial genera, requiring at least eight members with 
sequenced genomes and intra-genus phylogenetic distances comparable to 
that of the streptomycetes analyzed. Based on pan genome comparisons, we 
show that streptomycetes are exceptional in three ways: they have a larger 
fraction of auxiliary genes than other genera; they encode large repertoires 
of secondary metabolite biosynthetic gene clusters; and their dynamic 
chromosome arms appear tuned to specialized biological functions. 
 
This project has been funded in whole or in part with Federal funds from 
the National Institute of Allergy and Infectious Diseases National Institutes 
of Health, Department of Health and Human Services, under Contract No. 
HHSN272200900006C 
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Deep sequencing approaches can interrogate genomes and transcriptomes at 
unprecedented resolution to reveal major molecular alterations. Transcriptome 
profiling with next-generation sequencing (RNA-Seq) has dramatically changed 
our understanding of the extent and complexity of eukaryotic transcription. 
RNA-Seq provides more accurate measurements of gene expression and enables 
the quantification of the relative abundance of transcript isoforms. More 
recently, RNA-Seq has been applied to discover chimeric transcripts, where 
mRNAs of two genes are joined together. Such chimeric transcripts arising 
from genomic rearrangements have shown to be driving the molecular events in 
cancer. 
Here we describe a computational framework, FusionSeq, to process and 
analyze paired-end (PE) RNA-Seq data to detect fusion transcripts. This 
framework consists of three modules: a fusion transcript detector, a filtration 
cascade, and a junction-sequence identifier. The fusion-transcript-detection 
module finds candidate chimeric transcripts from PE reads joining two genes. 
The filtration-cascade module discards candidates with artifacts such as 
misalignment due to homology or random pairing of transcript fragments. The 
junction-sequence identifier module unravels the exact sequences at the 
breakpoints. Furthermore, to prioritize experimental validation, FusionSeq 
ranks the candidates by several statistics, including SPER (supportive-PE-reads-
per-million mapped reads) and the comparison between the observed SPER and 
various expectations. To calibrate this method, we deeply sequenced six cancers 
harboring known genomic rearrangements, one sample with no known 
rearrangements and one normal HapMap cell line. We demonstrate that 
FusionSeq is able to identify known fusions as well as characterize different 
isoforms of these events. Moreover, we show that no fusions are detected in the 
samples known not to have rearrangements. Finally, FusionSeq was able to 
detect two novel fusions in the cancer samples that were subsequently 
experimentally validated. 
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DNA methylation may play an important role in the etiology of 
neuropsychiatric disorders, perhaps as equally important as genetics and the 
environment. However, In order to better understand both the wild type 
genomic DNA methylation patterns and aberrant methylation events that occur 
in disease states, we first examined DNA methylation profiles within the normal 
human brain. We have developed a cost-effective, unbiased, whole-genome 
methylation profiling technique that can assay the methylation state of more 
than 80% of the CpG sites in the human genome. This method, methylation 
mapping analysis by paired-end sequencing (Methyl-MAPS) couples advances 
in next generation sequencing with enzymatic fractionation of DNA by 
methylation state. 
In this large-scale study we have mapped the methylation state of 36% of CpG 
sites in the human cerebral cortex of 10 normal non-psychiatric subjects 
(including 6 prefrontal and 4auditory cortical samples). We focused on the 
prefrontal cortex (PFC) due to converging evidence from neuroimaging and 
functional studies implicating this region in both depression and schizophrenia. 
Secondarily, we also examined the auditory cortex, because schizophrenia 
disorder includes defects in sensory perception and processing. With these data 
we are for the first time able to explore DNA methylation profiles within two 
distinct brain regions with differing neurodevelopmental trajectories; the 
evolutionarily conserved auditory temporal cortex developing early as 
compared to the prefrontal cortex which undergoes maturation well into early 
adulthood. Our data reveal that DNA methylation is significantly more 
conserved in the auditory cortex then the PFC (P<10-15). Despite this 
significant difference, DNA methylation signatures in the cortex are highly 
conserved, with >25% of the total CpG sites in cortex showing less than 20% 
difference in methylation state across the 10 samples examined. Cross-species 
analysis of DNA methylation conservation between human and mouse brains 
show that DNA methylation is not correlated with sequence conservation. 
Instead, increase in cross-species DNA methylation conservation is correlated 
with increasing CpG density. Genomic regions with significant human-mouse 
DNA methylation conservation (correlation >80%) typically have greater than 5 
CpG dinucleotide in 100bp window. Although enriched in gene promoters, 
these regions also cover gene bodies, as well as repeat sequences that represent 
both methylated and unmethylated states. These data provide insight in studies 
of neuropsychiatric disorders, in identifying genomic regions that are 
developmentally and evolutionarily conserved that when aberrantly methylated 
may confer increase risk for disease.  
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Structural variation (SV) is a rich source of genetic diversity in mammals, 
but due to the challenges associated with mapping SV in complex genomes, 
basic questions regarding their genomic distribution and mechanistic origins 
remain unanswered. We have developed an algorithm (HYDRA) to localize 
SV breakpoints by paired-end mapping, and a general approach for the 
genome-wide assembly and interpretation of breakpoint sequences. We 
applied these methods to two inbred mouse strains: C57BL/6J and DBA/2J. 
We demonstrate that HYDRA accurately maps diverse classes of SV, 
including those involving repetitive elements such as transposons and 
segmental duplications, however our analysis of the C57BL/6J reference 
strain shows that incomplete reference genome assemblies are a major 
source of noise. We report 7196 SVs between the two strains, more than 
two-thirds of which are due to transposon insertions. Of the remainder 59% 
are deletions, 26% are insertions of unlinked DNA, 9% are tandem 
duplications, and 6% are inversions. To investigate the origins of SV we 
characterized 3316 breakpoint sequences at single nucleotide resolution. We 
find that approximately 16% of non-transposon SVs have complex 
breakpoint patterns consistent with template switching during DNA 
replication or repair, and that this process appears to preferentially generate 
certain classes of complex variants. Moreover, we find that SVs are 
significantly enriched in regions of segmental duplication, but that this 
effect is largely independent of DNA sequence homology and thus cannot 
be explained by non-allelic homologous recombination (NAHR) alone. This 
result suggests that the genetic instability of such regions is often the cause 
rather than the consequence of duplicated genomic architecture. 
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An immunorepertoire is the sum of functionally diverse B and T cells in 
circulation at any given moment. The antigen receptors of T and B cells are 
produced by somatic recombination of a limited, but large number of gene 
segments: V, D, and J, which determine the specificity of antibodies and T 
cell receptors. Because the list of possible V, D, J arrangements is so 
extensive, studying immunorepertoires is challenging. Additional 
mechanisms such as somatic hypermutation in B cells, N addition, and 
nibbling before insertions contribute to an even higher level of diversity. 
Another challenge is the scarcity of samples. Each V(D)J arrangement may 
only be represented by a few cells in a peripheral blood sample. Therefore, 
to study the immunorepertoire comprehensively, a method to amplify the 
V(D)J signal from a limited amount of sample is crucial. Even more 
challenging is the requirement for such a method to be inclusive and semi-
quantitative, so the sample’s original V(D)J diversity and distribution can 
be evaluated without any bias associated with the amplification process. 
However, such a multiplex PCR assay is difficult to develop, mainly 
because of incompatibility among the primer sets used in the amplification 
system. Other difficulties encountered when using conventional multiplex 
PCR include high background caused by primer dimers and non-specific 
amplifications, poor reproducibility, and inefficient amplification of V(D)Js 
in B cells due to somatic hypermutations. Amplicon rescued multiplex PCR 
incorporates hundreds of VDJ specific primers in one reaction, semi-
quantitatively amplifying all the expressed VDJs in B and T cells in an 
RNA sample. The amplicon mixture is then subjected to high-throughput 
sequencing with the next-generation Roche 454 platform. In one run, more 
than 174,495 and 176,095 unique V(D)Js were obtained from B and T cells, 
respectively.This novel technology can be used to uncover disease 
mechanisms associated with abnormal immunorepertoires, to evaluate 
vaccine efficiency, to identify new biomarkers, and to develop new 
therapeutics. An online dababase and unique analytical tools have been 
developed for data sharing, deposition, and mining. 
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In recent years, the NIH Intramural Sequencing Center (NISC) has been 
performing large scale, PCR-based Sanger sequencing of genes of interest. 
To date, we have sequenced over 4.2Gb of genomic sequence in more than 
5,000 individuals, depositing over 3.8 million Sanger traces into the NCBI 
trace repository. Recently, we have begun to perform whole exome capture 
and Next Gen sequencing on some of these same samples using solution 
hybridization selection (SHS) and sequencing by synthesis (SBS) 
technologies. We plan to complete more than 200 whole exomes this year. 
To analyze this data, we have developed an informatics pipeline that 
performs paired, gapped alignments of paired-end short reads using Eland 
and cross_match, detection and genotyping of single nucleotide and 
deletion/insertion variants using our own Bayesian genotype caller, "MPG", 
and functional annotation of protein-coding variants with CDPred, which 
uses evolutionary conservation in protein domains in a position-specific 
manner to predict severity of observed amino acid substitutions.  
 
Comparison of these second generation-based variants with our rich data set 
of Sanger derived genotypes and SNP genotyping chip based assays shows 
our genotypes to be 99.8% accurate. Called variants are stored in a 
production scale Oracle database, along with functional annotation of 
coding and splice-site variants, allowing for quick identification of novel 
variants of interest that conform to expected Mendelian inheritance models. 
These automated predictions and annotations are then displayed through a 
wiki, allowing researchers to make notes and commentary suggesting 
further investigations. 
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The commitment of multipotential progenitor cells to a particular lineage 
and the differentiation and maturation of that lineage are driven by 
induction of lineage-specific genes and repression of others. Gene 
expression is regulated by occupancy of cis-regulatory modules by 
transcription factors, recruitment of co-activators and co-repressors and 
modifications of the chromatin structure, but a full picture of these 
epigenomic features and how they result in induction versus repression of 
specific genes is not yet available. We explore these questions in a mouse 
cell line model of erythroid maturation. A genetic knockout of the gene 
Gata1 in the G1E cell line arrests differentiation at the proerythroblast 
stage, and rescue by expressing the transcription factor GATA1 in a subline 
allows the cells to mature to erythroblasts. We have measured 
comprehensively changes in gene expression during this GATA1-dependent 
maturation and concomitantly, genome-wide occupancy by the transcription 
factors GATA1, GATA2, TAL1, and CTCF, as well as chromatin 
accessibility and histone modifications in the chromatin, using Illumina 
sequencing technology for ChIP-seq. The changes in protein occupancy and 
histone modification levels after restoration of GATA1 should reveal 
features that can account for the expression patterns of the genes and their 
differential response to GATA1. Surprisingly, we find that only limited 
changes in histone modification status accompany the substantial changes in 
gene expression, and rather than altering chromatin structure upon 
restoration, GATA1 binds to genomic sites that already have activating 
histone modifications. However, the occupancy of CRMs by specific 
transcription factors and changes in H3K4me3 at the transcription start site 
do explain a considerable amount of the largest responses in gene 
expression. 
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Targeted sequencing of candidate genes in individuals at the extremes of a 
quantitative phenotype distribution is a method of choice to analyze the 
contribution of rare variants to disease susceptibility. The endocannabinoid 
(EC) system mediates signaling in the brain and peripheral tissues involved 
in the regulation of energy balance, is highly active in obese patients, and 
thus a strong candidate pathway to examine genetic association with BMI. 
We sequenced two intervals (188kb) encoding the EC metabolic enzymes, 
FAAH and MGLL, in 147 normal controls (BMI≤30) and 142 extremely 
obese cases (BMI≥40). After applying quality filters, we called 1393 SNVs, 
55% of which are rare (MAF<0.01), and 143 indels. We used two different 
approaches, single marker tests and collapsed markers tests, to identify 4 
intervals associated with BMI: the FAAH promoter, MGLL promoter, 
MGLL intron 2, and MGLL intron 3. Two of these intervals are composed 
of rare (MAF<0.01) variants, one of rare and low frequencies (MAF≈0.03) 
variants and one of common (MAF≈0.15) variants. The majority of the 
associated variants are located in promoters or in predicted transcriptional 
enhancers, suggesting a regulatory role. Additionally, we demonstrate that 
the set of rare variants in the FAAH promoter associated with BMI are also 
associated with increased level of FAAH substrate AEA, further implicating 
a functional role in obesity. Our study provides insights into study design 
and analysis approaches and demonstrates the importance of examining 
regulatory elements rather than exon sequences. 
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RGASP: RNASEQ GENOME ANNOTATION ASSESSMENT PROJECT  
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RNAseq is revolutionizing eukaryotic transcriptomics and highlighting the 
extent different loci are alternatively spliced. Following the successful 
format of the EGASP workshop in 2005, the RNAseq genome annotation 
assessment project was launched to assess the current progress of automatic 
gene building using RNAseq as its primary dataset. The goals of the 
analysis are to assess the success of computational methods to correctly 
map RNAseq data to the genome, assemble transcripts and quantify their 
abundance in particular datasets. Data from different sequencing platforms 
(illumina, SOLID and Helicos) were analysed as well as transcriptional data 
from three different organisms Human, Drosophila and C.elegans, since the 
genome and reference annotation is of high quality.Eighteen groups 
submitted transcript predictions which were evaluated against annotation 
datasets for the three organisms. In addition human chromosomes 3 and 4 
were newly manually annotated by the GENCODE consortium as an 
additional “blind” test. Quantification predictions on transcript level are 
being compared against a gold standard subset of 100 loci selected for each 
organism. Probes are being designed against at least two transcripts per loci 
and nanostring experiment performed, since it is a non-RTPCR derived 
method, to quantify the transcripts. The first round analysis proved 
challenging because of the volume of data submitted and the variation in 
data sets (ie pair-end, single and directional data from human K562 cell 
line). Actually defining the gold standard gene set expressed in particular 
tissues also raised much debate. Therefore the outcome of the workshop 
was to rerun the prediction algorithms on a more standardize dataset (75bp 
pair end read set,at similar depth of sequencing and limit submission to 3 
per organism). In addition the submitter were asked to supply BAM 
alignment files so the read alignments against the genome and annotation 
could be analysed. Closing date for resubmission was 22nd Jan 2010 and 12 
groups resubmitted. The results of the second phase of RGASP will be 
presented at the meeting including the results of experimental validation of 
novel predictions.  
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Since microRNAs are required for both maintenance of stem cell 
pluripotency and differentiation, and since many more microRNAs have 
been computationally predicted in genome than have been found, there are 
likely to be many previously unknown microRNAs expressed early in 
differentiation. We used deep sequencing of small RNAs from 
undifferentiated human embryonic stem cells (hESC) and neural-restricted 
precursors to computationally predict 818 novel microRNA genes. These 
predicted genomic loci are relatively unique to humans or primate mammals 
and are found to be associated with patterns of modified histones consistent 
with gene expression. A subset of 146 of the predictions was found to be 
enriched in Ago2-containing complexes, consistent with RISC-associated 
microRNAs. Expression of these novel microRNAs parallels the patterns of 
developmental regulation of other microRNAs and some 30% of the novel 
microRNAs share seed elements with other microRNAs. To demonstrate 
function of these microRNAs, we have devised a strategy to detect 
bioactivity of all microRNAs in cultured cells using synthetic response 
elements built into a library of GFP-expressing plasmids. The presence in 
hESC of a broad collection of developmentally-regulated novel 
microRNAs, lacking broad species conservation but associated with Ago 
and having detectable bioactivity, predicts a role in modulating gene 
expression during differentiation.  
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BARCODING DNA IN POOLED LIBRARIES IMPROVES VARIANT 
SENSITIVITY OVER A POOLED PCR APPROACH 
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Gabriel  
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A major goal of medical sequencing is the identification of rare variants across 
many individuals. One approach is to sequence DNA libraries formed by 
pooling DNA from multiple individuals, optionally ligating the DNA fragments 
at their 5' ends with 6-base oligonucleotide "barcodes" identifying the DNA 
originator. Without barcodes, only population frequencies can be estimated for 
each variant, whereas barcoding allows direct computation of genotypes for 
each sample in the library.  
 
We evaluated these two approaches with data from the Framingham Heart 
Study (FHS). Sequencing for FHS is approached in two phases: a pooled phase 
using PCR; and a barcoded hybrid-capture phase. Associated with each phase is 
a pilot study, using DNA from individuals with known HapMap genotypes. 
 
The pilot for unbarcoded pooled PCR libraries uses DNA from 117 CEU 
individuals, combined into 3 pools of 40 individuals (3 appear in two pools). 
The barcoded library, comprised of 24 individuals, was prepared using solution 
hybrid selection. Comparisons of recovery rates were performed on the 
intersection of the target regions of the two pilots. 
Library Unbarcoded Barcoded 
Samples 117 24 
Genes 163 163 
Coverage 2000x 1000x 
Calls 1221 898 
HapMap Variants 502 291 
HapMap Singletons 111 54 
Sensitivity 80% 98% 
Sensitivity to Singletons 24% 98% 
 
The vast increase in barcoded hybrid selection's sensitivity over that of pooled 
PCR may be due to the fact that sequencing artifacts at a rate of 1-2% are often 
indistinguishable from a 1-2% allele. Associating reads with individuals 
increases the tolerance to sequencer errors, as true variation is expected to 
appear at 50% or 100% for each individual. These results inform the design of 
FHS production sequencing, which will use barcoded hybrid selection to 
maximize power to detect rare variants.  
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DYNAMICS AND DIVERSITY OF THE DROSOPHILA 
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Drosophila melanogaster is perhaps the most widely studied metazoan 
organism, yet the genome still contains numerous unannotated genes, non-
coding RNAs, alternatively spliced isoforms, and RNA editing sites. Our 
understanding of the temporal and spatial patterns in which these genes are 
expressed, spliced, and edited to direct development remains limited. I will 
describe several ongoing projects that are aimed at understanding the 
dynamics and diversity of the Drosophila transcriptome. As part of the 
modENCODE project, we have generated over 2 billion uniquely mapped 
single and paired-end RNA-seq reads using the Illumina platform from 
poly(A)+ RNA isolated from 30 time points throughout development.  In 
parallel, we performed strand-specific sequencing of 12 total, rRNA-
depleted embryonic RNA samples using the SOLiD platform. These data 
have identified many new genes and thousands of alternative splicing 
events resulting in the discovery of new mRNA and inferred protein 
isoforms. Second, using paired-end RNA-Seq of RNA isolated from 
Drosophila interspecies hybrids, we have identified ~80 genes that undergo 
trans-splicing, in which the mRNAs are synthesized by splicing exons from 
two different pre-mRNAs. Finally, we have been working to understand the 
true diversity of transcripts that are expressed from the Drosophila Dscam 
gene, which has the potential to generate up to 38,000 isoforms. We have 
developed a three read sequencing method using the Illumina platform and 
have found that over 92% of the predicted isoforms are indeed expressed, 
and that these are regulated throughout development. Together, these 
studies provide tremendous new insight into the extraordinary diversity and 
regulation of the Drosophila transcriptome. 
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Little is currently known in how variation in individuals of chromatin 
structure and transcription factor binding influence phenotypes. We have 
catalogued both individual variation and allele-specific variation in 
chromatin structure, using DNaseI, FAIRE and Chip assays in cell lines 
from the 1,000 genomes project. We used high coverage trios for in-depth 
analysis and selected loci for sampling more individuals. ~10% of active 
chromatin sites were individual-specific, and ~11% were allele-specific. We 
specifically confirmed some allele specific signals using a mass 
spectroscopy assay. Both individual-specific and allele-specific sites were 
commonly transmitted from parent to child, showing that they are heritable. 
Using the structure of the families compared to signals on unrelated 
individuals we can show that there is a local, cis-based genetic component 
to this heritability. 
 
We examined the functional role of this individual and allele specific 
variation by comparing to known molecular phenotypes, such as RNA 
expression and to X-inactivation in the female individuals. As expected 
there is a strong signal of allele specific chromatin data on X. Interestingly 
variation in RNA expression has a different pattern of correlation to 
variation in either DNaseI or to CTCF individual expression. This study 
shows we have the ability to accurately measure such chromatin variation 
and its downstream impact on phenotypes, providing opportunities to 
correlate this information with other more complex phenotypes in the 
future. 
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Genomes are known to be organized into 3D structures in vivo through 
interactions with protein factors for nuclear process such as transcription, 
and DNA elements separated by long genomic distances are known to 
functionally interact. This view has been further emphasized by recent 
observations that many transcription factors bind remotely to gene 
promoters. However, it is still largely unknown to us how and to what 
extent chromatin interactions are involved in transcription regulations on a 
whole genome scale. To study these questions, we have developed the 
Chromatin Interaction Analysis using Paired-End-Tag sequencing (ChIA-
PET) strategy for de novo detection of genome-wide chromatin interactions, 
and demonstrated this approach through the comprehensive mapping of 
chromatin interactions involved in transcription regulations mediated by 
estrogen receptor α (ERα) in a human genome (Nature 2009 462: 58-64). In 
order to map all chromatin interactions involved in all transcription 
regulation networks in the human genome, we have applied the ChIA-PET 
strategy to active transcriptional marks such as RNA polymerase II 
(RNAPII) and trimethylation of lysine 4 on histone H3 (H3K4me3) as 
analysis targets in a number of human cells. Our results have shown that 
both RNAPII and H3K4me3 are excellent targets for ChIA-PET 
experiments to detect long-range chromatin interactions between gene 
promoters and distal regulatory elements, as well as to identify co-
localization of remote genes (intra-chromosome and inter-chromosome) in 
close proximity of nuclear space. Through comprehensive mapping of 
chromatin interactions and transcriptional activities, we have revealed that a 
large proportion of actively transcribed genes are involved in extensive 
chromatin interaction looping structures. The most abundant gene-centric 
chromatin interactions are appeared to be within local range of megabase 
genomic span, and nearby genes such as gene family members are 
organized to share common transcription factories. In addition, we have 
identified many hot spots of interaction hubs, in which clusters of genes 
crossing large megabase distance and different chromosomes are co-
localized in close proximity. Collectively, our data suggests that long-range 
chromatin interaction is a primary mechanism for transcription regulation in 
human genomes. Further analyses of the chromatin interaction and 
transcription maps will provide deep insights to advance our understanding 
of transcription regulatory networks and the human genome biology. 
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The goal of the modENCODE project (model organism ENCyclopedia of 
DNA Elements) is a systematic identification of all functional elements in 
fly and worm and their dynamics across development and in multiple 
cell lines, through large-scale data generation and integration, 
including gene expression, transcription factor binding, chromatin 
modifications, histone variants, microRNAs. 
 
In this talk, we describe the data integration efforts of the 
Drosophila consortium. We have used supervised and unsupervised 
probabilistic methods for combining multiple datasets to define active 
and repressed promoter regions, tissue-specific and stage-specific 
enhancers, and a map of insulator elements and regulatory units. We 
have used comparative genomics methods to define conserved regulatory 
motif instances within these regions that are associated with 
functional binding of transcriptional regulators. We have combined 
these datasets to gain insights into gene regulation, including 
defining candidate tissue-specific regulators of active and repressed 
regions, identifying combinations of regulatory motifs predictive of 
transcription factor binding by their synergistic and antagonistic 
effects, and combinations of transcription factors predictive of 
distinct chromatin states at specific stages of development. 
 
Overall, our integrative analysis provides a general framework for 
studying the logic of transcriptional regulation in metazoan genomes 
from systematic large-scale genomic and epigenomic datasets, 
assembling the building blocks of gene regulation, towards a 
systems-level mechanistic understanding of regulatory control. 
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Rare monogenic diseases have been of incredible value to biomedical 
research, as the identification of the genes underlying phenotypes of interest 
has yielded fundamental, medically relevant insights into human biology. 
However, many rare disorders have yet to be solved. In many cases, this is 
because only a small number of cases/families are available, limiting the 
power of traditional gene mapping strategies. As most disease-causing 
variants affect coding sequences, comprehensive sequencing of all genes in 
affected individuals has the potential to serve as a genome-wide scan for the 
underlying cause of a rare monogenic disease. Consequently, we have 
sought to apply second-generation methods for targeted sequencing of the 
human exome as a cost-effective, genome-wide scan for coding mutations 
underlying monogenic diseases that is independent of linkage data or 
assumptions inherent to a candidate gene approach. Our progress includes 
the proof-of-concept demonstration that Freeman-Sheldon syndrome, an 
autosomal dominant disorder previously determined to be caused by 
mutations in MYH3 through a candidate gene approach, could be solved 
directly by exome sequencing. More recently, we applied exome 
sequencing to identify DHODH as the causative gene for Miller syndrome, 
a previously unsolved, autosomal recessive disorder. We are currently 
extending this strategy to additional genetic diseases of unknown etiology. 
Low-cost, high throughput technologies for exome resequencing have the 
potential to rapidly accelerate the discovery of candidate gene(s) and 
mutations that underlie rare monogenic diseases that have been resistant to 
conventional analysis. This strategy may also be applicable to the 
identification of rare variants contributing to diseases with more complex 
genetics through larger sample sizes, better filters against common variants, 
and appropriate weighting of nonsynonymous variants by predicted 
functional impact. 
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The transcriptional networks that control organism development are precise, 
highly coordinated, and complex. Our ability to analyze these networks is 
limited because existing methods cannot trace transcription factor binding 
throughout a cell lineage, making it impossible to correlate DNA-binding 
events in progenitor cells to the final cell fates of their progeny. We report 
on our progress towards developing transposon “Calling Cards”, a 
technology that combines aspects of ChIP-Seq and lineage tracing. The 
method entails fusing the transposase of a transposon to a transcription 
factor, thereby causing it to direct the insertion of transposon DNA into the 
genome near where it binds. The transposon becomes a "Calling Card" that 
permanently marks the transcription factor's visit to that place in the 
genome. By recovering these Calling Cards along with some of the genomic 
DNA that flanks them and then determining their DNA sequences, it is 
possible to map the genome-wide binding history of the transcription factor. 
As a proof-of-principle, we have implemented Calling Cards in yeast, and 
multiplexed the method, mapping the binding of 8 transcription factors in a 
single expeirment. Recently, we have ported the method into a mammalian 
system and benchmarked our results to ChIP-Seq. 
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We present two complementary approaches to detect methylated and 
unmethylated genomic DNA. The first, methyl DNA immunoprecipitation 
and sequencing (MeDIP-seq), uses antibody-based immunoprecipitation of 
5-methylcytosine and sequencing to map the methylated fraction of the 
genome. In the second method, unmethylated CpG sites are identified by 
sequencing size-selected fragments from parallel DNA digestions with the 
methyl-sensitive restriction enzymes (MRE-seq). We generated a genome-
wide, high-resolution methylome map of human brain tissue, and a second 
map of human ES cell H1. These maps on average interrogate close to 90% 
of all CpGs (25 million of 28 million total) and 98% of CpG islands in the 
human genome, at the modest expense of relatively small amount specimen 
and a few lanes of Illumina flowcell. 
 
We investigated the role of DNA methylation in gene bodies with these 
methylome maps. From high-resolution coverage of CpG islands, the 
majority of methylated CpG islands were revealed to be in intragenic and 
intergenic regions, while less than 3% of CpG islands in 5’ promoters were 
methylated. The CpG islands in all three locations overlapped with RNA 
markers of transcription initiation, and unmethylated CpG islands also 
overlapped significantly with trimethylation of H3K4, a histone mark 
enriched at active promoters. The general and CpG-island-specific patterns 
of methylation are conserved in mouse tissues. These and other results 
support a major role for intragenic methylation in regulating cell context-
specific alternative promoters in gene bodies.  
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To gain insights into the global and local organizaiton of nucleosomes in 
primary human cells, and understand mechanisms that govern this organization, 
we performed high-resolution mapping of genome-wide nucleosome 
organization in three primary human cell types. To understand sequence-
dictated rules that govern nucleosome organization, we reconstituted human 
genomic DNA with recombinantly derived nucleosome particles in vitro, and 
sequenced nucleosome bound DNA fragments to high depth. Across these 
experiments, we have obtained 2.2 billion mapped SOLiD sequence and 
additional 240 M RNA-seq reads to determine expression levels of these cells. 
Our analysis of in vivo and in vitro nucleosome organization revealed highly 
unexpected results that help us better understand organization of chromatin. 
Human chromatin contains a large number of sites with stereotypically 
positioned nucleosomes that are also evenly spaced relative to each other 
(nucleosome phasing). Our in vitro experiment informed that many sites 
throughout the human genome encode stereotypically positioned nucleosomes 
by their underlying DNA, but this positioning signal does not account for 
phasing of nucleosomes observed in vivo. Sites that encode stereotypic 
positioning of nucleosomes in vitro, contain a novel sequence signal that is not 
based on 10 bp dinucleotide periodicities, as was previously thought, but rather 
contains a specific sequence motif. The same DNA signal positions 
nucleosomes in vivo across the three primary cell types. 
We observe a significant deviation from the sequence-dictated rules of 
nucleosome organization in vivo at CpG islands, binding sites of transcription 
factors and promoters of genes. CpG islands have a dramatic reduction of 
nucleosome occupancy, transcription factor binding sites contain distinct and 
cell-type specific organization of positioned and phased nucleosome arrays with 
binding sites localizing to the linker DNA. Promoters of actively transcribed 
genes adopt distinct organization of nucleosomes that is not present at silent 
promoters. There are substantial global differences in the chromatin structure. 
The average distance between the nucleosomes is 11 bps shorter in granulocytes 
compared to T-cells. We found that inter-nucleosome distance varies across the 
genome and depends on the local transcriptional levels within the occupied 
genes. Significantly more compact packing of nucleosomes was observed 
within the genes with high transcriptional activity. These results demonstrate 
that multiple forces shape nucleosome organization of the human chromatin. 
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Recombination is typically thought as a symmetrical process resulting in 
large-scale reciprocal genetic exchanges between homologous 
chromosomes. Recombination events, however, are also accompanied by 
short-scale, unidirectional exchanges in the neighborhood of the initiating 
double-strand break: gene conversion. A large body of evidence suggests 
that gene conversion is GC-biased in many eukaryotes, including mammals 
and human. AT/GC heterozygotes produce a larger amount of GC- than 
AT-gametes, thus conferring a population advantage to GC-alleles in high-
recombining regions. This apparently unimportant feature of our molecular 
machinery has strong evolutionary consequences. Structurally, GC-biased 
gene conversion explains the spatial distribution of GC-content in 
mammalian genomes - the so-called isochore structure. Functionally, GC-
biased gene conversion promotes the "undesired" segregation and fixation 
of deleterious AT->GC mutations, thus increasing our genomic mutation 
load. I will review the recent evidence for a GC-biased gene conversion 
process in mammals, its consequences on genomic landscapes, molecular 
evolution, and human functional genomics. 
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The 1000 Genomes Pilot 3 Project generated high coverage sequence data 
primarily in the coding regions of approximately 8,300 exons totaling 1.43 
Mbp from 697 individuals sampled from seven different populations. The 
data was collected using multiple DNA capture technologies combined with 
two different next generation sequencing platforms (Illumina and 454). 
Boston College (BC) and the Broad Institute (BI) independently 
implemented informatics pipelines for data analysis that includes read 
mapping; duplicate filtering (i.e. the removal of reads from duplicated DNA 
fragments); base quality score recalibration; and SNP calling with similar 
multi-sample Bayesian algorithms. 
 
Median per-individual sequence coverage within the seven populations 
ranged from 30 to 67X. Analysis of all 697 samples BC and BI yielded 
19,890 total SNPs, 64% of which were in consensus between the BC and BI 
callsets. 30% of these consensus calls overlapped known SNPs in dbSNP 
v129, in line with population genetic expectations. The number of 
segregating sites within the different population samples ranged from 3,729 
(Tuscany) to 6,370 (Luhya). The number of sites within African populations 
was significantly higher than in European or Asian samples. Initial analysis, 
based on comparison to experimental validation results originally collected 
for Pilot 1 (many samples, whole-genome, 4x-coverage), indicates that the 
accuracy of the SNP calls is well above 90%.  
 
The considerable sequence depth makes it possible to detect low-frequency 
variants with very high sensitivity, and therefore, ascertain the low-
frequency end of the site frequency spectrum with much better accuracy 
than achievable in low-coverage sequence data. The ability to detect rare 
alleles in genomic regions of interest make capture-sequencing approaches 
attractive for medical re-sequencing studies. 
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Experimentally defining the complete transcriptome of eukaryotic 
organisms has traditionally been a challenging task, but advances in 
sequencing RNA (RNAseq) offer new and powerful approaches to the study 
of transcriptomes. Recent studies have used RNAseq to quantify the 
expression levels of known genes, identify splice isoforms and refine gene 
boundaries. However, many studies depend on existing annotation, limiting 
the ability of discovering novel transcripts, and most require mapping to an 
available genome sequence, limiting their applicability to organisms 
without a sequenced genome, complex environmental samples, and cancer.  
Here, we present a novel approach for de novo assembly of a transcript 
catalog from read data alone. At the heart of our approach is a novel 
algorithm that takes read data and generates a host of assembly graphs, each 
one ideally corresponding to a single transcript. Our algorithm then extracts 
from each graph one or more transcript isoforms, quantifies their levels, and 
scores their confidence. These transcripts can then be mapped to a reference 
genome, from the same organism or a related species.  
We show how these approaches scale to organisms from yeasts to 
vertebrates, helping in genome annotation of newly discovered organisms 
from the Schizosaccharomyces clade, transcriptome analysis in the Anolis 
grahami lizard for which the genome sequence is not available, and for the 
discovery of novel fusion transcripts in human cancers.  
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Proliferation of DNA sequencing instruments has enabled any investigator 
to produce enormous amounts of sequence data. However, working with 
these raw sequences presents significant problems. For an experimental 
group with no computational expertise, simply running a data analysis 
program is a barrier, let alone building a compute and data storage 
infrastructure capable of dealing with this scale of data data. A 
computational model, “Cloud computing”, has emerged that is ideally 
suited to the analysis of large-scale data. However, formidable challenges 
need to be addressed to make these resources available to individual 
investigators. We have developed a solution that allows experimentalists to 
perform large-scale analysis using cloud-computing resources with nothing 
more than a web browser. A user without computational expertise can 
instantiate an analysis environment on a cloud, adding storage and compute 
resources to this environment as needed. Popular tools and analysis 
workflows are built-in, ready to run. 
 
Using this analysis solution, we analyzed a mitochondrial genome re-
sequencing experiment representing three mother and child pairs. For each 
mother and child pair the DNA was collected from cheek swab specimen 
and from blood by our clinical collaborators at Penn State Medical School 
and mtDNA was amplified with PCR. To control for possible PCR-induced 
errors, each amplification was performed twice. In total we generated 24 
Illumina datasets (eight for each mother and child pair - two mtDNA 
amplification for each cheek swab and blood samples). All analysis steps 
from data pre-processing to polymorphism calling were performed using a 
Galaxy instance instantiated on the cloud. Within Galaxy we use a variety 
of analysis tools to process this data and identified a number of somatic 
mutations and heteroplasmic sites. This is the first practical demonstration 
that cloud-computing resources can be made available to researchers with 
no computational infrastructure to successfully perform complex large-scale 
analyses. 
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The Human Microbiome Project (HMP) was launched by the National 
Institutes of Health (NIH) Roadmap for Medical Research and is designed 
to fuel research into the microbes that live in the various environments of 
the human body (http://nihroadmap.nih.gov/hmp/). A major goal of the 
HMP is to look for correlations between changes in the microbiome and 
human health. The Institute for Genome Sciences at the University of 
Maryland School of Medicine is involved in multiple HMP projects 
including an investigation of gut microbiota and obesity in the Amish 
population, the structure of the gut microbiome in Crohn’s disease, and the 
microbial ecology of bacterial vaginosis. In addition, we provide the Data 
Analysis and Coordination center for the HMP, providing a specialized data 
management and analysis infrastructure to support the collection, 
integration and standardization of HMP data to facilitate research 
(http://hmpdacc.org). The intersection of second generation sequencing 
technologies and the field of metagenomics is driving an explosion of data 
and presenting unique informatics challenges. I will discuss a number of 
these challenges and how we are attempting to tackle them in the context of 
our HMP projects.  
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Metagenomic shotgun sequencing permits the study of genetic material 
recovered from environmental samples, without isolation or culturing. This 
technique has identified millions of previously unknown genes in microbial 
communities in situ, ranging from the ocean to the human gut. Phylogenetic 
trees enable powerful analyses of taxonomy, community diversity, and 
evolutionary patterns. It is not obvious, however, how to quantify 
evolutionary distance between fragmentary, non-overlapping metagenomic 
sequence reads. Our aim is to establish whether metagenomic phylogenies 
can be reliably constructed for individual gene families. 
 
Most molecular phylogenetic methods depend upon a multiple sequence 
alignment. We exploit complete gene sequences from fully sequenced 
microbial reference genomes to compute probabilistic profiles for gene 
families. To build alignments from metagenomic data, we match and align 
reads and reference sequences to the family profiles. From the alignments, 
we infer phylogenies that enable us to assess phylogenetic relationships 
between reads that may not overlap in the alignment. 
 
To validate our profile alignment approach and compare performance of 
tree-building algorithms, we developed a well-parameterized simulation 
pipeline that considers, in particular, the size and complexity of the 
simulated community and reference database. As a command-line tool, it 
can be run in batch to generate large sets of simulated metagenomic data. It 
leverages existing databases of protein marker genes and 16S rRNA, as well 
as existing software including MetaSim and HMMER.  
 
We compared phylogenies inferred in the simulated metagenomic context to 
those inferred from corresponding full-length gene sequences. Initial results 
indicate that many measures of performance are strongly influenced by the 
size and breadth of the reference database. We also evaluated the robustness 
of downstream analyses that rely on trees, such as identifying taxa and 
measuring diversity within and between metagenomic samples. Our results 
highlight the potential and limitations of phylogeny-based metagenomic 
analyses. 
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The human genome contains hundreds of regions whose patterns of genetic 
variation indicate recent positive natural selection, yet for most the 
underlying gene and the advantageous mutation remain unknown. We 
recently reported the development of a method, Composite of Multiple 
Signals (CMS), that combines tests for multiple signals of natural selection 
and increases resolution by up to 100-fold.  
 
Applying CMS to candidate selected regions from the International 
Haplotype Map, we localized several hundred signals to ~50-100kb, 
identifying individual gene and polymorphism targets of selection. These 
regions included genes involved in processes known to be targets of 
selection, such as infectious disease, skin pigment, metabolism, and hair 
and sweat. We further identified many candidates that are like regulatory 
elements. In several regions we identified variants that are significantly 
associated with expression of nearby genes in the selected population. 
Moreover nearly half of the ~200 regions we examined localized to regions 
with no genes at all. Thirteen of contain long non-coding RNAs that have 
been shown to often regulate nearby genes, suggesting that variation within 
the RNAs may have functional consequences. 
 
With preliminary data now available from the 1000 Genomes Project, we 
are beginning to explore full sequence data which should contains most if 
not all of the causal selected polymorphisms. We extended the CMS 
method to the preliminary dataset, validating our previously identified 
candidates and identifying many new intriguing coding and regulatory 
variants.  
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Methylomes and genome-wide maps of histone marks are being produced at 
an increasing pace and, with the advance of massively parallel sequencing 
technologies, at an increasing level of resolution. As part of the NIH 
Epigenomics Roadmap Initiative, we are developing and validating methods 
for comparative epigenome analysis and the construction of a Human 
Epigenome Atlas. The human germline methylome was reconstructed based 
on an evolutionary CpG mutability index and was compared to the H1 
(embryonic stem cell line) and IMR90 (fetal fibroblast cell line) 
methylomes using the newly developed Epigenomic Triangulation method. 
Cell-lineage-specific demethylation is detected in both IMR90 and the 
germline. Germline methylation deserts, regions that are extremely 
hypomethylated specifically in the germline, comprise a total of 1.5% of the 
human genome and contain 15% of structural rearrangements that occurred 
in the human genome since the branching of human and chimpanzee. More 
than 20% of human-specific structural rearrangements are attributable to 
hypomethylation between extreme and moderate levels in the germline. 
These results point to a likely role of chromatin structure and the epigenome 
in mediating structural mutability of the human genome. The results also 
validate the utility of the Epigenomic Triangulation method for identifying 
specific biologically significant epigenomic characteristics of individual cell 
types and for the eventual construction of a Human Epigenome Atlas. 
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Most findings from genome-wide association studies (GWAS) are 
consistent with the simplest disease model, in which each additional copy of 
the associated allele increases disease risk by a multiplicative factor, in 
contrast to recessive or dominant effects. Using theoretical and empirical 
results we show that imperfect linkage disequilibrium (LD) markedly 
distorts these effects, with the power to detect dominant or recessive effects 
dropping off dramatically. For example, power to detect departures from the 
simplest model decays as a function of r4, where r2 is the usual correlation 
between the causal and marker loci. Compared to the well-known result that 
power to detect a multiplicative effect decays as a function of r2, this is 
striking. Similar results apply to the detection of interactions among distinct 
GWAS loci. Disease model distortion may explain the relative paucity of 
observed non-multiplicative signals of association, and we show that it can 
also account for some of the "missing" heritability in common diseases. 
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The nature of the evolutionary processes underlying the generation 
of macroevolutionary changes has been a long-standing debate in 
evolutionary biology. Genome-sequencing quickly established that gene 
content is a poor explanation of complexity of the organism and changes in 
gene expression have since been a popular explanation for the organismal 
complexity unaccounted for by differences in gene content. 
 
The exact mechanisms underlying gene expression divergence and their 
adaptive significance have been the subject of intensive debate in the recent 
past. The last few years have seen a wave of studies starting to address 
those questions on a systematic level and we are beginning to understand 
some of the relationships between sequence evolution and gene expression. 
Cross-species studies of cis-regulatory DNA and conservation of 
transcription factor (TF) binding suggest extensive evolutionary plasticity 
of transcriptional regulatory networks. A systematic study of the 
evolutionary dynamics experienced by TFs, being the protein components 
of transcriptional regulatory networks, has yet to be published. 
 
In order to examine the evolutionary pressures experienced by TFs and 
speculate on the role they play in the evolution of transcriptional regulation, 
we have collected TF repertoires from 15 species of yeasts whose most 
recent common ancestor existed about 300 mya. These repertoires comprise 
all known sequence-specific DNA-binding proteins in those species. 
Overall, the TFs we recovered contained 50 families of DNA-binding 
domains and accounted for about four to five percent of the annotated 
protein-coding genes in each genome.  
 
We found the overall composition of these repertoires to be similar across 
the species examined. Species- and clade-specific patterns of duplications 
and losses however indicate extensive rewiring of regulatory pathways even 
at intermediate evolutionary range. This is also reflected in the substitution 
rates experienced by the TFs themselves. The DNA-binding domains tend 
to be highly conserved whereas the remainder of the protein is evolving 
fast. Here we will discuss the patterns of duplications and losses observed 
within their topological context of the regulatory network as well as the 
results of the evolutionary rate analysis and their implications towards the 
mutational mechanisms governing the rewiring of transcriptional regulatory 
networks in yeast. 
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Somatic genome rearrangements are thought to play important roles in 
cancer development. However, our ability for thorough characterization of 
cancer genome architecture is still very limited. We optimized the paired-
end-tag (PET) sequencing approach for analyzing large genomic DNA 
fragments to study human genome structural variations, and applied this 
approach for comprehensive characterization of 2 normal, 8 breast cancer 
and two other cancer genomes. Our analyzes revealed that most deletions, 
inversions, and insertions are germ line structural variations, whereas 
tandem duplications, inverted orientations, isolated translocations, and 
complex rearrangements are over represented as somatic events in breast 
cancer genomes. Large tandem duplications are probably among the initial 
rearrangement events that trigger the genome instability for extensive 
amplification in breast cancer genomes. 
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The use of next generation sequencing approaches has expanded the 
analysis of genetic variation in human genomes. The amount of SNPs and 
extent of structural variations have not yet reached a plateau. In addition, an 
individual pair of chromosomes may differ in gene and sequence content, 
thus, mixed diploid sequencing may not be sufficient to fully resolve the 
underlying molecular haplotype sequences. A prime example illustrating 
these limits is the human major histocompatibility complex (MHC), 
recognized as the most important genomic region related to common 
diseases.  
We have established key resources and technologies to sequence and 
assemble molecular haplotypes separately: 1) A unique ‘Haploid Reference 
Resource’ of 100 human fosmid libraries from a representative German 
population cohort, each library with 1.44 million fosmids pooled in units of 
5000 cfu (~ 5% of the human genome), and 2) a SOLiD next generation 
sequencing (NGS) and data analysis pipeline including fosmid specific 
detection modules. MHC haplotype sequence information is generated by 
use of targeted enrichment of MHC sequences and complemented by NGS 
of selected MHC haplotype-informative fosmid pools.  
Up to now, we have generated more than 60 GB of unique data, providing 
the basis for a fosmid-based phasing of the ~4 Megabase MHC region. 
Preliminary results demonstrate major advantages of this approach as 
compared with data obtained on genomic DNA. 
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Stripes and spots in multicellular animals are a prominent feature in nature 
that contributes to camouflage, species recognition and morphologic 
diversity. The molecules and pathways that give rise to different types of 
pigment have been well-characterized from the genetics of mouse coat 
color, but patterned control of those pathways in animals such as cheetahs 
and zebras is still a mystery. However, the scale of next gen sequencing 
technology and the increasing availability of mammalian genome sequences 
has allowed us to investigate the basis of pigment patterns using a genomic 
approach. 
 
We developed a highly sensitive and robust methodology—EcoP15I-tagged 
Detection of Gene Expression, or EDGE—that is suitable for detecting and 
comparing gene expression among tissues from animals for whom fully 
assembled and annotated genomes do not yet exist. Our method is adapted 
for the Illumina Genome Analyzer platform, and involves building and 
sequencing a cDNA library where each transcript is represented by a unique 
27 bp sequence tag. Consequently, the frequency at which a particular 
cDNA tag appears in a library serves as a proxy for quantifying and 
comparing transcript abundance. Because there is a one-to-one 
correspondence between transcript and tag, the method allows gene 
expression differences to be assayed in organisms where genome sequence 
or transcript annotation is not yet available. 
 
In a pilot study, we applied EDGE to a mouse model for red hair, fair skin, 
and skin cancer susceptibility, and discovered a set of co-regulated genes 
that lie downstream of the melanocortin 1 receptor (Mc1r) but which 
control non-pigmentary phenotypes. We then carried out an EDGE analysis 
of patterned skin from dogs (yellow and black brindled stripes), cheetahs 
(yellow and black spots), and zebras (white and black stripes). In brindled 
dogs, the striping pattern is caused by a segmental duplication that leads to 
gene silencing, and our results suggest that epigenetic alterations in gene 
expression are confined to the duplicated segment. In zebras, the striping 
pattern is limited to hair rather than skin, and our results indicate that 
alterations in hair color are accompanied by alterations in hair structure. 
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Core promoters are primary sites of gene regulation, and transcription start 
sites (TSS) are primary indicators of promoter activity. To identify and 
characterize active promoters, we determined TSSs within promoters of 
long capped transcripts expressed in the D. melanogaster embryo using 
integrative analysis of four data types: Cap Analysis of Gene Expression 
(CAGE [42M 27nt reads]), RNA Ligase Mediated Rapid Amplification of 
cDNA Ends (RLM-RACE [2.1M ~130nt reads]), cap-trapped ESTs [71K 
ESTs] and RNA-seq (SOLID [100M 50nt stranded reads]). We modeled the 
biochemical background in the CAGE assay as proportional to the signal 
RNA-seq signal. Thresholding under this model reduced mapping of the 
CAGE reads from 5M to 300K sites, which cluster into 45K distinct peaks. 
Integration with EST and RACE data supports ~10K of the strongest CAGE 
peaks, which account for >80% of the signal. We have discovered hundreds 
of unannotated promoters. 
 
These data also resolve promoter boundaries and TSS distributions. About 
20% of promoters have a peaked TSS distribution, usually < 8 bp wide. The 
other 80% have broad TSS distributions. TF binding motifs are 
differentially enriched in peaked and broad promoters, indicating different 
regulatory modes. 
 
We have also discovered CAGE peaks in annotated 3' UTRs, many of 
which are supported by RNA pol II peaks from ChIP assays, some of which 
are supported by ESTs. Sequencing of cDNAs corresponding to these ESTs 
defines transcripts of ~1 kb that are polyadenylated at the annotated 3’ end 
of the parent protein-coding transcript. Similar transcripts have been 
described in mammals. These CAGE peaks may mark promoters of primary 
transcripts of miRNAs, piRNAs or TASRs, or they may represent a 
previously reported re-capping phenomenon. 
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Genotype imputation has helped discover many putative disease loci in 
people of European ancestry, but it has been less successful in other 
populations. This challenge can be addressed by better imputation 
algorithms and better reference panels; our recent work spans both of these 
approaches. 
 
On the algorithmic side, we have developed an extension of IMPUTE2 that 
can handle large and diverse reference panels. By modeling local 
genealogies, our method allows every individual to choose custom 
reference panels in different parts of the genome. This leads to many 
practical advances, such as the ability to impute genotypes in modern 
African populations using African American reference data. 
 
To assess the prospects for new reference panels like those being generated 
by the 1,000 Genomes Project, we applied our method to three African 
datasets collected through the Malaria Genomic Epidemiology Network 
(MalariaGEN) and genotyped on the Illumina 650Y array: 666 trios from 
Gambia, 608 trios from Ghana, and 122 trios from Malawi. After removing 
the children, we constructed a panel of 100 individuals from each country to 
mimic three target panels of the 1,000 Genomes Project. We used the 
remaining parents to assess imputation accuracy in cross-validation 
experiments with: (1) a well-matched reference panel of 100 individuals; (2) 
a "cosmopolitan" reference panel of 300 individuals; (3) a HapMap 3 panel 
containing 2,022 haplotypes from around the world. For comparison, we 
also performed a number of cross-validations within HapMap 3. 
 
We found that imputation quality in African populations remains low, even 
when large and well-matched reference panels are available. Nonetheless, 
the 1,000 Genomes project is likely to make meaningful improvements over 
HapMap 3, even at the relatively common SNPs considered in this study. 
IMPUTE2 can be applied now to make good inferences from the HapMap 3 
data, and it will be even more effective when the full 1,000 Genomes 
dataset is finished. Despite previous findings that strong selection pressures 
and population structure can hinder the transfer of reference data between 
African populations, we find that it is usually better to use a large, 
cosmopolitan reference panel than a smaller, well-matched panel. 
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Ants represent a significant portion of the biomass in terrestrial ecosystems 
and play critical roles in nutrient cycling. Invasive ants can drastically alter 
native arthropod biodiversity and protect agricultural pests. Ants are 
renowned for their behavioral complexity and division of labor, yet few 
molecular or genomic resources are available to facilitate study of ant 
biology. Here we present the draft genome assembly and annotation for the 
first two ant species, Linepithema humile (Argentine ant, 251Mb) and 
Pogonomyrmex barbatus (Harvester ant, ~260Mb). Both species were 
sequenced using next-generation pyrosequencing technologies, assembled, 
and annotated in only a few months for less than $100,000 each. The 
assembled haploid genomes are 215 Mb and 235 Mb and represent 86% and 
~90% of the estimated total genome size for L. humile and P. barbatus, 
respectively. Scaffolds were assembled using the Celera assembler and 
annotated using the MAKER genome annotation pipeline using 
transcriptome data. Preliminary analyses reveal that both ants have over 
98% of conserved CEGMA protein functional domains. Preliminary 
annotations support the presence of complete de novo DNA methylation 
and RNA interference gene systems as well as numerous chemosensory 
proteins. Both ants have a rich diversity of transposable elements and 
repetitive sequence profiles more similar to solitary wasps than to the only 
other sequenced social insect, the honeybee. These two ant genomes 
provide the basic information necessary for future molecular studies in 
other ants, comparison to other social and solitary hymenopterans, and to 
provide insights into the genetic components of behavioral complexity. 
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The Illumina Genome Analyzer has been instrumental in transforming a 
wide range of genomic, genetic and functional studies in many laboratories. 
The principle for sequencing by synthesis (SBS) on this platform is well-
established: genomic DNA fragments are attached to the modified surface 
of an eight-channel flowcell to form high-density random arrays, amplified 
to form clusters and then sequenced using reversible terminator chemistry 
by cycles of incorporation, imaging and deblock of deoxynucleotide 
triphosphates that are fluorescently labelled in a base-specific manner. 
During the past twelve months we have introduced chemistry, hardware and 
software developments which have resulted in progressive improvement of 
the performance and utility of the system. Improved image analysis 
software enables delineation of clusters at higher resolution, leading to 
increases in data density and yield. Image processing has also been fully 
automated for near real-time analysis (RTA) to allow deletion of images 
after each cycle. The sequencing chemistry has been optimized to improve 
reaction efficiency and cycle time, yielding improved accuracy and enabling 
runs of 60 or 95 Gb (2 x 100 or 2x150 base paired reads). The SBS system 
has also been transferred to a new platform, the HiSeq2000, which employs 
a 4-camera line-scanning epifluorescent detection system for fast 
sequencing (25 Gb/day). Data from 1 billion clusters are collected by 
imaging both top and bottom surfaces of two independently operated 
flowcells during a single run of paired 100 base reads and generates ~200 
Gb of purity filtered data. The recent technology developments on both 
platforms are being implemented in production sequencing and used in 
multiple applications including cancer genome sequencing and whole 
transcriptome expression studies. 
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Recent studies have demonstrated that the number and location of meiotic 
recombination events influences the likelihood of meiotic non-disjunction in 
humans. For reasons that remain unknown, increasing maternal age is the 
only factor indisputably known to modulate the risk of meiotic non-
disjunction. Furthermore, in rodents, the frequency of recombination events 
of oocytes is reported to decrease with age. We focus here on determining 
whether recombination rate is related to the age of the mother in humans. 
We present a study of French-Canadian multi-generation pedigrees. This 
study focuses on a very dense genome-wide SNP survey (6.0 Affymetrix 
platform) genotyped among all 478 individuals from 89 pedigrees. We 
localized crossovers at high spatial resolution and observed similar variation 
in fine-scale recombination rates and patterns as previously observed in 
Hutterites families (Coop et al. Science. 2008). However, we observed that 
viable offspring of older mothers tend to have significantly reduced 
recombination rates, and the most pronounced effect is seen between 
mothers, particularly for mothers over the age of 30. The observation is a 
genome-wide effect but, among submetacentric chromosomes, the effect 
was significantly far more pronounced, suggesting a subtelomeric effect. 
This result contradicts a previous study that found a positive correlation 
between maternal recombination counts of an offspring and maternal age 
(Kong et al. Nature Genetics. 2004) based on ~1000 markers. Furthermore, 
we observed that both males and females exhibited significant increases in 
recombination moving distally from the centromere, although males exhibit 
more pronounced elevated rates of recombiniation in sub-telomeric regions, 
as previously reported. We postulate that, in humans as in other species, 
recombination rates decrease with maternal age, and that age-related altered 
recombination patterns may be implicated in age-dependant meiotic non-
disjunction leading to aneuploidy. 
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Chromosome aberrations, especially gene fusions, are implicated in the 
initiation of tumorigenesis. Gene fusions are important diagnostic and 
prognostic indicators in leukemia, sarcomas, and other solid tumors.  
The high throughput of massively parallel sequencers (up to 1 billion 
mapped reads on a single run of the SOLiDTM System 4.0) enables genome-
wide hypothesis-free detection of gene fusions. The availability of DNA 
barcoded paired-end reads facilitates cost-effective concurrent sequencing 
of many samples on a single slide.  
We developed a novel algorithm to detect exon junctions with strand-
specific SOLiD transcriptome sequencing, to predict fusion transcripts and 
to facilitate identification of alternative splicing. For paired-end whole 
transcriptome sequencing experiments, we require two types of evidence; 
the two tags must map uniquely to two different exons, and a single tag 
must span the exon junctions. Single-read placement is done with a novel 
suffix array single read junction finder algorithm that allows fast detection 
of reads split between any pair of exons. Gene fusions are called if there is 
sufficient non-redundant evidence of both types, mapping to exons in two 
different genes.  
We validated the algorithm with real and simulated data. We use real reads 
spanning existing exon boundaries, and simulate gene fusions. We detect 
>80% of these simulated human gene fusions at exons having sufficient 
unique coverage.  
We sequenced UHR (Universal Human Reference sample), and we 
predicted 36 fusions using initial thresholds. We validated these predictions 
with TaqMan. 44% of our predictions were correct, including the three 
previously annotated gene fusions in UHR; two inter-chromosomal (BCR-
ABL1 and BCAS4-BCAS3) and GAS6-RASA3 on chr13. We validated an 
additional 13 novel gene fusions in this sample, many of which are putative 
read-throughs from genes in close proximity. Testing these candidate 
fusions in the breast cancer cell line MCF7 reveals that 13 of these gene 
fusions are also present in MCF7.  
Easy and low-cost genome-wide detection of novel gene fusions allows 
interrogation of large numbers of tumor samples and the discovery of 
biologically important gene fusions. 
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An area of fundamental biomedical research that merges population and 
quantitative genomics is the identification of transcriptional and other 
intermediate biomarkers for disease susceptibility and disease status. These 
biomarkers are quantitative traits whose architecture is modulated through 
mechanisms that can incorporate genetic and environmental cues. But what 
are the relative magnitudes of these effects, and how gene expression 
profiles correlate with other haematological and clinical phenotypes? To 
address these questions, we generated gene expression profiles from 
peripheral blood samples from a random aging cohort in Québec, Canada 
coming from a number of different geographic locations and lifestyles and 
for which clinical material and medical information spanning a wide range 
of medically relevant phenotypes from a well characterized and extended 
pedigree have been collected. We documented latent structure in gene 
expression profiles and identified genes and networks of genes that best 
correlate with haematological and metabolic syndrome phenotypes. The 
analysis is being extended to incorporate genotypic data in order to identify 
the genetic control points of the transcriptional and clinical traits studied. 
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A fundamental goal in population genetics is to understand the extent to 
which natural selection has shaped evolution, and to understand the nature 
and function of variants that have been selected for in the origin and 
diversification of a species. Population-scale genome sequencing offers the 
potential to identify genetic variation in a manner that is not biased by the 
type of variant or the completeness of the reference sequence. However, 
most current approaches to the analysis of genome-sequence data require 
the mapping of sequence reads to an assembled reference genome and in 
doing so inevitably leads to the loss of sequence that is novel or 
unassembled in the current reference. 
 
To overcome these problems we have developed a novel approach to the 
analysis of genomic variation in which we de novo assemble a coloured de 
Bruijn graph from the sequence reads of a population. Applying the method 
to 1.9 Terabases of data from 179 individuals sequenced within the 1000 
Genomes Project we can identify variants through searching for 
characteristic motifs within the graph and identify regions of strong 
population differentiation through the presence of nodes in the graph with 
strong frequency differences (greater than 80% difference) between 
populations. This approach reveals a remarkable density of high-
differentiation variants of at least 1 per Mb in the human genome. Such 
differentiation is extremely unlikely to occur by chance alone and is most 
likely the result of strong local adaptation. In addition to SNP variants 
known to have experienced strong selection we find many indel and 
structural variants with strong differentiation that map to genomic features 
of diverse function, from antigen recognition to centromere formation. 
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Copy number abnormalities (CNAs) represent an important type of genetic 
mutation that can lead to abnormal cell growth and proliferation. 
Microarray technologies have been used successfully to identify CNAs in 
cancer, but their resolution is limited by the location of probes on the array. 
New high-throughput sequencing technologies promise comprehensive 
characterization of CNAs. In contrast to microarrays, where probe design 
follows a carefully developed protocol, reads represent a random sample 
from a sequence library and may be prone to representation biases due to 
GC-content and other factors. With the deep coverage achievable from 
decreasing sequencing costs, the discrimination between true and false 
positives becomes an important issue. 
 
Here we present a novel approach, called HMM-seg, to identify CNAs 
using next-generation sequencing data. It uses depth of coverage to estimate 
copy number states and flowcell-to-flowcell variability in cancer and 
normal samples to control the false positive error rate. The algorithm 
comprises several steps: the GC-normalized read counts are de-noised using 
a discrete wavelet transform, segmented with an HMM, and followed by a 
segment merging step, where inter-lane variability in cancer and control 
samples is used to estimate the merging threshold. It uses the Skellam 
distribution to compare read depth in tumour and control samples, which 
allows smaller window size for count estimation. 
 
We tested the method using COLO-829 melanoma cell line sequenced to 
40-fold coverage on Illumina GAII [1]. An extensive simulation scheme 
was developed to recreate different scenarios of copy number changes and 
depth of coverage based by altering a real dataset with spiked-in CNAs. 
Comparison to alternative approaches using both real and simulated datasets 
showed that HMM-seg achieves superior precision and improved sensitivity 
estimates.  
 
[1] Pleasance, E., et al. (2010) Nature, 463, 191-196 
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GWAS and other types of genetic studies have nominated genes 
contributing to hypertension and renal failure. Functional studies must now 
be undertaken for these genes. The rat is the dominant model for the 
physiological assessment of the cardiovascular system, but has lacked the 
ability to target genes. Using zinc finger nucleases, which takes a fraction of 
the time of ES cell technology, we have KOed 30 genes in 6 months. An 
additional 70 genes will be KOed over the next 18 months. As hypertension 
is caused by genes, multiple risk factors and environmental factors, we are 
using a sensitized screening strategy whereby we deploy candidate gene KO 
on top of a genetically susceptible, but not necessarily hypertensive strain. 
For select genes we also use transgenic rats over expressing a gene of 
interest.  
Phenotyping of the first few strains using our high throughput physiology 
program for BP, renal function, vascular function and response to the top 
three classes of anti-hypertensive drugs is just beginning. We have studied 
Rab38 a gene responsible for a QTL for renal failure and a host of other 
traits associated with protein trafficking using both transgenic rescue and 
site directed gene KO, and replicated the entire range of phenotypes 
originally found in the congenic animal. Finally, we KOed the renin gene 
(the renin-angiotensin system is the dominant pathway used to treat 
hypertension) in a low renin (common in African Americans) model of 
hypertension. Such a KO would not be expected to modify BP. Mean 
Arterial Pressure in these KO animals was a remarkably low 60 mmHg 
demonstrating that low renin hypertension does not mean this system is not 
playing a role in blood pressure maintenance, but rather that it is not 
contributing to the development of low renin hypertension, which is a novel 
finding.  
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Each sequencing technology performs poorly on certain motifs, for example 
extremes of base composition, homopolymer runs or dinucleotide runs. As a 
result of this bias, coverage of a genome by reads is uneven, and coverage 
by high quality bases is generally even more uneven. Increasing data 
density on the Illumina sequencing instrument (to increase coverage) can 
actually exacerbate bias, further reducing coverage of difficult motifs. 
 
Sequencing bias has a deleterious effect on many applications: 
• Variants cannot be discovered if there is no coverage, and uncovered loci 
can be biologically important. For example, in some datasets, as a result of 
their proximity to CpG islands, thousands of human promoter regions have 
essentially no coverage. 
• De novo assemblies can be shredded by loss of coverage at recalcitrant 
motifs, and this appears to be the single greatest challenge for genome 
assembly. The impact of bias varies widely among genomes. Notably 
challenging genomes include medically important pathogens at GC 
extremes such as P. falciparum (19% GC) and M. tuberculosis (66% GC). 
Bias can also have dramatic effects on assembly of genomes whose overall 
GC content is intermediate, but which are punctuated by difficult regions. 
 
We developed computational assays to facilitate comparisons of bias 
between and across genomes, sequencing technologies, and datasets, and to 
drive laboratory experiments that could mitigate the problem. These assays 
take as input the community standard BAM files. Using these assays we 
compared and contrasted bias in reads from eight technologies. 
 
Here we describe four key categories of challenging sequence motifs, 
hypothesize their physical causes, and outline a plan of attack to improve 
performance. These categories are high GC, G runs, AT runs, and very low 
GC. We demonstrate a reduction in sequencing bias obtained via assay-
driven improvements to laboratory protocols. 
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Non-human primate (NHP) species are important models to study molecular 
mechanisms underlying neurobehavioral processes relevant to human 
neuropsychiatric phenotypes, but which cannot be modeled in species more 
distantly related to humans such as rodents. Here we use an extended 
pedigree of vervet monkeys (Chlorocebus aethiops sabaeus) phenotyped for 
a wide range of brain-related traits to present an approach for mapping 
expression quantitative trait loci (eQTL) acting in brain, using peripheral 
blood as a surrogate tissue. Although blood is frequently used as a surrogate 
for tissues that are difficult to obtain, its utility has often been limited by 
insignificant or conflicting results, as only a fraction of the transcriptome is 
readily comparable between tissues. We developed a strategy to maximize 
such comparability, utilizing data from individuals in whom we obtained 
gene expression profiles in both brain and blood, to select a subset of 
transcripts (a) in which brain expression levels are well reflected in 
peripheral blood and (b) which display greater inter-individual variation 
than intra-individual variation. We have confirmed our hypothesis that these 
selection criteria would identify good candidates for eQTL mapping. We 
previously found significant heritability in 29 out of 32 transcripts selected 
by these criteria, based on gene expression levels in blood in almost ~350 
pedigree members. We now have genetically mapped eQTL for 12 of the 29 
heritable candidate transcripts, using microsatellite genotype data from 261 
STRs in the pedigree. We identified 10 cis eQTL and 2 trans eQTL at a 
genome wide significance threshold (>LOD 3). Next steps will include 
refinement of the linkage regions and studies of correlations between eQTL 
transcripts and other complex traits investigated in the vervet pedigree. 
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Over the last few years there has been a major drive to identify submicroscopic 
structural variations in the human genome, ranging from a few hundred base 
pairs to some Mb. The main type of variations found are copy number 
variations (CNV), which have been shown to have a significant impact on gene 
expression and genome architecture. As more CNVs are identified, the portion 
of the human genome that is known to be variable increases. Highly variable 
regions and the genes within them have been carefully characterized, but less 
effort have been put into characterizing the non-variable regions. Our aim is to 
define a list of genes and elements that are dosage sensitive in humans, which 
may facilitate interpretation of novel CNVs in patient data. Here we attempted 
to define these Copy Number Constant regions and the elements and genes that 
are associated with them.  
 
We used CNV data from the The Database of Genomic Variants, which 
contains experimentally defined structural variations > 1kb, identified in healthy 
controls. To exclude false positives and rare variants, only regions reported in at 
least two different studies were included. In the resulting dataset 92% of the 
nucleotides were considered as non-variable. To more easily characterize the 
non-variable regions, the genome was divided into 500kb bins analyzed 
independently and the non-variable bins comprise 64% of the genome. In 
addition, we identified the longest stretches of non-variable regions in the 
genome and regions located at a maximum distance away from any variation. 
We then characterized these regions in correlation to a large number of genomic 
features. All results were compared to the average for the entire genome, the 
highly variable regions and randomized datasets.  
 
Our results show that non-variable regions have a lower gene-density and 
contain longer genes than variable regions. The genes within these regions also 
contain a higher fraction of OMIM-genes, cancer related genes and lethality-
phenotype associated genes identified through knock-out experiments in mouse. 
These correlations are stronger in longer non-variable segments and regions 
located farther from the closest variations. The SNP density is decreased in 
these regions and important functional elements such as enhancers, miRNA and 
ultra-conserved regions are more abundant.  
 
Genes within the non-variable regions are enriched in GO-terms associated with 
developmental processes and transcriptional control. We use these features to 
identify a list of genes that are highly dosage sensitive, causing large regions 
around them to also be structurally conserved. 
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We introduce a novel model of gene expression aimed at uncovering the  
differential regulation that underlies immune cell development. This  
model builds on a body of work in module network reconstruction and  
extends it by permitting within module regulatory program variation.  
This new framework trades off two competing desiderata. First is the  
preference for preserving regulatory programs among related stages in  
cell development. Second is the flexibility to capture sudden and  
substantial changes in regulator roles, for example, a switch from  
activator to repressor. Importantly, the fitting of the model is  
achieved in a statistically consistent manner which prevents the  
introduction of spurious regulators or regulator role change events.  
We demonstrate the utility of this model by analyzing ImmGen  
compendium data. This data consists of gene expression measurements  
from 118 distinct cell types of the mouse immune system. In this  
analysis, the model leverages a developmental tree to encourage  
conservation of the regulatory programs between daughter and parent  
cells. Thus, regulatory programs preserved throughout a particular  
lineage are recovered, in addition to deviations specific to  
sublineages. We present examples of differential regulation specific  
to T-cells, B-cells and NK lineages. 
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For evolutionary reasons, it is believed that rare genetic variants that 
contribute to complex disease should have larger effect sizes (relative risks 
or odds ratios) than more common variants. The results of Genome-Wide 
Association Studies (GWAS) and candidate resequencing studies support 
this hypothesis, and have lead many to suspect that a glut of rare large-
effect variants will be discovered by case-control resequencing. However, a 
number of potentially confounding effects on the observed relationship 
between frequency and risk throw the usefulness of these observations into 
doubt. 
 
Firstly, the lower power to detect disease association in rare variants means 
that they are more likely to be near the P-value threshold, and thus more 
likely to be affected by the Winner's Curse. Secondly, there is a larger 
sampling variance associated with risk estimates for rare variants; we show 
that this can cause drastic inflation of mean risk estimates. Thirdly, the 
lower power to detect rare variants means that only those with large effect 
sizes are picked up in GWAS, compared to a less skewed effect size range 
for common variants; this introduces a sampling-induced frequency-risk 
bias. 
 
We demonstrate how these effects can be compensated for in order to detect 
the existence of an underlying frequency-risk relationship. The Winner's 
Curse can be compensated for using established statistical methods, or by 
estimating risk in independent cohorts, and the effect of increased sample 
variance can be estimated in a logistic regression framework. 
 
By combining expressions for the power to detect disease association, 
multiplicative models of genetic risk, and a model of risk prevalence, we 
show how the observed relationship between frequency and risk in sampled 
data can be predicted, conditional on there being no underlying relationship. 
These predictions can be used to compensate for sampling-induced 
frequency-risk bias. 
 
We apply these techniques to both simulated and empirical case-control 
data, and evaluate the remaining power to detect frequency-risk 
relationships after correcting for confounding effects. Our general 
conclusion is that the majority of the observed frequency-risk relationship at 
intermediate effect sizes (OR < 2) is due to confounding effects; however, 
there is evidence that very large effect sizes (OR > 2) are truly enriched in 
low-frequency variants. 
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Although recent outstanding progress of deep sequencing technology has 
enabled us to obtain enormous amount of data about human each transcript, 
we are still facing great difficulties in understanding interaction among 
transcripts. In order to reveal the molecular basis of gene expression 
regulation, we employed multiple methods such as RNA-seq, small RNA-
seq and RNA Immuno-precipitation (RIP) -seq. First, we used the small 
RNA-seq method to observe small RNA expression changes in DLD1 
(colon cancer cell line) and TIG3 (normal lung fibroblast), where both 
cultured in normoxic and hypoxic conditions. The total tag number mapped 
to genome uniquely were: 8623614 tags in TIG3-Normoxic condition, 
9506308 tags in TIG3-Hypoxic condition, 8309609 tags in DLD1-
Normoxic condition, and 2083635 tags in DLD-Hypoxic condition. 
7234226 tags out of 8623614 tags (84%) were mapped to known miRNA 
positions in TIG3-Normoxic condition, 8520106 tags out of 9506308 tags 
(90%) in TIG3-Hypoxic condition, 7215951 tags out of 8309609 tags (86%) 
in DLD1-Normoxic condition, and 186816 tags out of 2083635 tags (9 %) 
in DLD1-Hypoxic condition. Next, we compared small RNA expression 
levels between normoxia and hypoxia. Surprisingly, in TIG3 cells cultured 
in hypoxic conditions, only three miRNAs,( has-mir-200b, has-mir-210, and 
has-mir-770) showed elevated levels of expression, While in DLD1cells 
cultured hypoxic condition There were 35 miRNAs with elevated 
expression.were elevated expression. We are currently constructing Target 
RNA library by RIP, hoping that the combination of libraries constructed by 
multiple methods will allow us to better understand our transcriptome. 
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We have developed a new ~170,000 SNP canine array, CanineHD, based on 
Illumina’s High Density BeadChip technology, in collaboration with the 
LUPA consortium. This array offers more uniform genome coverage and 
exceptional call accuracy compared to earlier resources, and can assay 12 
samples simultaneously. The SNPs were selected from among the 2.5 
million discovered in the Dog Genome Project, as well as through targeted 
resequencing of sparsely covered regions (1696 SNPs). Of those chosen, 
93% validated, resulting in a final set 173,662 markers with mean spacing 
of 13kb and just 21 gaps larger than 200kb. To validate the panel, we 
genotyped: 1) 352 dogs representing 26 breeds; 2) two families, several 
trios and replicates; 3) the CanFam2.0 reference boxer; 4) buccal whole 
genome amplified (WGA) samples. Call rates and reproducibility exceeded 
99% for all breeds genotyped, with blood samples yielding marginally 
higher call rates (99.8%) than the buccal WGA samples (99.1%). The 
number of polymorphic markers per breed ranged from 85,193 in Greenland 
Sledge Dogs, a relatively isolated breed, to 126,387 in Jack Russell Terriers. 
With even, dense coverage across the genome, high call rates and 
exceptional accuracy, this array is a significant step forward for canine gene 
mapping, especially for mulitgenic, complex diseases such as cancer, 
neurological disease, and autoimmune disease. 
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Accurate and complete information on haplotypes and individuals’ 
diplotypes is required for population-genetic analyses; however, 
microarrays do not provide data on a phased diplotype (e.g., 1 copy in one 
haplotype and 2 copies in the other) at a copy number variation (CNV) 
locus, but only provide data on a diploid number, which is the total number 
of copies/bases over a diplotype (3 copies in the above example). Moreover, 
the data often include large errors on the estimated diploid numbers when 
the signal intensities deriving from different diploid numbers are not clearly 
separated due to noises.  
 
Here we report an algorithm and computational tool to infer CNV 
haplotypes and individuals’ diplotypes from noisy microarray data, 
incorporating uncertainty due to noises into the expectation-maximization 
procedure. The uncertainty is represented by likelihoods that a given 
observed signal intensity may be derived from different underlying diploid 
numbers. This tool can handle a combination of integer copy numbers, 
single nucleotide variations in CNV regions (e.g., AAB, unlike AB of single 
nucleotide polymorphism), and single nucleotide polymorphisms.  
 
We performed simulation studies based on the known diplotypes of 600 
individuals in a European population as well as an error model obtained 
from real microarray data. The new algorithm can outperform previous 
algorithms not using likelihood information: the accuracy of estimated 
haplotype frequencies is increased from 78-92% to 99-99.6%. In addition, 
our algorithm can also correct diploid numbers wrongly determined due to 
noises: the rate of wrong diploid numbers is decreased from 17-40% to 4-
10%. Our algorithm thus enables one to accurately analyze the population-
genetic nature of CNVs and to attain a greater statistical power in disease 
association studies.  
 157 
A COMPREHENSIVE WHOLE-GENOME MAP OF ENDOGENOUS 
RETROVIRAL ELEMENTS AND THEIR FUNCTIONAL EFFECTS 
ACROSS 17 LABORATORY MOUSE STRAINS 
 
Thomas M Keane1, Kim Wong1, Jim Stalker1, Richard Mott2, Jonathan 
Flint2, Wayne Frankel3, David J Adams2  
 
1Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, 
Hinxton, Cambridge, CB10 1SA, United Kingdom, 2Wellcome Trust Centre 
for Human Genetics, Oxford University, Oxford, Oxford, OX3 7BN, United 
Kingdom, 3The Jackson Laboratory, The Jackson Laboratory, 600 Main 
Street, Bar Harbor, ME, 04609 
 
It has been estimated that endogenous retroviral elements (ERVs) are a 
significant source (~10%) of spontaneous germline mutations among 
laboratory mouse strains. Two high-copy families of ERVs in particular, 
IAP and ETns, have been found to be responsible for the vast majority of 
these mutations. We have recently completed deep illumina sequencing of 
17 key mouse laboratory strains to between 20-35x depth. In this study, we 
report the first use of new sequencing technologies data to catalogue the full 
repertoire of ERVs across these strains. 
 
Our strategy utilises paired-end information to build a highly accurate map 
of several types of ERVs across the strains. Our method finds clusters of 
mate-pairs where only one end maps well to the reference genome and the 
other to a set of ERV reference sequences. From the initial set 1-2kb call 
regions, we then further refine the calls by using the read depth information 
to identify the exact breakpoints. To identify insertions that are shared 
between the reference sequence and the strains, we search for clusters of 
bridging mate-pairs to already annotated insertions. We assess the accuracy 
of our calls by comparing the set of calls we make in the C57B6NJ strain 
sequenced by us compared to the insertions annotated in the C57B6J 
reference genome. We find extremely high concordance between these two 
sets with just a few differing insertions. We have also compared our 
findings to a large set of manually PCR validated insertions falling into 
introns across five strains and find that our illumina predictions show 
extremely high accuracy. We have focused on young ERVs that occur in 
just a single strain and compared this set of ERVs found across the strains 
to existing expression data finding several examples of gene expression 
being affected by the occurrence of ERVs. Work is on-going to map these 
ERVs to QTL regions across the strains. 
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Two methods were applied to discovering de novo mutations within the 
1000 Genomes Project Pilot 2 trios (CEU and YRI), producing a direct 
estimate of the human mutation rate. One approach involves a probabilistic 
framework that leverages the relatedness between family members to 
produce a probability for the entire pedigree rather than genotypes at each 
site. A drawback of jointly inferring genotypes in this manner is exposed by 
short-read sequencing datasets, which may be enriched with sequencing and 
alignment errors; errors at a site within one individual can percolate through 
the pedigree and affect genotype calls for closely related individuals. A 
second approach uses the MAQ genotype consensus model to 
independently call genotypes for each individual, potentially avoiding this 
issue. Through collaboration between two groups, the two methods were 
applied in tandem, comparing results and uniformly applying filters to 
create a list of candidate mutations. With the intention of capturing as many 
of the true mutations as possible, we liberally considered 3,286 sites for the 
CEU trio and 2,757 sites for the YRI trio as possible mutations. We 
attempted to validate these candidate de novo mutations using targeted 
genomic DNA sequence capture and massively parallel oligo-ligation 
sequencing (SOLiD) of available samples within the two pedigrees, 
allowing inference of the germline or somatic status of each mutation. In 
addition to simulation results for the pedigree-based approach, we present 
these mutation findings. 
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Allele frequency differences across populations can provide valuable 
information both for studying population structure and for identifying loci 
that have been targets of natural selection. Building on the expectation that 
regions with low recombination rate are more likely to be indirectly affected 
by natural selection (hitchhiking or background selection), we used the 
variability of recombination rate across the genome as a tool to learn about 
how substantially the forces of natural selection have shaped patterns of 
allele frequency differentiation across human populations. We studied two 
genome-wide data sets in which SNPs have been uniformly ascertained 
across the genome, in a manner that is independent of local recombination 
rate: Perlegen "class A" SNPs and the uniformly-ascertained subsets of 
HapMap that we previously reported.  
 
We found that in both data sets population differentiation as assessed by 
inter-cotinental FST shows a strong inverse correlation with recombination 
rate, with FST decreasing by an average of 4% for every 1 cM/Mb increase 
in recombination rate. As we studied ascertained polymorphisms, the 
mutagenic effect of recombination is not a confounder as it is for the study 
of the correlation between nucleotide diversity and recombination rate. 
Instead, the negative correlation between FST and recombination rate 
reflects the impact of selection in the last 100,000 years since human 
continental populations split, which is further supported by a stronger 
correlation that we observed in coding regions.  
 
Interestingly, the relationship between recombination rate and population 
differentiation is qualitatively different for FST between African and non-
African populations and for FST between European and East Asian 
populations. While the former relationship is pretty linear, the latter exhibits 
an inverse U-shaped relationship, with a dip in differentiation at very low 
recombination rate loci, and a significant quadratic term when regressing 
FST as a function of recombination rate. These results suggest that varying 
levels or types of selection have prevailed in different epochs of human 
history. Studying the differences in the patterns across different epochs 
should make it possible to gain new insight into the mixture of selective 
pressures that have shaped human genetic variation. 
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We and others have found that conservation can be used to identify 
functional regulatory motif instances. Here we describe our work in using 
diverse experimental data in order to characterize these motif instances. We 
have applied our methods to chromatin modification and TF binding data 
both from the literature and in the context of the White and Karpen 
modENCODE groups and the Bernstein ENCODE group. 
 
We find that annotations of chromatin modifications complement 
conservation in identifying motif instances that are likely to be bound by the 
corresponding factors. Active modifications from conditions matching 
when factor binding was surveyed appear to be the datasets most useful in 
finding bound motif instances. Considering dips in the chromatin signal, 
which may arise from nucleosome exclusion in the footprint of bound 
factors, leads to even higher precision. We also find that dips specific to a 
cell type were preferentially enriched in the motifs of factors expressed in 
that cell type. 
 
In order to understand the dynamics of factor binding, we investigate motif 
enrichment patterns in regions unique to a condition. Through this analysis, 
we identify activator and repressor signatures by examining the relationship 
between motif enrichments and expression. For example, we predict that 
STAT5 is a likely activator in K562 cells as its motif is enriched in 
chromatin states associated with enhancers in concordance with its 
expression. By focusing specifically on activators, we are able to use this 
analysis to produce an activator association for the modifications which is 
consistent with their known roles. 
 
Moving beyond single factors acting in isolation, we have developed 
signatures to identify cooperation including (1) over-representation of 
instances near one another, (2) a mutual increase in conservation, (3) and 
biases in the strands and ordering of their instances. We find that all three of 
these metrics correlate with known interacting factors. We also find that a 
small number of motif instances very likely to be bound can be identified by 
combining conservation with homotypic clustering of motif matches. 
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We have previously used linkage and LD mapping to analyze an extended 
pedigree from Central Finland (CF) to search for rare, potentially high 
impact autism susceptibility variants enriched in this isolate. Here, we have 
used high-density SNP data and an extended family set from CF (n=51) to 
follow up this study by investigating allelic sharing at previously identified 
loci, hypothesizing that these genealogically connected individuals would 
share a common predisposition to their phenotype. 
 
We also analyzed global gene expression in an available subset of ten ASD 
cases and controls from the CF extended pedigree and combined this 
information with SNP data through pathway and promoter analysis. We 
proceeded to replicate our findings in a larger Finnish dataset and multiple 
other autism datasets, such as the AGRE. However, bearing in mind the 
family-specificity of most autism-predisposing variants identified so far, we 
sought primarily for replication on the level of biological pathways. 
 
Based on the SNP data, risk factors of autism show considerable locus 
heterogeneity even within genealogically connected individuals, and no 
significantly enriched haplotype sharing was detected in the isolate. CNV 
analysis revealed two large (~2Mb) duplications at 1q42 and 9q21 in two 
nuclear families. Pathway analysis was performed using a non-parametric 
GO-based algorithm which searches for the optimal regulated pathway 
compositions without a priori criteria for significance of individual genes, 
and accounts for bias introduced by variable gene length by extensive 
permutations. No single biological theme connected all datasets, but 
interesting overlap in the identified pathways and involved genes was found 
between the datasets from the CF isolate, further supporting family-
specificity of predisposing factors. Preliminary results of promoter analysis 
identified two TFs linked to the CF-specific pathways, which implicated 
angiogenesis-related processes and highlighted multiple previously reported 
autism susceptibility genes. 
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As with earlier sequencing technologies, the new high-throughput 
sequencing technologies have specific limitations and problems. Such 
problems either require consideration during project design, or need to be 
handled during data analysis. We focused our analysis on the Illumina 
Genome Analyzer I/II system. This platform provides parallel fluorescence-
based readout of millions of immobilized sequences by iterative detection 
using fluorescent-dye reversible-terminator chemistry. 
In addition to creating a high-quality sequencing library, handling as well 
the sequencing chemistry has a strong impact on the quality of a run. 
Particles like chemistry lumps, dust and lint in the sequencing chemistry 
can cause pseudo-sequence signals which result in the analysis of artificial 
reads not belonging to the library sequenced or distorted dye readouts. 
Additionally, reflections, air bubbles, uneven application of oil and an 
imperfectly calibrated instrument may cause the quality of the data to vary 
between sequencing runs and even between lanes of the same run. 
Identification of adapter and chimera sequences is not part of the standard 
processing and is often hampered by higher error rates at the ends of reads 
as well as by short reads showing only a few adapter bases. Finally, short 
read lengths and high error rates can complicate downstream analyses, like 
mapping and assembly. 
We present principles for good analysis practice that facilitate handling of 
these problems, or at least their identification in a sequencing run. First, 
indexing/tagging as well as filtering low complexity sequences is efficient 
in removing most non-adapter related sequencing artefacts. Second, we 
suggest that PHRED-like base quality scores should be used for quality-
based read filtering on the complete sequence rather than on only the first 
bases. Third, we identify protocol-specific library artifacts like adapter 
chimeras. We recommend using these for filtering library artefacts and 
trimming starting adapters. Further contamination from other DNA sources 
(e.g. enzyme DNA contamination) is expected and should be filtered before 
data analysis. 
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Cassava (Manihot esculenta) is a root crop that serves as the primary food 
source for more than 750 million people each day. However, it has many 
limitations as a food – particularly poor nutritional content, and it is 
susceptible to many pathogens, particularly in Africa, where one third of the 
continental harvest is lost each year to viral diseases. Through a partnership 
between Roche 454, DOE Joint Genome Institute and Steve Rounsley at the 
University of Arizona, we produced a draft sequence of the cassava genome 
primarily using 23 fold sequence coverage from 454’s FLX Titanium 
sequencing technology. Despite significant repetitive content, the draft 
genome that we assembled using the Newbler assembler appears to contain 
95% of known cassava genes.  
 
Since then, we have made significant improvements to the preliminary draft 
assembly by incorporating an additional 6 fold sequence coverage from 
Roche’s unreleased 1K GS FLX Sequencing Kits and upgraded 
instruments. With the addition of long reads, we now have an improved 
assembly of 573 Mb in size containing more than 98% of the gene space, 
thus demonstrating the importance of high quality long reads for generating 
de novo reference assemblies of complex non-model genomes. The updated 
genome assembly is a useful substrate for genome annotation, gene 
discovery and identification of useful SNPs. We present here the results 
from the assembly, annotation and analysis of our latest version of the 
Cassava genome.  
 
Genomic information generated by this project will serve as a great resource 
that will benefit key breeding programs throughout Africa by facilitating 
discovery of useful markers, fine mapping in the region of a candidate 
resistance gene for Cassava Brown Streak Disease and crop improvement in 
Cassava.  
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A characteristic of anticancer resistant cells and/or metastasizing cells is 
their transition from an epithelial state to a mesenchymal phenotype, a 
process known as epithelial-mesenchymal transition (EMT). We’ve 
already known that several molecules’ expressions are changed according to 
EMT or mesenchymal-epithelial transition (MET), and some of those 
molecules are related to the mechanism of EMT or MET. Identification of 
genes that show specific expression in epithelial or mesenchymal type cells 
leads not only to the elucidation of EMT-mechanism but to the 
identification of molecular target of novel anticancer drugs. Now we tried to 
identify EMT-related genes by analyzing comprehensive gene expression 
data of NCI-60 cell lines. 
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Genes encoding kinases tend to evolve slowly over evolutionary time, and 
only rarely do they appear as recent duplications in sequenced vertebrate 
genomes. Consequently, it was a surprise to find two families of kinase 
genes that have greatly and recently expanded in the zebra finch 
(Taeniopygia guttata) lineage. In contrast to other amniotic genomes 
(including chicken) that harbour only single copies of PAK3 and PIM1 
genes, the zebra finch genome appeared at first to additionally contain 67 
PAK3-like and 51 PIM1-like protein kinase genes. An exhaustive analysis 
of these gene models however revealed most to be incomplete, owing to the 
absence of terminal exons. After re-prediction, 31 PAK3-like genes and 10 
PIM1-like genes remain, and all but three are predicted, from the retention 
of functional sites and open-reading frames, to be enzymatically active. 
PAK3-like, but not PIM1-like, gene sequences show evidence of recurrent 
episodes of positive selection, concentrated within structures spatially 
adjacent to N- and C-terminal protein regions that have been discarded from 
zebra finch PAK3-like genes. At least seven zebra finch PAK3-like genes 
were observed to be expressed in testis whilst two sequences were found 
transcribed in the brain, one broadly including the song nuclei, the other in 
the ventricular zone and in cells resembling Bergmann’s glia in the 
cerebellar Purkinje cell layer. Two PIM1-like sequences were also observed 
to be expressed with broad distributions in the zebra finch brain, one in both 
the ventricular zone and the cerebellum and apparently associated with glial 
cells, the other showing neuronal cell expression and marked enrichment in 
midbrain/thalamic nuclei. These expression patterns do not correlate with 
zebra finch-specific features such as vocal learning. Nevertheless, our 
results show how ancient and conserved intracellular signalling molecules 
can be co-opted, following duplication, thereby resulting in lineage-specific 
functions, presumably affecting the zebra finch testis and brain. 
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While the cost of whole genome sequencing is rapidly decreasing with next-
generation technologies, capture of specific target regions of the genome for 
re-sequencing is often necessary to enable sampling of large numbers of 
individuals. Two of the most widely used target capture methods are 
amplicon tiling and array capture. Here we present a comparison of these 
methods for targeted gene capture and Illumina sequencing. 
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Mobile elements comprise ~50% of the human genome. Polymorphism 
arising from the genomic insertions of these elements is a major contributor 
to human genetic variation, but the precise extent of this contribution is not 
fully elucidated. We developed algorithms for detecting insertion sites of 
three of the most active mobile element types (Alus, L1s, and SVAs) from 
high-throughput sequencing data: a method based on paired-end fragments 
spanning the insertion breakpoint, and a split-read approach enabling the 
direct, single-base accuracy characterization of breakpoints. 
 
We analyzed the 1000 Genomes Project Pilot 1 (150 low-coverage samples) 
and Pilot 2 (6 high-coverage samples), and identified a total of 5,364 mobile 
element insertion loci. Experimental validation indicates a very high 
accuracy (false positive rate <5%). The detection efficiency is estimated at 
90 % for Alu insertions in the high coverage set (6 samples). 
 
The events discovered represent the largest catalogue of polymorphic 
mobile element insertions to date. Initial analysis of these events within the 
populations they were discovered indicates segregation properties that are 
similar to SNP markers. Based on the number of events detected within the 
high-coverage samples we estimate that roughly 3,000 Alu, 350 L1, and 40 
SVA insertion polymorphisms occur between two individuals, significantly 
higher than expected the number of insertion events previously reported 
from Human-Chimpanzee comparisons.  
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Identifying genetic variation from short-read genome-wide sequencing is 
fundamentally dependent upon the alignment strategy. In order to assess 
which alignment software would be suitable to the objectives of the 1000 
Genomes Project we compared several different software packages on 
simulated data. Two sets of reads were simulated. The first set of simulated 
data was generated by adding SNPs and indels into a reference genome to 
create an ancestor, with respective rates of 0.0005 and 0.0001. Two 
haplotypes were then generated by adding further SNPs and indels to the 
ancestor at an independent set of sites, effectively creating SNPs that were 
1/3rd homozygous and 2/3rds heterozygous. The program STAMPY was 
then used to generate reads with a defined insert size and introduce 
sequencing error based on representative data sets from the 1000 genomes 
production centers. Quality scores were introduced by sampling 
representative runs. Read names were provided indicating the genetic 
variant and its location. In the second set of simulated data structural 
variants were introduced within individual reads. Reads containing 200 bp 
deletions, 100 bp deletions, 20K insertions and 1-30 bp indels were 
generated using STAMPY under a similar procedure to the first dataset. 
Simulated sets for SOLiD included both paired 25mers with 1.5Kb inserts. 
Simulated datasets for Illumina included paired 37, 54, 76 and 108 bp reads 
on 400 bp fragments. Only alignment software producing the SAM format 
was considered. SOLiD aligners included BWA, BFAST, iMAP, 
Corona_lite, Mosaic, and Karma. Illumina aligners included BFAST, 
Bowtie, BWA, Eland2, Karma, MAQ, Novoalign, Soap, Smalt, Srprism, 
and Stampy. Each software package was assessed for memory footprint, 
input/outputs, and alignment speed on clusters at TGen (SOLiD datasets) or 
Sanger (Illumina datasets). Alignment accuracy was assessed for each type 
of read class (no variants, SNPs, indels, etc). These are reported either 
categorically, as a relation to mapping quality, or through an ROC curve 
comparing mapped reads to incorrectly mapped reads. 
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As next-generation sequencing gains increasing use as a tool for studying 
variation and disease, improvements in sequencing continue to decrease 
cost and increase dataset size. For example, Illumina reports that its HiSeq 
instrument generates 25 gigabases of sequence per day, and the cost of a 
gene-expression experiment is $200 per sample. Lower costs and greater 
adoption and throughput create an urgent bioinformatics challenge: can 
computing infrastructure keep up with this ever-growing data deluge? 
Recent studies [1, 2] propose Cloud Computing as a paradigm that 
addresses challenges faced by academic researchers working with sequence 
data. Cloud Computing combines a parallel software framework with a 
resource model whereby large clusters can be rented over the Internet for a 
per-computer-per-hour fee. 
 
We present Myrna, a Cloud Computing pipeline for computing differential 
expression of genes from large RNA-seq datasets. Myrna is scalable, 
flexible in the choice of statistical and gene models used, and readily 
handles input data consisting of many experiments, samples, and 
sequencing runs and lanes. Myrna is built on Hadoop, a parallel software 
framework providing scalability and fault tolerance. At its core, Myrna uses 
Bowtie [3] to align short reads to the reference transcriptome, then uses 
Bioconductor [4] to assign alignments to exons and genes, normalize 
alignment counts, calculate observed and null statistics, and report final per-
gene P values. 
 
We present results from re-analyzing multiple large, publicly-available 
RNA-seq datasets with Myrna, including timing results demonstrating that 
it scales efficiently to millions of input reads. More significantly, we show 
how this cloud-scale analysis sheds new light on the appropriateness of 
often-used statistical assumptions about technical and biological artifacts. 
 
[1] Schatz, MC: CloudBurst: highly sensitive read mapping with 
MapReduce. Bioinformatics 2009, 25:1363-1369 
[2] Langmead, B, et al. Searching for SNPs with cloud computing. Genome 
Biol 2009, 10:R134 
[3] Langmead, B, et al. Ultrafast and memory-efficient alignment of short 
DNA sequences to the human genome. Genome Biol 2009, 10:R2 
[4] Gentleman, R, et al. Bioconductor: open software development for 
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In this study, we have analyzed evolutionary patterns of expression 
quantitative trait loci (eQTLs) in different populations and in different 
tissues in order to shed light on the importance of natural selection in gene 
expression differentiation between human populations as well as systemic 
targets of selection in humans. A combination of population genetic 
statistics and conservation scores was used to study both recent and ancient 
natural selection, and these analyses will gain additional power from the 
emerging genomic and RNA sequencing data.  
 
We investigated global patterns of natural selection on gene expression by 
analyzing eQTLs detected from LCLs in a total of 792 samples from 8 
populations of the HapMap3 sample set, genotyped for 1.5 million SNPs. 
Comparison of eQTL SNPs with similar variants without proven regulatory 
potential showed an interesting combination of purifying and positive 
selection. The patterns eQTL sharing between populations suggest that also 
other processes than genetic drift affect differences in gene expression 
between populations.  
 
Natural selection is expected to target genes and regulatory regions active in 
different tissues in a distinct manner. We studied systemic targets of natural 
selection from a dataset of gene expression levels in fibroblasts, T-cells and 
B-cells of 75 Caucasian individuals with genome-wide SNP data. 
Comparison of signs of natural selection in eQTLs and in the entire gene 
regions specific to different tissues suggested stronger purifying selection in 
B- and T-cell specific than fibroblast specific genes and eQTLs.  
 
Altogether, this study sheds light on the tissue-specific mechanisms of 
natural selection, and supports the important role of regulation of gene 
expression in the recent evolution of human populations. 
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The seasonal influenza A virus undergoes rapid evolution to escape human 
immune response. This process occurs primarily in the viral epitope, the 
antibody-binding domain of the surface protein haemagglutinin. Aminoacid 
changes within the epitope have antigenic effects, whereas changes outside 
the epitope may affect protein stability. Here, we study the genome 
evolution of influenza A (H3N2) and quantify its underlying selective 
forces. Our analysis is based on frequency time-series of single-nucleotide 
polymorphisms, which are obtained from coalescence trees of influenza 
sequences over 39 years. We analyze these data in terms of a simple 
population-genetic model with positive selection for aminoacid changes in 
the epitope, negative selection for changes outside the epitope, and 
complete genetic linkage (i.e., absence of recombination) between both 
classes. This model quantitatively reproduces the statistics of 
polymorphisms and substitutions of the influenza sequences. Our main 
findings are: 
 
1. Influenza evolution shows strong clonal interference, which can explain 
the punctuated pattern of evolution observed in this system: the competition 
between strains produces recurrent selective sweeps with clusters of 
simultaneous fixations every 3 to 4 years, without additional assumptions 
that selection itself is punctuated. Our analysis shows that influenza 
evolution is governed not only by antigenic adaptation within the epitope, 
but also by background selection outside the epitope.  
 
2. The high mutation rates of influenza generate a complex competition 
between strains, which involves the combinatorics of coexisting strongly 
beneficial mutations (driving mutations). A given driving mutation often 
arises independently in two or more competing strains. At the same time, a 
selective sweep has 3 to 4 driving mutations on average.  
 
3. This process produces efficient adaption: of the 80 epitope aminoacid 
substitutions in 39 years, at least 50 are predicted to be adaptive. The total 
rate of adaptive epitope changes is about twice the rate expected under 
neutral evolution.  
 
Thus, the joint evolutionary forces of positive and negative selection, 
genetic linkage, and high mutation rates in the viral haemagglutinin 
determine the red queen race between viral strains and set the speed of their 
turnover. 
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DNA rearrangements are known to drive certain cancers; for example, 
discovery of the BCR-ABL fusion in chronic myelogenous leukemia 
(CML) led to the development of imatinib, the classic example of a targeted 
cancer therapeutic. Complete understanding of a tumor will require study of 
its genomic rearrangements. 
 
We report the deep-coverage whole genome shotgun (WGS) sequencing of 
more than 60 tumor/normal pairs: 26 multiple myeloma, 10 ovarian, 8 
prostate, 5 glioblastoma multiforme (GBM), 2 chronic lymphocytic 
leukemia (CLL), 4 melanoma, and 6 colorectal cases. We describe the 
analysis of this data using dRanger, an automated method for detecting 
somatic structural alterations, by identifying clusters of paired reads 
bridging distant genomic loci, and BreakPointer, which assembles the 
basepair-resolution fusion sequences. Somatic rearrangements were 
validated with a rate of 90% by PCRing and sequencing the chimeric DNA 
in the tumor, and confirming its absence in the normal. 
 
The results reveal astonishing diversity between and within tumor types: 
some cases have hundreds of rearrangements, others only a few. Some have 
many interchromosomal events, others extremely complex locally 
scrambled regions. Most of the GBM cases have EGFR amplified to 
hundreds of copies and rearranged with other chromosomes. We have 
detected novel PTEN and NF1 fusions, and confirmed a known TMPRSS2-
ERG fusion. RNA-Seq evidence has confirmed expression of some fusions. 
A prostate case is unique in the data set, having a large set of mutually 
balanced translocations, with many of the breakpoints located in important 
cancer genes, including TP53 and ABL1. Our findings emphasize the 
prevalence and importance of DNA rearrangements as potential cancer 
drivers. 
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Eczema (atopic dermatitis) is a chronic inflammatory skin disorder and a 
major manifestation of allergic disease. In a genome-wide association study 
for eczema, a common variant on chromosome 11q13.5 (rs7927894) has 
been identified as a susceptibility locus in four study populations from 
Central Europe. 
The aim of this study was to determine the effect of this risk variant on 
various allergic diseases on the population level. More than 7,400 
individuals from a large English birth cohort born in 1991 and 1992, were 
genotyped for rs7927894. Association analyses were performed for eczema, 
asthma, hay fever, allergic sensitization, and combinations of these 
phenotypes. The population attributable risk fractions were estimated. 
Beyond replicating the association with eczema, we found that the effect of 
this risk variant was restricted to individuals with the allergic subtype of 
eczema (OR, 1.31; 95% CI, 1.07-1.60). In contrast, no association of 
rs7927894 with non-atopic eczema was observed. Moreover, we detected 
association with concomitant asthma (OR, 1.50; 95% CI, 1.14-1.97) and 
hay fever (OR, 1.54; 95% CI, 1.15-2.06). The population attributable risk 
fraction for atopic eczema was estimated to be 23.8%. 
We conclude that the rs7927894 risk allele is a common variant that confers 
a moderate risk for atopic disase, but carries a large public health effect on 
atopic eczema and allergic airways disease. Furthermore, the association 
with atopic eczema as well as concomitant asthma and hay fever points to a 
key role in the atopic march. 
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Highly conserved non-coding elements (HCNEs) are one of the most 
intriguing features of Metazoan genomes. HCNEs cluster around key 
developmental genes, and many were also shown to be enhancer that 
driving the expression of those genes. The need to keep HCNEs as 
enhancers in cis to their target gene puts constraints on gene rearrangements 
and genome organization, leading to strong synteny conservation. These 
findings lead us formulate the genomic regulatory block (GRB) model, in 
which one or more target genes are located in an HCNE-dense area, often 
along with other “bystander” genes that do not respond to regulatory input 
from HCNEs.  
 
In this work we present innovative computational approaches for the 
characterization of genomic regulatory blocks and their target genes. First 
we demonstrate that non-coding sequence conservation in GRBs reveals a 
characteristic and unusual pattern of purifying selection on GRB sequences 
even between closely related species, enabling the detection of large 
lineage-specific developmental regulatory changes. Second, we present a 
method for the automated genome-wide detection of target genes of GRBs. 
While these genes are among the most important and most well studied 
genes in developmental biology, their determination has been a manual and 
insufficiently well defined process until now. We have shown that GRB 
target genes have specific features, most notably long and multiple CpG 
islands and broad transcription initiation regions, as well as a distinct set of 
epigenetic markers. We now present an expanded list of genomic features 
that make GRB target genes distinguishable from other genes in their 
neighborhood and the rest of the genome. Using these features, we have 
developed a predictive method based on random forests to aid in 
cataloguing genome-wide sets of all possible GRBs and their target genes. 
We uncover an exhaustive list of target genes of long-range developmental 
regulation and the regulatory blocks around them, and show compelling 
evidence for their complex regulation and high long-range regulatory 
potential. 
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The genomes of Holstein bull “Chief” and his son “Mark” were sequenced 
to 7x and 13x coverage, respectively, using 454 Titanium chemistry. We 
identified ~1.4 million SNPS that were useful for reconstruction of IBD 
segments inherited by Mark from Chief. The precision of SNP genotyping 
and phasing of alleles in Mark haplotypes were validated by genotyping 
Mark and 92 offspring using the Illumina Bovine SNP50 array. Using 
SNP50 genotypes as a reference, the precision of allele phase reconstruction 
of the Mark genome was 97%. The shared IBD segments distinguishing the 
alternative haplotypes of the two first order relatives were resolved to a 
median spacing of 800 bp. The Mark genome shows runs of homozygosity, 
indicating inbreeding due to the reduced effective population size following 
the domestication of cattle, and regions of dense heterozygosity, indicating 
a large effective population size pre-domestication. The approach used will 
facilitate the simultaneous identification of the candidate QTL regions and 
QTNs for several economically important traits segregating among the 
offspring of these two champion bulls. 
 176 
COMBINED EVIDENCE FROM EVOLUTIONARY, POPULATION-
GENETIC AND DISEASE STUDIES POINTS TO A ROLE OF THE 
EPIGENOME IN MEDIATING STRUCTURAL MUTABILITY OF THE 
HUMAN GENOME 
 
Jian Li1,2, Pawel Stankiewicz1, Ronald A Harris1, Sau Wai Cheung1, Ankita 
Patel1, Sung-Hae Kang1, Chad A Shaw1, Craig Chinault1, Lisa White1, 
Tomek Gambin3, Anna Gambin4, James R Lupski1,5,6, Aleksandar 
Milosavljevic1,2  
 
1Baylor College of Medicine, Department of Molecular and Human 
Genetics, Houston, TX, 77030, 2Baylor College of Medicine, Program in 
Structural and Computational Biology and Molecular Biophysic, Houston, 
TX, 77030, 3Warsaw University of Technology, Institute of Computer 
Science, Warsaw, 00-661, Poland, 4 University of Warsaw, Institute of 
Informatics, Warsaw, 02-097, Poland, 5Baylor College of Medicine, 
Department of Pediatrics, Houston, TX, 77030, 6Texas Children's Hospital, 
Houston, TX, 77030 
 
Submicroscopic structural variation is highly non-randomly distributed in 
the human genome. Non-Allelic Homologous Recombination (NAHR) 
mediated by Low Copy Repeats (LCRs) can account for only a small 
fraction of it. Prompted by the recently discovered association of 
hypomethylation and structural instability in white-cheeked gibbons, we 
examined the relative contribution of LCR-mediated NAHR and 
hypomethylation to the submicroscopic structural mutability in humans. We 
combined evidence from human genome evolution, structural 
polymorphisms in the human population, and disease studies. Combined 
evidence from multiple sources, including our study of association of 
hypomethylation in human germline with human-specific structural 
rearrangements, copy number variation from published disease and 
HapMap studies, and our own study of 400 patient samples conducted using 
custom oligonucleotide arrays specifically designed to probe NAHR-
susceptible regions consistently points to a stronger association of germline 
hypomethylation with genomic instability than LCR-mediated NAHR, 
indicating a major role for the epigenome in mediating structural mutability 
of the human genome. 
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Exome capturing and sequencing have been utilized to characterize 
polymorphisms in exonic regions in human with ever-highest resolution. 
Nonetheless, current mapping-based approaches still have limited in 
detection of insertions and deletions, which in general have more potential 
functional impact than SNPs. Here we present an unprecedented discovery 
of coding insertions and deletions in 1000 Danish Caucasians by de novo 
assembly of captured exome sequences with approximately ~10,000-fold 
coverage in total. Experimental and computational validations prove the 
detected indels have high accuracy and they are much less biased to short 
indels (1-3bp in length) than previous studies. The data enables us to 
characterize the population pattern of coding indels with minor allele 
frequency >0.02 in over 90% of the exon region. Investigations in genomic 
distribution and frequency spectrum have unveiled novel population and 
selection aspects of coding indels that are different from SNPs. Our results 
provide an abundant source and new insights of this important variation 
type. 
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A core goal of next generation sequencing (NGS)-based studies is to 
provide information on a full spectrum of genetic variants including SNPs 
and CNVs. Sequencing based studies pose analytical and computational 
challenges due to the sheer volume of data generated, short read lengths and 
high sequencing error rates. These problems become even more challenging 
when a low-coverage sequencing design is used to cost-effectively analyze 
genetic variation in as many individuals as possible.  
Here we describe an approach for integrating numerous features of NGS 
data to obtain highly accurate CNV genotypes in population-sequencing 
studies. The approach builds upon our hidden Markov model proposed 
earlier that generates accurate SNP calls by leveraging LD information from 
a population sample of individuals, using either genotype or sequencing 
data. Here we have extended the method to analyze SNPs and CNVs 
jointly. We applied our methods to NGS data with an average coverage ~5X 
from the 1000 Genomes Project. We obtained preliminary CNV likelihoods 
by analyzing the local distribution of read depth across a population 
together with the presence of read pairs that have unexpected spacing when 
aligned to the genome. We obtained preliminary SNP likelihoods using read 
depth, base and mapping quality. We then integrated the two sets of first 
round likelihoods to obtain refined CNV genotypes. Comparing these 
refined CNV genotypes with experimental counterparts, our preliminary 
results show that a large class of human CNVs – those containing at least a 
kilobase of unique, mappable sequence – can be genotyped with a call rate 
of 99.30% and an error rate of 1.2%. We thus demonstrate that joint 
analysis of CNV and SNP data from massively parallel sequencing can 
generate more complete and accurate CNV genotypes. Our method is 
sufficiently flexible to handle low-coverage sequencing data from many 
individuals in a population sample. Our imputation method is implemented 
in C/C++ and is at www.sph.umich.edu/csg/abecasis/mach/ for free 
downloading. 
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Selank is a synthetic peptide, an analogue of tuftsin (the short fragment 
Thr–Lys–Pro–Arg of the human immunoglobulin G heavy chain), elongated 
at the C terminus with the tripeptide Pro–Gly–Pro. Selank showed dual 
influence on organism: on the one hand it has a nootropic and anxiolytic 
characteristics, on the other – exhibits an antiviral effect. 
Taking into account the bipartite action of Selank we have carried out two 
lines of analysis. In the first, we have analyzed the expression profiles of 
12000 genes in rat hippocampus using the SBC–R–RC–100–13 
microtemplate (BiochipTM). Single and course Selank administration caused 
a more than 2,5-fold change in the expression of 18 and 15 genes, 
respectively. In both cases, under Selank administration the most expression 
changes were observed for five genes Actn1, Cx3cr1, Fgf7, Ptprn2 and 
Xtrp1. In the second place we studied the effect of Selank on the expression 
of these genes in the spleen. Selank showed much stronger influence on the 
gene expression in this organ than in the hippocampus. After a single 
Selank administration the most significant increase of the expression was 
observed for three genes: Ptprn2, Actn1 and Cx3cr1. 
Moreover we have carried out detailed study of the Selank and its fragments 
(Gly-Pro, Arg-Pro-Gly-Pro and tuftsin) action on the gene expression. We 
analyzed the expression of 84 genes (the panel of genes RT2ProfileTM PCR 
Array SABiosciences) involved in processes of inflammation in the mouse 
spleen 6 and 24 hours after single intraperitoneal injection of peptides. 
There was a significant alteration in the expression of 34 genes. In most 
cases the maximal response was observed after 6 hours of peptides 
injection. It was revealed that each peptide gives an individual pattern of 
changes in the expression of genes studied. 
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It is now established that E2A, FOXO1 and EBF play critical roles in B cell 
development. However, how they act in concert to induce lineage-specific 
programs of gene expression and how their DNA binding patterns relate to 
architectural proteins like CTCF is unknown. We demonstrate that E2A, 
FOXO1 and EBF, primarily associate with H3K4 monomethylated regions. 
In contrast, CTCF occupancy and H3K4 monomethylation are mutually 
exclusive. We further demonstrate that: (1) E2A binds coordinately with 
EBF and FOXO1 to a vast spectrum of B-lineage specific enhancers, (2) 
these associations are dynamic during developmental progression, (3) E47 
directly modulates the pattern of H3K4 monomethylation, (4) the induction 
of H3K4me patterning correlates well with B-lineage specific gene 
expression and enhancer activity. From these data, a regulatory network is 
generated that shows how the combined activities of E2A, FOXO1 and EBF 
orchestrate B cell development.  
 
Keywords: ChIP-seq, HOMER de novo motif finding algorithm, Ward’s 
hierarchical clustering, B cell development, regulatory network, tumor 
suppression 
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Induced pluripotent stem cells (iPSCs) are capable of differentiating into 
diverse cell types, and thus hold enormous potential for personalized 
regenerative therapies. We have recently developed an iPSC system 
whereby readily available adipocyte progenitor cells are rapidly 
reprogrammed to a pluripotent state at very high efficiency in a completely 
feeder-free environment, enabling efficient and convenient iPSC generation. 
However, central questions remain regarding epigenetic regulatory 
processes in the iPSC system. What are the epigenetic changes that take 
place during the reprogramming process? How closely does the iPSC 
epigenome resemble that of embryonic stem (ES) cells? Do residual 
epigenetic marks characteristic of the pluripotent state remain in somatic 
cells derived from iPSCs? To address these questions we have characterized 
the DNA methylomes and transcriptomes throughout the transition of a 
differentiated cell into an iPSC, and subsequent differentiation back into the 
original cell type. Using the Illumina HiSeq2000 sequencer, which yielded 
over 200 gigabases per run, genome-wide single-base resolution mapping of 
DNA methylation sites (MethylC-Seq) and strand-specific whole 
transcriptome (RNA-Seq) profiling were performed for progenitor 
adipocytes, adipocyte-derived iPSCs, and progenitor adipocytes that were 
derived from differentiation of the iPSCs. Integration of these data and 
comparison to an extant human ES cell DNA methylome has enabled for 
the first time a high-resolution characterization of the epigenomic and 
transcriptional changes during iPSC generation, and interrogation of the 
epigenomic patterns within differentiated cells derived by iPSC technology. 
 182 
ANALYSIS OF COPY NUMBER VARIATIONS AMONG CATTLE 
BREEDS 
 
George E. Liu, Yali Hou, Bin Zhu, Maria F. Cardone, Lu Jiang, Angelo 
Cellamare, Apratim Mitra, Lee J. Alexander, Luiz L. Coutinho, Lou C. 
Gasbarre, Michael P. Heaton, Robert W. Li, Lakshmi K. Matukumalli, Dan 
Nonneman, Luciana C. de A. Regitano, Tim P. Smith, Jiuzhou Song, Tad S. 
Sonstegard, Curt P. Van Tassell, Mario Ventura, Evan E. Eichler, Tara G. 
McDaneld and John W. Keele  
 
USDA-ARS, Bovine Functional Genomics Lab., ANRI, 10300 Baltimore 
Ave, Building 200 Rm 124B, Beltsville, MD, 20705 
 
Genomic structural variation is an important and abundant source of genetic 
and phenotypic variation. Here we describe the first systematic and 
genome-wide analysis of copy number variations (CNVs) in the modern 
domesticated cattle using array comparative genomic hybridization (array 
CGH) and quantitative PCR and fluorescent in situ hybridization (FISH). 
Our panel includes 90 animals from 11 Bos tarus, 3 Bos indicus and 3 
composite breeds for beef, dairy or dual purposes. We identified over 200 
candidate CNV regions (CNVRs) in total and 177 of which are within 
known chromosomes, which harbor or are adjacent to gains or losses. These 
177 high-confidence CNVRs cover 28.1 mega bases, ~1.07% of the 
genome. Over 50% CNVRs (89/177) were found in multiple animals or 
breeds and analysis of them reveals breed-specific frequency differences 
and reflects aspects of the known ancestry of these cattle breeds. Selected 
CNVs were further successfully validated by independent methods using 
qPCR and FISH. About 67% CNVRs (119/177) completely or partially 
span cattle genes and 61% CNVRs (108/177) directly overlap with 
segmental duplications. CNVRs span about 400 annotated cattle genes that 
are significantly enriched for specific biological functions such as 
immunity, lactation, reproduction and rumination. For gene families like 
ULBP which have gone through ruminant lineage-specific gene 
amplification, we detected and confirmed marked differences in CNV 
frequencies across diverse breeds, demonstrating the evolutionary 
contributions of CNVs to cattle domestication and breed formation. Our 
results provide a valuable resource beyond microsatellites and single 
nucleotide polymorphisms to explore the full dimension of genetic 
variability for the future cattle genomic research.  
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The highly endangered orangutan species, Pongo abelii (Sumatran 
orangutan) and Pongo pygmaeus (Bornean orangutan), are the most 
phylogenetically distant great apes with respect to humans. The orangutan 
genome sequence thus provides a unique perspective from which to 
investigate great ape and human evolution. We present here the draft 
genome assembly of a Sumatran orangutan, as well as genome sequence 
from 10 additional Bornean and Sumatran orangutans. Our analysis 
indicates that the structural evolution of the orangutan genome proceeded 
more slowly than that of the chimpanzee and human genomes. We observe 
a lower rate of chromosomal rearrangements, segmental duplications, gene 
duplications and Alu retroelement transposition. Other notable observations 
include a polymorphic neocentromere, numerous lineage-specific gene 
inactivation events among great apes, and suggestive positive selection 
signals from six components of a single metabolic pathway. From a 
population perspective, Bornean and Sumatran orangutans exhibit 
pronounced divergence, including several megabases of species-specific 
duplication. Demographic analysis of our SNP dataset (13 million SNPs) 
estimates the Bornean-Sumatran split time at 400,000 years ago, with 
subsequent reduction in Bornean effective population size and exponential 
expansion of Sumatran effective population size since the split. These data, 
considered together, present a unique view into the evolutionary history of 
the biologically rich orangutan species and provide extensive resources for 
conservation efforts. 
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Discovery of regulatory networks from genome-wide gene expression and 
genotype data is an idealized goal of systems biology. We have developed a 
new algorithm, which we have named ANCHoR, that is novel in its 
capacity to learn unique directed, undirected, and cyclic regulatory 
relationships among genes. We use our method to identify gene expression 
networks in cell lines collected from eight populations in HapMap 3 and 
compared these reconstructed regulatory networks among populations.  
 
ANCHoR solves a major theoretical concern for network learning: 
unmeasured network components and connections can produce spurious 
regulatory signals among a set of expressed genes. We address this problem 
in ANCHoR by requiring a sufficient set of cis-expression Quantitative 
Trait Loci (cis-eQTL), which act as perturbations of expression, to be 
present for an analyzed gene set. With sufficient cis-eQTL, a graph that 
captures both observed directed and undirected regulatory relationships, as 
well as unobserved relationships, can be efficiently learned from a 
combination of gene expression and genotype data.  
 
Using ANCHoR, we reconstructed networks for genes expressed in the 
immortalized lymophoblastoid cell lines for eight populations from 
HapMap3. For each population, a global undirected expression network was 
first reconstructed for expression probes and modularized into 10-40 highly 
connected sub-networks each containing 5-30 genes. A combined directed 
and undirected sub-network was then inferred for each module. As an 
example of our results, networks involving immune response genes, (e.g. 
CD79B and LY86) were conserved across populations, indicating 
conserved immunological response for certain genes. 
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RNA-seq analyses of non-model organisms suffer from the lack of a 
reference gene set to map the reads against. We propose to tackle this 
problem by aligning the reads to multiple alignments of gene phylogenies 
from related species using the PAPAYA sequence graph aligner. Our 
simulation study and analyses of real data indicate better performance than 
current de novo assembly approaches. 
 
Our approach builds profile-HMM models from EnsemblCompara 
GeneTrees codon alignments, scans the RNA-seq reads using HMMER3 
and clusters reads as putatively homologous to the highest scoring gene tree 
with evalue<1e-3. For each gene tree we then construct a sequence graph 
representing the ancestral gene model, with alternative splicing if present, 
using the codon alignment and its phylogeny. We align graphs representing 
the putatively homologous reads to this ancestral graph, accommodating 
possible sequencing errors and lowly scoring bases in the graph structure; 
reads with low overlap are discarded. We finish by merging the reads from 
each species using the underlying paralogous haplotype structure in 
duplicating genetrees and indicating the inferred missing site information.  
 
We performed simulations to study the expected coverage of a given RNA-
seq run for a non-model species with no close sequenced genome available. 
For a subgroup of vertebrate species with 5 available reference genomes 
encompassing a divergence of 200-300 MYA (e.g. Saurias or Teleosts), and 
given a 30x coverage RNA-seq run of a complex tissue sample for a new 
ingroup species 100 MYA to the closest reference genome, our comparative 
genomics approach would be able to reconstruct 60% of the coding gene 
structures with a median of 80% of the predicted full length.  
 
We applied our approach to reconstruct the brain transcriptome of 12 birds 
publicly available in the NCBI SRA against the 5 available genomes in 
Ensembl (chicken, turkey, duck, zebrafinch and lizard), and for these low-
coverage runs (1x-4x of 454 Ti sequencing) we already obtained an average 
coverage of 50% avian genes at 60% median of full length. Considering 
current NGS technologies, we predict that our phylogenetic approach would 
be able to deliver comprehensive transcript models for a vertebrate species 
in a sampled subgroup for less than $10k in sequencing costs.  
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Small insertions and deletions (indels) are a common yet under-studied 
class of variation. The 1000 Genomes project allows, for the first time, a 
genome-wide and systematic study of common indel polymorphisms.  
 
Candidate indels of length up to 50bp were called by several groups and 
methods. From these we called a single high-confidence set of indels with 
genotypes. Validation is in progress. 
 
We found that indels are often in strong LD with neighbouring SNPs, 
showing that indels can be imputed from sparse genotype data. As 
databases of disease-causing variants (eg HGMD) are enriched with indels, 
they may be enriched for causal variants of common diseases too, making 
them interesting targets in GWAS studies. Using imputation this is currently 
being investigated on several existing GWAS datasets, and preliminary 
results will be discussed. 
 
We were also interested in determinants of indel accrual rates. We found 
significant variations, e.g. G+C content has a strong and non-linear effect. 
As expected rates are lower in inter-species conserved regions, UTRs, and 
particularly in coding exons, while in recombination hot-spots indel accrual 
rates are up by 25%. No evidence for a previously reported mutagenic effect 
of heterozygous indels was found (Tian et al., Nature 455). 
 
Indels are particularly prevalent in homonucleotide runs (HRs): e.g. in 12bp 
HRs, per-bp rates are increased 150-fold, so that about 50% of indels are 
predicted to occur in the 5% longest HRs by genome coverage. A 
substantial (~1%) HR indel error rate in Illumina reads make HR indels 
difficult to call; while we accounted for this, it suggests some caution in 
interpreting results. Nevertheless, the site-frequency spectrum suggests that 
calls are reliable, and the inferred rates and HR abundance are consistent 
with an equilibrium model of HR evolution. 
 
* E Banks, K Chen, D Craig, M DePristo, M Gerstein, M Hurles, F Hyland, 
T Keane, R Li, G Marth, Z Ning, A Siddiqui, C Sougnez, K Walter, K Ye, 
Z Zhang, authors 
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The phenotypic differences between individuals are an outcome of genetic 
and epigenetic variation. Whereas variation at the sequence level (SNPs and 
CNVs) has been studied extensively, much is still unknown regarding the 
extent and function of epigenetic variation. Disturbance in DNA 
methylation leading to aberrant gene expression has been shown to be 
involved in many diseases, and variation in DNA methylation may 
contribute to the risk of common disease.  
 
The aim of this study is to explore variation and patterns of epigenetic 
variation using twins. Since each cell type has its own epigenome, we have 
isolated different lymphocyte subpopulations (CD19+, CD8+, CD4+ and 
CD4+CD25+) from more than 350 twin pairs. 
We have used both region-specific and genome-wide analyses. First, we 
studied DNA methylation in the classical human major histocompatibility 
complex (MHC). The MHC is a gene dense and highly polymorphic region 
on human chromosome 6p21.3, containing genes with a broad range of 
functions within the innate and adaptive immune systems. We performed 
extensive bisulphite sequencing of 1670 individual CpG sites distributed in 
176 regions in the classical human Major Histocompatibility Complex 
(MHC) in 49 monozygotic (MZ) and 40 dizygotic (DZ) healthy Norwegian 
twin pairs. Regions of interest include CpG islands, the 5’end of genes and 
non-coding conserved regions. We observed significant variation in DNA 
methylation both between and within regions. Interestingly, the heritability 
of this variation is low, ~6% for individual CpGs and ~11% for amplicons, 
suggesting DNA methylation variation is not under strong genetic control. 
Second, we are using genome-wide methods to examine disease 
discordance in monozygotic twins. We have performed genome-wide 
methylation analyses using both Infinium arrays and bisulphite sequencing 
using the Illumina platform. In parallel, covalent histone modifications were 
examined by chromatin immuno-precipitation (ChIP). 
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Genome-wide association and genetic linkage analyses have identified almost 
50 genetic loci that modify risk of type 1 diabetes. In an effort to identify the 
underlying candidate genes and sequence variants responsible, four regions 
were selected for resequencing. These regions, on human chromosomes 7, 10, 
16, and 19, were identified as having genome-wide levels of significance, and 
were not known to be the target of ongoing sequencing efforts. The regions 
were each ~250 kb, for a total of 1 Mb of sequence. As part of the Type 1 
Diabetes Genetics Consortium (T1DGC), a custom Nimblegen DNA capture 
array targeting the four regions was designed. DNA samples were pooled in 
groups of 10 T1D cases (drawn randomly from the T1DGC WTCCC-UKGrid) 
or 10 controls (drawn to match the geographic location of cases). Pooling, DNA 
capture, and 454 sequencing were performed on 100 pools (50 case, 50 control), 
with an initial 1/4-plate of sequencing per pool. DNA samples were not 
barcoded in this 100 pool study; however, samples from two pools (one case 
and one control) were barcoded, captured, pooled and resequenced at one plate 
per pool, to provide a reference sample for comparison. While barcodes for the 
100 pool sequences were not available, donor genotype information from 
genome wide SNP arrays for all 1000 DNA samples were obtained from the 
WTCCC. These data provided expected allele frequencies across 131 SNP loci 
contained in the four targeted regions, which were used to estimate the final 
donor sequence composition of each pool. The known genotypes were also used 
to assess our ability to discover and genotype the rarest possible variants in each 
pool. A mixed linear model was used to test associations between common 
allele frequencies to disease, adjusting for pool compositional bias. We were 
able to replicate known T1D associations to marker SNPs in the Affy panels, 
and to identify nearby SNPs exhibiting increased significance. Many novel rare 
variants were also seen. We have also interrogated the unaligned 454 reads for 
mosaic sub-alignment patterns indicative of large-scale structural variation, 
identifying a number of candidates for further study. 
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Many medical research topics require a comprehensive catalog of variations in a 
group of related individuals. Deep (30x) sequencing of whole genomes is still 
too expensive for most studies. However, since many variations are shared 
among individuals, the amount of sequencing per individual can be drastically 
reduced. 
 
We describe a process for detecting variations in low-coverage (4x) sequencing 
of a population. Our method was developed to discover SNPs in the 1000 
Genomes Project Pilot 1, This method is one of the three approaches that have 
been combined for the official project release. 
 
Our method consists of three steps: 
 
1. Compute (by evaluating in all samples sequenced) the odds in favor of a 
variant being present at each base in the genome. Emit these odds along with 
other annotation such as depth and strand bias.  
 
2. Collect all sites having non-zero odds of being a SNP, and pick optimal 
annotation thresholds via a grid search.  
 
In 60 CEU individuals at 4x depth, 90% of discoveries have an estimated true 
positive rate of 97%, another 5% have a TP rate of 80% and a final 5% have a 
TP rate of 67%. 
 
In replication of a small number of sites, we meet a >90% true positive rate for 
SNP discovery. 
 
3. For the sites that pass optimization, refine genotype likelihoods by leveraging 
inferred haplotype information using the program BEAGLE by Brian and 
Sharon Browning. 
 
After refinement with BEAGLE, we attain a 5% non-reference genotyping error 
rate (GER) per individual when compared with genotype calls from a custom 
microarray. Without BEAGLE our average GER was 20%. 
 
The complete tools for this pipeline are publically available in the Broad's 
GATK and in the BEAGLE software by Browning & Browning. 
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We and others have performed genome-wide association studies (GWAS), 
which have identified a significant number of new loci associated with 
increased risk of developing breast cancer. Predictions are that most of the 
unidentified underlying variants have a regulatory function, as most are 
located in intergenic regions or in “gene deserts”. We performed differential 
allelic expression (DAE) analysis, a robust technique to identify cis 
regulatory loci, in normal breast tissue to prioritise loci from the GWAS for 
further follow-up analysis. 
Sixty-four samples were genotyped and assessed for allelic expression using 
Illumina Exon510S-Duo BeadChips. In 665 SNPs located in exons and 
UTR regions, 240 (36%) displayed preferential allelic expression (p<0.05) 
with 22 of these (3%) displaying highly significant DAE (p<10-5). We have 
also identified genes known to be imprinted in other tissues, which also 
show allele-specific expression in breast tissue. 
We are combining our data with the UK GWAS1 (Easton et al Nature 2007) 
and GWAS2 (unpublished) studies for breast cancer susceptibility, to 
generate a list of genes that show regulatory variation for further evaluation 
as candidates. We have initiated genotyping of these in a set of 14,000 cases 
and controls, to determine their association with susceptibility to breast 
cancer. 
This is the first genome-wide differential allelic expression study in normal 
breast tissue, and has revealed a global cis regulatory map of breast tissue. 
We predict that this will be a powerful tool to combine with GWAS data to 
identify breast cancer susceptibility loci. 
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Microsatellite sequences are abundant in eukaryotic genomes and have high 
germline rates of strand slippage-induced repeat number alterations. 
However, the minimal number of repeats required to constitute a 
microsatellite has been debated, and a functional definition of a 
microsatellite that takes into account their mutational behavior has been 
lacking. To address the definition of a microsatellite, we investigated 
slippage dynamics for a range of repeat sizes, using two approaches. 
Computationally, we assessed size polymorphism at repeat loci in ten 
ENCODE regions resequenced in four human populations, assuming that 
the level of polymorphism reflects strand slippage rates. Experimentally, we 
determined the in vitro DNA polymerase-mediated strand-slippage error 
rates as a function of repeat number. In both approaches, we compared 
strand slippage rates at tandem repeats to the genome-wide background 
slippage rate at two-unit monitor loci. We observed two distinct modes of 
mutational behavior. At small repeat numbers, slippage rates were low, and 
indistinguishable from background measurements. A marked transition in 
slippage rates was observed as the tandem repeat array lengthened, such that 
at large repeat numbers, slippage rates were significantly higher than at 
monitor loci. For both mononucleotide and dinucleotide microsatellites 
studied, the transition length corresponded to a similar number of 
nucleotides: 9-10 repeats for [A/T]n and 5-6 repeats for [GT/CA]n. Our 
results argue for the existence of microsatellite threshold that is determined 
not by the presence/absence of strand slippage at repeats, but by an abrupt 
alteration in slippage rates and directionality, relative to background. These 
findings have implications for understanding microsatellite mutagenesis, for 
standardization of microsatellite analyses in completely sequenced 
genomes, and for predicting polymorphism levels of individual 
microsatellite loci. 
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Unraveling the genetic relationship between domestic and Przewalski’s 
horses is critical for understanding the domestication history of the former 
and for formulating conservation strategies for the latter. Indeed, the 
endangered Przewalski's horse is the only true wild horse surviving today 
and is the closest relative of the domestic horse. Once found throughout the 
Eurasian steppe, Przewalski’s horse had become virtually extinct, but was 
later bred in captivity and reintroduced to the wild. The present 
Przewalski’s horse population originated from a mere 12 horses.The 
question of whether Przewalski’s and domestic horses form distinct genetic 
clades is still contentious. To resolve this controversy, we used the next 
generation sequencing technology to determine the sequences of complete 
mitochondrial genomes as well as of substantial portions of the nuclear 
genomes in four Przewalski’s horses representing all four surviving 
mitochondrial lineages. Two markedly distinct mitochondrial haplotypes 
among Przewalski's horses were observed, which was unanticipated, since 
their population went through a severe genetic bottleneck. The two mtDNA 
haplotypes discovered did not form a separate clade on a horse phylogenetic 
tree, thus rejecting the monophyly of Przewalski’s horses, and were 
estimated to split 120,000-180,000 years ago, simultaneously with the 
divergence of the major modern horse lineages and significantly preceding 
horse domestication. The phylogenetic network analysis indicated that, 
among horse haplotypes analyzed, one of the Przewalski’s horse mtDNA 
haplotypes might be ancestral to the extant horse mtDNA haplotypes. Thus, 
Przewalski’s horses have ancient origins and are more genetically varied 
than previously realized.  
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The less-is-more hypothesis has argued that some aspects of human 
evolution may have emerged by the loss of gene functions that are common 
among all other primates. Since the human genome shows extensive copy-
number variation, we set out to identify and characterize segmental 
deletions (> 1kbp) that emerged specifically within the human lineage of 
evolution. To avoid potential assembly artifacts from non-human primate 
genomes, we developed a method to use chimpanzee and orangutan whole 
genome-shotgun datasets in combination with end-mapping, to identify and 
map segments that are missing from the human reference genome. Using 
aCGH, we experimentally validated 1,291 human-specific deletions when 
compare to all other great-ape species. The events ranged in size from 1 to 
42 kbp and corresponded to 3.54 Mbp of sequence. Based on RefSeq data 
and gene models present in orangutan, we detected 65 genes that have been 
affected by these deletions and identified more than 500 Kb (~150 sites) of 
deleted ultra-conserved sequence among mammals, suggesting the possible 
loss of functional important elements during the course of human evolution. 
We assessed experimentally the polymorphism of these sequences in 60 
human individuals from 7 different populations and from several 
individuals in different species of non-human primates. We show that 
95.6% of the events are fixed in all human populations. Of the 56 remaining 
polymorphic segments that are present in at least one individual, we 
estimate that 30% of these sites restricted to one human continental group 
while 41% are fixed as a deletions in a particular population but still 
polymorphic in others. These data allow us to assign different events to 
different periods of human evolution and provide the first characterization 
of genes and gene families that have been completely erased from our 
lineage. Our preliminary data suggest that human specific duplications have 
affected 3-fold more sequence to our genome when compared to human 
specific deletions. 
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The regulation of gene expression is biologically essential, and differences 
in gene expression are an important source of phenotypic variations 
between species. Regulatory divergence can result from changes in cis-
acting sequences (cis) or in trans-acting factors (trans). Changes in cis are 
predicted to affect the regulation of single genes, while changes in trans are 
more likely to be pleiotropic. Subsequently, trans-regulatory divergence is 
predicted to be less common than cis-regulatory divergence. 
We used RNA-seq to quantify total mRNA levels in two closely related 
Drosophila species (D. melanogaster and D. sechellia) and allele-specific 
gene expression in their F1 hybrid. By comparing these results, we 
dissected the genome-wide cis and trans contributions to regulatory 
divergence. 78% of expressed genes are differentially expressed between 
species, and 51% and 66% of expressed genes are affected by cis- and trans-
regulatory divergence, respectively. This is a relatively larger trans 
contribution than expected, which may result from the historically small 
population size of D. sechellia. Genes with cis-regulatory divergence have 
lower rates of sequence conservation in their promoter regions. In addition, 
our results support numerous correlations between gene regulatory 
divergence mechanisms and the inheritance of gene expression. 
We are currently investigating the regulatory divergence of alternative 
isoform expression. Our preliminary results suggest that regulatory 
divergence also contributes to species-specific differences in RNA-
processing. For example, the spinster gene contains a set of mutually 
exclusive cassette exons that are known to modulate its function in ovarian 
and neuronal development. We identified and validated cis-acting 
regulatory divergence of pre-mRNA splicing that has resulted in differential 
exon utilization at spinster. In summary, our results illustrate the power of 
mRNA-seq for investigating the genetic changes underlying interspecific 
differences in gene expression and pre-mRNA splicing. 
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Therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-
AML) is a uniformly fatal complication that occurs in up to 5% of cancer 
survivors treated with chemotherapy or radiation. As more cancer patients 
achieve longer remissions, t-AML has increased in incidence, yet remains 
refractory to current therapy, with a median survival of 8-10 months. T-
AML is thought to be a direct product of genetic mutations induced by 
alkylating agents, topoisomerase II inhibitors, and radiation. Two main 
subtypes of t-AML have been described that differ in their morphology, 
cytogenetic karyotype, and prognosis: alkylator-agent-induced and 
topoisomerase-II inhibitor-induced. Further understanding of t-AML will 
provide insight into non-therapy related, de novo AML, the most common 
acute leukemia of adults, with 12,000 new cases per year in the U.S. alone. 
Additionally, t-AML may serve as a model for the development of other 
cancers, which are often the result of the interaction between environmental 
exposures, such as carcinogens, and induced genetic changes. To identify 
genetic mutations associated with leukemogenesis, we have sequenced the 
leukemic mRNA of 26 t-AML patients to identify genetic abnormalities, 
including gene fusions, single nucleotide variants (SNVs), small insertions 
and deletions, and alternative mRNA isoforms, using Illumina paired-end 
sequencing. We have found over 50,000 SNVs per sample. Some of the 
affected genes have been previously described in t-AML, supporting our 
protocol and computational pipeline. Phenotypically relevant SNVs are 
prioritized by population-level allele frequency estimates, evolutionary 
constraint estimates, and the frequency of the aberrant gene or biological 
pathway within the patient samples. Putative disease-relevant SNVs are 
being compared between the two main subtypes of t-AML, as well as 
between therapy-related and de novo AML. Findings are being validated by 
constrast to germline DNA genotypes, as well as in a larger cohort of 100 t-
AML leukemia samples and 50 de novo AML leukemia samples. This 
information will allow the identification of pathways altered in t-AML, 
correlation of mutations with clinical outcome, identification of potential 
biomarkers, and generation of candidate targets for leukemia therapeutics. 
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One in 75 men and women will be diagnosed with pancreatic ductal 
adenocarcinoma (PDAC) during their lifetime. Most will die of their disease 
within one year following diagnosis with an overall 5-year relative survival 
rate of only 5% - an outcome that has not appreciably changed since the 
1970’s. Unlike many other cancers, PDAC has remained recalcitrant to 
advanced treatments with little benefit seen from new therapeutics and 
targeted strategies. Identifying the molecular mechanistic undercurrent 
behind the disease will provide opportunities for developing strategies for 
prevention, treatment and early detection of PDAC. 
As a contributing member of the International Cancer Genome Consortium, 
the OICR will generate a comprehensive catalogue of genomic 
abnormalities found in >350 PDAC. To obtain sufficient samples newly 
consented for large-scale sequencing, the OICR has established 
collaborations locally, at the Mayo Clinic, Rochester and three Boston-area 
Hospitals (Massachusetts General and Beth Israel Hospitals and Dana 
Farber Cancer Institute). 
Our program utilizes xenografts generated from each tumor analyzed to 
augment the primary tumor and matched normal control. The xenografts 
provide ample material for analysis as well as reagents for functional 
analyses and pre-clinical models for target validation. In addition, 
establishment of cell lines from all xenografts is attempted with ~50% 
success rate. Initial efforts have focused on the deep characterization of 
early matched sets of normal, primary tumor, xenograft and associated cell 
line to establish the extent to which the xenografts and cell lines are 
representative of the initial tumor state. Data sets which are compared 
include copy number variation, miRNA, transcriptome, exome and whole 
genome obtained through next-generation sequencing. Xenografts derived 
from PDAC have proven to vary greatly in their human tumor content 
requiring the investigation of methods for enriching the tumor content prior 
to sequencing.  
Comparison of somatic variants across sample types and enrichment 
methods will be presented as well as preliminary analyses of identified 
somatic events at this early stage of the ICGC project. 
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The centromere is a chromosomal locus that is essential for proper 
chromosome segregation during cell division. Despite their conserved, 
essential function, centromeres are characterized by the rapid evolution of 
both centromeric DNA sequence and centromeric structure. Most animal 
and plant species studied thus far have fast-evolving high copy tandem 
repeats in their centromeric regions. Centromere tandem repeat arrays are 
difficult to manipulate, so we are taking a comparative genomics approach 
to study their function. To gain a better understanding how widespread this 
feature is, we developed bioinformatics tools to identify candidate 
centromere sequences from whole genome shotgun sequences, and have 
looked at hundreds of eukaryote genomes. Tandem repeat sequences were 
identified with Tandem Repeats Finder. One theory states that the 
centromere repeat unit is about the size of one nucleosome; this is appealing 
because centromere function requires a centromere-specific form of histone 
H3. A large survey of centromere repeat unit size contradicts this theory. 
One model to explain the rapid evolution of centromeres is the ‘library’ 
hypothesis. This model predicts the presence of various tandem repeat 
arrays in a given genome, which, through stochastic amplification, compete 
to become the functional centromere. Homologies between centromeric 
sequences in species A and non-centromeric sequences in species B may be 
a signature of this type of evolution. By identifying similarity between 
centromeric and non-centromeric tandem repeats of different species we can 
test this ‘library’ hypothesis. 
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GWAS have identified at least nine independent cancer susceptibility loci 
upstream of the c-myc oncogene at chromosome 8q24. One of these, an 
approximately 80kb haplotype block, confers risk for both prostate and 
breast cancer. Genetic mapping studies have suggested that this haplotype 
block contains distinct causative variants for the two cancer types. We 
argued that candidate causative SNPs are likely to reside in open chromatin 
and have therefore mapped DNase I hypersensitive sites (DHSs) as means 
of prioritising regions for further functional analysis. Within the risk region, 
we have identified a strong, ubiquitous DHS that maps to a 500bp region 
known to carry H3K4me2, H3K4me3 and H3K9ac modifications in K562 
cells. Within a 1.2kb fragment overlapping the DHS only few common 
SNPs exist, one of which, rs378854, is in perfect linkage disequilibrium 
with rs620861, the SNP most highly associated with prostate cancer within 
this risk interval. For this SNP the common allele carries increased risk, 
while the minor allele is protective. Using electrophoretic mobility shift 
assays we demonstrate that the minor allele of rs378854 generates a site 
with increased binding affinity for YY-1, a protein known to be able to act 
as transcriptional repressor. Two closely spaced Sp-1 binding sites are 
unaffected by the SNP. Using transient transfection assays we demonstrate 
that in the context of a 395bp fragment overlapping the DHS the minor 
allele of the rs378854 functions as a potent transcriptional repressor in the 
prostate cell lines PC3. In chromatin conformation capture experiments the 
DHS surrounding rs378854 was found to interact both with the c-myc and 
the pvt-1 promoters, suggesting that both of these are potential targets of the 
identified repressor element. In conclusion, we have identified a likely 
causative variant for one of the 8q24 prostate cancer susceptibility loci, 
unusually the minor allele is protective and generates a site of 
transcriptional repression.  
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Recurrent somatic aberrations can implicate individual genes in cancer 
progression. Gaining insight into the roles of these genes often requires 
analyzing them in the context of pathways, interactions, and functional 
modules. Such analyses are typically limited by the incompleteness of 
pathway and interactome databases. To overcome this key problem, we 
develop a method that identifies functional modules without any 
information other than patterns of recurrent and mutually exclusive 
aberrations (RME patterns) that arise due to positive selection for key 
cancer phenotypes.  
 
These RME patterns exist between sets of altered genes, and may be 
explained by the presence of functional relationships. Specifically, an 
aberration in one of the genes may result in the development of a key 
tumorigenic phenotype, removing selective pressure for mutation of the 
others.  
 
We use this algorithm to do an integrative analysis of 145 glioblastoma 
tumors, using copy-number alteration and somatic mutation data from the 
TCGA. Without any knowledge of the interactome, we are able to extend 
known pathways by adding new members and discover new functional 
modules. After discovering that EP300 may play a role in glioblastoma, in 
the context of the TP53 pathway, we validate this hypothesis in two 
independent data sets by demonstrating that expression of EP300 predicts 
survival independent of age at diagnosis and tumor grade. We also 
demonstrate that the method is useful for generating hypotheses on very 
large data sets, like those that will be produced by current tumor 
characterization projects. 
 
Though we apply this algorithm to tumor data, we suggest that it will be 
useful in a variety of other contexts, like identifying patterns of epigenetic 
marks that alter gene expression or finding specific sequence motifs. 
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Helminth parasites are parasitic worms, from the phyla Nematoda 
(roundworms) and Platyhelminthes (flatworms). They infect one-third of 
humanity, and the collective burden of the common helminth diseases rivals 
that of the major high mortality conditions such as HIV/AIMDS or malaria. 
The diseases caused by helminth infections range from the dramatic 
sequelae of elephantiasis and blindness to the more subtle effects on child 
development, pregnancy and productivity, resulting in maintenance of 
poverty in the developing countries.  
Recent transcriptome and genome projects have dramatically expanded the 
biological data available across the phylum Nematoda. At The Genome 
Center, we have continued development of molecular information, 
bioinformatics tools, and reagents for the study of parasitic nematodes, 
which is crucial to accelerating basic research and developing new 
diagnostics and therapeutics. 
Here we present the genome of a basal nematode, the zoonotic parasite 
Trichinella spiralis that provided a bridge between basal and crown 
nematode species, thus spanning the phylum Nematoda. The analysis 
revealed genomic and molecular details of evolutionary relationships 
among this organism, and other lineages of parasitic and free-living 
nematodes, and the next closest relatives, the arthropods. Intrachromosomal 
rearrangements persisted along the evolution of the phylum, and 
circumscribed extensive genome plasticity in the Nematoda with more 
numerous gene loss and gain events than in the phylum Arthropoda. Within 
the Nematoda, protein family deaths outnumbered births for the parasitic 
relative to the free-living species, consistent with host exploitation. Finally, 
comparison of the basal nematode to other sequenced nematodes including 
Caenorhabditis elegans identified archetypical genes of potential 
evolutionary importance along with molecular signatures exclusive to all 
nematodes. These molecular determinants are of great value and provide 
foundations for developing broad new strategies to treat and/or eradicate 
global parasites that infect over 2 billion humans, and impede production of 
food animals and crops that provide basic nutrition for the global poor. 
Furthermore, delineation of these basic characteristics is essential for 
elucidation of principles underlying the evolution of metazoan animals.  
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Persistent cell memory and plasticity are results of interactions between 
multiple transcriptional and epigenetic modifications in a cell’s genome. 
These events are cell-specific and largely unknown. We (i) developed an 
unbiased single-neuron assay of genome-wide DNA methylation 
complemented by RNA-seq analysis from the same cell, and (ii) identified 
target genes involved in the control of unique neuronal identities and 
learning processes within one of the simplest memory-forming circuit of the 
mollusc Aplysia, a powerful model in neuroscience. For single cell 
methylome, we employed of a novel enrichment strategy (for selective 
capture of 5-methylated cytosines) and massive parallel sequencing 
(SOLiD) & designed sequencing libraries for directional RNA-seq. We 
achieved >40x coverage of the cellular genome in each of 6 neuronal types 
tested. Our data suggest that >45% of neuronal transcripts are differentially 
expressed among tested cells. We unexpectedly revealed very rapid (<2hrs) 
and global DNA demethylation in postmitotic neurons in response to 
application of serotonin (5HT; 9% vs 20% in control). 5HT is known as the 
inductor of long-term plasticity and the described process releases 
transcriptional repression (e.g. gene silencing via DNA methylation of 
promoter regions) leading to coordinated activation of multiple genes 
underlying learning and memory. The examples of methylated targets are 
the promoter regions of the CREB 2 cAMP-response element binding and 
Ubiquitin Hydrolase – 2 “master genes” essential for the initiation of 
coordinated gene expression cascades. DNA methylation also occurs 
outside of CpG islands, expanding the scope of regulatory mechanisms and 
the need for genome-wide correlation of methylome and transcriptional 
outputs from the same cell at different functional states that leads to cell fate 
specification including transcription dependent changes in synaptic efficacy 
in memory circuits. 
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The origin and early evolution of animals is enigmatic, primarily because of 
the lack of molecular data from the basal Metazoa. The phylum Ctenophora 
(comb jellies) is one of the earliest lineages of prebilaterian animals having 
Precambrian fossil records (>560 Mya). They may be descendants of the 
most ancestral groups of the animals, branching before cnidarians and have 
the most basal neural & “true” mesoderm-derived muscular systems. The 
sea gooseberry, Pleurobrachia bachei, has one of the most compact 
genomes (~150 Mb). These large (1-3 cm) holoplanktonic predators are 
common in Northern Seas and have highly sophisticated ciliated 
locomotion, unique glue-based capture mechanisms & distinct 
development. We constructed paired-end sequencing libraries for 454-
Roche/Illumina platforms, and achieved >50x coverage of the genome. In 
parallel, we performed RNA-seq profiling from major tissues and used 
these data for the genome annotation. As a result we have predicted ~15,000 
genes in the Pleurobrachia genome. Using a subset of evolutionarily 
conserved genes, we validated the phylogenetic position of Ctenophora 
within the animal tree as the most basal group (however with a possibility 
that ctenophores could be a sister group of sponges). Such phylogenetic 
profiling is supported by comparative analysis of genes encoding homeo-
domain transcription factors from basal metazoans (i.e. Sponges, 
Placozoans, Cnidarians and now Ctenophores). Next, we have characterized 
a subset of neurogenic genes as well as genes involved in intercellular 
signaling in Ctenophores. In concert with phylogenetic data, this analysis 
suggests that the nervous system in ctenophores involved independently 
from other animals. Surprisingly, we found that many “classical bilaterian 
neuron-specific” genes are not expressed in neurons of Pleurobrachia. 
Injury-associated adaptations leading to secretion of signal peptides, 
regenerative growth and formation of polarized secretory cells can be 
considered as the major factors driving the appearance of neurons in the 
first place. Identification of evolutionary predecessors of inter-neuronal 
signaling and candidate molecules for such ancestral signal peptides are 
currently under experimental validation using the tools of microanalytical 
CHEMISTRY. 
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Nematodes are one of the largest invertebrate phyla with an estimated one 
million species occupying every conceivable niche. Besides the free-living 
model organism Caenorhabditis elegans, many nematode species are 
parasites of plants, insects, livestock, and humans; these parasites typically 
demonstrate great specificity to their hosts. We have sequenced and 
assembled the genome and transcriptomes of two very different nematode 
species as a pilot of the applicability of Illumina-only sequencing to a wider 
exploration of the phylum: an 85 Mb assembly of Caenorhabditis sp. 3 
PS1010 with an N50 of 9.4 kb and an 84 Mb assembly of the beneficial 
entomopathogen (insect parasite) Steinernema carpocapsae with an N50 of 
32 kb. We are using our developmentally staged RNA-seq transcriptomes of 
S. carpocapsae to make a quantitative, paired comparison of gene 
expression levels during development with the corresponding stages in C. 
elegans to identify which genes are most likely to enable nematodes to 
infect their hosts. We are currently sequencing Steinernema scapterisci and 
Steinernema intermedium, each of which have distinct host-specificity, to 
identify the evolution of non-coding cis-regulatory elements within the 
Steinernema clade, and to compare these elements to those conserved 
throughout the Caenorhabditis clade. The in-depth, systematic genomic 
exploration of parasitic nematode clades should give us better insight into 
how changes in gene content and regulation adapt different nematodes to 
their environmental niches. 
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Structural variants (SVs) are a major source of human genomic variation; 
however, characterizing them at nucleotide resolution remains challenging. 
Here we assemble a library of breakpoints at nucleotide resolution from 
collating and standardizing ~2,000 published SVs. For each breakpoint, we 
infer its ancestral state (through comparison to primate genomes) and its 
mechanism of formation (e.g., nonallelic homologous recombination, 
NAHR). We characterize breakpoint sequences with respect to genomic 
landmarks, chromosomal location, sequence motifs and physical properties, 
finding that the occurrence of insertions and deletions is more balanced than 
previously reported and that NAHR-formed breakpoints are associated with 
relatively rigid, stable DNA helices. Finally, we demonstrate an approach, 
BreakSeq, for scanning the reads from short-read sequenced genomes 
against our breakpoint library to accurately identify previously overlooked 
SVs, which we then validate by PCR. We have recently extended our 
BreakSeq approach to the 1000 Genomes Project pilot phase and compiled 
a breakpoint library of ~15,000 SVs thereof. 
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Recent advances in protein mass spectrometry are of great excitement to 
genome annotators, offering the chance to marry high-throughput peptide 
sequencing to predicted coding sequences (CDS), and to identify new 
coding loci. Here, we discuss the incorporation of tandem MS data into the 
HAVANA annotation pipeline, utilising the new software package Mascot 
Perculator which gives reliable confidence values to peptide assignments. 
 
The HAVANA group have been manually annotating the gene content of 
the human and mouse genomes for 10 years. The intron / exon structures of 
our existing gene loci are already well described on the basis of EST / 
mRNA libraries, although additional alternative transcripts will be 
discovered as RNAseq data is collected from increasing numbers of cell 
types and developmental stages. In contrast, we have less confidence in the 
annotation of CDSs, simply due to the lack of direct evidence for 
translation. In particular there is a lack of experimental validation for 
alternative protein isoforms predicted to arise through alternative splicing. 
As such, estimations regarding mammalian proteome size can vary 
dramatically. 
 
One million peptide fragments (generated in-house or taken from Peptide 
Atlas) were searched against a superset of Ensembl, Vega and IPI 
annotation, and the resulting alignments were subjected to manual analysis. 
These fragments represent a fraction of the proteomics data likely to be 
available in the near future. Even so, we could validate 32% of known 
protein coding loci whist identifying 29 completely novel putative genes. 
Furthermore, we observe translation from several pseudogene loci, 
potentially indicating their resurrection into coding forms. Our data also 
allow us to confirm putative protein isoforms generated by alternative 
splicing, refine existing splice junctions, and extend existing CDS 
predictions at the 5' and 3' ends. In all, this analysis demonstrates the 
potential of peptide to gene mapping in validating and refining genome 
annotation. 
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Transposons are mobile genetic elements, present in virtually every known 
genome, that have great impact on chromosome structure by their sheer 
numbers and propensity to recombine. Transposons are also useful tools for 
genome exploration by insertional mutagenesis, and eventually they may be 
vectors for gene therapy. Analysis of large datasets of transposon insertion 
sites is useful for understanding the molecular mechanisms that underlie 
target selection by eukaryotic transposases. We have applied Solexa high-
throughput sequencing methods and a ligation-mediated PCR approach to 
map the sites of insertion of the eukaryotic DNA transposon Hermes in the 
genome of the bakers’ yeast Saccharomyces cerevisiae. We induced 
transposon insertions into naked DNA in vitro as well as into chromatin in 
vivo using both haploid and diploid yeast genome. We found that despite 
the relatively relaxed target site sequence preferences of the Hermes 
transposon, insertions are not uniformly or randomly distributed across the 
yeast genome but are clustered in specific regions and in certain locations. 
Here we illustrate the experimental strategy as well as bioinformatics 
methods used to study the targeting behavior of the autonomous Hermes 
transposable element in Saccharomyces cerevisiae; we have extended the 
consensus target site sequence and analyzed insertion preferences for 
specific genomic features. Hermes shows a strong bias for intergenic 
regions, and more specifically, for regions that flank transcriptional units 
and are free of nucleosomes. 
 
* authors contributed equally 
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ClinSeq is a pilot project to investigate the use of large-scale medical 
sequencing as a tool for clinical research. Since 2007, this prospective study 
has recruited more than 800 of its targeted 1000 participants, who are 
consented broadly for research on all traits and for whole genome 
sequencing (WGS). With recent rapid advances in sequencing technology, 
we are now converting from a candidate gene approach focused on 
cardiovascular disease to whole exome sequencing (WES) and WGS. One 
participant was selected for WGS after analysis of 251 candidate genes did 
not identify a genetic etiology for his high coronary calcification level. We 
generated over 50X sequence coverage of this individual’s genome using 
Illumina GAiiX instruments. Reads were aligned to the human genome 
reference sequence using a hybrid eland/cross_match process, followed by 
genotype calling using a Bayesian method called Most Probable Genotype. 
Initial sequence coverage analysis indicated a 1.4Mb hemizygous deletion 
that is known to cause hereditary neuropathy with liability to pressure 
palsies (HNPP, OMIM: 162500); a result, which after CLIA validation was 
returned to this participant. However, this is not the cause of his elevated 
coronary calcification. Thus we have inspected the heterozygous non-
synonymous variants after removing those seen in other datasets and 
ranking the severity of amino acid changes to prioritize the review process. 
We have recently generated WES for this individual, and interestingly, the 
WES yields higher coverage of the CCDS than the 50X WGS, thus we will 
combine both data sets to increase our completeness across the coding 
portion of the genome in search of the causative mutation. 
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Most species and subspecies of apes have now been sequenced and the 
genomes of these closely related species are easily aligned. Along such an 
alignment, divergence times between species differ due to segregating 
polymorphism in the ancestral species. For some species the population size 
of the ancestral species is sufficiently large and the time span between 
speciation events is sufficient small that ancestral polymorphism may lead 
to gene trees with a topology different from the species tree. This 
phenomenon is termed incomplete lineage sorting (ILS) and implies that 
segments of the genome will display a closer relation to species other than 
the sister species. ILS is well established between human, chimpanzee and 
gorilla and has also been proposed between chimpanzee, bonobo and 
humans. 
 
We have developed a theoretical framework that allows for inference of 
population genetic parameters and patterns of ILS. The framework is based 
on a hidden Markov model where the hidden states along the alignment 
represent gene trees with separate topologies and separate coalescent times. 
We apply the model to the bonobo genome and demonstrate ILS between 
bonobo, chimpanzee and humans. We also present results from the gorilla 
genome with focus on the human, chimpanzee speciation time and ancestral 
population size. We describe how the occurrence of ILS correlates with 
gene annotation and recombination rate and with the X/autosome contrast. 
We find evidence for more ILS in regions of high recombination and in 
regions of low gene density consistent with widespread selection.  
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The BCM-HGSC is one of four major centers performing the Human 
Microbiome Project. To date, 104 microbial genomes have been assembled 
as part of the jumpstart portion of this project. Of these assembled 
microbes, 33 have been finished. As we have continued to evaluate 
additional microbial genomes, we have identified some key issues related to 
assembly and finishing. A major hurdle in assembly and finishing of 
microbial genomes has been the initial assembly of large repeats such as 
rRNA operons. These regions are about 5kb in length and cause 
inconsistencies in the draft assembly and scaffolding due to the presence of 
multiple copies of this highly similar sequence within each genome. 
Ordering and orienting these regions within the assembly requires extensive 
work with multiplex and long range PCR. Here we show that larger 454 
insert paired end libraries of 8-10Kb significantly improve the quality of the 
draft assembly and scaffolding, providing a mechanism to sequence and 
finish highly repetitive genomes. These longer 8Kb inserts have been 
applied to 13 organisms and sequenced along with the traditional 3Kb 
inserts for assembly comparison using N50 scaffold and N50 contig 
metrics. As part of the evaluation, 4 organisms of high GC content (63 to 
72)% and demonstrated poor contiguity were included. Using a normalized 
20 fold sequence coverage the traditional 3Kb libraries produced 183Kb to 
1.3Mb scaffold N50, while the 8Kb libraries increases the scaffold N50 as 
much as 8 fold (1.2-5.2 Mb). The contig N50 statistics remained constant at 
an average of 80Kb. Most significantly, scaffolding statistics showed that 
for 63% of these organisms, the genome was found in one large scaffold 
obviating the need for optical mapping. Success with this new technique 
indicates the majority of microbial genomes will be ordered and oriented 
upon initial assembly, providing greatly enhanced draft assemblies that 
require significantly less finishing efforts. This strategy has been 
implemented for all reference strain sequence assemblies and finishing. 
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Current NexGen technologies have now become the vehicle by which 
genome analysis will transform medicine. For the HGSC SOLiD pipeline, 
capacity is projected to increase with the use of higher density slides to 
yield 90-100Gb per run and a total center capacity of 6 Tb/month. Internal 
activities have developed library automation, bulk emPCR processes and 
application of read mapping tools such as BFAST to match pipeline flow 
with instrument capacity.  
 
Development of whole exome capture protocols using NimbleGen arrays 
and solution-based reagents have been a major pipeline focus. Laboratory 
advances include optimizations of adaptor ligation efficiency, input DNA 
quantity, and pre-and post-capture LM-PCR cycle number as well as 
automation of the capture process. Whole exome liquid phase reagents 
(NimbleGen SeqCap EZ Exome) have been tested for SOLiD sequencing. 
A second, larger custom whole exome design (VCROME) was developed at 
the HGSC and includes 20K genes. Over 200 whole exome capture samples 
have been completed for cancer and functional mutation discovery projects 
including TCGA- glioblastoma, Hepatocellular carcinoma (HCC), Autism 
and two projects (Diabetes and Hypertension) in collaboration with Eric 
Boerwinkle and the Atherosclerosis Risk in Communities Study. Current 
capture metrics for whole exome studies achieve 80% of the target bases at 
20X coverage. 
 
Whole genome sequencing activities have also expanded with over 30 deep 
coverage (30X) whole genomes now completed for medically related 
diseases including TCGA- ovarian and glioblastoma, breast cancer, HCC, 
Charcot-Marie-Tooth neuropathy (CMT) and a new Marfan-related disease. 
Here our functional mutation detection program has succeeded in 
identifying clinically relevant variants in a pedigree afflicted with an 
inherited neuropathic disease using whole genome sequencing. 
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Plasmodium falciparum is the most virulent agent of malaria; affecting 300-
500 million people a year. Due to the parasite's unique relationship with the 
human and mosquito hosts, coupled with rapid evolution of anti-malarial 
drug resistance, the evolutionary history of adaptive changes mediating 
drug resistance has been the focus of recent research. Genome-wide 
association studies provide the framework to test for candidate loci 
mediating drug response, and with newly available genotyping arrays, 
researchers are able to use this approach in P. falciparum. The first genome-
wide scan of recombination, positive selection, and anti-malarial drug 
resistance associations in a world-wide collection of samples yielded 
several results; e.g. pfcrt had strong signatures for both positive selection 
and association with chloroquine response. Among other results from this 
study, we noted the population structure analysis of the samples collected 
from Asia revealed separate populations corresponding with samples from 
Thailand, Cambodia, and admixture between the two countries. We refined 
our analysis of these three sub-populations; Thai, Cambodian, and Thai-
Cambodian admixed, to characterize the admixture, estimate recombination 
events and rates, and identify signals of natural selection shared and specific 
to each sub-population. We related these findings to those of drug resistance 
measurements, finding differences between the admixed group and the 
remaining two populations for key anti-malarial drugs. This gives us new 
insight to occurrence and spread of drug resistance in P. falciparum. 
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A new generation of DNA sequencing technologies has enabled a variety of 
novel genome-scale experimental techniques. What is perhaps most unique 
about this recent data explosion is that it is distributed – relatively 
inexpensive instruments allow any lab or institution to produce enormous 
amounts of data. Yet the infrastructure upstream and downstream of 
sequencing instruments is largely undeveloped. In addition to the 
instrument cost labs, core facilities and sequencing service providers are 
forced to spend thousands on commercial LIMS systems and sequence 
analysis packages, which are in-turn based on tools from the public domain.  
 
Galaxy (http://usegalaxy.org) provides a robust open-source alternative. Its 
lightweight sample tracking system is aimed at helping small labs and core 
facilities managing requests for sequencing runs. It allows one to track the 
entire “life-cycle” of sequencing request from the initial sample submission 
to the resulting dataset. Once the run is complete the user can apply a 
variety of NGS tools including format converters, mappers, ChIP-seq and 
transcriptome utilities. Results of these analyses can be visualized, shared, 
and published. 
 
In this interactive poster we will demonstrate sample tracking functionality 
from the moment of sample submission to the sequencing facility, through 
the sequencing run, until the sample becomes a dataset and can be analyzed 
with a variety of NGS tools. 
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Regulation of gene expression is a crucial cellular function determining a 
significant proportion of the phenotypic variance. In the current study we 
thoroughly explore the complexity of the human regulatory variation 
landscape and how regulation is differentially variable in three tissues 
(LCLs, fat and skin) derived from a subset (N ~ 200) of phenotypically 
well-characterized twins from the MuTHER resource 
(http://www.muther.ac.uk/). We discover an abundance of expression 
quantitative trait loci (eQTLs) per tissue using standard methods and we 
apply factor analysis to remove effects of latent variables and further 
increase the power to detect larger numbers of eQTLs. Our discovery rate is 
similar to previous studies for such sample size, however the factor analysis 
doubles the number of eQTLs in each tissue at the same threshold of 
significance. The study design permits immediate replication between twins 
of the same family and hence validation of the substantial gain in eQTL 
discovery. With both strategies we observe and confirm extensive tissue 
specificity in all tissues, two of which are of clinical importance and one 
has not been previously characterized. As current threshold based estimates 
of tissue specificity are highly dependent on power, we explore and propose 
alternative methods to measure tissue specificity. We map the discovered 
eQTLs to historically independent genomic regions being thus able to 
provide a refined description of the tissue dependent particularities of 
regulatory variants. We observe that the majority of the genes are regulated 
by single independent eQTLs and we describe their spatial properties and 
distribution around basic gene structure landmarks. These discoveries, 
combined with the thorough phenotypic information available, will 
substantially aid the project’s further efforts to understand the mechanisms 
behind complex trait susceptibility. 
 214 
HIGH-RESOLUTION LANDSCAPE OF UBE3A ALLELIC EXCLUSION 
REVEALED BY USING HIGHLY PARALLEL SNP TYPING 
 
Koji Numata1, Chihiro Kohama2, Kuniya Abe1,2, Hidenori Kiyosawa2,3  
 
1RIKEN BRC, Team for Mammalian Cellular Dynamics, Koyadai, 
Tsukuba, 305-0074, Japan, 2University of Tsukuba, Graduate School of Life 
and Environmental Sciences, Tennoji, Tsukuba, 305-8577, Japan, 3RIKEN 
BRC, Team for BioSignal Program, Koyadai, Tsukuba, 305-0074, Japan 
 
Recent transcriptomic studies in mammals have identified many examples 
of natural antisense transcript (NAT), which is transcribed from the 
opposite strand of an annotated gene. A possible regulatory role of NAT is 
the regulation of monoallelic gene expression. Many monoallelically 
expressed genes have been identified thus far, and some of them have been 
shown to possess an antisense counterpart. These NATs are often broadly 
transcribed in the vicinity of 100–1000 kb, suggesting that NAT-mediated 
regulation of the loci is achieved in a locus-wide manner. 
We have studied the locus-wide landscape of Ube3a (ubiquitin protein 
ligase E3A) expression and its antisense expression along with the strand- 
and allele-specificity. We have initially identified 1,420 single nucleotide 
polymorphism (SNP) sites between C57BL/6J (B6) and MSM/Ms, which is 
an inbred strain derived from the Japanese wild mouse (M. musculus 
molossinus), within the Ube3a-Snurf/Snrpn region according to the 
nucleotide sequences of MSM BAC clones and Illumina GoldenGate 
genotyping assay.  
We then performed RNA-targeted highly parallel SNP typing by obtaining 
RNA from the brain and liver tissues of two reciprocal F1 hybrids. This 
provided a detailed view of the transcriptional landscape of Ube3a allelic 
exclusion. Because Ube3a is biallelically expressed in the liver in the 
absence of antisense transcription, antisense expression may play a crucial 
role in monoallelic gene expression. Moreover, the present study revealed 
that (1) brain-specific maternal expression of Ube3a is restricted in the 
second half of the locus but not in the first half, and (2) the brain-specific 
antisense of Ube3a is significantly decreased in the upper region of the 
Ube3a transcription start site. Although these findings do not reflect the 
conditions in a particular cell type of the tissue, our result reveals many 
aspects of the locus-wide landscape of sense and antisense transcriptional 
competition. 
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Accurate determination of population structure and ancestral origin of 
individual haplotypes in admixed individuals can be used to detect recent 
historical events and can be leveraged to avoid spurious associations 
between disease and genetic loci in genome-wide association studies. Most 
proposed methods for mapping admixture require unlinked markers or 
phased data, and most are computationally inefficient for analyzing entire 
genomes when considering high coverage marker data. We present a novel 
method using support vector machines to classify segments of the genome 
based on the alleles of ancestral or approximately ancestral genomes. 
Support vector machines are extremely efficient classifiers that we use over 
windows of the genome. By simultaneously testing the ability of the support 
vector machine to classify the ancestral populations we are able to 
dynamically assign window sizes that corresponds to the amount of 
information present in the genome over the window. We show that this 
method is almost independent of prior knowledge of recombination rates, 
generations since admixture and tunable parameters in the algorithm. The 
algorithm also efficiently scales to millions of markers and hundreds of 
genomes. To demonstrate the value of this method, we analyze a population 
from Qatar of varying degrees of admixture between populations from 
Northern Africa, Persia and the Arabian peninsula. 
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Autism is the most genetic of all neuropsychiatric syndromes. However, 
identifying the genetic factors involved has proved difficult. We are using 
exome and targeted resequencing as complementary approaches to identity 
novel risk loci. Our targeted approach is focused on 17 “hotspot” regions of 
the genome where recurrent copy number variants (CNVs) have been 
associated with autism, including: 1q21.1, 16p11.2 and others (Itsara et al. 
2009). Most of these regions are large and involve >10 genes, making the 
identification of the underlying risk loci difficult. We aim to identify the 
causative genes by resequencing of all coding exons within each CNV 
interval using molecular inversion probes (MIPs) in a large set of autistic 
individuals. Early studies using MIPs have demonstrated extensive 
multiplexing, high specificity, low DNA input requirements, and simplified 
library construction (Porreca et al. 2007, Turner et al. 2009). We have 
designed a 13k probe MIP set to simultaneously target 450 genes within our 
hotspot intervals and 65 autism candidate genes (1Mb). We have begun a 
pilot screen, with the goal of increasing to a final set of 1,320 samples. 
Initial findings and performance of the MIP assay will be presented. We are 
comparing the efficacy of this high-throughput targeted approach with 
complete exome sequencing (Ng et al. 2010). We have selected 20 autism 
trios showing a strong likelihood of sporadic autism where deleterious 
CNVs and point mutations have not been identified, with the goal of 
identifying de novo disruptive coding mutations. By analyzing complete 
trios we can determine the global rate of de novo events in these families 
and prioritize those genes carrying disruptive mutations. Furthermore, we 
will search for evidence of genic overlap with rare CNVs in a database of 
over 20k patients with developmental delay, autism, or intellectual 
disability. The development of methods to rapidly and economically screen 
large numbers of individuals over large number of loci is a critical 
complement to next-generation sequencing. 
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Large-scale sequencing of mRNA should reveal, with unprecedented 
quantitative detail, the complete pattern of gene expression for any cell 
type. However, this potential has not yet been fully realized because of 
computational and experimental hurdles. One difficulty is that genes have 
multiple isoforms that complicate the assembly of short reads into complete 
transcripts and confound abundance estimation. We introduce an approach 
to transcript discovery coupled with a statistical model for RNA-Seq 
experiments that produces estimates of transcript abundances. Our 
algorithms are implemented in a freely available and open source software 
program called Cufflinks. To test Cufflinks, we sequenced and analyzed 
more than 430 million paired 75bp RNA-Seq reads from a mouse myoblast 
cell line representing a differentiation timeseries. We detected 13,689 
known transcripts and 3,724 previously unannotated ones, 62% of which 
are supported by independent expression data or by homologous genes in 
other species. Analysis of transcript expression over the timeseries revealed 
complete switches in the dominant transcription start site (TSS) or splice-
isoform in 330 genes, along with more subtle shifts in a further 1,304 genes. 
These dynamics suggest substantial regulatory flexibility and complexity in 
this well-studied model of muscle development. 
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Early surveys of Class II transposable element (TE) activity in mammals 
revealed a widespread shutdown around 40 mya in the genomes of model 
organisms. The first deviation from these observations appeared in the little 
brown bat, Myotis lucifugus, which was found to harbor multiple highly and 
recently active Class II elements. Further analyses of recent activity from 
the hAT superfamily suggested reasons to question the extent of Class II TE 
extinction in mammals. Anthropoid genomes analyzed thus far showed no 
signs of recent activity. Thus, we chose to probe the genome of the gray 
mouse lemur (Microcebus murinus) in order to determine if Class II TEs 
have also become extinct in strepsirrhine primates. Several elements were 
found to have been active within the last 40 my. Most notable were 
members from the piggyBac superfamily, which included an autonomous 
element which is very similar (Blastn E-value = 0) to piggyBac2_ML in the 
genome of M. lucifugus yet absent from other strepsirrhine primates and 
from the genomes of other surveyed mammals. Age analyses and 
comparative analyses with other primates indicate recent, lineage-specific 
activity. In combination with a second, novel piggyBac family, these results 
suggest that horizontal transfer has played an important role in the 
continued success of Class II TE elements in the genome of Microcebus 
murinus and in avoiding a complete shutdown of Class II activity in 
primates. 
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To achieve dosage balance of X-linked genes between mammalian males 
and females, one female X chromosome becomes inactivated. However, 
approximately 15% of genes on this inactivated chromosome escape X 
chromosome inactivation (XCI). Here, using a chromosome-wide analysis 
of primate X-linked orthologs, we test a hypothesis that such genes evolve 
under a unique selective pressure. We find that escape genes are subject to 
stronger purifying selection than inactivated genes and that positive 
selection does not significantly affect the evolution of these genes. The 
strength of selection does not differ between escape genes with similar vs. 
different male-female expression levels. Intriguingly, escape genes 
possessing Y homologs evolve under the strongest purifying selection. We 
also found evidence of stronger conservation in gene expression levels in 
escape than inactivated genes. We hypothesize that divergence in function 
and expression between X and Y gametologs is driving such strong 
purifying selection for escape genes. 
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Regulatory RNA structures in both cis-regulatory elements and ncRNAs are 
often members of families with multiple paralogous instances spread across 
the genome. Based on genome-wide alignments of 41 vertebrate genomes 
produced by the 2x mammalian sequencing consortium, we developed a 
computational method, EvoFam, to identify new families of regulatory 
RNAs in human. 
Method: First, the EvoFold program, which identifies stem-pairing regions 
from their characteristic substitution pattern, was used to predict structural 
RNAs genome-wide. We modeled both the sequence and structural 
information of these predictions in a position-specific manner using profile 
stochastic context-free grammars. We defined an inter-model similarity 
measure used to cluster the EvoFold predictions into families, correcting for 
model-dependent false positive rates, using a graph-based approach that 
detects densely connected subgraphs and is robust in the presence of noise. 
Results: We detected 220 families, with an estimated FDR of < 5% (for 
families of size > 3). The method correctly identifies known families of cis-
regulatory structures, e.g., iron responsive elements in TFRC, and 
translational control elements found in collagen gene 5' UTRs. Amongst 
ncRNAs, the method identifies known miRNAs, snoRNAs and a recently 
characterized family including the linc-RNA MALAT1.  
More excitingly, it identifies multiple new candidate families, e.g., a family 
of six long hairpins in the 3'UTR of the key metabolic gene MAT2A, 
producer of the primary methyl donor, that we hypothesize is involved in 
transcript stability regulation in response to substrate concentration. We 
have also identified families of short six base-pair long hairpins enriched in 
immunity-related genes, e.g., TNF, FOS and CTLA4. Individually, these 
hairpins would be extremely difficult to detect with high confidence, but 
taken together the family is supported by strong evidence, and includes 
known transcript destabilizing elements. Another family includes a tRNA-
like structure in the intron of the tRNA maturation gene POP1, potentially 
involved in auto-regulation. The identification of these structural families 
has generated hypotheses testable by directed experiments, which may 
further elucidate human post-transcriptional regulation.  
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Melanoma is the most common lethal skin cancer. Despite years of 
research, the median patient survival is six months following metastatic 
diagnosis, with less than 5% surviving five years. As a pilot towards 
cataloging all genetic variations associated with melanoma, we present the 
sequence and analysis of multiple pairs of melanoma tumor and patient-
matched normal genomes. 
 
Using the Illumina GAIIx and HiSeq 2000 platforms coupled with new 
bioinformatics methods, we generated 30X coverage genome builds. For 
each pair of tumor and normal genomes, we identified copy number and 
single nucleotide variants (CNVs and SNVs). Variant calls were verified 
with an array platform and with Sanger sequencing technology, allowing us 
to develop a robust algorithm for identifying variants from the whole 
genome builds. 
 
The vast majority of tumor-specific variants occur in non-coding regions 
and it is unclear how these SNVs are partitioned among passenger and 
driver classes of mutations. Since DNA shape can be important for protein 
binding specificity, we searched for SNVs that disrupt potentially functional 
shapes. Evolutionarily conserved non-coding regions accumulate 
significantly less mutations than expected. A previous study reported the 
DNA mutational signature of a melanoma genome and how it reflects 
ultraviolet light exposure. Here, we examine this signature from the 
perspective of local DNA structure. 
 
We provide results that help identify the underlying genetic components of 
melanoma. Future plans include sequencing additional melanoma genomes 
TO BUILD TUMOR-SPECIFIC SIGNATURES AND BETTER 
CLASSIFY DISEASE STATE. 
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The high heritability of bipolar disorder emphasizes a significant genetic 
component of the illness, and several genetic studies have been conducted 
in order to characterize its etiology. However, linkage and genome-wide 
association studies have had limited success in identifying common variants 
and particular genes consistently associated with bipolar disorder, 
suggesting that rare genetic variants and multiple genes may play 
significant roles in the bipolar phenotype. To continue the efforts to identify 
genes and variants that contribute to bipolar disorder, we have initiated a 
targeted re-sequencing approach that focuses on genes that encode synaptic 
proteins as well as genes that were identified through genome-wide 
association studies of bipolar disorder. The synapse is a critical component 
of brain and neurological function, and studies continue to associate 
psychiatric and cognitive disorders with mutations in synapse genes. Our 
approach involves the use of custom Agilent 244K arrays that are designed 
to target the exons and promoters of up to 1,124 genes. Currently, our 
largest data set consists of Illumina sequence data generated from array 
captures performed with 30 pilot study samples and a synaptome array 
design that targets 618 genes and a total of 3.9 Mb of genomic space. Our 
best captures with our pilot study samples have produced over 99% target 
coverage and 78% of the targets covered at ≥ 20X depth when evaluated 
using our original ELAND-based analysis method. Subsequent data 
analyses using BWA and strict requirements for unique mapping 
coordinates at the base level per sequence read have revealed that 
significant improvements in the capture procedure are necessary in order to 
obtain proper and adequate coverage of our targets. We have also started 
classifying the variants that we have found based on the results of genetic 
studies performed by other groups in order to formulate a strategy to 
validate these variants. 
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Direct mapping of cis-rSNPs in human cells using genome-wide allelic 
expression (AE) measurements on Illumina 1M BeadChips shows a high 
prevalence of common cis-rSNPs in CEU LCLs, explaining >50% of 
population variance in AE (Ge et al., NG 2009). Follow-up with allele-
specific validation tools allows for isolation of causal cis-rSNPs (Verlaan et 
al., AJHG 2009). 
 
Our systematic approach to isolate causal cis-rSNPs involves expanding 
AE-mapping to YRI LCLs and intersecting with catalogs of common SNPs 
(1000 Genomes) and functional non-coding elements (wgENCODE). For 
570 genes, we fine-mapped the effect to <5 SNPs, with bias near the TSS 
and with significant enrichment (5-10x) of regulatory elements (e.g. 
RNAPII, DHS). Reporter gene assays validated 62% of promoter cis-
rSNPs. We tested ~2500 RefSeq genes with cis-rSNPs altering transcription 
in YRI for enrichment of functional sites by inclusion of published eQTL 
data (Stranger et al., NG 2007). Conditioning AE-data on converging cis-
eQTLs (n=402) showed minor increase in overlap with functional sites 
(~1.2x). Conditioning with positive AE-data (n=294) revealed a more 
pronounced (~2x) improvement. 
 
Comparison of top AE-associations in fibroblasts of Caucasian origin (36 
trios) to top cis-rSNPs replicated in both LCL panels among transcripts 
expressed in both cell types show 50% overlap. Tissue-independent effects 
are concentrated to TSS, whereas tissue-specific cis-rSNPs are enriched 50-
100kb 5’ of TSS. Finally, tissue-specificity of chromatin activity and cis-
rSNPs are correlated. 
 
This indicates that AE-mapping in primary transcripts: 1) reveals non-
coding SNPs altering transcription and 2) captures heritable variation in 
transcription not detected by eQTL mapping. Tissue-specific cis-rSNPs 
yield additional functional sites. Combination of allele-specific tools will 
allow comprehensive cataloging of causal cis-SNPs. 
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Genome-wide association studies (GWAS) have identified loci harbouring 
common genetic variants associated with diseases, including coronary artery 
disease (CAD) and its main complication, myocardial infarction (MI). These 
loci have usually small effects, whereas the underlying causative variant(s) 
remain typically unknown. In parallel, GWAS on quantitative haematological 
traits, e.g. the count and volume of blood cells, have started to shed some light 
on the biological processes through which such disease-associated loci are 
likely to act. 
 
As most association signals are intra- or intergenic, causal variants are likely to 
impact regulation of gene expression. Our aim was to map regulatory elements 
at loci associated with CAD/MI and blood traits to aid the identification of 
functional variants. We performed FAIRE-chip (formaldehyde-assisted 
isolation of regulatory elements), a robust method for identifying accessible 
chromatin and regulatory regions in human chromatin, in a megakaryocytic 
(MK) and an erythroblastoid (EB) cell line. Our array comprises all replicated 
and/or meta-analysed GWA loci (n=61, PubMed query, October 2009) 
associated with CAD, MI, and blood traits (385K tiling array, 9.6 Mb). We 
found 259 and 267 FAIRE peaks in MK and EB cells respectively, of which 
148 (57.1%) were common to both. 
 
In seven of the 61 tested loci, we identified sequence variants located within a 
FAIRE peak in strong LD with the GWA lead SNP (r2≥0.8, HapMap2, CEU). 
For these loci, FAIRE peaks were either shared among both cell types (n=3), 
unique to EB cells (n=2), or MK cells (n=2). As a proof of principle, we 
investigated a 65-kb locus associated with mean platelet volume and function at 
chr7q22.3, which harbours a MK-specific FAIRE peak containing the lead SNP. 
Resequencing of this nucleosome-depleted region in 882 healthy individuals 
from the Cambridge BioResource did not reveal additional sequence variation, 
strongly suggesting that the lead SNP is most likely the functional variant. 
Preliminary results of the functional annotation of this region by ChIP-seq, 
showed the presence of a binding site for the MK-specific transcription factor 
MEIS1 overlapping the lead SNP, and was contained within the nucleosome-
depleted region, further corroborating our findings. 
 
We are in the process of following up this variant through in vitro tests, such as 
electrophoretic mobility shift assays (EMSA), to unravel its function and 
targets. 
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The methylation of cytosines in CpG dinucleotides, which is usually 
accompanied by gene silencing, plays a crucial role in cellular 
differentiation and cancer progression. To study DNA methylation in 
human cell lines, we adapted Reduced Representation Bisulfite Sequencing 
(RRBS; Meissner et al. Nature 2008), a method that involves next-
generation sequencing of size-selected bisulfite-treated Msp1 restriction 
fragments. With this method, we measure more than 500,000 CpGs with 
greater than 10X coverage throughout the human genome in each sample. 
Data from more than 60 biological samples, including primary and cancer 
cell lines, lymphocytes from a three generation family, and some primary 
tissues, indicates that RRBS is highly reproducible (R2 = 0.94), that non-
cancer cell lines are very similar and distinct from cancer cell lines, and that 
CpGs in the body of transcribed genes downstream from the first exon 
exhibit high overall methylation. We observe many instances of allele-
specific DNA methylation, and we are using these in the family to 
determine whether methylation events are inherited or are a consequence of 
imprinting. We are analyzing the association of different sequence features 
(repeats and DNA motifs) with levels of DNA methylation. Overall, these 
data provide detailed pictures of genome-wide DNA methylation patterns 
and how these patterns vary over a large number of cell lines and primary 
tissues from different people. 
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The ability to evolve is a fundamental feature of organisms. Changes in 
gene and chromosome copy number are widely observed in cancers and 
closely associated with genome evolution. Despite the importance of 
aneuploidy to many phenomena, little work has been done to determine 
how cells adapt to such extreme changes in gene dosage. Prior work from 
the Dunham lab using the eukaryotic model yeast, has found that 
aneuploidy can be detrimental to cells at high growth rates, but can be 
beneficial to cells growing in poor environments. A series of experiments 
using the well-defined system of yeast experimental evolution in the 
chemostat in different nutrient environments could be done to begin to 
understand how aneuploidy affects the fitness in a rigorous, systematic, and 
genome-wide manner. To accomplish this, we took advantage of strain 
collections consisting of every yeast gene deleted in one copy and every 
gene amplified to multiple copies. By competing these strains against each 
other and measuring their abundance via high- throughput sequencing, we 
can determine the fitness effect associated with changes in copy number for 
every gene simultaneously. For the collections carrying barcodes (MoBY 
and the deletion collection), each strain is tagged with two unique 20mer 
sequences that can be amplified with common primers. The change in strain 
abundance can be measured using Solexa sequencing, also known as “Bar-
seq”. The quantification of the non-barcoded plasmids is done by 
sequencing the insert-vector junctions. By comparison with the time zero 
sample, a relative frequency of each plasmid is calculated and from this, a 
fitness measurement. 
 
These data, which are in progress, will be compared to the fitness of 
aneuploid strains recovered in experimental evolution. One particularly 
interesting question that will be answered by these experiments is whether 
the observed copy number changes that are recovered from experimental 
evolutions are actually the best possible mutations. An alternate possibility 
is that certain events are predisposed by virtue of their mutability, for 
example, their proximity to repeat elements. This is the first genome-wide 
attempt to dissect the precise molecular causes of the fitness changes, 
positive and negative, associated with aneuploidy. 
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We are examining how fluctuations in the GI microbiota associate with 
various chronic and acute diseases, including Travelers’ Diarrhea and 
Diabetes Mellitus. Diabetes: We are identifying the fluctuations in gut 
microbiota in a cohort of Mexican Americans having high rates of obesity 
and diabetes (52% and 20% respectively). Phylogenetic and sequence 
alignment-based analytical methods are being used to compare the 
microbial populations in these groups. We are also correlating microbiome 
composition to plasma levels of adipokines, cytokines and other molecules 
known to link the microbiome with obesity and diabetes using a limited 
systems biology analytic approach. This will be a critical first step to 
understanding the role of the microbiome in obesity and diabetes in 
influencing important cross-talk between metabolic and inflammatory 
pathways within cells and between adipocytes and immune cells. 
Travelers’ Diarrhea: Secretory diarrhea is one mechanism by which the 
GI community can be altered, and up to 60% of individuals traveling from 
industrialized countries to developing countries acquire a form of secretory 
diarrhea know as Travelers’ Diarrhea (TD). Enterotoxigenic Escherichia 
coli (ETEC) is the leading cause of TD and produces two toxins: heat labile 
toxin (LT) and heat stable toxin (ST). Predisposition to and the specific 
associations of TD-ETEC and its toxins on the GI microbiota have not been 
studied. 16S metagenomic sequencing technologies are examining the GI 
microbiome of three groups of individuals: healthy, TD-ETEC positive and 
non-ETEC diarrheal control. This research details the differences in the GI 
populations between these three groups of samples and aims to determine if 
LT or ST have a similar effect on the GI community. These data will 
provide a more complete understanding of the alterations caused by TD-
ETEC and aid in development of preventative treatments. 
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Elephant endotheliotropic herpesvirus (EEHV) causes significant morbidity 
and mortality in both captive and wild juvenile Asian elephants, which are 
an endangered species. Advancements in the diagnosis, treatment, and 
prevention of this disease are needed to ensure the survival of this 
endangered species. All 6 Asian elephant calves born at the Houston zoo in 
the last two decades have died from EEHV infection. The most recent death 
of Mac, a highly charismatic 2-year old elephant calf in November of 2008, 
prompted the Houston zoo to contact experts at Baylor College of Medicine 
to provide some help to solve the EEHV problem. The goal of our research 
program is to better detect and prevent lethal disease from this virus in both 
captive and wild Asian elephants through the development of diagnostics 
and a protective vaccine to EEHV. Understanding the genetics of EEHV, its 
mechanisms of pathogenesis, and how elephants generate immune 
responses to EEHV will facilitate the development of effective vaccines and 
therapeutics for this virus. Toward this goal, the Human Genome 
Sequencing Center at Baylor College of Medicine (HGSC-BCM) has 
sequenced total genomic DNA isolated from infected heart tissue from Mac. 
The viral to host genome ratio in this tissue has been estimated to be 
approximately 50:1 using a RT-PCR assay. Over 22 Gb of 75bp read-length 
sequence was generated on the Illumina platform, and EEHV reads from a 
previously sequenced ~50kb fragment were mined from these data using a 
k-mer based, e-Genome-typing strategy. These data suggest that this initial 
sequencing has generated ~30X coverage of the EEHV genome (estimated 
to be between 250 and 500 Kb in size). Efforts are underway to mine all 
EEHV reads from the sequence pool using previously sequenced fragments 
and homology to other EEHV genomes. Assembly of these reads will 
provide the gene/protein targets to serve as potential vaccine candidates that 
will hopefully limit the devastating effects of these viruses in the elephant 
population. 
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We have developed a high mass accuracy-based proteomic strategy for 
rapid, large-scale, identification and quantitation of proteins and PTMs. 
This technology was combined with transcriptomic analyses to compare 
human embryonic stem cells (lines H1 and H9), induced pluripotent stem 
cells (iPS), and their differentiated precursors – newborn foreskin 
fibroblasts (NFF). 
 
We identified 7,962 proteins and 15,091 phosphorylation sites. 
Phosphorylation was identified on 3,714 proteins including many involved 
in the maintenance of pluripotency including OCT4, SOX2, and LIN28. To 
facilitate the interrogation of such a large data set we developed software 
for automated detection and enrichment analysis of proteins that differ 
between any of the four samples. While ES and iPS cells were nearly 
identical at all levels of regulation, 35% of proteins differed by two-fold or 
more between pluripotent and NFF cell lines. Proteins upregulated in 
pluripotent cells were enriched in GO terms and KEGG pathways that 
reflected the proliferative nature of the pluripotent cells. Proteins depleted 
in these cells were enriched developmental function. Phosphorylation sites 
upregulated in pluripotent cells were enriched in 25 motifs, all containing 
acidic residues or the combination of a proline and a lysine. Downregulated 
phosphorylation sites were characterized by a strikingly different set of 
motifs, most containing an arginine upstream of a phosphorylated serine. 
Motifs enriched in pluripotent cells pointed to activity of kinases relevant to 
pluripotency such as ERK1, ERK2, and GSK3. While the protein levels of 
these kinases were largely unchanged, activating sites of phosphorylation 
were upregulated in pluripotent cells suggesting that modulation of these 
kinase activities may be effected by PTM rather protein level. Finally, we 
detected a subset of genes whose mRNA and protein levels changed in 
opposite directions. These genes were enriched in developmental functions 
which shed light on the mechanisms that govern the maintenance of 
pluripotency of cells grown in culture. 
 
DHP is supported by an NHGRI training grant to the Genomic Sciences 
Training Program (5T32HG002760). 
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Understanding the genetic mechanisms underlying natural variation in gene 
expression is a central goal of both medical and evolutionary genetics, and 
studies of expression quantitative trait loci (eQTLs) have become an 
important tool for achieving this goal . While all eQTL studies to date have 
assayed mRNA levels using expression microarrays, recent advances in 
RNA sequencing enable the analysis of transcript variation at 
unprecedented resolution. We sequenced RNA from 69 lymphoblastoid cell 
lines (LCLs) derived from unrelated Nigerian individuals that have been 
extensively genotyped by the International HapMap Project. Pooling data 
from all individuals, we generated a map of the transcriptional landscape of 
these cells, identifying extensive use of unannotated untranslated regions 
(UTRs) and over 100 novel putative protein-coding exons. Using the 
genotypes from the HapMap project, we identified over a thousand genes at 
which genetic variation influences overall expression levels or splicing. We 
demonstrate that eQTLs near genes generally act via a mechanism 
involving allele-specific expression, and that variation that influences the 
inclusion of an exon is enriched within and near the consensus splice sites. 
Our results illustrate the power of high-throughput sequencing for the joint 
analysis of variation in transcription, splicing, and allele-specific expression 
across individuals. 
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The availability of genome wide data on representative population samples 
provides an opportunity to apply a strategy of inverse mapping for 
correlating human traits with genotypes. Whereas the traditional forward 
mapping aims to define genotypic sharing accounting for a common 
phenotype among group of individuals, the inverse mapping seeks to 
discover phenotypic features shared among individuals demonstrating 
allelic similarity. This approach would avoid the inherent imprecision in 
phenotype definition that makes it difficult to determine a priori which 
individuals are sharing a phenotype. Here we provide a proof of principle of 
this inverse mapping approach by systematically scanning all CNVs >500 
kb in a population cohort (N= 4,932). The participants were drawn from a 
prospective birth cohort of all individuals born in 1966 in North of Finland. 
Follow ups at different time points have resulted in extensive phenotype 
battery collected from the study participants. We identified 634 large CNVs 
observed in 529 individuals. To narrow down our data inquiries to a 
reasonable number of phenotypes, we focused on a category of traits 
postulated to relate with previous CNV findings in neuropsychiatric 
deficits. We observed significantly higher frequencies of cognitive defects 
defined as 8 among carriers of large deletions (5.0%) compared to non 
carriers (1.4%) (p <0.0024). Intriguingly, the deletion carriers were also 
more likely to present with sub clinical learning difficulties than the general 
population (10% vs. 3.9%; p=0.00088). Our results suggest that large 
deletions confer risk to intellectual defects. The study highlights the 
opportunity to utilize inverse mapping as a strategy to characterize 
phenotypic consequences related to genetic variants in an unbiased 
population sample. 
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Transposable elements are key drivers of genome evolution. Understanding 
the dynamics of their mobilization will lead to a more complete 
understanding of speciation mechanisms, morphological evolution, 
karyotypic megaevolution, as well as population genetics. The release of 
genomic scaffolds from the Spermophilus tridecemlineatus sequencing 
project presents the opportunity to study the history of transposable element 
mobilization in a highly diverse rodent lineage. In general, many questions 
regarding the evolution of Spermophilus exist. A recent mitochondrial 
phylogeny (Herron et al. 2004) found that prairie dogs (Cynomys), marmots 
(Marmota), and the antelope-ground squirrels (Ammospermophilus) form a 
paraphyletic relationship with Spermophilus. A better understanding of 
transposable elements in Spermophilus may lead to a better understanding 
of this unique phenomenon. Transposable elements were recovered and 
characterized using various computational approaches. In total the 
Spermophilus genome contains 80 transposable elements not found in other 
species at the sub-family level. Herein 44 uncharacterized elements are 
presented. Class I elements, the retrotransposons, dominate the genomic 
landscape with Spermophilus specific SINEs, LINEs, and LTRs occupying 
5.44%, 7.98%, and 3.71% of the genome respectively. Class II elements, 
the DNA transposons, do not appear to be actively amplifying and occupy 
less than 0.13% of the genome. Elements were dated based on sequence 
divergence and phylogenetic methods and validated using clustered 
insertion analyses (TCF; Giordano et al. 2007) to better ascertain 
correlations between peak mobilization periods and diversification events. 
Though in an unassembled form, data gleaned from Spermophilus is 
important from a phylogenetic perspective. Additionally, comparisons 
between Spermophilus, Mus, and Rattus are important to gain a more 
complete understanding of transposable element dynamics in rodents since 
Spermophilus represents a basal rodent lineage. More work remains to fully 
elucidate the dynamics of transposable element mobilization in the genome 
of Spermophilus; however data presented herein represents a crucial starting 
point.  
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A major focus in our laboratory has been to understand context-dependent 
evolution in genes and genomes. In particular, we have been developing 
new methods to better understand the repeat structure of genomes, and to 
use that information to evaluate evolutionary rates across genomes. Here, I 
will discuss new results on evaluating the repeat structure of genomes using 
“element-specific” P-clouds, and present evidence that previous evaluations 
of repeat structure in genomes are extreme underestimates. Furthermore, I 
will discuss how sample sequencing of eukaryotic genomes can be used to 
better understand transposable element evolution. I will then discuss how 
new rapid context-dependent Bayesian mixture model approaches we have 
recently developed can be used to analyze substitution processes in a local 
and genome-wide context-dependent fashion. Such analyses have been 
shedding light on important molecular evolutionary phenomena such as 
adaptation, convergence, and coevolution. I will also discuss how the 
nucleotide substitution processes can then be used to obtain better genome-
wide evolutionary models of functional (selected) entities such as proteins 
and transcription factor binding sites.  
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There are now terabytes of next generation sequencing data being produced 
by sequencing centers all around the world. Sequencing machines provide a 
confidence metric, or quality score, with every called base in a read which 
represents the probability that this particular base is erroneous. These base 
quality scores are often both uninformative -- a substantial percentage of the 
called bases are assigned the same quality score -- and inaccurate -- the 
actual probability of mismatching the reference genome is higher than the 
stated value. We have developed a software package to recalibrate these 
base quality scores which significantly reduces residual error between the 
reported base quality score and the empirical quality of each base. Use of 
this procedure greatly increases the performance of downstream 
probabilistic models (for example, Bayesian mutation calling). The 
recalibration tool attempts to correct for covariation in quality with machine 
cycle and sequence context, among other things, and by doing so provides 
not only more accurate quality scores but also more widely dispersed, and 
therefore more informative, scores.  
 
The system works with data generated by the Illumina, SOLiD, 454, and 
Complete Genomics platforms taking into account the specifics of the 
chemistry of each platform in order to provide increased accuracy. 
Additionally, the recalibrator takes full advantage of the color space 
information found in data produced by the SOLiD platform and 
substantially reduces reference bias caused by some of the early color space 
aligners. 
 
The recalibration tool is already being used for all sequencing data in the 
1000 Genomes Project and is now an integral part of the sequencing 
pipeline at the Broad Institute. Full documentation including graphs 
showing before- and after-recalibration accuracy can be found at: 
http://www.broadinstitute.org/gsa/wiki/index.php/ 
Base_quality_score_recalibration 
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Autism spectrum disorder (ASD) is a neurodevelopmental condition which 
has a strong genetic component. Previous studies have indicated that copy 
number variations (CNVs) are associated with ASD. There are several 
different platforms available for detection of CNVs including SNP and 
CGH arrays. Each platform has its own advantages and can complement the 
other. In the present study, we used Agilent 1M (CGH) arrays for detection 
of CNV in >200 unrelated ASD probands that were previously run on the 
Illumina 1M single SNP array. 
The Agilent high resolution 1×1M array contains 963,029 distinct probes 
evenly distributed across the genome. CGH experiments using genomic 
DNA of cases was competitively hybridized to a pool of fifty sex-matched 
individuals as a reference. The CNV calling was performed using the 
Aberration Detection Method-2 (ADM-2) algorithm implemented in the 
DNA Analytics 4.0.85 software. The calls were compared with the CNV 
data from the Illumina 1M single SNP array analyzed using the iPattern and 
QuantiSNP algorithms. We found that only 41 % of the total Agilent 1M 
call set was detected using the Illumina 1M platform. Conversely, 38% of 
calls in the Illumina call set were not detected using the Agilent 1M 
platform. The average number of calls generated for Agilent 1M and 
Illumina 1M is 66 and 50 respectively, and the average size of these calls is 
119 kb and 143 kb respectively. The differences in the number and size of 
CNVs discovered between platforms are possibly due to distinct probe 
distribution and sensitivity of the detection algorithms used. In addition, we 
are performing analysis of the data using both the Genome Alteration 
Detection Algorithm (GADA) and iPattern for the Agilent 1M experiments 
to minimize the possible effect of algorithm-specific sensitivity. We 
conclude that the use of multiple platforms and algorithms is advantageous 
for both maximizing CNV discovery and validation rates in case cohorts.  
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A multi-stage genome-wide association study (GWAS) has identified a SNP 
rs10486567 within the JAZF1 gene to be associated with prostate cancer 
(PrCa) in individuals of European ancestry (p=7.79x10-11). Fine mapping 
based on 106 additional SNPs did not reveal additional independent signals 
in this region. Now, we aimed to identify all variants within JAZF1 gene in 
high LD (r2>0.8) with rs10486567. We combined data from 454-
sequencing of 127 Kb in 63 samples and data from the HapMap and 1000 
Genomes projects. For confirmation we genotyped 27 SNPs found to be in 
an r2>0.6 with rs10486567 in any of these sets in 60 samples used for 454-
sequencing and in 1,000 samples (500 PrCa cases and 500 controls) of 
European ancestry. Based on genotyping in 1,000 samples, 14 SNPs were 
found to be in r2>0.8 with rs10486567. The selection of SNPs in an r2>0.8 
with rs10486567 based only on 454-sequencing, data from HapMap or 1000 
Genomes projects would miss up to 50% of these SNPs. The problematic 
SNPs were located in repetitive regions (LINE and SINE repeats) that are 
difficult to genotype and sequence with 454 technology. Among 742 SNPs 
identified by 454-sequencing of 127 Kb of JAZF1 in 63 individuals, the 
completion rate for SNPs located within repetitive sequences (n=268) was 
51.1%, compared to 75.9% for SNPs located within unique sequences (n= 
474), p=7.75x10-23.  
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Next generation sequencing holds the promise of facilitating the study of 
new large and complex genomes in shorter time and at lower cost compared 
to previous technology. However, the sequences generated by next 
generation sequencing are generally shorter and differ in the type and 
amount of sequencing error from sequences generated by the Sanger 
technology. Here, we present the first de novo assembly of a large and 
complex genome sequence from 454 data. 
We analyze the quality of the bonobo genome assembly, generated from 25-
fold coverage of 454 SequencingTM data, encompassing both shotgun and 
paired end reads. This assembly has a N50 scaffolds size of 9.6 megabases 
and a N50 contig size of 67 kilobases. The bonobo genome sequence is 
particularly suited for the analysis of assembly quality since the genome 
sequences of two closely related species (human and chimpanzee) are 
available for comparison.  
Our analysis – based on whole genome alignments between the genomes of 
human, chimpanzee and bonobo – shows that the bonobo assembly achieves 
comparable quality to the chimpanzee assembly in terms of sequence 
accuracy and genome completeness. Using the high quality of the finished 
chimpanzee chromosome 21 we are able to estimate a rate of approximately 
two errors in 10,000 base pairs for the bonobo genome. The quality of the 
Bonobo X chromosome assembly is as good as the other autosomes since a 
female individual was selected for sequencing. This places this bonobo's X 
and all her autosomes in an excellent position for comparative analysis to 
other primates. We conclude that large and complex genomes can be de 
novo assembled from next generation sequencing data. 
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Most heritable traits, including many human diseases1, are caused by 
multiple loci. Studies in both humans and model organisms, such as yeast, 
have failed to detect a large fraction of the loci that underlie such complex 
traits2,3. A lack of statistical power to identify multiple loci with small 
effects is undoubtedly one of the primary reasons for this problem. We have 
developed a method in yeast that allows the use of much larger sample sizes 
than previously possible and hence permits the detection of multiple loci 
with small effects. The method involves generating very large numbers of 
progeny from a cross between two Saccharomyces cerevisiae strains and 
then phenotyping and genotyping pools of these offspring. We applied the 
method to 17 chemical resistance traits and mitochondrial function, and 
identified loci for each of these phenotypes. We show that the level of 
genetic complexity underlying these quantitative traits is highly variable, 
with some traits influenced by one major locus and others by at least 20 
loci. Our results provide an empirical demonstration of the genetic 
complexity of a number of traits and show that it is possible to identify 
many of the underlying factors using straightforward techniques. Our 
method should have broad applications in yeast and can be extended to 
other organisms. 
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High rates of inbreeding lead to reduced heterozygosity both within 
populations and at the level of individual genomes. Reduced heterozygosity 
in turn contributes to reduced genetic and phenotypic diversity in inbred 
populations. The life cycle, mating system, and population structure of 
Saccharomyces cerevisiae are thought to promote inbreeding. Using whole 
genome sequencing of diploid isolates sampled from a variety of 
environments, I show that many yeast strains have extensive genomic 
heterozygosity. Clinical isolates in particular have very high levels of 
heterozygosity, typically in excess of 20,000 heterozygous sites across the 
genome. The impact of heterozygosity on the proteome and cellular 
phenotypes is significant; in highly heterozygous strains more than 30% of 
proteins are represented by two distinct peptide sequences and segregants 
derived from naturally heterozygous diploids exhibit a wide range of 
variation for many traits. I further show that heterozygous sites have a non-
uniform chromosomal distribution that suggests that loss-of-heterozygosity 
(LOH) events are frequent. The size and location of LOH regions is 
consistent with mitotic, rather than meiotic, recombination. These findings 
suggest that both sex and mitotic recombination play important roles in 
shaping the genome architecture of this model eukaryote. 
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Mammalian transcription factor binding evolves rapidly, yet tissue-specific 
transcription is highly conserved. To explore this apparent paradox, we 
experimentally determined the genome-wide occupancy of two transcription 
factors (TF) CEBPα and HNF4α in livers of multiple vertebrates.  
 
Although each TF has highly conserved DNA binding preferences, most 
binding is species-specific and ultra-shared events are rare. Functional 
target genes are associated with an enrichment of shared TF binding, yet 
collectively, the binding events near functional targets show no increase in 
sequence constraint. Most lineage-specific lost TF binding can be explained 
by sequence mutations of the binding motif, and only half of the apparently 
lost binding events appeared to have turned over to a nearby location.  
 
Our results reveal the plasticity of vertebrate TF binding and the complex 
evolutionary dynamics of transcriptional regulation. 
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Orangutans (Pongo pygmaeus) are the only living Asian ape and are highly 
endangered. We investigated the mobile DNA composition (mobilome) of 
the orangutan draft genome sequence derived from a female of Sumatran 
origin (Pongo pygmaeus abelii). Similar to other primate genomes, about 
half of the orangutan draft genome sequence is comprised of repetitive 
sequences. L1 and SVA have been highly active within the orangutan 
lineage and show a mostly linear subfamily evolution. L1 and SVA 
elements have expanded in the orangutan lineage at a rate comparable to 
other higher apes. In contrast, Alu elements appear to be relatively quiescent 
and have propagated at a very low rate in orangutans. The identification of 
polymorphic and population-specific Alu insertions indicates that Alu 
retrotransposition may be ongoing albeit at a very low rate. In addition, we 
investigated the population structure within orangutans. For this purpose, 
we performed a structure analysis with 37 orangutans (18 Bornean and 19 
Sumatran) using polymorphic retrotransposons. These elements were 
selected from the orangutan draft genome and also from Illumina paired-end 
reads from a Bornean orangutan. The Bornean orangutans were clearly 
distinct from the Sumatran population with almost no evidence of ongoing 
admixture. In addition, Sumatran orangutans showed clear evidence of 
population substructure. The clear distinction of Sumatran from Bornean 
orangutans supports the recent suggestion that Bornean and Sumatran 
orangutans represent separate species. 
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ADAPTATION IN DROSOPHILA IS NOT LIMITED BY MUTATION 
AT SINGLE SITES 
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Adaptation in eukaryotes is generally assumed to be mutation-limited 
because of small effective population sizes. This view is difficult to 
reconcile, however, with the observation that adaptation to anthropogenic 
changes such as the introduction of pesticides can occur very rapidly. Here 
we investigate adaptation at a key insecticide resistance locus (Ace) in D. 
melanogaster and show that multiple simple and complex resistance alleles 
evolved fast and repeatedly within individual populations. Our results imply 
that the current effective population size of modern D. melanogaster 
populations is likely to be substantially larger („100 fold) than commonly 
believed. This discrepancy arises because estimates of the effective 
population size are generally derived from levels of standing variation and 
thus reveal long-term population dynamics dominated by sharp - even if 
infrequent - bottlenecks. The short-term effective population sizes relevant 
for strong adaptation, on the other hand, might be much closer to census 
population sizes. Adaptation in Drosophila may therefore not be limited by 
waiting for mutations at single sites, and complex adaptive alleles can be 
generated quickly without fixation of intermediate states. Adaptive events 
should also commonly involve the simultaneous rise in frequency of 
independently generated adaptive mutations. These so-called soft sweeps 
have very distinct effects on the linked neutral polymorphisms compared to 
the standard hard sweeps in mutation-limited scenarios. Methods for the 
mapping of adaptive mutations or association mapping of evolutionarily 
relevant mutations may thus need to be reconsidered. We also argue that 
these results apply broadly to all populations of large census size and 
specifically to modern human populations. 
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The Neandertals are the closest evolutionary relatives of present-day 
humans. Thus, for any definition of what sets fully anatomically modern 
humans apart from other hominin forms, the relevant comparison is to 
Neandertals. 
 
We present a draft sequence of the Neandertal genome composed of over 3 
billion nucleotides from three individuals. Through comparisons of the 
Neandertal genome to the genomes of five present-day humans from 
different parts of the world we identify a number of genomic regions that 
may have been affected by positive selection in ancestral modern humans. 
These include genes involved in metabolism, cognitive and skeletal 
development. We also present a catalog of genomic changes that have 
become fixed or have risen to high frequency in modern humans during the 
last few hundred thousand years. Finally, we analyze the relatedness of 
Neandertals and other early hominins to present-day humans in different 
parts of the world in order to analyze their relationship to each other and 
present-day humans. 
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The availability of several primate whole genome sequences has spurred 
great excitement for the prospect of understanding the molecular basis of 
what makes us human. Recent investigations have discovered conserved 
non protein coding genomic loci that have experienced accelerated base pair 
changes in the human lineage, as well as protein coding genes that show 
similar evidence of positive selection. 
 
Here we expand these studies to look for a type of event particularly likely 
to produce functional effects: complete deletion in humans of sequences 
that are otherwise highly conserved in other organisms. By searching for 
regions of the chimpanzee genome highly conserved over mammalian 
evolution that are clearly missing in humans, we discover hundreds of 
human-specific losses of putatively functional ancestral DNA.  
 
PCR and computational validation show that roughly 80% of the deletions 
are fixed in human populations, while others are polymorphic in different 
individuals. Most of the deletions removed conserved non-coding sequences 
rather than protein-coding regions, and many lie in proximity to genes 
involved in development, neural function, and steroid hormone signaling. 
 
We have functionally tested a subset of these regions in mice, and have 
found intriguing examples of regulatory alterations in humans that appear to 
be associated with evolution of specific anatomical differences between 
humans and other animals. 
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Microbes adapt to changing selective pressures in their natural environments, 
leading to a potentially dynamic process of ecological specialization and 
speciation, even over short periods of time. Yet little is known about the 
microevolutionary processes leading to ecological differentiation of microbial 
populations in the wild. In particular, it is unclear how species emerge and 
diverge in face of the homogenizing force of recombination. 
 
We sequenced and analyzed complete genomes from 8 closely-related strains of 
Vibrio splendidus, representing two nascent populations, that appear to have 
recently diversified ecologically: 3 strains found primarily on small particles, 
and 5 strains found primarily attached to zooplankton in the coastal ocean. To 
assess patterns of recombination among strains, we developed a dynamic-
programming algorithm, and inferred ~2500 recombination breakpoints in the 
population genome. Although gene-flow between populations in the two 
habitats is common, we observe a significant excess of recent recombination 
within habitats, suggesting the emergence of ecologically differentiated 
populations. Gain and loss of DNA is extensive among these strains (each strain 
contains ~100-300 kb of strain-specific DNA), and a few recently acquired 
genes may provide habitat-specific adaptive value. For example, a suite of 
genes involved in O-antigen and mannose-sensitive hemagglutinin (MSHA) 
biosynthesis are absent in small-particle strains but present in zooplankton-
associated strains, perhaps promoting preferential attachment to zooplankton.  
 
We also identified a few 'core' genomic regions that, while present in all strains, 
are highly differentiated between the two habitats, and are likely targets of 
habitat-specific positive selection. These ecologically-associated loci include 
genes involved in stress response (rpoS), DNA repair (cysteine 
methyltransferase), and chitin metabolism, leading us to hypothesize that 
switching between zooplankton-associated (rich in insoluble exoskeletal chitin) 
and small-particle-associated lifestyles may require fine-tuning of chitin 
metabolism. 
 
Taken together, these results support a model of microbial genome evolution 
where habitat-specific genes follow species boundaries, but the majority of 
other loci are freely recombined across species. 
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The Mouse Genomes Project (http://www.sanger.ac.uk/mousegenomes/) has 
sequenced the genomes of 17 inbred mouse strains; NOD/ShiLtJ, A/J, 
BALBc/J, CBA/J, C3H/HeJ, DBA/2J, CAST/EiJ, AKR/J, LP/J, 129S5, 129P2, 
SPRETUS/EiJ, C57BL/6N, PWK/PhJ, NZO/HILtJ, WSB/EiJ and 129S1/SvImJ 
with the aim of generating a complete map of nucleotide and structural 
variation, and ultimately a de novo genome assembly of each strain. We have 
sequenced each of these inbred genomes to on average 24x using Illumina 
paired-end sequencing of 200-600bp fragments.  
 
From the sequence of these genomes we have been able to harvest >125M high-
quality SNPs in addition to short indels, SVs, and CNVs providing unparalleled 
resolution of the variation between these strains of mice. With these data we set 
out to answer several questions; 1) Are there different mutagenic processes 
operative in different mouse strains? 2) What effect do mutations have on genes 
and regulatory regions? and 3) Can the sequence of these genomes help identify 
causal variants within QTLs in crosses derived from the sequenced strains 
(including the collaborative cross and heterogeneous stock mice)? 
 
Using the sequence of these strains, we have built an extensive catalogue of all 
types of variants from single base substitutions and short indels, right up to 
larger structural events such as large insertions, deletions, inversions, and 
translocations. From this set, we have assembled a near complete catalogue of 
coding differences between strains and found thousands of truncating loss of 
function mutations, and sequence variants predicted to have a deleterious affect 
on protein function. Many of the mutated genes cluster into pathways possibly 
reflecting the effects of selective inbreeding for traits of interest during the 
derivation of these strains. We have also observed significant differences in the 
type, frequency and distribution of transposable elements between strains of 
mice with many intragenic transposon insertions being predicted to disrupt 
genes.  
Using these data we have been able to refine the location and assign candidate 
genes to QTLs identified in crosses between the sequenced strains. 
Confirmatory experiments using knockout and transgenic models are underway. 
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The 1000 Genomes Project pilot generated over 5Tbp sequence in three 
separate pilot experiments. These assess the effectiveness of low coverage 
(2-4x) sequencing to find shared variants in human, a high coverage trio 
design, and targeted sequencing of 1000 genes in 700 samples. Over 15M 
consensus variant calls from these have now been made and extensive 
validation has been carried out or is being completed. Much has been 
learned about data processing, variant calling and sampling properties. A 
wide variety of analyses are being carried out, including investigations of 
population differentiation and of polymorphic novel sequence (i.e. sequence 
present in a subset of individuals but not the reference). The data are being 
used in a large number of other studies. 
 
Beyond the pilot, data collection for the main project is well under way. We 
aim to collect genome-wide data at 4x depth from 2000 people from 22 
populations in 4 population groups of 500 each, which we project will meet 
the goals of having ~95% power to find 1% variants in the accessible 
genome per population group. Currently we have data from several hundred 
individuals, perhaps approaching 1000 by the time of the meeting, and will 
present initial analyses showing how these data are developing the 
information resource from the project as we go to deeper depth. 
 
We will also discuss how the lessons and data from the project can be 
applied to strategies for population sequencing from phenotyped sample 
sets that are now being designed or planned. 
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Understanding the contribution of rare and common genetic genetic variants 
to disease susceptibility will likely require multi- and trans-ethnic 
sequencing studies that compare the genomes of many individuals with and 
without a particular disease. Of particular importance will be accounting for 
the role of population stratification at fine scales both in terms of genomic 
and geographic location. Here, we present results from sequencing, 
assembly, and genomic analysis of two diploid genomes from Phase 3 
HapMap sequenced to ~20X coverage using SoLiD technology. The donor 
individuals are of Mexican-American and African-American ancestry and 
represent the first "admixed" genomes to be sequenced to high coverage. 
We demonstrate that genomic sequencing provides finer resolution of 
"admixture breakpoints" based on allele frequency estimates from HapMap 
and TGP. For each admixed genome, we use the distribution of admixture 
breakpoints to infer the personal admixture history of the sample and 
patterns of genomic diversity to reconstruct the demographic history of 
European, African, and Native American continental populations. 
Furthermore, we compare the distribution of functional and putatively 
neutral genetic variation among 12 sequenced genomes and find that 
difference in demographic history may account for statistically significant, 
differences in distributions of synonymous vs. benign, possibly damaging, 
and probably damaging non-synonymous coding variants. Finally, we use 
the SoLiD comparative personal genomic data sets and TGP data to 
quantify the relative proportions of private, rare, and common functional 
and neutral genetic within and among populations. 
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In spite of its evolutionary significance, there is only limited polymorphism 
data and no genetic map available for our closest evolutionary relative. We 
have sequenced 10 Western chimpanzees (Pan troglodytes verus) to 6-10X 
coverage using paired end sequencing with 50-bp reads. This resource, 
which will be publicly released, is the first to document genome-wide 
sequence variation in the chimpanzee. We identified over 4.5 million novel 
SNPs, representing a four-fold increase over those previously documented. 
We show that patterns of variation are correlated between species, but with 
interesting differences. This resource will enable analyses of polymorphism 
patterns; inference of selection in the chimpanzee; genome-wide 
comparative study of human and chimpanzee diversity patterns; comparison 
of evolutionary patterns in particular genes of interest, for example those 
involved in immunity; the construction of fine-scale genetic maps and the 
detection of recombination hotspots; detection and analyses of copy number 
polymorphism in the chimpanzee; and improvement of the chimpanzee 
reference sequence.  
 
The talk will focus on comparative population genomics, in assessing and 
comparing levels of diversity in human and chimpanzee, and on initial 
results on a chimpanzee genetic map and its implications for the regulation 
of chimpanzee recombination.  
 
*Joint senior authors.  
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Next generation sequencing provides a powerful tool for generating 
genome-wide population genetic data. However, most data is at a relatively 
low coverage (e.g., <20x). The analyses of such data introduces new 
inferential problems because the genotypes for each individual will be 
associated with statistical uncertainty. 
We will present methods for addressing these problems, that quantify the 
statistical uncertainty and incorporates it into methods for population 
genetic analyses. We will show that accurate Site Frequency Spectra (SFS) 
can be obtained for data with very low coverage (e.g., <2x), and can be used 
for accurate and valid population genetic inferences. In many cases, the 
most cost-effective design is, therefore, to sequence many individuals at 
low coverage rather than sequencing few individuals at a high coverage. We 
will discuss a number of applications, including applications to a large 
sample of humans of European descent and a sample of Tibetan and Han 
Chinese individuals.  
 
 251 
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Many current human groups, such as Latinos in the United States, have 
been formed by the recent mixing of different continental source 
populations over the last several hundred years. The genomes of individuals 
from admixed populations are mosaics of chromosomal ‘chunks’ inherited 
from different ancestral populations, and the boundaries of these chunks can 
be estimated from dense genotype data. We demonstrate how dense 
genotyping followed by targeted resequencing of admixed individuals can 
be used to assay genetic variation in the ancestral source populations, even 
if these source populations are unknown or no longer exist. We concentrate 
on genetic variation in Native Americans, inferred from genotype and 
resequencing data from extant Mexican Americans. We observe low levels 
of diversity and high levels of linkage disequilibrium in the Native 
American-derived sequences, consistent with a recent, severe population 
bottleneck associated with the initial peopling of the Americas. We also 
estimate the timing and the strength of this bottleneck from the patterns of 
genetic variation in Native American-derived sequences. 
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Nearly 200 genomes from four populations have been resequenced for the 
first pilot experiment of the 1000 Genomes Project. These data avoid many 
of the ascertainment biases that have plagued previous large-scale human 
data sets, allowing long standing evolutionary questions to be resolved. We 
used these data to characterize genomic signatures of natural selection. We 
show that diversity increases with distance from coding regions, with the 
strongest effect for regions of low recombination, suggesting that selection 
on coding regions leads to distortionary effects on diversity. In particular, 
we report a clear footprint of natural selection on diversity patterns around 
human-specific amino acid substitutions. In addition, we identified regions 
of the genome with extreme differences in allele frequencies between 
population samples. While all three findings reflect the action of natural 
selection, it remains unclear to what extent they are explained by adaptive 
evolution or purifying selection, with recent reports offering conflicting 
conclusions in this regard. To disentangle the relative contributions of the 
two evolutionary forces, we ran extensive simulations of the human 
genome, incorporating information about functional annotations, fine-scale 
genetic maps, and realistic demographic models of all four populations. 
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One approach for understanding the complex architecture of quantitative 
traits is to study offspring of two natural strains that are phenotypically 
different. However, there are two major limitations to the classical linkage 
analysis: low resolution of linkage intervals, and large labour requirements 
for genotyping and phenotyping. We have developed a novel approach to 
map quantitative trait loci (QTLs) rapidly and in narrow intervals using 
massively parallel sequencing. We created an F12 population (12 
generations of random mating and meiosis) between two phenotypically 
different wild isolates of baker’s yeast Saccharomyces cerevisiae with 
sequenced reference genomes. The resulting haploid intercross pools consist 
of 10-100 million segregants with an average of ~1000 crossovers per 
segregant. We then applied selective pressure on the intercross pool by 
growing it asexually in a restrictive condition to enrich for individuals with 
alleles that confer a positive fitness effect. Three different stress conditions 
(heat, paraquat, and caffeine) were used, as well as a control in permissive 
condition. Genotyping of the intercross pool before and after selection has 
confirmed a large change in the population allele frequency for a known 
heat QTL in a subtelomeric region of chromosome XIII, as well as 
increased resolution. We are currently sequencing DNA from the pool 
before and after selection to >100X to pinpoint alleles responsible for the 
increased fitness. We expect to dramatically improve on power and 
resolution by enriching for alleles that have modest fitness effects, and 
narrowing the causative locus down to a few hundred bases due to the 
power of the selection experiment and the increased number of 
recombination events. This method will provide a rapid and fine scale QTL 
mapping strategy, improving resolution by up to two orders of magnitude 
with the potential of pinpointing quantitative trait nucleotides, and may be 
adapted to other genetic systems like Drosophila melanogaster and 
Caenorhabditis elegans. 
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DNA cytosine methylation is essential in biological processes including 
gene transcription regulation, reprogramming and development. Here we 
report the first single-base-resolution DNA methylomes of a fish, medaka 
(Oryzias latipes). We have observed methylomes for three representative 
cell lines, liver, testis and blastula (0.5 day embryo considered to maintain 
germ-line character) with genome coverage over 70%, using whole genome 
bisulfite sequencing on Illumina GA. Significant differences among the 
DNA methylation profiles suggest a different methylation mechanism is 
used in cells having differentiation potency, which accords with mammalian 
DNA methylome studies on different cell lines that a different methylation 
mechanism (non-CG context) may be involved in the gene regulation in 
mammalian embryonic stem cells. Furthermore, we provide a more direct 
answer to how the methylation changes relate to chromatin structure by 
using nucleosome positioning maps, in contrast to previous studies which 
focus on the relation between DNA methylation and chromatin 
modifications. 
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Stroke is a heterogeneous disorder with both environmental and genetic risk 
factors. Several studies have shown different association peaks for ischemic 
stroke but none has been consistently replicated. We have looked at 
structural variants as potential risk factors for stroke. We have screened an 
initial dataset of 169 hemorrhagic stroke, and 729 ischemic stroke cases, 
and 477 populational controls, and found an association of an 
insertion/deletion variant on chromosome 5. The breakpoints of this variant 
have been identified, and an allele-specific multiplex PCR assay has been 
designed and used for genotyping. Carriers of the intact allele are more 
frequently affected by stroke, while carrying one or two copies of the 
deleted allele confers protection against stroke. Association was significant 
in both the ischemic stroke (p –val: 0.0005; OR: 0.66) and the hemorrhagic 
stroke subsets (p –val: 0.002; OR: 0.58). This result has been replicated in 
an additional dataset with 475 ischemic stroke cases (p –val: 0.0087; OR: 
0.71), and further replication in a second hemorrhagic stroke dataset is 
underway. Surrounding SNPs have been genotyped in order to assess 
linkage disequilibrium in the region, and identify potential tagging SNPs. 
The deletion spans 55Kb and affects two genes from the same family, 
generating a chimeric gene. Expression in EBV transformed lymphocytes of 
the two intact genes is correlated with copy number state, while the 
chimeric gene is expressed at a lower mRNA level. Downstream expression 
analysis from expression array data from HapMap samples carriers of zero, 
one, or two copies of the deleted allele shows differential expression of 
several genes, including genes involved in blood vessel formation and 
angiogenesis. 
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Flax seed is a rich source (~45-65%) of linolenic acid, an omega-3 fatty 
acid associated with multiple health benefits in human. To date, only two 
linkage maps of flax have been published and they were based on RAPD, 
RFLP and AFLP markers. In this study, a linkage map was generated based 
on 114 EST-derived SSR markers developed in our lab, as well as 5 SNP 
markers, 4 fatty acid desaturase genes (FAD2A, FAD2B, FAD3A and 
FAD3B) and seed coat color. A doubled haploid population of 78 
individuals, generated from a cross between SP2047 (a yellow seeded 
Solin™ line with 2-3% linolenic acid) and UGG5-5 (a brown seeded flax 
line with 60-65% linolenic acid) was used for mapping. This population 
was grown in the field in five environments and was evaluated for fatty acid 
profiles. This map consists of 24 linkage groups with 112 markers spanning 
~833.8 cM. QTL analysis detected two major QTLs for each of linoleic acid 
(LIO), linolenic acid (LIN) and iodine value (IOD). The mutant allele of 
FAD3A mapped to the chromosomal segment inherited from the parent 
SP2047 forms the basis of the QTL on linkage group 7 and was positively 
associated with high linoleic acid content but negatively associated with 
linolenic acid and iodine value. This FAD3A locus accounted for ~34%, 
~25% and 29% of phenotypic variation observed for LIO, LIN and IOD, 
respectively. The QTL localized on linkage group 16 accounted for 
approximately 20%, 25 % and 13% of the phenotypic variation for these 
traits, respectively. For palmitic acid, a major QTL was localized on linkage 
group 9 which accounted for ~42% of the phenotypic variation. Being the 
first SSR based linkage map in flax, this will serve as a resource for 
mapping additional genes and traits, map-based cloning and molecular 
breeding programmes. 
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The current revolution in sequencing technologies allows us to obtain a 
much more detailed picture of transcriptomes. Studying them under 
different conditions or in mutants will lead to a considerably improved 
understanding of the underlying mechanisms of gene expression and 
processing. An important prerequisite is to be able to accurately determine 
the full complement of RNA transcripts and to infer their abundance in the 
cell.  
 
We present the first integrative platform for quantitatively analyzing RNA-
seq experiments. It is based on the Galaxy-framework [1] and builds on 
recently developed methods for NGS sequence analysis: a) We extended the 
alignment method QPALMA [2] and combined it with GenomeMapper [3] 
to align both spliced and unspliced reads with high accuracy, while taking 
advantage read quality information and splice site predictions. b) We 
extended the gene finding system mGene [4] to take advantage of read 
alignments to more accurately predict gene structures de novo. c) We 
developed the method rQuant that simultaneously estimates biases inherent 
in sequencing protocols and determines the abundances of transcripts [5]. It 
more accurately predicts abundances of alternative transcripts. d) Finally, 
we developed test techniques that determine significant differences between 
two RNA-seq experiments to find differentially expressed regions (with or 
without knowledge of transcripts). 
 
The platform can be used for many purposes, including 1) to (re-)annotate 
genomes while profiting from NGS data; 2) to identify novel transcripts that 
are only expressed under certain conditions; and 3) to identify regions or 
transcripts that are the target of gene or RNA processing regulation. We 
have tested the system with data from several model organisms and human. 
Moreover, we have participated in the RGASP competition for an external 
evaluation of alignment, transcript identification and quantification 
accuracy. 
 
[1] D. Blankenberg et al., Curr Protoc Mol Biol., Chapter 19, 2010. 
[2] F. De Bona et al., Bioinformatics, 24 (16): i174, 2008. 
[2] http://1001genomes.org/downloads/genomemapper.html 
[4] G. Schweikert et al., Genome Research, 19(11):2133-43, 2009. 
[5] R. Bohnert et al., BMC Bioinformatics, 10(S13):P5, 2009. 
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Rhesus macaques (Macaca mulatta) are widely used as a model organism to 
study neurobiology and behavior, including susceptibility to anxiety 
disorders, depression or drug addiction among humans. Extensive 
knowledge of single nucleotide polymorphisms (SNPs) in genes related to 
neurobiology will facilitate genetic analysis in those studies, but to date, 
only very few (less than 800) total validated SNPs are currently available in 
public databases for this species. In order to increase the number of exonic 
SNPs in rhesus macaque in genes relevant to neurobiology, we carried out a 
re-sequencing study using NimbleGen capture arrays and Roche 454 
sequencing. We selected 540 genes expressed in the human and or rhesus 
amygdala and 2234 genes expressed in hippocampus 
(http://www.ensembl.org/index.html). 37,266 exons from these 2,774 genes 
were printed on the 2.1M high density NimbleGen sequence capture array 
along with the full length (exon and intronic regions) sequences for 60 of 
these genes. The total number of target base pairs on the chip is 8.5Mbp. 
Three unrelated female rhesus macaques were selected for study and their 
DNA pooled and hybridized to the capture array following NimbleGen 
protocols. Eluted DNA was sequenced in two runs on a Roche 454 Genome 
Sequencer FLX Instrument. Duplicate reads were removed from the 
resulting sequence and SNPs called using the Atlas-SNP program (http: 
//www.hgsc.bcm.tmc.edu/cascade-tech-software-ti.hgsc). To date we have 
identified 55,647 potential SNPs in genes expressed in rhesus brain. We are 
in the process of validating these SNPs by comparing with data from other 
rhesus macaques using multiple chemistries. This approach can be used to 
identify SNPs in the exome or any subset of genes chosen due to tissue-
specific expression or relevance to disease endophenotypes.  
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Transposable elements (TEs) are major players in the evolution of 
eukaryotic genomes. They contribute to genome mass, recombination 
processes, the evolution of novel genes and are particularly effective 
mutagens. Vespertilionid bats appear to be unique among mammals in 
having been home to multiple waves of Class II TE activity in the recent 
past as exhibited by one WGS target, Myotis lucifugus. It is unclear, 
however, how far this activity extends taxonomically. Unfortunately, 
identifying the the unique TE signature of a genome can be a difficult and 
time-consuming process, especially in taxa that are not targets of whole 
genome sequencing projects. We have employed next-generation 
sequencing and a variety of computational tools to screen five vespertilionid 
bat genomes for TE content. Using a single run of a 454 GS FLX using 
Titanium chemistry, we generated between 6.8 and 25.3 Mbp for each 
taxon, corresponding to between 0.76% and 3.36% genome coverage. As 
would be expected from related taxa, analysis indicates both shared and 
unique TE histories for each species. For example, while all vespertilionids 
share common hAT and helitron, landscapes, genus Myotis remains the sole 
playground of piggyBac elements in these and other surveyed chiropterans. 
This methodology is an effective and relatively inexpensive method to gain 
an understanding of the unexplored genome landscapes of taxa not targeted 
for whole genome sequence analysis. 
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Microbes possess a wealth of metabolic capabilities that have enormous 
potential in the development of environmentally-friendly technologies. We 
have been using the rich species variation found among natural isolates of 
the purple, nonsulfur, phototrophic bacteria Rhodopseudomonas palustris as 
a model system for exploring phenotypic variation in the context of strain-
specific differences in genomic architecture. By gathering detailed 
phenotypic information, corresponding whole transcriptome profiles, and 
complete genome sequences, we intend to further our understanding of how 
environmental conditions coupled with genetic variation influence 
phenotypic outcome.  
 
In this presentation, we will focus on the development of tools that enable 
sequencing-based whole transcriptome profiling and complete genome 
sequencing. Genome sequencing is necessary to reveal strain-specific 
genomic variation and to provide a scaffold onto which transcriptome 
information can be mapped. The complementary transcriptome profiles 
provide a complete picture of how genetic variation and diverse growth 
conditions influence genome wide transcription patterns. This coupled 
approach is broadly applicable across microbial species. Our goal is to 
enable the research community to extract systems biology information from 
a variety of model systems.  
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Identifying functional regulatory DNA sequence variants in the human 
genome is a major challenge. The use of high-throughput next-generation 
DNA sequencing to measure transcription factor occupancy in chromatin 
(ChIP-seq) allows us to witness not only the binding sites but also the DNA 
sequence underlying functional regulatory sites on a genomic scale. 
Sequencing the transcriptome with RNA-seq reveals the sequence of 
expressed transcripts. Through the efforts of re-sequencing projects such as 
the 1,000 Genomes Project, individual diploid genome sequences are now 
becoming available. By aligning sequence tags from ChIP-seq and RNA-
seq experiments to the individual’s diploid reference genome, it is possible 
to identify functional regulatory variants in the human genome. 
 
In this work, we developed an alignment approach and a statistical 
framework to measure allelic specificity in next-gen, short-read sequencing 
data. We applied this approach to ChIP-seq data that we generated for RNA 
Polymerase 2 as well as for more than 30 transcription factors in a 
lymphoblastoid cell line from one individual. We observe many instances of 
various transcription factors binding preferentially to a single allele, with 
allelic specificity ranging from absolute to weak. Many of the allele-specific 
transcription factor binding events are associated with allele-specific gene 
expression that we observe in the accompanying RNA-seq data, giving 
further evidence that the allele-specificity of the binding is functionally 
important. For a subset of these transcription factors, we also performed 
ChIP-seq in lymphoblastoid cell lines from both parents of the original 
individual. By using these datasets, we can trace the inheritance of 
functional events in a family. In doing so, we are beginning to understand 
the extent to which inherited regulatory DNA sequence variants direct 
allele-specific gene expression. 
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The morphological features typical of Neandertals first appear in the 
European fossil record about 400,000 years ago, followed by the 
appearance of progressively more distinctive Neandertal forms. The 
archaeological record shows that Neandertals likely came into contact with 
anatomically modern humans in the Middle East by about 120,000 years 
ago, and subsequently overlapped geographically and temporally with 
anatomically modern human in parts of Europe and western Asia before 
dying out about 30,000 years ago.  
 
There is controversy about whether Neandertals exchanged genes with 
modern humans during the period when they overlapped. Morphological 
features of early modern human fossils as well as some present-day human 
populations have been interpreted as evidence both for and against genetic 
exchange. Deep lineages at specific genetic loci have also been interpreted 
as evidence of gene flow. However, only mitochondrial DNA has been 
compared in detail between Neandertals and modern humans, and this locus 
provides no evidence for gene flow.  
 
To perform a high resolution test for evidence of gene flow beween modern 
humans and Neandertals, we analyze more than 3 billion base pairs of data 
that we obtained by sequencing three Neandertal bones, and compare it to 
five diverse present-day humans. We measure how Neandertals are related 
to different populations of present-day humans both by searching for 
differences in average relatedness and by searching for haplotype patterns 
diagnostic of gene flow.  
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With the increasingly rapid pace of sequence production, the development 
of tools to provide sequence comparison results rapidly has become 
essential to large-scale sequencing. Building on our e-GenoType allele 
comparison approach (www.e-genotype.com), which screens raw read data 
for expected alleles (in silico genotyping), we have expanded the sensitivity 
of our probe sequence screening algorithm and developed a variety of tools 
that use sequence fragment screening to support a broad spectrum of 
analysis approaches packaged in a traditional open source software 
framework. 
 
Beyond improvements that allow for one or two differences between the 
probe sequence and the read data, we have also generated tools for 
characterizing and filtering finished genome data. A variety of fragment 
screening approaches will be discussed, including screening of all (fixed-
size) subsequences from a genome against any given probe set to 
characterize the specificity of probes, screening the genome subsequences 
against other genomes to identify probes that can serve as unique markers 
for any given genome relative to a metagenomic background, fragment 
screening for contamination detection and filtering in de novo sequencing, 
along with a general discussion of optimized sequence fragment screening. 
As this analysis is orders of magnitude faster than mapping, it is ideal for 
QA/QC applications. For example, in tumor/normal pair sequencing it can 
distinguish the tumor from the normal rapidly, and provides an instant 
snapshot of the biology to inform downstream analysis. 
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As normal B-cells mature in the germinal center, IgVh sequences become 
hypermutated. In CLL, patients without hypermutated IgVh have a poor 
prognosis. Our aim is to quantify the diversity and frequency of IgVh 
mutations in the population of leukemic cells within a CLL patient. Next 
generation sequencing has enabled deep sequencing of individual DNA 
molecules and thus a digital read out of DNA variant frequency. However, 
the identification of rare variants (<10% frequency) remains challenging 
due to relatively high sequencing error rates. 
 
In this study, we used Sanger sequencing to obtain a consensus DNA 
reference sequence of the IgVh locus DNA for 2 CLL tumors (CLL1 
indolent, IgVh 91.2% homologous to germline ; CLL2 aggressive, IgVh 
99.6% homologous to germline). We then deeply sequenced the 
transcriptomes of each tumor using an ABI SOLiD instrument. Using the 
BFAST aligner, we mapped the 50 base-pair reads to the consensus IgVh 
reference of each sample (120k reads mapped in CLL1; 152k reads mapped 
in CLL2). Statistically significant variants were called using a script based 
on the SAMtools library, assuming a Poisson distribution for the number of 
sequencing errors at each base, and using a 5% family-wise significance 
level adjusted for multiple tests. To estimate the sequencing error rate, we 
mapped 28k reads in CLL1 and 30k in CLL2 to GAPDH and CD20, 
housekeeping genes without known hypermutation in CLL. We applied 
stringent quality filters to each read and basecall.  
 
In each sample, we were able to successfully identify several high-
confidence variants that were present at low prevalence (<10% frequency). 
We also reduced the expected false-positive rate in comparison to the 
SAMtools consensus base-caller. In future work we will determine the 
halplotype phase of the variants and trace their divergence from the 
consensus reference, to investigate clonal selection in CLL. 
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Genomic sequence comparisons between individuals are usually restricted 
to the analysis of single nucleotide polymorphisms (SNPs). While the 
interrogation an analysis of SNPs is efficient, they are not the only form of 
divergence between genomes. We expand the scope of polymorphism 
detection by investigating the occurrence of double nucleotide 
polymorphisms (DNPs) and triple nucleotide polymorphisms (TNPs), in 
which consecutive nucleotides are altered compared to the reference 
sequence. We have found such DNPs and TNPs throughout two complete 
genomes and eight exomes. The overall abundance of DNPs and TNPs in 
these genomes is approximately 1% of that of SNPs, encompassing tens of 
thousands of DNPs and thousands of TNPs in each genome. Within exons, 
these novel polymorphisms are over-represented amongst protein-altering 
variants; nearly all DNPs and TNPs result in a change in amino acid 
sequence and, in some cases, two adjacent amino acids are changed. DNPs 
and TNPs represent a potentially important new source of genetic variation 
which may underlie human disease and they should be included in future 
medical genetics studies. The preponderance of pathogenic protein 
alterations caused by a DNP or a TNP indicates their potential for causing 
illness. 
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Ion Torrent has developed a DNA sequencing system that directly translates 
chemical signals into digital information on a semiconductor chip. This 
approach leverages a trillion dollars of investment from the semiconductor 
industry taking advantage of existing state-of-the-art chip fabrication 
technology, and the entire semiconductor design and supply chain. 
Unprecedented scalability and cost reduction result from decades of 
Moore's Law advances in semiconductor technologies that are brought to 
bear within a few years for DNA sequencing. 
 
Ion Torrent sequencing takes place in semiconductor microchips that 
contain sensors which have been fabricated as individual electronic 
detectors, allowing one sequence read per sensor. Current configurations 
have 1.5 million sensors in a 1 cm2 chip, with proof of principle to enable 
densities over 100 million sensors per chip. 
 
The sequencing chemistry itself is remarkably simple. Native nucleotides 
are incorporated into the growing strand by native DNA polymerase. As a 
base is incorporated, a direct electrical measurement of the incorporation 
event is made and the sequence is read out directly into the digital domain. 
Thus, sequencing is direct, efficient, and massively parallel, requiring no 
specialized reagents and no optical systems. Using native DNA chemistry 
with real time detection enables run times to be very short, on the order of 
an hour with a throughput on the order of 100 Megabases per hour. We will 
present data and describe metrics from the adenovirus and E. coli genomes. 
 
The Ion Torrent sequencer provides a powerful tool for driving research, 
which will be commercially available in 2010. The simplicity of a 
semiconductor chip that reads itself means that desktop and portable 
instruments will be available at a fraction of the cost of other next-
generation instruments; The use of standard reagents, low reaction volume 
and high data density keep reagent costs low; Computational infrastructure 
and staff support requirements are modest; Finally, the short run time 
supports fast research cycle times and promotes the use of sequencing in 
everyday research.  
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Deletion of most of the Y-chromosome's AZFc region causes severely low 
sperm count. Other deletions involve only part of AZFc, and many studies 
have focused on the influence of these deletions on sperm count. However, 
lack of fundamental knowledge of the population genetics of partial AZFc 
deletions has hampered these studies. To better understand the population 
genetics of these deletions, we studied them in a total of 20,884 men in five 
populations. In contrast to previous studies, the men were unselected for 
sperm count or fertility. We found that two classes of partial AZFc deletion 
are present at polymorphic frequencies and vary significantly in prevalence 
by population. The prevalence of gr/gr-deletions ranges from 2% (US) to 
15% (Vietnam). The prevalence of b2/b3 deletions ranges from 0.5% (India 
and Tunisia) to 2.2% (Poland). A third group of partial AZFc deletions, the 
b1/b3 deletions, is much rarer, at 0.1% across the five populations 
combined. This is only three times the prevalence of b2/b4 "complete" 
AZFc deletions, which cause severely low sperm count and which are 
almost never inherited. The prevalence of different classes of deletions also 
varies significantly by Y haplogroup within population, even after 
excluding the known association of b2/b3 deletions with haplogroup N1. 
We hypothesize that this variation results mainly from founder effects. 
However, haplogroup-specific variation in the frequency of mutations 
causing the deletions is also conceivable. In either case, the variation in 
deletion prevalence by haplogroup implies that haplogroups must be 
considered when assessing the effects of partial AZFc deletions on 
spermatogenesis. 
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Transposable elements (TEs) are intragenomic parasites with the potential 
to restructure genomes through element-mediated chromosomal 
rearrangements. However, their actual contribution to chromosomal 
evolution in the genus Drosophila is still controversial. We have previously 
found that three D. buzzatii polymorphic inversions were generated by 
ectopic recombination between copies of the transposon Galileo. In contrast 
no evidence for an implication of TEs in the generation of inversions fixed 
as interspecific differences has been found in the genus at large. In order to 
assess the contribution of TEs to the generation of Drosophila inversions 
and contrast different hypotheses to explain inversion breakpoint reuse, we 
have cloned and sequenced the breakpoints of six second-chromosome 
inversions fixed in the buzzatii complex (repleta group). The six inversions 
have different ages as shown by their phylogenetic distribution and include 
three instances of cytological breakpoint coincidence. We found that in all 
cases but one the coincident breakpoints fall in the same intergenic region 
corroborating the cytological observations. Fragments of Galileo elements 
were found in the breakpoint junctures of two inversions sharing one 
breakpoint whereas in all breakpoint junctures (but one) of the other four 
inversions, fragments of the transposon BuT5 were detected, sometimes 
along with fragments of other TEs. These observation suggest that ectopic 
recombination between Galileo or BuT5 copies may have generated at least 
some of these inversions. However, the situation is much more complex for 
one inversion that has been accompanied by a gene duplication and 
subsequent microinversion of the duplicate gene. This inversion could have 
been caused by insertion of a hybrid BuT5 element or by staggered breaks 
and reparation. We conclude that (i) TEs are involved in the generation of at 
least some fixed inversions, (ii) cytological coincidences are often 
confirmed at the molecular level and (iii) TEs are possibly responsible for 
some inversion breakpoint coincidences. 
 
*Authors contributed equally. 
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Nonsense-mediated mRNA decay (NMD) is a surveillance pathway that 
rids cells of mRNAs that contain premature translation termination codons. 
It is active in all eukaryotes examined and the core factors are highly 
conserved. NMD pathways in higher eukaryotes can employ factors that are 
not present in the yeast Saccharomyces cerevisiae, such as components of 
the exon junction complex (EJC), which has a role in mRNA splicing. The 
genome of the model filamentous fungus Neurospora crassa contains core 
NMD components as well as EJC components, and, unlike S. cerevisiae, 
many of its mRNAs are spliced. We have established that knockouts of N. 
crassa genes for the NMD components UPF1 and UPF2 lead to the 
increased stability of specific mRNAs that are NMD substrates. We are 
using 454 whole transcriptome sequencing to perform studies of transcripts 
in N. crassa strains that are wild-type or deficient in NMD to evaluate at the 
genome-wide level the changes that occur when this surveillance pathway is 
eliminated. Here we present the results of our comparative analysis of the 
whole transcriptome data from wild type and knockout Neurospora strains 
and provide further evidence for the extent and complexity of NMD in 
regulating transcript metabolism. 
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In NGS data analysis, we have to organize variety of tasks into a workflow, 
including index construction of genomes, read alignment, detecting notable 
patterns from the results, etc. An ideal scenario would be that the workflows 
run perfectly without any modification. In reality, however, parameter 
values of the programs have to be tuned to achieve better alignment results. 
Sometimes we also need to switch alignment programs (e.g, BLAST, 
Bowtie, BWA, SOAP2, etc.) since each of them has pros and cons in their 
performance, tolerance to mismatches and the number of results to be 
produced. Refinement of workflows involves such try-and-error tests, and 
thus their management are strongly demanded. To ease the burden of 
designing workflows, we 
developed a workflow management system, called Silk Weaver, which 
enables us to organize bioinformatics workflows and supports partial 
evaluation of the workflows, which can be used to test various program 
options. Silk Weaver also manages tuning options used to produce the 
results for ensuring the reproducibility of the data analysis. In addition, we 
extended the UTGB genome browser to visualize the execution of the 
workflows and the detailed read alignments including in/dels and mutations. 
Silk Weaver and UTGB are open-source projects, and their source code is 
freely available at http://utgenome.org/. 
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The genetic structure of human populations is a potential confounding 
factor in genome-wide association studies, and it can also yield information 
on population history. We have studied the population structure within 
Sweden using more than 410,000 autosomal single nucleotide 
polymorphisms (SNPs) genotyped in 754 Swedes on the Illumina 
HumanHap550 array. We have also compared the Swedes with over 3000 
reference samples from other European populations based on almost 25,000 
SNPs overlapping between the Illumina and Affymetrix 250K Sty arrays. 
We observed a general correspondence of genetic and geographic distances, 
which is consistent with previous findings from Europe. Within Sweden, 
different parts of the country showed varying amounts of influence from the 
neighboring populations of Finland and Germany, which may reflect 
historical immigration patterns. Furthermore, the northernmost part of 
Sweden, Norrland, clearly differed from the central and southern parts of 
the country and exhibited a loose north-south pattern, whereas the genetic 
substructure in the rest of the country was subtle. The distinctive genetic 
features of Norrland probably result mainly from isolation by distance and 
genetic drift caused by low population density. Overall, the population 
structure within Sweden appears less pronounced than that previously 
detected within the neighboring population of Finns. These results underline 
the potential of genome-wide data in analyzing populations that might 
otherwise appear relatively homogeneous, such as the Swedes. 
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CHD7 is one of nine members of the chromodomain helicase DNA-binding 
domain family of ATP-dependent chromatin remodeling enzymes found in 
mammalian cells. De novo mutation of CHD7 is a major cause of CHARGE 
syndrome, a genetic condition characterized by multiple congenital 
anomalies. To gain insights to the function of CHD7, we used ChIP-Seq to 
map CHD7 sites in mouse ES cells, representing the earliest precursor to the 
cell types affected in CHARGE syndrome. We detected 10,483 sites on 
chromatin bound by CHD7 at high confidence. Most of the CHD7 sites 
show features of gene enhancer elements, i.e., they are located distal to 
transcription start sites, contain p300 and high levels of H3K4 mono-
methylation, positioned within open chromatin, and enriched near genes 
that are specifically expressed in ES cells. We were surprised to find that 
CHD7 can modulate genes in either the positive or negative direction, given 
that enhancers are typically associated with gene activation. Next, we 
aligned CHD7 ChIP-seq reads to sequences corresponding to rDNA (not 
included in the genome assemblies), and detected multiple CHD7 sites on 
rDNA. The binding of CHD7 to rDNA was validated by standard ChIP and 
is consistent with immunofluorescence and western blot analysis of 
subcellular fractions, showing high levels of CHD7 in the nucleolus. ChIP-
chop analyses demonstrate that CHD7 specifically associates with 
hypomethylated, active rDNA, suggesting a role as a positive regulator of 
rRNA transcription. Consistent with this hypothesis, siRNA-mediated 
depletion of CHD7 results in hypermethylation of the rDNA promoter and 
concomitant reduction of 45S pre-rRNA levels. Reduced cell proliferation 
and protein synthesis were also observed upon reduction of CHD7 
expression. Furthermore, compared to wild-type, the levels of 45S pre-
rRNA are reduced in both Chd7+/- and Chd7-/- mouse ES cells, as well as 
Chd7-/- whole mouse embryos and multiple tissues dissected from Chd7+/- 
embryos. Together, these results indicate that CHD7 dually functions as a 
transcriptional regulator in the nucleoplasm and the nucleolus. We propose 
that the multiple anomalies in CHARGE syndrome are due to the combined 
effects of dysregulated tissue-specific gene expression and reduced rRNA 
biogenesis. Lastly, the results serve as proof of principle for ChIP-seq 
analysis of rDNA-binding proteins. 
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Gorillas are our closest evolutionary cousins after chimpanzees, and in fact 
are sufficiently akin to us that ~17% of our genome is closer to gorilla than 
to chimpanzee. Thus the gorilla genome is essential to a fuller 
understanding and interpretation of our own evolution since divergence 
from the other great apes. We present the assembly and analysis of a whole 
genome sequence for gorilla, based on 2x capillary and 35x Illumina 
sequencing of a female Western Lowland gorilla (Gorilla gorilla gorilla), 
‘Kamilah'. The assembly is 3.0 Gbp in length, containing ~95% of 
Kamilah's genomic sequence, with typical base-pair contiguity (N50) of 11 
kbp and scaffold contiguity of 913 kbp. Chromosomes comprising 96% of 
the assembly have been constructed from scaffolds using human homology 
and incorporating known large-scale human-gorilla rearrangements. A final 
assembly stage using BAC and fosmid end pairs to correct and confirm the 
chromosomal structure is nearly complete. 
 
Gene annotation and orthology/paralogy analysis using the Ensembl-
Compara pipeline has identified models for over 21,000 protein-coding 
genes, with orthologs to more than 90% of those in human. We have also 
sequenced gorilla transcriptome data and are using it to add further 
annotation and to investigate non-coding RNA and gene expression in 
comparison with human and other primates. We have generated a multiple 
alignment of the human, chimpanzee, gorilla, orangutan and macaque 
genomes in which 90% of the gorilla assembly is represented, and using a 
coalescent inference model we are able to significantly improve the 
estimates of timescales and population sizes involved in the great ape 
speciation. We also identify those regions genome-wide where humans are 
closest to gorilla, and are investigating the characteristics of such regions. In 
the orthology analysis, 26% of gene trees involving 1-1 orthologs had 
human/gorilla as the closest pair. 
 
We have compared the sequence content of human, chimpanzee and gorilla 
genomes using reference assemblies and Illumina data from all three. 
Surprisingly, chimpanzee and gorilla share ~100 Mbp of sequence not 
found in human, of which 20% is non-repetitive and contains functional 
material. We have also obtained sequence data for other gorillas from both 
the Eastern and Western species, and are able to measure sequence diversity 
and copy-number variation, providing insights into recent evolution within 
the gorilla genus. 
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Malaria’s rapid adaption to new drugs has allowed it to remain a 
devastating infectious disease; understanding and tracking adaptation's 
genetic basis is critical to the success of therapeutic and intervention 
strategies. We developed a high-density genotyping array with 17,000 
single nucleotide polymorphisms (SNPs) across the P falciparum genome 
(~1 SNP/kb), and applied it to 48 culture-adapted malaria parasites from 3 
continents, characterizing population structure and identifying signatures of 
selection throughout the genome. We also created a platform for high 
throughput assessment of drug-sensitivity phenotypes and performed 
genome-wide association studies (GWAS) for chloroquine and halofantrine 
resistance. Besides detecting the known chloroquine resistance locus pfcrt, 
we discovered a novel halofantrine resistance locus, PF10_0355. Functional 
analysis showed that overexpression of PF10_0355 reduces sensitivity to 
halofantrine, mefloquine and lumefantrine but not to unrelated 
antimalarials. Our results demonstrate the power of genome-wide 
approaches to identify resistance loci and point to PF10_0355 as mediator 
of drug resistance in the parasite. 
* Contributed equally. 
 275 
DE NOVO ASSEMBLY OF LARGE GENOMES USING CLOUD 
COMPUTING. 
 
Michael C Schatz, Dan Sommer, David Kelley, Mihai Pop  
 
Univ. of Maryland, Center for Bioinformatics and Computational Biology, 
3104B Biomolecular Sciences Building #296, College Park, MD, 20742 
 
The first step towards analyzing a previously unsequenced organism is to 
assemble the genome by merging together the sequencing reads into 
progressively longer contig sequences. New assemblers such as Velvet, 
Euler-USR, and SOAPdenovo attempt to reconstruct the genome by 
constructing, simplifying, and traversing the de Bruijn graph of the reads. 
These assemblers have successfully assembled small genomes from short 
reads, but have had limited success scaling to larger mammalian-sized 
genomes, mainly because they require memory and compute resources that 
are unobtainable for most users.  
 
Addressing this limitation, we are developing a new assembly program 
Contrail (http://contrail-bio.sf.net), which uses the Hadoop/MapReduce 
distributed computing framework to enable de novo assembly of large 
genomes. MapReduce was developed by Google to simplify their large data 
processing needs by scaling computation across many computers, and the 
open-source version called Hadoop (http://hadoop.apache.org) is becoming 
a de facto standard for large data analysis, especially in so called “cloud 
computing” environments where compute resources are rented on demand. 
For example, we have also successfully leveraged Hadoop and the Amazon 
Elastic Compute Cloud for Crossbow (http://bowtie-bio.sf.net/crossbow) to 
accelerate short read mapping and genotyping, allowing quick (< 4 hours), 
cheap (< $100), and accurate (> 99% accuracy) genotyping of an entire 
human genome from 38-fold short read coverage. 
 
Similar to other leading short read assemblers, Contrail relies on the graph-
theoretic framework of de Bruijn graphs. However, unlike these programs 
Contrail uses Hadoop to parallelize the assembly across many tens or 
hundreds of computers, effectively removing memory concerns and making 
assembly feasible for even the largest genomes. Preliminary results show 
contigs produced by Contrail are of similar size and quality to those 
generated by other leading assemblers when applied to small (bacterial) 
genomes, which scales far better to large genomes. We are also developing 
extensions to Contrail to efficiently compute a traditional overlap-graph 
based assembly of large genomes within Hadoop, a strategy that will be 
especially valuable as read lengths increase to 100bp and beyond.  
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The fungal pathogen Mycosphaerella graminicola is a recently evolved 
pathogen of wheat. We performed whole genome sequencing of 2 
individuals M. graminicola and 10 individuals of two very closely related 
progenitors. 
Paired end Illumina sequencing at 30-50X allowed de novo assembly of the 
12 genomes with scaffold N50 of 100 kb. Alignment of these scaffolds to a 
reference genome of M. graminicola resulted in a ~30Mb multiple 
alignment covering >80% of the reference genome including 13 essential 
chromosomes of the pathogen and a variable number of small dispensable 
chromosomes. Pulse field gel electrophoresis revealed presence/absence 
polymorphism of these chromosomes predating the speciation as well as 
several large scale rearrangements. 
Levels of polymorphism and divergence were largest on dispensable 
chromosomes. We assessed Ka/Ks ratios in 9725 aligned genes and 
identified 9 candidate genes (4 with signal peptides) likely involved in host 
specialization or speciation. Signal peptides were also highly enriched 
among the genes showing evidence for adaptive evolution using the 
McDonald-Kreitman test. Global analysis of MK tables showed that 
adaptive evolution has played an important role in shaping patterns of 
variation within and between species. 
We applied a coalescent HMM to decipher the evolutionary history of M. 
graminicola and its close relatives. We found that speciation of M. 
graminicola was associated with a bottleneck ~10.000 years ago from a 
more variable ancestral species. Incomplete lineage sorting (ILS) affects 
40% of nucleotides. The amount of ILS decreases with gene density and 
increases with the amount of recombination, both in accordance with a large 
role of natural selection in the evolution of these genomes. 
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Recent dramatic decreases in the cost of DNA sequencing have enabled the 
rapid production of human genomes, revealing vast genetic diversity in the 
genome sequence between individuals. In addition, the first genome-wide 
single-base map of DNA methylation in humans was recently reported for 
H1 human embryonic stem cells (hESC) and differentiated fibroblasts, 
revealing widespread differences in cell-type DNA methylomes. However, 
to date, no comprehensive characterization of the consequences of sequence 
diversity on the epigenome has been reported. Here we present the high 
coverage genome sequencing of the widely used H1 hESC line. We have 
used the SOLiD platform to sequence the H1 hESC line with short single-
end reads in addition to sequencing short (1.5 kb) and long (5 kb) mate-pair 
libraries for a total of ~50X read coverage and >1000X clone coverage. The 
combination of these library types has allowed us to characterize extensive 
genetic variation revealing SNPs, small insertion/deletions, inversions and 
structural variants. Because of the high depth of sequence coverage in our 
dataset and the two-base encoding strategy used in SOLiD sequencing we 
have confidently identified heterozygous loci within the H1 hESC genome. 
These heterozygous loci have allowed us to identify allele specific RNA 
expression and DNA methylation. These results demonstrate the importance 
of matching the genome with the transcriptome(s) and the epigenome(s) 
from the same individual for studying the relationship between genetic and 
epigenetic variation. 
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Major efforts to sequence and assemble the human genome culminated in 
2004, resulting in a reference assembly of very high coverage and quality. 
Since that time, the reference genome has played critical and diverse roles 
in many aspects of biological research. Among the important findings 
facilitated by the reference genome was the discovery of an unanticipated 
degree of genetic variation between individuals, coupled with the realization 
that the extant assembly is insufficient in its representation of these often 
divergent and complex genomic regions. Providing alternative assemblies 
of such regions is a major focus of the Genome Reference Consortium 
(GRC), the group responsible for ongoing efforts to improve the reference 
genome (http://genomereference.org). In 2009, the GRC released the 
current version of the human reference genome, GRCh37, which for the 
first time puts alternate locus representations into a chromosome context. 
We will review these alternate assemblies and demonstrate their importance 
to personal genomics projects and improving phenotype to genotype 
correlations. The GRC also strives to correct sequencing errors and close 
the remaining gaps in the reference genome. While such assembly updates 
are crucial to researchers working in poorly-represented regions, frequent 
assembly releases disrupt the coordinate system relied upon by other 
researchers working at the whole-genome level. To balance the need for 
timely updates with the need for a relatively stable coordinate system, the 
GRC has developed a system of assembly patches. Patches consist of new 
or updated sequence contigs defined outside the coordinate system of the 
current assembly that can be released between full assembly updates. 
Patches will be incorporated into the reference assembly at the time of the 
next full update. We will present the first set of assembly patches for 
GRCh37 and review their relationship to the current and future reference 
genomes, as well as their biological importance. The work presented is a 
collaborative effort of the GRC member institutions: NCBI, EBI, The 
Genome Center at Washington University and The Wellcome Trust Sanger 
Institute. 
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The Flash Sequencing System allows for acquisition of DNA sequence 
information from individual molecules—without use of cycles or 
amplification. Single molecules of genomic DNA, from hundreds of 
kilobasepairs to megabasepairs in length, are site-specifically labeled with a 
fluorochrome-labeled nucleotide. At each site, the amount of fluorochrome 
label is quantitated when each individual molecule map is interrogated; 
thus, the quantity of the labeled base is determined. Sequence information 
from multiple sites spread across the context of large DNA molecules leads 
to the phasing of haplotype and elucidation of single nucleotide 
polymorphism as well as larger scale structural alteration. The information 
rich physical maps derived from the single molecules can be assembled to 
provide comprehensive analysis of human genomes.  
 
T.M.S. is supported by an NHGRI training grant to the Genomic Sciences 
Training Program (5T32HG002760). 
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Rapid advances in next-generation sequencing technologies allow ever 
more complete surveys of targeted genomic regions and whole genomes 
and are beginning to generate a flood of genetic association studies of rarer 
variants. Assessment of results from existing genome-wide association 
studies (GWAS) and linkage studies for complex diseases, such as type 2 
diabetes (T2D), can help provide estimates of the upper limits of allelic 
relative risks (RR) that might be expected for variants with risk allele 
frequency (RAF) < 1% and also address whether variants with RAF < 1% 
can account for the observed GWAS signals. A meta-analysis of 23 T2D 
linkage studies, containing an equivalent of ~6500 affected sib pairs, did not 
detect genome-wide significant linkage signals (Guan et al., 2008). Under a 
multiplicative model, this study would have had 80% power to detect causal 
variants with total RAF of 0.5% and RR = 6 or RAF of 1% and RR = 4. 
Taking these RRs as the plausible upper limits of RR for causal variants of 
frequency 0.5% - 1% we next asked if the associations we detected in our 
T2D GWAS could have been caused by variants consistent with the linkage 
results. The three previously known T2D loci, as well as the initial six T2D 
loci identified through GWAS, were identified in sample sizes of up to 
~32,000 cases and controls. In a total sample of ~32,000 cases and controls, 
we would have had < 5% power at p = 5 x 10-8 to detect an association from 
a causal variant with RAF = 0.5% (1%) and RR < 6(4) for a GWAS SNP in 
D' = 1 with the causal variant with a RAF > 45% (>55%). Four of the initial 
nine T2D loci have RAF > 50% suggesting that causal variants with 
combined RAF < 1% are unlikely to underlie these signals. In a subsequent 
DIAGRAM meta-analysis, with an effective sample size of up to 64,000, 
two of six associated SNPs had RAF > .65 and would have had < 5% power 
to detect causal variants with RAF = 0.5% and RR < 6. In conclusion, a 
substantial portion of the T2D GWAS loci identified to date are unlikely to 
be explained by variants with RAF < 1%. 
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A major aim of Ensembl is generating annotation on vertebrate genomes. 
We have previously developed systems for annotating protein coding and 
short non coding (ncRNA) genes. These methods have been applied to over 
50 genomes. Several recent additions to the annotation system will be 
described including an improved pipeline for the merging of manual 
annotation into the automatically predicted set, a pipeline for predicting 
long ncRNA genes, and the systems we are developing for generating 
annotation from RNASeq data.  
 
Ensembl had previously incorporated a subset of models from manual 
annotation from the HAVANA group. The latest merge process now 
incorporates all HAVANA annotation into the final set. The manual 
annotation contains more alternative isoforms than the Ensembl automatic 
annotation, and includes extra non coding gene types and more pseudogene 
annotation, but currently only covers 70% of the genome. Merging manual 
and automatic annotation provides a set which covers the complete genome 
while retaining the extra depth from the manual set. Although increasing the 
number of transcripts approximately 3 fold, there has been only a small 
change in the number of protein coding genes in the merged set (22320 
compared to 22218).  
 
We have developed a pipeline to predict long ncRNA genes, based on a 
method previously described by Guttman et al. The approach is based on 
the distinctive chromatin signature which marks actively transcribed genes 
located outside of known protein-coding loci. This is implemented in 
Ensembl utilising data from the Ensembl functional genomics, comparative 
genomics and annotation databases. When applied to human the pipeline 
identified 4502 long ncRNA genes, and is currently being applied to mouse. 
 
We have developed a system for generating transcript models from 
RNASeq data and applied this to a large set of RNSeq data for Zebrafish, 
and are working on merging this with the standard Ensembl annotation. The 
method has also been entered in the RGASP RNASeq model building 
competition. Results for this will be released shortly. 
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Copy number variations (CNVs) are an increasingly recognized cause of 
human disease and variation. We have analyzed rearrangement breakpoints 
in 100 pathogenic CNVs detected in a cohort with intellectual and 
developmental disabilities. 17/100 (17%) CNVs resulted from NAHR 
between highly homologous segmental duplications (SDs), a significant 
enrichment, considering that SDs only make up 5% of the genome. Almost 
all of these 17 CNVs were recurrent and the frequency was directly 
proportional to the size and sequence identity shared between the 
paralogous SDs mediating NAHR. The remaining 82 CNVs were mostly 
non-recurrent, singletons with a few instances of overlapping CNVs but 
with different breakpoints. We used custom-designed, tiling microarrays to 
refine the rearrangement breakpoints in a subset of these allowing the rapid 
cloning and sequencing of 42 breakpoints (21 CNVs). 25 breakpoints 
localized to repetitive DNA elements like Alus and LINES, but only three 
CNVs appeared to result from NAHR between repeats. The majority of the 
breakpoints appeared to result from Non-Homologous End Joining (NHEJ). 
In each of the CNVs analyzed, 1 -14 base pairs of microhomology was 
observed at the breakpoints further supporting the involvement of NHEJ. 
We identified a Poly(dA:dT) tract at an average distance of 85 bp from 
41/42 breakpoints. This motif has been shown to be important in 
nucleosome organization, suggesting a correlation between chromosome 
breakpoints and chromatin structure. We further analyzed each of the 
breakpoint regions for sequence motifs that have previously been identified 
at or near rearrangement breakpoints. Although many such “hotspot” motifs 
were identified, none were significantly enriched when compared to control 
sequences. Further analysis of additional CNV breakpoints, both pathogenic 
and normal variants, will help determine the relative contribution of these 
variable rearrangement mechanisms in generation of CNVs in the human 
genome. 
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Individual variation of gene expression contributes to phenotypic 
variability. Thus the understanding of the genetic control of gene expression 
is important to decipher the etiology of genetic traits and disorders. Genetic 
analysis in cells and tissues from different individuals has revealed both cis 
and trans expression quantitative trait loci (eQTLs) for many genes; the 
effect of these cis-eQTLs is relatively strong since they have been 
discovered and replicated with relatively small sample sizes. Recent studies 
have revealed that the majority of the discovered eQTLs are tissue specific 
(Dimas et al. Science 2009), a finding compatible with the tissue specificity 
of the phenotypic characteristics of genetic disorders. The challenging 
question for each eQTL is to identify the functional variant that controls the 
gene expression variation.  
We hypothesize that copy number variation of short sequence repeats in the 
human genome contributes to the gene expression variation of some genes. 
Our laboratory has previously identified that rare expansions of a 
dodecamer repeat (CGGGGCGGGGCG) in the promoter region of the 
CSTB gene on chromosome 21q lead to silencing of the gene, resulting in 
progressive myoclonus epilepsy (Lalioti et al Nature 1997). The majority of 
alleles in the human population contain either 2 or 3 copies of this 
dodecamer repeat. Since the large expansion to more than 200 repeat copies 
results in silencing of the CSTB gene, we hypothesized that the common 2 
or 3 copy variation may be a causative cis-eQTL for CSTB expression 
variation.  
We used PCR to genotype the repeat length and quantified CSTB expression 
by TaqMan qRT-PCR in 170 lymphoblast and fibroblast samples from the 
GenCord collection. Although there is considerable variation in expression 
of this gene in the normal population, we observed that in lymphoblasts 
repeat length is strongly correlated with CSTB expression (p=3x10-11), with 
individuals homozygous for the 3-repeat allele showing ~2-fold higher 
expression than individuals homozygous for the 2-repeat allele. In 
fibroblasts a weaker effect was observed (p=0.03), showing that this effect 
is cell-type specific. Examination of both genotyped and imputed SNPs 
within 1Mb of CSTB revealed none that were significantly correlated with 
CSTB expression. Therefore, the dodecamer repeat represents the strongest 
cis eQTL for CSTB in lymphoblasts, explaining 23% of expression 
variation. We conclude that polymorphic tandem repeats likely represent the 
causative variation of a fraction of eQTLs in the genome.  
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Hematopoietic differentiation – the process of differentiation from a 
hematopoietic stem cell into all blood and immune cells – is a much-studied 
differentiation process in mammals. Despite decades of research, the 
transcriptional circuitry controlling this process is still only partially 
understood. The generation of two unprecedented compendia of gene 
expression measured in a range of multipotent and differentiated cell types 
across the human (DMAP) and mouse (www.immgen.org) hematopoietic 
lineages opened the way to systematically decipher the regulatory circuitry 
controlling this process. Here, we build on a novel extension of probabilistic 
graphical models to model gene expression using the topology of the 
differentiation tree to construct a unified regulatory model in the lineage 
(Jojic, Shay et al, in preparation). We applied this approach to both human 
and mouse compendia, identifying the key transcription factors that drive 
this process. We compare the resulting models between the two organisms 
to detect the conserved and divergent features of the regulatory code. Our 
analysis represents a first comprehensive model of gene regulation within a 
complete cell lineage, highlights similarity and differences between mouse 
– a common model in immunology – and humans, and can shed light on the 
role of dis-regulation of cell circuits in hematologic disorders and 
malignancies.  
 
* Equal contribution 
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Whole-genome resequencing (WGS) allows direct interrogating of rare 
variants, which will facilitate the study of human diseases. One of the 
emerging problems where rare variants are crucial is the missing heritability 
observed in genome-wide association studies (GWAS) of common diseases. 
However, the cost of sequencing is a limiting factor in designing large-scale 
case-control association studies. Here we describe theoretical considerations 
to maximize the power of detecting association under the constraint of cost. 
First we considered the scenario where the cost was proportional to the total 
amount of base pairs to be sequenced, i.e., proportional to the number of 
subjects times the average depth-coverage per subjects. In an association 
study, the power of detecting association increases when the number of 
subjects increases. Meanwhile, the power of correctly calling rare variants 
increases when the average depth-coverage increases. Therefore it is 
important to strike a balance between the number of subjects and the 
average depth-coverage per subject. We established a depth-coverage 
distribution model based on empirical data. Assuming publicly available 
population control data (such as that from the 1000 Genomes Project) will 
be used in a study, and the rare variants of interest are near absent in the 
control data, we demonstrated that the optimal power of detecting 
association was always achieved at medium depth-coverage (<15x) under 
realistic conditions. We then considered a second scenario where the 
number of subjects alone determined the cost and the power of variant 
detection is always close to 1. This is in line with whole exome sequencing, 
where a smallest unit (lanes or slides) of high-throughput sequencing 
platform yields large depth-coverage for a subject. Assuming it is necessary 
to sequence both cases and controls, the problem of study design is then 
what is the optimal ratio of cases and controls that maximizes the power of 
detecting association of rare variants. We deduced that if the rare variants of 
interest are near absent in controls, the optimal ratio of cases is 1/e. 
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Epigenetic modification plays an important regulatory role in diseases such 
as cancer. While bisulfite sequencing is the most powerful method to study 
DNA cytosine methylation,approximately 99% of cytosine bases are 
converted to uracil thus creating essentially a 3 base bisulfite-converted 
genome that has less signature than a 4 base genome and is more difficult to 
map against with short reads. Traditional approaches to map the bisulfite-
converted tag to both a bisulfite-converted reference and an unconverted 
reference can lead to loss of information when mapping reads with a 
moderate number of methylated cytosines. For example a read that has 6 
methylated and 6 unmethylated bases would not map to either reference 
when mapped allowing up to 5 mismatches. In order to enable accurate 
mapping to the highly redundant bisulfite-converted genome,we have 
developed a mate-pair scheme in which only one mate-pair tag is bisulfite 
converted while the other tag remains unconverted. The adapters and non-
converted tag are protected via incorporation of 5-methyl-cytosine,which is 
resistant to bisulfite conversion.We used this protocol to make a mate-pair 
library from a human MCF-7 cell line. The non-converted sequence 
provides an “anchor” in the genome and facilitates the identification and the 
methylation status of the bisulfite-converted tag. This approach reduces 
mis-mapping since the anchor sequence regulates the mapping of the 
bisulfite-converted tag and allows the non-anchored tag to tolerate more 
mismatches and thus map more of the moderately methylated tags and open 
a window to these previously difficult to obtain regions. This novel 
technique has the potential to provide a routine and reliable method for 
hypothesis free genome-wide methylation detection. Studying the role of 
methylation on gene expression will provide useful information on the role 
of epigenetic mutations in human breast cancer. 
The SOLiD instrument is For Research Use Only. Not intended for any 
animal or human therapeutic or diagnostic use. 
 287 
IN-DEPTH METABOLIC CHARACTERIZATION OF GENETIC LOCI 
UNDERLYING SERUM-LIPIDS 
 
S-Y Shin1, A-K Petersen2, W Römisch-Margl 3, G Zhai4, K Small4, R 
Wang-Sattler 2, E Grundberg1,4, J Ried2, A Döring2, H-E Wichmann2,5,6, M 
Hrabé de Angelis 7,8, H-W Mewes3,9, T Illig2, TD Spector4, J Adamski7,8, K 
Suhre3,10, C Gieger2, N Soranzo1,4 
 
1Wellcome Trust Sanger Institute, Human Genetics, Hinxton, CB10 1HH, 
United Kingdom, 2Institute of Epidemiology, Helmholtz Zentrum München, 
Neuherberg, Germany, 3Institute of Bioinformatics and Systems Biology, 
Helmholtz Zentrum München, Neuherberg, Germany, 4 King's College 
London, DTR, London, SE1 7EH, United Kingdom, 5Institute of Medical 
Informatics, Ludwig-Maximilians-Universität, Munich, , Germany, 
6Klinikum Grosshadern, Munich, Munich, Germany, 7Institute of 
Experimental Genetics, Helmholtz Zentrum München, Neuherberg,  
Germany, 8Institute of Experimental Genetics, Technische Universität 
München, Munich, Germany, 9Technische Universität München, 
Department of Genome-oriented BioinformaticsMunich, Germany, 
10Ludwig-Maximilians-Universität, Faculty of Biology, Munich, Germany 
 
Emerging metabolomics technologies enable monitoring of small 
metabolites from body fluids, and can help elucidate processes underlying 
inherited variation in established disease risk factors. To dissect the effect 
of recently published genetic variants influencing serum lipids and heart 
disease, we profiled 151 metabolites in 1,797 participants from the KORA 
population (Germany), replicating results in the TwinsUK cohort (n=1,236). 
We aim to identify cases where a genetic locus is associated with both a 
lipid and a metabolite concentration. We report here the initial results of this 
effort, as well as discussing methodological approaches to metabolite 
analyses. Among others, we identify associations of GCKR variants with 
different ratios of plasmalogens and phosphatidylcholines (P = 3.2 × 10−8). 
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The advent of high throughput next generation sequencing enables 
experiments to study genome variations, transcription of coding and non-
coding RNAs and epigenetic profiles. The ability to design effective 
experiments that make efficient use of samples and highly parallel sequence 
generation requires a clear understanding of the impact of system accuracy 
on the power to detect a variety of meaningful biological differences 
between or within samples. Standard expressions of sequence quality are 
important, but insufficient, to support rational experimental design.  
In developing the SOLiD System we include system validation and the 
release of system data sets. With mapped data accuracy at greater than 
99.9%, we continue to analyze reference samples so that we can continue to 
report concordance with a reference genome. 
Using the SOLiD 3+ System, we generated 128 GBases of alignable 
sequence for the HuRef genome. We used the Bioscope Software to 
produce BAM files, calling SNPs, indels, inversions and CNVs. Validating 
against the 7x Sanger and SNP chips for this individual (Levy et al., 2007), 
we found 99.7% SNP concordance. Small indel sensitivity was 80-85% 
depending on the choice of mapping parameters.  
Using the SOLiD 4 System, we have generated over 100 GBases of 
additional HuRef genome sequence data to date. We will present data that 
demonstrates the power of Bioscope and SOLiD to detect SNPs, indels and 
CNV in standard resequencing experiments and comparisons of the SOLiD 
4 system with its predecessor. 
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Complete genome sequences are now available for individuals representing 
several distinct human populations. Interest in these sequences so far has 
focused on the technical feasibility of individual genome sequencing, the 
identification of single nucleotide and structural variations, and implications 
for personalized medicine. However, these data also represent a rich source 
of information about human evolution. Here we describe an effort to 
estimate key evolutionary parameters -- including the times at which major 
human population groups diverged, the effective sizes of these populations, 
and the rates of migration between them -- from the complete genome 
sequences of seven individuals, including two European Americans, a 
Yoruban, a Han Chinese, a Korean, a Bantu, and a Khoisan. 
 
To extract information about ancestral populations from this data set, we 
rely on patterns of variation in genealogies across loci, using a coalescent-
based method called MCMCcoal (Rannala and Yang, Genetics, 2003). We 
adapt this method to accommodate (unphased) diploid genomes and 
migration between populations. In addition, we realign all reads using a 
uniform pipeline, and employ a novel algorithm to integrate over 
uncertainty in both genotypes and haplotype phasings in the calculation of 
genealogy likelihoods. Finally, we apply a comprehensive set of filters to 
minimize biases from both sequencing/alignment error and natural 
selection. 
 
Preliminary results indicate a split time of about 100 thousand years ago 
(kya) for the ancestral Khoisan population, a split time of ~50 kya for the 
Eurasian and African populations, and a split time of ~40 kya for the 
Europeans and East Asians. Estimates of Eurasian population sizes are 
sharply reduced in comparison with ancient and modern African sizes. We 
estimate an effective size of ~5000 for the population ancestral to all 
modern humans. 
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Genome-wide detection of transcription factor binding sites (TFBSs) is 
difficult because they are short, degenerate sequences buried in unknown 
locations within regulatory regions of a gene. Earlier prediction methods 
incorporated genome-wide expression data and promoter sequences into a 
linear-model framework, regressing measures of expression onto counts of 
putative TFBSs in promoters for a single species. More recently, it has been 
shown that including genomic sequence data from multiple species 
improves the predictive ability of this regression model. We describe two 
extensions of this single-species, linear regression method using a 
multivariate modeling framework. The resulting algorithms extend the 
search space to both sequence and expression information from all 
available genes across multiple species. We also constrain our multivariate 
models to account for the phylogenetic relationships among the multiple 
species. We show that the multiple-species method results in an 
improvement in the prediction of TFBS over the single species method 
using several evaluation criteria. In summary, utilizing both sequence and 
expression data across species appears to be beneficial for genome-wide 
prediction of TFBSs. 
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The aim of the project was to develop targeted re-sequencing of candidate 
genomic regions to identify novel genomic variants using sequence capture 
microarrays in non-human species. Recent technology advances in DNA 
sequencing has revolutionized how genetic variants are discovered, 
allowing millions of nucleotides to be sequenced in one single run. For re-
sequencing of megabase sized candidate genomic regions a single 
sequencing run of Illumina Genome analyzer would be more than enough. 
The major obstacle has been to efficiently select or amplify the region of 
interest from the rest of the genome prior to sequencing. For this purpose 
selective sequence-capture methods using hybridization on microarrays 
have been developed. On example is the custom-made microarray from 
Roche-Nimblegen that includes 385 K probes that can capture 1-5 Mb of 
genomic sequence. This technique has been developed for human and 
mouse samples, but has so far not been applied on other genomes. 
 
We have modified the protocol to perform sequence capture on microarrays 
followed by Illumina sequencing in a variety of species including dogs, 
horses and cattle. Our protocol involves sheering to ~300bp, ligating 
Illumina adapters, sequence capture on Nimblegen microarray, adapter 
mediated PCR followed by sequencing. We typically map 60% of sequence 
back to the target, and with an average coverage of ~100x we expect to see 
>96% of the target covered by at least 5x. 
 
The methodology has worked robustly for several applications including 
regions in the dog genome to detect SNPs, indels and CNVs associated with 
several canine diseases, the Leopard Complex spotting in the horse and 
arachnomelia in cattle. We conclude that the method works robustly across 
species. 
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Projects such as 1000 Genomes and The Cancer Genome Atlas are 
employing next-generation sequencing technologies to resequence many 
individual genomes. Alignment of sequenced reads to the reference genome 
allows one to discover both single nucleotide variants and structural 
variants. Numerous methods have been developed to identify structural 
variation from resequencing data. The two primary signals used are read-
depth (RD) coverage and paired-end mapping (PEM). Both rely on the 
correct alignment of reads to a reference genome; thus the power to detect 
variants with breakpoints in repetitive sequence is reduced. To overcome 
this, other methods incorporate reads with multiple possible mappings. 
 
We introduce two probabilistic models for structural variation detection. 
One combines signals from both RD and PEM (GASV+CC), while a 
second also includes ambiguous reads (GASV-Prob). Each is built on our 
established Geometric Analysis of Structural Variants (GASV) program 
that precisely localizes the breakpoints of variants (Sindi et al, 09). To our 
knowledge, GASV+CC and GASV-Prob are the first methods that integrate 
RD and PEM (of all discordant pairs) into a single probabilistic model.  
 
We compared GASV+CC and GASV-Prob with existing methods on 
simulated structural variants from the Venter genome and resequencing data 
from two individuals in the 1000 Genomes project (NA18507 and 
NA12878). For the individual genomes we used a set of validated structural 
variants from fosmid data (Kidd et al, 08) to estimate the true positive rate. 
On simulated deletions our probabilistic methods, GASV+CC and GASV-
Prob, out performed competing methods using only PEM or RD. 
GASV+CC has the most balanced performance, making 50% fewer 
predictions at equal sensitivity of other methods. GASV-Prob showed the 
highest sensitivity, detecting 65% of deletions with 40% fewer predictions 
than other methods. On the 1000 Genomes data the relative performance of 
GASV-Prob and GASV+CC was maintained. GASV-Prob was the most 
sensitive method (>70%), while GASV+CC was the most specific. These 
results demonstrate combining multiple signals of structural variation into a 
single model achieves increased sensitivity and specificity of detection. 
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With advances in sequencing technology, greater and greater amounts of 
genomic data are becoming available every day. A large portion of these 
genomics sequences consists of transposable elements; frequently 50% or 
more in vertebrates. Transposable elements are known to act as drivers of 
genomic evolution and diversification and are important genetic markers. 
Each transposable element family may have thousands of copies within a 
given genome, and therefore it can take an exorbitant amount of time and 
effort to process data in a meaningful fashion. In order to combat this 
problem, we developed a set of modern bioinformatics techniques and 
programs to streamline the analysis. This includes a unique perl script 
which automates the process of taking BLAST, Repeatmasker and similar 
data and extracting the hit sequences from the genome. This script, called 
Process_hits uses an Object-oriented methodology to compile all hit 
locations from a given file for processing, organize this data into useable 
categories, and output it into multiple formats. It is capable of handling 
large amounts of transposon data in an efficient fashion, with each of the 
major sub-functions, hit processing, nucleotide sequence extraction, and hit-
object methods, are contained within their own sub-modules to allow for 
greater expandability and as foundation for future program design. 
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Somatic genome rearrangement is often a cause and consequence of cancers 
or other “genomic disorders”. However, a few metazoan and protist lineages 
are known to undergo tightly-regulated and large-scale somatic 
recombinations during the normal course of their development. The 
discovery of programmed genome rearrangement in lamprey (a vertebrate) 
fills an important gap in our understanding of dysregulated rearrangement 
of vertebrate genomes and the capacity for tight regulation of genome 
rearrangement other taxa. Several lines of evidence demonstrate that the 
lamprey undergoes a dramatic remodeling of its genome, resulting in the 
elimination of hundreds of millions of base pairs (~20% of the genome) 
from many somatic cell lineages during embryonic development. 
Embryological studies reveal that many of these rearrangements take place 
early in development, resulting in a situation wherein an individual’s 
“germline” and “somatic” cell lineages differ substantially in genome 
structure and gene content. Computational, array CGH (comparative 
genomic hybridization), and 454 sequencing studies reveal that several 
distinct genomic regions are altered during this process and have identified 
specific rearrangement breakpoints that differentiate germline and somatic 
genomes. Genomic regions that are removed via programmed 
rearrangements include hundreds of genes, many of which are transcribed in 
adult and juvenile testes or during early embryonic development. A large 
fraction of these somatically-deleted genes have homologs that are known 
to contribute to genome stability or the specification/maintenance of 
pluripotent cell lineages.  
 
It is worth noting that ostensibly similar rearrangements have also been 
observed in hagfish (another basal chordate lineage), suggesting that this 
dynamic genome biology can be traced to a point very near the common 
ancestor of all vertebrates. Understanding the mechanisms by which 
lamprey regulates such extensive remodeling of its genome will provide 
invaluable insight into factors that can promote stability and change in 
vertebrate genomes, as well as the consequences of reorganization in the 
context of “normal” vertebrate development and cell biology.  
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The HMP has produced some of the largest metagenomic data sets thus far 
generated in the field (~50 subjects, ~900 specimens) and allow a number 
of questions to be approached in more detail than previously: 
reproducibility of sampling methods, Sanger vs 454 16S sequencing, 
stability of microbiomes between visits, variation in microbiomes between 
or within individuals for different body sites, variation between body sites, 
etc. These specimens have been subjected to 16S rRNA sequencing by both 
Sanger and 454 (using 3 windows within the 16S gene). Tools for analyzing 
these 16S community descriptions are being developed to answer these 
questions.  
 
Shotgun data provides superior information compared to 16S, allowing 
species and gene content description. Using both Illumina and 454 will 
produce terabases of shotgun sequences, requiring the development of new 
approaches for metagenomic analysis. An integrated analysis system is 
being developed to use sequence overlaps and coverage, GC content, 
phylogenetic markers, similarity to known sequences and association to 
pathway networks. Species identification and abundance is being 
approached by comparison to ~1000 reference genomes. 
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Targeted enrichment and indexed library sample preparation are two key 
technologies that, when combined, enable full utilization of next generation 
sequencing technologies. We have developed a targeted sequencing assay 
capable of enriching up to 10 Mb of genomic region (exonic or contiguous) 
in a single-tube “pull-down” assay. The enrichment protocol uses single 
and/or tiled biotinylated 80-100mer oligonucleotides to specifically target 
short DNA library elements of interest (150-450 bases). After annealing of 
the biotinylated oligo pool to standard Genome Analyzer (GA) DNA 
libraries, excess biotinylated oligos are removed, and the oligo-library 
duplex pulled down onto streptavidin beads. The bound library elements are 
stringently washed to remove non-specifically bound DNA. The library 
elements are eluted and subjected to amplification before clustering and 
sequencing on the GA. In order to match the throughput of the GA with the 
desired sample coverage (e.g., 50-80X) per lane, sample indexing in 
targeted sequencing is required. We demonstrate simultaneous, uniform 
enrichment of 12 different indexed sample libraries in a single pull-down 
across over 5500 different exons. Additionally we have demonstrated scale-
up of enrichment complexity to over 55,000 exons from a single sample and 
demonstrated mock complexity to over 300,000 pull-downs. At this 
complexity, the human exome can be enriched in a single pull-down. In 
summary, our enrichment assay exhibits scalability, high specificity with 
60-80% of reads on target, good coverage uniformity with greater than 90% 
of the targeted bases covered at 0.2X or greater of the mean coverage, 
minimal allelic bias, and concordance with Infinium® genotyping of over 
99.8%. We show practical utility of our exon enrichment assay for both 
detection of cancer mutations and copy number changes in DNA from 
tumor cell lines. These technologies provide a flexible, automatable, highly-
specific and relatively unbiased route towards rapid targeted sequencing of 
the genome. 
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Large-scale and genome-wide studies have concluded that approximately 
80% of the yeast (Saccharomyces cerevisiae) genome is occupied by 
positioned nucleosomes. In vivo this nucleosome organization can result 
from a variety of mechanisms, including the intrinsic DNA sequence 
preferences for wrapping the DNA around the histone core. Recently, 
genome-wide studies were reported using massively parallel sequencing to 
directly compare in vivo and in vitro nucleosome positions. In one case, it 
was concluded that intrinsic DNA sequence preferences indeed have a 
dominant role in determining the in vivo nucleosome organization of the 
genome, consistent with a genomic code for nucleosome positioning. Some 
other studies disagreed with this view. We have attempted to clarify a 
fundamental question concerning the packaging of genomic DNA: To what 
extent are nucleosome positions in vivo determined by histone-DNA 
sequence preferences? We have analyzed data obtained from different 
laboratories in the same way, and have directly compared these data. We 
examine the difference between nucleosome occupancy and nucleosome 
positioning. We compute the precise effect of statistical nucleosome 
positioning for yeast chromatin. We question using read numbers from 
massively parallel sequencing to determine nucleosome occupancies. We 
also identify possible problems with some of the data analyses. Our findings 
suggest that DNA sequence preferences have only small effects on the 
positioning of individual nucleosomes throughout the genome in vivo. 
However, these small effects may still be significant in influencing 
chromatin higher-order structure. 
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High-throughput sequencing is expanding the catalogue of variation at an 
unprecedented rate, enabling a more comprehensive understanding of the 
underlying linkage disequilibrium (LD) patterns within and across 
populations. This information is required to optimally design the next 
generation of whole-genome genotyping (WGA) arrays. Until recently the 
primary source of information for developing WGA arrays was the 
International HapMap Project as it provided detailed information on 
frequencies and LD between almost four million SNPs in three distinct 
populations. Selecting an optimal subset of these SNPs allows the creation 
of arrays that interrogate over 90% of all common HapMap variants either 
directly or indirectly through LD with only 600-800k tagSNPs. However, 
the catalog of SNPs available through HapMap represents only a small, and 
potentially biased, subset of the total variation in the human population. 
With the advent of high-throughput sequencing, the 1000 Genomes Project 
has greatly increased the spectrum of known variants and provides an 
excellent resource for content to develop the next generation of microarrays 
for “rich” genome-wide association studies (GWAS). These microarrays 
will interrogate the entire genome, including rarer content down to ~1% 
MAF. We have evaluated the whole-genome coverage provided by chips 
whose content was based on the HapMap data. Using the phased genotype 
data from the 1000 Genomes Project, we calculate that less than 70% of the 
common (>5%) variants and less than 60% of all variants seen at least twice 
are tagged by even the most comprehensive arrays currently available. 
Using a “greedy” approach to selecting tag SNPs, we show that ~2 million 
intelligently selected markers can effectively cover the SNPs from the 1000 
Genomes Project in all three HapMap populations, excluding singletons. 
Additionally, because the 1000 Genomes Project is sequencing to ~4x 
depth, many of the available genotype calls have been imputed and/or are 
based on only a limited number of reads leading to potential false positives 
and genotype errors. We will also present the results of validation 
experiments using hundreds of thousands of SNPs to assess false positive 
rate and categorize potential errors in these imputed genotype calls. 
 299 
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Copy number variants (CNVs) play significant roles in human biology, but 
existing array platforms struggle to accurately genotype multi-allelic CNVs 
within segmental duplications. As a result, these regions and the genes 
therein have generally been regarded as inaccessible. We develop methods 
to accurately estimate copy using NGS read depth and to assess content 
using ‘singly unique nucleotides’ (SUNs) that discriminate the copies. We 
report here the first large-scale, accurate genotyping of multi-allelic CNVs 
from the sequence of 151 human genomes. Using FISH, qPCR and aCGH, 
we show 86-100% concordance in predicting the copy number of segments 
>1.6kb that range from 0-56 copies. We show that 17% of previous CNV 
genotypes from SNP microarrays are in error and that 95% lie within these 
multicopy regions. We detect the most variable and most population 
stratified genes (n=383) in the human species and show that most of this 
diversity has not been previously characterized. To genotype specific 
duplicated segments, we identify 4.6 million SUN positions and show that 
91% of these are informative in distinguishing specific copies. Using read 
depth at SUNs we estimate individual paralogs' copy, even for deeply 
nested duplications, and show that ~12% of SDs are diploid and nearly 
copy-invariant across genomes sampled. Conversely, we identify specific 
paralogs with high copy number variability and population stratification. 
We detect previously undetectable patterns of structural variation embedded 
within SDs, including paralog-specific deletions of duplicated genes and 
also find patterns suggestive of large-patch gene conversion events between 
tandem SDs at several loci. We demonstrate, for the first time, the ability to 
assay both copy and content of complex regions of the human genome, 
opening these regions to disease association studies and further population 
and evolutionary analysis.  
(*) contributed equally 
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Mutations in the germline are the source of genetic variation. While there 
have been observations of germline mutations in humans at specific 
disease-causing loci, a large-scale genome-wide direct observation of 
mutations transmitted from parent to offspring has not been possible 
because the mutation rate is low.  
 
To provide an accurate estimate of the human mutation rate at a common 
type of polymorphism, we focus on microsatellites, which are pervasive in 
the genome and mutate at a much higher rate than single nucleotide 
substitutions. We estimate the mutation rate using data from over 95,000 
Icelanders at up to 2555 loci. We estimated mutation rates using two 
approaches: (1) using 19,134 trios and (2) using 2,406 extended families. 
We discovered 2,131 germline mutations in 6 million parent-offspring 
allele-transfers. Experimental re-genotyping of a subset of the mutations 
demonstrated a false-positive rate of <10%.  
 
Our results show: 
i. The overall mutation rate is 3.5x10-4, which is 3-times lower than 
previous studies. Tetra-nucleotide loci almost exclusively mutate by 1-
repeat unit, while the di-nucleotide loci show a spectrum. Based on the 
mutation rates and length distributions, we demonstrate that the stepwise-
mutation-model is inadequate in estimating absolute coalescent times.  
ii. Mutation rate is strongly correlated with microsatellite length.  
iii. The paternal-to-maternal mutation rate ratio (α) is 3.1. 
iv. The paternal mutation rate is significantly correlated to paternal age, but 
none on the maternal side. This suggests that the maternal rate may be 
relatively well described as proportional to the number of generations that 
elapse, while the male mutation rate may be better described as a quantity 
proportional to the number of years. 
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Although recent studies have revealed the complete structure of the 
transcripts for the major part of the human genes, they are mostly virtual 
transcript models deduced from collective information from hundreds of 
different cell types. Detailed figure of the transcriptome of a given 
particular cell type still remains elusive. We recently developed a method to 
enable deep sequencing analysis of the transcriptional start sites (TSSs) by 
combining our oligo-capping method and Illumina GA sequencing 
technology. Briefly, the 5’- and 3’-adaptor sequences necessary for the 
Illumina GA sequencing were introduced as the 5’-end-oligo at the RNA 
ligation and as the random hexamer primer at the first strand cDNA 
synthesis, respectively.  
By appling this TSS Seq technology, we characterized 140 million 
transcriptional start sites (TSSs) in 12 human cell types. Despite the large 
number of TSS clusters (TSCs), the TSCs with significant expression levels 
were rare; having strikingly characteristic sequence features and expression 
patterns from the other minor TSCs. Also, the significantly expressed TSCs 
had several distinctive biological features in their surrounding regions. 
Nucleosome-Seq analysis revealed highly-ordered nucleosome structures, 
and ChIP-Seq analysis detected strong RNA polymerase II binding signals. 
Evaluations of 16,080 previously sequenced and 846 newly shotgun-
sequenced complete cDNA sequences revealed that the preferable 
transcripts for translation are more frequently associated with those TSCs. 
Furthermore, RNA Seq analysis of polysome-incorporated RNAs yielded 
direct evidence that those transcript products are actually used for protein 
translation. Similar discriminative features were also found between the 
intergenic TSCs of significant expression levels and those of very low 
expression levels. We demonstrate that integrative transcriptome analysis 
provides a powerful tool to discriminate TSCs having clear biological 
significance from the other possible noise level transcriptions. 
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Retrotransposons comprise nearly half of mammalian genomes. Widespread 
genomic variation between normal mouse strains has been driven by recent 
endogenous mobilization of these elements, resulting in tens of thousands of 
insertional polymorphisms. Here we describe the identification, using next 
generation sequencing, of previously uncharacterized LTR (long terminal 
repeat) retrotransposon integrants in various mouse lineages. Integrant loci 
in divergent, wild mouse lineages such as MOLF/EiJ, CAST/EiJ and 
SPRET/EiJ are almost entirely different from those in laboratory mouse 
lines such as the C57BL/6J reference strain, suggesting independent, 
lineage-specific retrotransposition by ancestral master elements. In addition, 
we linked altered transcript structures and expression levels to nearby 
polymorphic LTR retrotransposon integrants in a variety of strains, tissues 
and developmental stages. The vast majority of genomic LTR 
polymorphisms appear to have little or no effect on neighboring genes’ 
transcripts. However, a small percentage of polymorphic LTR 
retrotransposons can initiate fusion transcripts, while others can terminate 
transcripts prematurely. We characterized expression of Slc15a2 (also 
called PEPT2), whose structure and function have been altered very 
strikingly by an intronic, polymorphic LTR retrotransposon integrant that 
can terminate its transcription at a distance. Substantially increased 
premature polyadenylation of Slc15a2 transcripts, triggered by the 
polymorphic LTR element, leads to dramatically reduced protein expression 
and significant functional consequences in affected mouse strains. Other 
candidate genes whose transcription may be terminated similarly by LTR 
polymorphisms are described. Thus endogenous mouse LTR 
retrotransposons can contribute to extensive genomic variation, leading in 
numerous cases to substantial alterations of nearby genes’ regulation, 
structure and function. The resulting phenotypic diversity may provide 
selective advantages for their hosts. 
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The contribution of balanced genomic rearrangements to common complex 
disorders remains unclear. Current genotyping methods preclude accurate 
detection of such changes and these events represent a complementary 
opportunity for determining causative pathways. We describe a series of 
experiments utilizing massively parallel paired-end (PE) sequencing to 
rapidly identify apparently balanced genomic rearrangements contributing 
to neurodevelopmental phenotypes. At the whole genome level we mapped 
balanced translocations, inversions, and other complex rearrangements 
using standard insert PE sequencing to 10X coverage on multiple lanes of 
an Illumina flow cell and large insert jumping libraries (3-8kb) on a single 
lane of a flow cell. In ongoing efforts to restrict genomic complexity, we 
used flow sorting to facilitate complete deep sequencing of derivative and 
normal chromosomes as well as a novel capture-seq approach to isolate 
chimeras and split reads in patients that have had rearrangement breakpoints 
narrowed to a finite region (less than 4 Mb). Our initial pilot experiment 
involves sequencing captured regions from ten cases pooled together on a 
single lane of an Illumina flow cell without the need for indexing. Notably, 
in addition to resolving genomic breakpoints to base pair resolution, our 
experiments have detected significant complexity at the breakpoint and 
from independent regions in the vicinity of breakpoints. Taken together, our 
experiments suggest that next-generation sequencing is a powerful tool to 
characterize these previously intractable sources of genomic variation and 
will enable detection of novel targets contributing to autism and other 
developmental disorders. 
 304 
HIF-1 CHIP-SEQ ANALYSIS OF CANCER CELL LINE DLD-1 
 
Kousuke Tanimoto1, Katsuya Tsuchihara2, Yutaka Suzuki1, Sumio Sugano1  
 
1the University of Tokyo, Department of Medical Genome Science, 5-1-5 
Kashiwanoha, Kashiwa, 277-8562, Japan, 2National Cancer Center Hospital 
East, Research Center for Innovative Oncology, 6-5-1 Kashiwanoha, 
Kashiwa, 277-8577, Japan 
 
Cancer cells in solid tumors are frequently lacking oxygen (hypoxia) 
because aberrantly growing cancer cells cause shortage of blood flow. 
Tumor cells adapt themselves to such hypoxic condition by regulating 
cellular responses. The central regulator of these responses is the 
transcription factor hypoxia-inducible factor 1 (HIF-1). In this study, we 
performed HIF-1α (oxygen-sensitive subunit of HIF-1) ChIP-Seq analysis 
to obtain the overview of HIF-1 target genes by using human colorectal 
cancer cell line DLD-1. We collected 4,134,678 sequence tags from the 
ChIP sample and 6,964,466 tags from the whole cell extract (WCE) sample. 
We selected binding sites as the regions having more than 60 bp continuous 
15-fold enrichment between the ChIP and WCE (whole cell extract). As a 
result, we identified 458 potential HIF-1α binding sites. Of these, HRE 
(Hypoxia Responsible Element) motif was observed in 95(21%) cases. In 
addition, we performed TSS (Transcription Start Site)-Seq analysis under 
hypoxia and normoxia to obtain the information about exact positions of 
transcription start sites. The TSS-tags were further clustered to generate 
TSS clusters (TSCs; Tsuchihara et.al. NAR 2009). In total, we generated 
19,213,284 tags and identified 1,428,455 TSCs under hypoxia. Of these, 
619 RefSeq gene TSCs were located from 10Kb upstream to 1Kb 
downstream of the HIF-1α binding sites which were identified by ChIP-
Seq. Also, we identified 297 intergenic TSCs which were located within the 
same distance from the identified HIF-1α bindig sites. Combination of the 
ChIP-Seq and TSS-Seq analyses should be a powerful approach to identify 
HIF-1α binding sites. 
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Comparative studies in nonhuman primates provide a unique and powerful 
perspective on human biology, disease and evolution. However, most 
primates lack the basic genomic sequence resources that are required for 
modern genetic and comparative genomic studies. The goal of our research 
project is to test efficacy of cross-species microarray-based genomic 
selection (MGS) and to then apply this methodology toward targeted 
population-based sequencing in a nonhuman primate model of HIV/AIDS. 
To evaluate the general cross-species capability of MGS, we are testing the 
ability of a human MGS array to capture ~500 -1000 kb segments near the 
CFTR locus in a 4 nonhuman primates that represent a range of sequence 
divergence levels of 1-10% from human. Preliminary studies completed to 
date have shown that the human probes can effectively enrich for the 
orthologous target regions in chimpanzees and orangutans. Enrichment of 
the target regions in the more divergent rhesus and marmoset are, however, 
greatly reduced. The results of ongoing detailed studies correlating the 
probe-target species divergence levels with along with additional 
experiments quantifying the efficiency of cross-species MGS will be 
presented. An overview of the second phase of our project which will 
involve the sequencing ~100 genes that are candidates for the benign versus 
pathogenic nature of SIV infection in two closely related Old World 
monkeys, the sooty mangabey and the rhesus macaque, will also be 
presented. In summary, we are investigating the utility of MGS as a method 
for simultaneously producing comparative and population-based sequence 
data from targeted regions in multiple species, and are applying this 
technology toward the identification of genetic factors that suppress the 
progression to AIDS in a natural nonhuman primate host of SIV. 
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Yeast respond to significant changes in their environment by activating 
massive alterations in their transcriptome. While different stresses stimulate 
transcriptional profiles that are unique in specific details, the broad strokes 
of the transcriptional responses are strikingly similar: about 300 genes 
(involved in all manner of cell defense and physiology) are reliably 
induced, and about 600 genes (mostly involved in RNA and protein 
synthesis) are reliably repressed. While this transcriptional response is very 
well characterized, the consequences for the proteome are still poorly 
understood.  
 
To improve our ability to appropriately interpret transcriptional data, this 
project simultaneously characterizes global changes in RNA and protein of 
a single population of Saccharomyces cereviciae, in response to osmotic 
stress (NaCl). Using time-course microarrays and quantitative, time-course 
proteomics, this experiment describes the coordinated temporal dynamics of 
both types of molecules. The data identifies different relationships between 
RNA and protein levels for subsets of genes, identifies candidate genes for 
phenomena such as acquired stress resistance and cellular memory, and 
provides evidence for a group of genes that are primarily regulated post-
transcriptionally.  
 307 
CUFFLINKS: TRANSCRIPT ASSEMBLY, ABUNDANCE 
ESTIMATION, AND DIFFERENTIAL EXPRESSION WITH RNA-SEQ 
 
Cole Trapnell1,2, Brian A Williams3, Geo Pertea1, Ali Mortazavi3, Gordon 
Kwan3, Marijke J van Baren4, Steven L Salzberg1, Barbara J Wold3, Lior 
Pachter2  
 
1University of Maryland, College Park, Center for Bioinformatics and 
Computational Biology, 3115 Biomolecular Sciences Building #296, 
College Park, MD, 20742, 2University of California, Berkeley, Department 
of Mathematics, Evans Hall, Berkeley, CA, 94720, 3California Institute of 
Technology, Division of Biology, 130 Kerckhoff, Pasadena, CA, 91125, 4 
Genome Sciences Center, Washington University, One Brookings Drive, St. 
Louis, WI, 63130 
 
High-throughput transcriptome sequencing has the potential to report the 
sequence and abundance of every RNA in a cell or tissue. This goal has not 
been fully realized due to computational and experimental challenges. We 
introduce a new transcript assembly algorithm coupled with a statistical 
model for RNA-Seq experiments that produces estimates of transcript 
abundances. Cufflinks constructs a parsimonious set of transcripts that 
"explain" the reads observed in an RNA-Seq experiment. Cufflinks 
implements a constructive proof of Dilworth's Theorem by constructing a 
covering relation on the read alignments, and finding a minimum path cover 
on the directed acyclic graph for the relation. Cufflinks uses a statistical 
model of paired-end sequencing experiments to compute a unique 
maximum likelihood set of abundances for transcripts in a sample. The 
package includes a tool, "Cuffdiff", which tests for statistically significant 
differential expression of genes and individual transcripts. Cuffdiff also 
tests for changes in relative abundance of transcripts within biologically 
relevant groups, such as those transcripts that share a common start site 
(TSS). By tracking relative changes within TSS groups, Cuffdiff can infer 
not only changes in expression, but changes in transcriptional and post-
transcriptional regulation. In a timeseries RNA-Seq experiment on 
differentiating myoblasts, Cufflinks assembled 13,689 and 3,724 known and 
novel transcripts, respectively, and detected differential splicing or 
promoter use in 330 genes (FDR < 5%). Cufflinks and its companion tools 
are available open source at http://cufflinks.cbcb.umd.edu 
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We are investigating genetic variation contributing to childhood cancer by 
sequencing probands with a family history suggestive of susceptibility to 
cancer. In each case the proband had cancer diagnosed in childhood and met 
one or more of these criteria, i)a second malignancy before the age of 30, 
ii)multiple members of a single family with a diagnosis of cancer before the 
age of 30,and iii)a developmental anomaly or significant developmental 
delay. An initial study using Sanger sequencing of 45 candidate cancer 
associated genes in genomic DNA from 48 families led to the discovery of 
pathogenic mutations in 14% of probands. To broaden the study,we are 
sequencing with whole exome capture and next generation sequencing 
methodologies to identify novel, cancer susceptibility loci. Our first kindred 
to undergo this analysis is a family predisposed to childhood lymphocytic 
leukemia/lymphoma with 4 affected individuals. The pattern of inheritance 
suggests autosomal dominant inheritance with incomplete penetrance. 
Genomic DNA was extracted from normal tissue of 3 affected and 1 non-
transmitting parent with subsequent sequencing of exons from the CCDS 
transcript sets (17,000 genes comprising 23 Mb of target). In total we 
obtained greater than 10X coverage of 80% of all targets via the SOLiD 
system of next-generation sequencing. The intersect of all three affected 
individuals results in 11,906 mutation sites,8% of which are novel sites. Of 
the novel variant sites,66% (n=629) were splice-site,missense or nonsense. 
We eliminated variants identified in the non-transmitting parent, reducing to 
180 the novel non-silent variants in affected probands. A systematic 
bioinformatic analysis is determining the severity of missense changes. We 
are validating these novel variants from this first level analysis in other 
existing families with lymphoid malignancies. 
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The most commonly used inbred laboratory rat strains have originated from 
limited founder populations which have been exclusively derived from 
Rattus norvegicus and the inherited genetic variation plays a crucial role in 
correlating genotype to phenotype. Here we report the re-sequencing of two 
commonly used inbred rat strains using paired-end (PE) technology on both 
Illumina and AB SOLiD platforms: FHH/Mcwi and SS/JrMcwi rats 
represent the parental founder strains of the consomic rat panel. These 
consomics serve as renewable animal resources and provide a valuable tool 
to generate and validate mapping data. For the PE sequencing on the 
Illumina platform, we used 2 different libraries with insert sizes of 150 bp 
and 1750 bp, respectively. For mate-pair sequencing on the SOLiD 
platform, we used a library of approx. 1600bp insert size. Both strains were 
sequenced to a minimum of 10-fold coverage. For subsequent analyses of 
the Illumina raw data we used the Illumina-Software-Package Pipeline 
1.4.0, CASAVA and GenomeStudio 2009. Overall we produced approx. 
60Gb post filtering with the Illumina platform. We also generated 1.3Gb of 
genomic sequence from 200 BACs for the SS, FHH and BN (reference 
strain originally sequenced) by capillary and 454 sequencing for select QTL 
regions.  
We compare the sequencing results with respect to alignment, assembly and 
accuracy for the different sequencing platforms in the QTLs of interest. We 
will also report SNPs, structural variants and copy number variants between 
the three rat strains. For example, in the FHH/Mcwi rat we identified some 
2.6 million SNPs compared to the BN reference sequence, of which 
899,000 are novel. Our data will guide the identification of the molecular 
variants underlying quantitative physiological traits that have been 
characterized in the FHH/SS/BN consomic panel and provide insight into 
how best to generate and assemble genomic regions of interest. 
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The differentiation of cells into distinct cell types is frequently driven by 
epigenetic mechanisms governed by regulators of transcription. White and 
opaque cells of the fungal pathogen Candida albicans are two such 
heritable cell types, each thought to be adapted to unique niches within their 
human host. While the transcriptional circuit of a master regulator of the 
switch between white and opaque cell types, White opaque regulator 1 
(Wor1), was previously described, several mysteries about this circuit 
remain. For example, it was unclear why so few genes bound by Wor1 are 
differentially expressed between the two cell types. Here we performed 
strand-specific massively-parallel ligation sequencing of RNA from C. 
albicans white and opaque cells. Combining the resulting data from both 
cell types, we first substantially re-annotated the C. albicans transcriptome, 
finding 1422 novel coding and non-coding transcriptionally active regions 
(nTARs). We then compared the new annotation to genomic regions bound 
by Wor1, finding that the revised transcriptional landscape substantially 
alters our understanding of the circuit controlling white-opaque switching. 
Helping to explain the improved concordance between binding and 
differential expression, we find that 36% of bound and differentially 
expressed transcripts were previously undiscovered, including transcripts 
antisense to ORF-encoding transcripts and others that are entirely isolated. 
Interestingly, 17 of the novel opaque-specific transcripts cluster in three 
genomic locations and encode short ORFs with homologs found only in the 
two species known to undergo white-opaque switching. Taken together, the 
results presented here greatly enhance our understanding of the circuit that 
differentiates these two cell types, a circuit bearing many similarities to the 
circuit that specifies the pluripotency of embryonic stem cells. 
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Continued emergence of highly pathogenic viral agents (e.g., West Nile 
Virus) that infect large numbers of individuals across broad geographic 
regions has driven the need to discover and more fully characterize the 
genomes of viruses present in the environment over time. While different 
viruses fluxing through the environment vary with respect to overall rates of 
infection and the severity of health and financial complications they induce, 
understanding the real-time geographic distributions of these pathogens 
would lead to significant public health benefit by enabling government 
agencies to better discover and contain infectious disease, providing 
advanced notification to at-risk populations; and providing advanced 
warning to healthcare providers and drug manufacturers of the increased 
risk so they may mobilize appropriate resources. With the advent of second 
generation sequencing technologies, it is possible to sequence DNA and 
RNA isolated from environmental swabs taken in areas at high risk of 
infection to identify the pathogens responsible. However, increasing cost-
per-run and time-to-result create challenges for these applications. Unlike 
the major second generation sequence by synthesis technologies, single 
molecule real time (SMRT™) sequencing exploits the high catalytic rates 
and processivity of DNA polymerase to radically increase the rate of 
synthesis (1–3 bases/second) and read length (from tens to thousands of 
bases/read). It is now possible to not only rapidly sequence the genomes of 
many viruses simultaneously at high fold coverage to identify the entire 
complement of viruses present in a DNA sample, but also to assess variants 
in the genomes found. SMRT Sequencing technology now makes it possible 
to sequence pathogens of public health concern from environmental 
samples at high coverage for under $99 in 15 minutes. We demonstrate the 
feasibility of SMRT sequencing for use in widespread disease monitoring 
through a pilot study. We collected and sequenced environmental swabs 
from a selection of sources including airports, rapid transit systems, fitness 
centers, and sewage treatment plants over a period of time. Samples were 
enriched for likely pathogens by amplification with primers selected from 
conserved regions of viral pathogens. The results and analysis will be 
presented with emphasis on the feasibility of a disease weather map based 
on molecular analysis of environmental exposures to disease. Please wash 
your hands before attending this talk. 
 312 
ORIGINS AND EVOLUTION OF SULFADOXINE RESISTANCE IN 
HUMAN MALARIA PARASITE, PLASMODIUM FALCIPARUM 
 
Sumiti Vinayak1,2, Md Tauqeer Alam1, Kanungnit Congpuong3, Chansuda 
Wongsrichanalai4, Laurence Slutsker1, Ananias A Escalante5, John W 
Barnwell1, Venkatachalam Udhayakumar1  
 
1Centers for Disease Control and Prevention, Malaria Branch, Division of 
Parasitic Diseases, 4770 Buford Highway, Atlanta, GA, 30341, 2Atlanta 
Research and Education Foundation, VA Medical Center, 1670 Clairmont 
Road, Decatur, GA, 30033, 3Ministry of Public Health, Laboratory 
Reference Center, Bureau of Vector Borne Diseases, Nonthaburi, 11000, 
Thailand, 4 Independent Scholar, 130, Sub Street, Bangkok, 10500, 
Thailand, 5Arizona State University, School of Life Sciences, PO Box 
874501, Tempe, AZ, 85287 
 
Gene flow has played an important role in the intercontinental spread of 
drug resistant Plasmodium falciparum malaria. Using microsatellite data 
flanking pfcrt (determinant for chloroquine resistance) and dhfr 
(determinant for pyrimethamine resistance), it has been shown that 
resistance to chloroquine and pyrimethamine originated at least four times 
globally, with one origin in the Thailand-Cambodia region of Southeast 
Asia. It was further shown that chloroquine and pyrimethamine resistant 
alleles spread from Southeast Asia to Africa. However, the global origins 
and evolution of sulfadoxine resistance in P. falciparum are not known. In 
this study, we characterized dhps genotypes (determinant for sulfadoxine 
resistance) and its flanking microsatellites in a large number of singly-
infected P. falciparum isolates from Thailand-Cambodia region to: (i) 
reveal the origin(s) of sulfadoxine resistance; and (ii) acquire evidence of 
selection operating on this gene. We also wanted to know if sulfadoxine-
resistant alleles in Southeast Asia have any relationship with African and 
South American dhps alleles. Our results show that resistant dhps alleles, 
especially those with 3 mutations, are fixed in the Thailand-Cambodia 
region, with strong evidence of selection, consistent with the extensive use 
of sulfadoxine-pyrimethamine in the past in this region. The most common 
resistant alleles were AGEAA, SGEGA, and SGNGA (amino acids at 
codons 436, 437, 540, 581 and 613; mutated codons are underlined). We 
provide evidence for at least two independent origins for the triple mutants 
in Thailand-Cambodia region, one for both, SGEGA/SGNGA and another 
for AGEAA, with neither sharing any evolutionary relationships with the 
alleles prevalent in Africa and South America. Thus, unlike CQ and 
pyrimethamine-resistance, sulfadoxine-resistance in Southeast Asia has 
more than one origin and, there is no evidence of intercontinental spread of 
sulfadoxine-resistant dhps alleles from Southeast Asia to Africa. 
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Transforming growth factor-beta (TGF-beta) controls many complex behaviors 
of normal and transformed cells. In early stage adenomas TGF-beta acts as a 
tumor suppressor, whereas in advanced carcinomas it promotes tumor cell 
invasiveness and metastasis. HepG2 cells provide a good model for advanced 
tumor cells. RNA sequencing (RNA-Seq) can provide a detailed view of the 
dynamic transcriptional landscape of cells experiencing environmental 
perturbation and was therefore applied here to study TGF-beta response. We 
serum starved HepG2 cells for 24 hours and then treated for 1 hour with 2 ng/ml 
TGF-beta1 or with vehicle control. Total RNA was isolated, depleted of rRNA, 
fragmented and then used to create strand-specific cDNA libraries with the 
SOLiD™ Small RNA Expression Kit. Approximately one billion 50 bp reads 
were sequenced with the SOLiD™ System, over half of which could be 
uniquely aligned to the human genome. The aligned transcriptomes cover 
roughly 4% of each strand of the genome and more than half of the reads align 
within known transcribed regions. The expression level of each gene was 
defined and hundreds of genes were determined to be differentially expressed 
between the two conditions. The 50 bp length of the sequenced fragments 
permitted us to accurately align reads to splice junctions. In all, ~5 million reads 
aligned to ~90,000 known and putative splice junctions in both the control and 
stimulated conditions, which allowed us to determine the effects of TGF-beta 
on alternative splicing in fine detail. By genotyping we identified over 300,000 
heterozygous SNP positions, which we employed to examine allele-specific 
gene expression. We observed many differences in the balance of expressed 
alleles between TGF-beta treated and untreated cells, which could be explained 
by linked SNPs in cis-regulatory elements. We are now comparing these results 
to ChIP-Seq data gathered under the same conditions to understand the 
relationship between allele-specific binding of transcriptional regulators and 
allele-specific expression of nearby genes. Furthermore, we have determined 
positions of nucleosome and critical histone modifications to see how they are 
related to the transcriptional output. 
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Analyses of sequencing data enable the discovery of a greater 
diversity of structural variants (SV) than is possible on microarrays, 
including novel insertions and inversions, as well as deletions and 
duplications. The presence of an SV can reveal itself through one or 
more of the following signatures: anomalous spacing and/or orientation 
of read-pairs, discrepant read-depth and split-reads. With sufficient 
sequencing coverage, the precise breakpoints of the SV can be reliably 
assembled. However, in order to assess the functional impact of SVs 
using genetics, it is necessary not only to discover SVs but also to 
genotype individuals for those SVs. The most efficient design is to 
spread the available sequencing resources across as many individuals 
as possible while generating sufficient data in each individual to 
allow genotypes to be robustly estimated. 
 
We have developed a probabilistic genotyping model that makes 
efficient use of information in the data by integrating read-pair, 
read-depth and split-read information to estimate genotype likelihoods 
for SVs. This approach is, in principle, applicable to all types of 
structural variation. These likelihoods can be further refined by 
incorporating SNP genotype information on the same individuals and 
imputing haplotypes. To demonstrate our approach we have focussed on 
genotyping large deletions (> 50bp) from the pilot phase of the 1000 
Genomes Project where 180 samples were sequenced at low-coverage 
(2-4X). We compared the resultant SV genotypes to published 
array-based genotypes for the same variants in the same samples and 
show high concordance indicating these genotypes are of high 
quality. Our genotyping approach, in combination with SV discovery and 
breakpoint assembly, promises to enable genetic study of structural 
variation across the full range of sizes and classes of SVs. 
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A determined genome sequence is the basis that will facilitate studies in the 
species and related creatures. In addition, comparison in between genomes 
could reveal interesting relationship and biological stories, which help 
understanding the evolution of life. Previous studies are generally restricted 
by funding or technical feasibility, yet recent advances in sequencing 
technology and bioinformatics analytical tools have unblocked the 
difficulties and demonstrated the possibility to decipher new genomes at an 
affordable cost. With the effort of collaborators, we have initiated a large-
scale project that aims to determine the genome sequences of 1,000 plants 
and animals. Over 20 genomes were already deciphered, with scores in 
production. Here we report the analysis results of recently completed the 
genome assemblies of polar bear, penguin as well as soybean and potato 
that are important for agriculture. By de novo assembly of new generation 
sequencing reads, the assemblies achieved high quality and displayed 
interesting biological points. The project is rapidly in progress and we 
believe it will significantly benefit the scientific community as an abundant 
public repository in future. 
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Genome-wide association studies (GWAS) have been successful in 
identifying disease susceptibility loci, but it remains a challenge to pinpoint 
the causal variants in subsequent fine-mapping studies. A conventional fine-
mapping effort starts by sequencing dozens of randomly selected samples at 
susceptibility loci to discover candidate variants, which are then placed on 
custom arrays or used in imputation algorithms to find the causal variants. 
We propose that one or several rare or low-frequency causal variants can 
hitchhike the same common tag SNP, so causal variants may not be easily 
unveiled by conventional fine-mapping efforts. Here, we first demonstrate 
that the true effect size and proportion of variance explained by a collection 
of rare causal variants can be severely underestimated by a common tag 
SNP, thereby accounting for some of the “missing heritability” in GWAS. 
We next describe a case-selection approach based on phasing long-range 
haplotypes and sequencing cases predicted to harbor causal variants. We 
compared this approach with conventional strategies on a simulated dataset, 
and demonstrated its advantages when multiple causal variants are present. 
We also evaluated this approach in a GWAS on hearing loss, where the 
most common causal variant has a minor allele frequency (MAF) of 1.3% in 
the general population and 8.2% in 329 cases. With our case-selection 
approach, it is present in 88% of the 32 selected cases (MAF=66%), so 
sequencing a subset of these cases can readily reveal the causal allele. Our 
results suggest that thinking beyond common variants is essential to 
interpret GWAS signals and identify causal variants 
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Whole transcriptome shotgun sequencing (RNA-seq) provides massive and 
invaluable information about the functional elements transcribed from the 
genome, such as (allele specific) gene expression, alternative splicing, novel 
transcribed regions, aberrant transcripts such as gene fusions, etc. However, 
one of the biggest challenges is to bridge the knowledge gap between our 
ability to generate these massive RNA-seq data and to interpret them. For 
instance, people have to deal with long transcript bias, large variation 
between replicates when profiling gene expression, and people also have to 
consider gene families, pseudo genes, and other paralog elements when 
using pair-end RNA-seq data to detect gene fusions. Here to overcome 
these obstacles and make use of the “gold mine” of RNA-seq data, we 
developed a RNA-seq analysis package (RAP). RAP is implemented in 
Python and Perl; it also incorporates several public available tools including 
samTools, BedTools and various R packages. 
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Rare functional variants in nuclear genes can lead to secondary mtDNA 
defects that present with clinically similar or different disease phenotypes. 
Here we analyzed thirty-nine candidate genes for disorders of mtDNA 
maintenance in forty medical cases and controls (4.3Mb) using a 
customized Affymetrix resequencing array. To identify DNA variants in 
each case with a minimal number of false discoveries, we performed single 
and multi-array data analysis that accounts for technical variables and the 
possibility of both low and high frequency genomic variation. Our 
Sequence Robust Multi-Array analysis (SRMA) in comparison to 
traditional Sanger sequencing achieved a false discovery rate of 2% (false 
negative rate 5%). In addition to mutations confirmed in positive control 
cases in the mitochondrial DNA polymerase gamma (POLG), we detected 
novel functional variants in multiple cases in the mitochondrial 
topoisomerase 1 gene (TOP1MT), the human homolog of E.coli mutY 
mismatch repair gene (MUTYH), and the apurinic-apyrimidinic 
endonuclease 2 (APEX2). Several cases carried rare heterozygous variants 
in multiple genes, which might indicate synergistic genetic effects in similar 
diseases. In summary, our optimized statistical methods increase the 
accuracy of identifying rare DNA variants and reduce the resequencing 
costs. This is particularly useful when studying sporadic cases and small 
families in which linkage cannot be established.  
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Interspecific hybrids provide an excellent opportunity to study the effects of 
a profound but well-defined and replicable genome-wide perturbation. The 
successful function of interspecific hybrids is a testament to the robustness 
of many biological processes, and is surprising given the profound 
dysregulation at the transcriptional level (at least in Drosophila). Here we 
focus on classical mammalian interspecific hybrids resulting from 
reciprocal crosses between horse and donkey. The mule is the product of a 
male donkey mated to a female horse, while a hinny is produced by the 
mating of a stallion horse with a female donkey. The wide disparities in 
function of mules and hinnies despite their identical genomes poses an 
interesting challenge for functional genomics.  
 
To obtain a quantitative genome-wide picture of the degree of dysregulation 
in these mammal hybrids, we did RNA-seq of invasive trophoblast cells 
(chorionic girdle) from horse, donkey and their reciprocal F1 hybrid 
progeny using Illumina technology. This tissue was chosen because it 
represents a focal point of interaction between the mother and fetus in the 
developing placenta. A total of 11.37 Gb of sequences were obtained from 
the four types of animal, and 70% of them were uniquely mapped to the 
horse RefSeq database, and they cover more than 12000 RefSeq genes in 
the two parents and reciprocal F1 hybrids. Total expression level for every 
gene in the trophoblast transcriptome was quantified by the normalized 
number of mapped reads. The expression profile of both mule and hinny 
placenta strongly resemble the horse (correlation coefficient 0.906 and 
0.967) more than the donkey (0.810 and 0.857). Whole genome Agilent 
expression microarray confirmed this finding. In addition, we found many 
instances of genes whose expression level in mule and hinny was outside 
the range of the parental horse and donkey.  
 
With the novel SNPs we discovered between horse and donkey, we have 
been able for the first time to quantify the allelic imbalance in these F1 
hybrid mammals. Our data provide a detailed quantitative assessment of the 
dysregulation of gene expression in interspecific hybrids, and identify many 
instances of cis-acting SNPs that drive the species-specific imbalance. 
Whole biological pathways generally express alleles from both species, but 
significant skews in horse vs. donkey allelic expression are rampant.  
 320 
RECURRING HUMAN LEUKEMIA MUTATIONS DISCOVERED BY 
SEQUENCING A MOUSE ACUTE PROMYELOCYTIC LEUKEMIA 
(APL) GENOME  
 
Lukas D. Wartman, MD1, David E. Larson, PhD2, Li Ding, PhD2, Ken Chen, PhD2, Zhifu 
Xiang, MD, PhD1, John S. Welch, MD, PhD1, Patrick Cahan, PhD1, Jacqueline E Payton, 
MD, PhD3, Michael D. McLellan, BS2, Heather Schmidt, BS2, Ling Lin, MS2, Robert S. 
Fulton, MS2, Rachel M. Abbott, BS2, Lisa Cook, AA2, Sean D. McGrath, MS2, Xian Fan, 
MS2, Adam F. Dukes, BA2, Tamara L. Lamprecht, BS1, Michael H. Tomasson, MD1, 
Elaine R. Mardis, PhD2, Richard K. Wilson, PhD2 and Timothy J. Ley, MD1 
1Depts. of Internal Medicine and Genetics, Div. of Oncology, Stem Cell Biology Section, 
Washington University School of Medicine, Siteman Cancer Center, St. Louis, MO, 2 
Genome Center, Washington University School of Medicine, St. Louis, MO, 3Dept. of 
Pathology and Immunology, Washington University, St Louis, MO. 
 
Acute promyelocytic leukemia (APL, FAB M3 AML) is a subtype of AML characterized 
by the t(15;17)(q22;q11.2) translocation that creates a fusion oncogene, PML-RARA. We 
previously targeted a human PML-RARA cDNA to the 5’ untranslated region of the 
mouse cathepsin G gene (mCG-PR) in a 129/SvJ derived ES line. F1 129/SvJ x C57Bl/6 
mice were subsequently backcrossed onto the B6/Taconic background for 10 generations. 
About 60% of the mCG-PR mice in the B6 background develop a disease that closely 
resembles APL after a latent period of 7-18 months, suggesting that additional 
progression mutations are required for APL development. To identify these progression 
events, we sequenced a cytogenetically normal mouse APL genome on the Illumina 
platform. We created 2 Illumina paired-end libraries (insert sizes of 300-350 bp and 550-
600 bp) and generated 59.64 billion base pairs of sequence with 3 full sequencing runs; 
mapped reads generated 15.6x haploid coverage. We detected 87,778 heterozygous 
Single Nucleotide Variants (SNVs) and 23,439 homozygous SNVs compared to the 
mouse C57Bl6/J reference sequence. Of the predicted heterozygous SNVs, 695 were 
non-synonymous (missense, nonsense, or altering a canonical splice site). Next, the 
129/SvJ genome was sequenced using the same approach (13.997x haploid coverage). 
After filtering out the SNVs present in the 129/SvJ genome, 392 putative somatic SNVs 
remained. 361 were not analyzed further because they occurred in contiguous blocks, 
suggesting that they were inherited. Of the remaining 31, 23 were false positives. 9 were 
tumor-specific, and by deep readcount analysis, present in virtually all tumor cells. Six of 
the 9 mutations were non-synonymous, and were screened for recurrence in 89 additional 
murine APL tumor samples. Validated mutations in the Jarid2 (L915I) and Capns2 
(N149S) genes occurred only in the proband. Four mutations were found in additional 
samples; 3 of these were derived from a common ancestor, and are therefore inherited, 
not somatic. The other recurring mutation was in the pseudokinase domain of JAK1 
(V657F), and was identified in 6 additional mice that were not closely related to the 
proband. This mutation is orthologous to the known activating mutation V617F in human 
JAK2, and is identical to a recently described JAK1 pseudokinase domain mutation 
(V658F) found in human APL and T-ALL samples (EG Jeong et al, Clin Can Res 14: 
3716, 2008).  We proved that this mutation cooperates with PML-RARA by expressing 
human Jak1 cDNAs (via retroviral transduction) in the bone marrow cells of young WT 
vs. mCG-PR mice.  9/10 mice transplanted with mCG-PR bone marrow transduced with 
the V658F JAK1 retrovirus developed a fatal myeloproliferative disease with a mean 
latency of 34 days (range 28-52 days), whereas the JAK1 WT or control viruses did not 
cause a phenotype; the mutant JAK1 virus did not cause disease in WT marrow cells.  
Finally, structural variation analysis of the genome from this cytogenetically-normal 
tumor revealed a somatic 150kb deletion involving the Kdm6A gene.  Kdm6A/Utx, a 
histone H3K27 demethylase, has recently been shown to be deleted in 2 human AML cell 
lines (G van Haaften et al, Nat Gen 41: 5, 2009).   3/14 addition mouse APL samples 
screened also had somatic deletions of Kdm6A/Utx that reduced its expression.  In 
summary, unbiased whole genome sequencing of a mouse APL genome has identified 
recurring mutations in Jak1 and Kdm6A/Utx in both human and mouse AML samples.
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Genome-wide pervasive transcription has been reported in many eukaryotic 
organisms, revealing a highly interleaved transcriptome organization that 
involves hundreds of non-coding RNAs. We have provided a complete 
transcriptome architecture including SUTs (Stable Unannotated Transcripts) 
and CUTs (Cryptic Unstable Transcripts) in yeast by profiling the 
transcriptome in multiple conditions, a mutant of the exosome machinery 
and different strain backgrounds. We have shown that most of non-coding 
RNAs (SUTs and CUTs) initiate from nucleosome-free regions (NFRs) 
associated with the promoters of other transcripts. We are now investigating 
the functional consequences of bidirectional promoters. When a non-coding 
RNA shares a bidirectional promoter with an ORF transcript and overlaps 
another ORF on the opposite strand, the possibility exists for spreading of 
regulatory signals from one ORF to the next. Our data provides preliminary 
evidence to suggest that non-coding RNAs may provide a mechanism for 
local spreading of regulatory signals. 
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Parent-of-origin effects (POE) refer to a genetic phenomenon where 
maternally and paternally-derived alleles differentially contribute to 
phenotypic variance. While the etiologic relevance for POE to several 
human disorders is well-established, less is known about POE in the context 
of systematic gene expression regulation. To this end, we conducted a 
transcriptome-wide survey of POE in human cell lines. 
 
We analyzed 865 transcripts and 968 autosomal linkage markers in 
lymphoblastoid cell lines derived from 15 CEPH families. Using MERLIN, 
we calculated identity-by-descent scores separately for maternal and 
paternal alleles and regressed these on transcript levels. This POE linkage 
test requires the simultaneous presence of imprinting effects and allele-
specific effects on gene expression levels. We used a logarithm of the odds 
score of 3.3 (two-sided p<9.8e-5) as threshold for genome-wide statistical 
significance per transcript. At this level, we expect 5% (N=43) of our 865 
transcripts to reach this threshold by chance alone. 
 
We observed N=151 transcripts whose expression levels were significantly 
linked to at least one maternally-derived locus, and N=213 transcripts 
linked to at least one paternal locus. In contrast, when using a joint model 
not accounting for POE, N=158 transcripts reached genome-wide 
significance. Thus, POE are common and approximately equally distributed 
between maternal and paternal inheritance models. Two transcripts showed 
particularly strong linkage to maternal loci: CDK12 on 17q12 (best marker 
rs1033348 on 8q21.3, p=7.5e-9) and KDM3A on 2p11.2 (D11S533, 
11q13.5, p=2.32e-8). Further, we identified several hotspot regions in the 
genome enriched for POE transcripts as well as a transcription factor 
binding motif (PBX1) that was highly enriched in the promoters of POE 
transcripts. Our results suggest that POE are a widespread, significant 
regulatory mechanism of gene expression. Additional studies in 
untransformed cell lines or tissues and biological studies now appear 
warranted. 
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Some high-throughput sequencing experiments are designed find 
boundaries between two sequence elements. The sequencing results are thus 
expected to contain “hybrid” reads which will be derived partly from the 
reference sequences and partly from another type of sequence, and the 
sequence boundaries are unknown in advance. 
 
A few different protocols produce such hybrid reads:  
— to find all retroviral or transposon insertions in a genome, one would 
look for sequencing reads that have a genomic segment fused to the inserted 
sequence. 
 
— sequences, such as miRNAs, are too short to span the entire length of a 
read and thus contain adaptor sequences on one or both ends. If the adaptor 
placement were always identical, it could be trimmed quite easily, but the 
miRNAs are of varying lengths, so the adaptor sequence can take up a 
variable amount of each read.  
 
— excessive (accidental) shearing causes fragments to be shorter than 
expected so that the sequencing reads run into the adaptors. 
 
In each of these cases, a short read aligner will not be able to align the 
hybrid sequences, as the index structures for these programs are typically 
optimized to align a known length of the read instead of dynamically 
deciding where boundaries could be. One solution is to first align all 
sequencing reads to the genome that was sequenced, and then take 
everything that did not align and examine those reads more closely for the 
presence of extraneous sequences. Depending on how many reads did not 
align and the number and types of errors allowed, this could be a lengthy 
process. 
 
We have developed a straightforward algorithm, using modifications to the 
Biostrings functions in R, that trims sequences from either or both ends of a 
sequencing read, allowing for a preset number of errors and indels on either 
side, based on a set of potentially contaminating sequences provided by the 
user. Comparisons made on several datasets suggest that this is both faster 
and more sensitive than the two-stage approach that we and others have 
used to date. 
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Hepatocellular carcinoma (HCC) is a global healthcare phenomenon, with 
1,000,000 new cases diagnosed annually and local incidences as high as 120 
cases per 100,000. It is the fifth most common solid tumor worldwide, and 
fourth leading cause of cancer-related death. While HCC is seen in the 
United States much less frequently than in developing countries, incidence 
has risen sharply with increased rates of Hepatitis C viral infection. Surgical 
resection or liver transplantation, the only potentially curative modalities, is 
an option in only a small fraction of patients. HCC is also of special interest 
due to the known roles of hepatitis B and C viruses in malignancy. To date 
we have collected 52 HBV, 35 HCV and 6 non-viral HCC patients. Initial 
sequencing of 28 candidate cancer genes known to be associated with HCC 
revealed significantly different mutation profiles in HBV and HCV-
associated cancers. TP53 and WNT pathway genes are more highly mutated 
in HBV than in HCV, in parallel with published results in studies with 
limited sets of candidate genes. Using targeted DNA capture, based on the 
Consensus Coding Sequence, we are sequencing whole exomes in these 
same patients. This will afford an unprecedented view of the mutational 
landscape obtained by sequencing in >17,000 genes (23 Mb) in HCC and 
provide new insights into pathways leading to cancers of viral etiology. 
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We have studied a systemic lupus erythematosus (SLE)-related disease 
complex in the canine breed Nova Scotia duck tolling retriever that 
comprises two different types. The first, which mostly resembles human 
SLE-related diseases, involves chronic musculoskeletal signs and pain from 
joints. The dogs often display antinuclear antibodies. The other variant is 
steroid-responsive meningitis-arteritis.  
Genome-wide association mapping identified five loci for the disease 
complex (Wilbe et al. Nature Genet 2010). Three of our associated regions 
contain genes involved in T-cell activation through the nuclear factor of 
activated T cells (NF-AT) pathway (PPP3CA, HOMER2, DAPP1 and 
PTPN3), which might be a novel SLE-pathway. We also identified BANK1 
as a strong candidate gene. 
To identify candidate mutations, re-sequencing of candidate regions was 
performed. 10 dogs were selected for hybridization of 3.2 Mb of sequence. 
Percentage on target reads ranged between 79-98% and the average 
coverage was 67x. SNP, indel and copy number variant calling was 
performed and ~ 3,000 SNPs were identified. Candidate mutations will be 
identified by searching in coding and non-coding conserved regions and 
then further validated in more dogs. 
Finding new causative variants will give better diagnostic methods for dogs 
and enhance our understanding of SLE for both canine and humans.  
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Libraries of large-insert clones are key requisites of traditional Sanger-
based whole-genome shotgun sequencing projects. For example, end 
sequencing of Fosmid libraries with forward and reverse primers generates 
read pairs spanning ~40 kb in the genome that provide long-range 
contiguity of sequence assemblies.  
 
To generate next-generation ~40 kb read-pairs, we modified the pFOS1 
cloning vector such that the cloning site is flanked by Illumina sequencing 
primer sequences and two Nb.BbvC1 nicking endonuclease sites. Using this 
vector we constructed Fosmid libraries that can be paired-end sequenced by 
Illumina (Fosill). Primary Fosill libraries were amplified by overnight 
liquid culture and maxi-prepped. To bring the ends of the cloned fragments 
together on short sequenceable PCR amplicons, we nicked the Nb.BbvC1 
sites, translated the nicks a few hundred bp into the cloned inserts and 
cleaved there by digestion with nuclease S1. After re-circularization and 
inverse PCR out of the vector using Illumina PE enrichment primers we 
sequenced the thus converted Fosill libraries by Illumina.  
 
Paired end sequencing reads for E. coli and R. sphaeroides had the gap-size 
distribution expected for Fosmid end sequences and a low rate of chimerism 
(~2%). The general approach of converting plasmid libraries into "jumping" 
libraries is an alternative to constructing mate-pair libraries by in vitro 
circularization of size-selected genomic DNA fragments. Since in vitro 
jumping libraries are not amplified until the very end, any prior loss of 
DNA reduces the complexity of the library. In contrast, for Fosill cloning, 
large DNA fragments are packaged and size-selected in bacteriophage 
lambda, circularized and amplified in vivo. Once amplified, any subsequent 
loss of DNA has little effect on library complexity.  
 
Our Fosill approach for generating read pairs spanning ~40 kb will be 
useful for de novo next-generation sequencing of complex genomes as well 
as for detecting chromosomal structural rearrangements such as 
translocations or inversions.  
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Male mutation bias theory predicts that the mutation rate in males is often higher 
than in females because male gametes, sperm, undergo significantly more rounds of 
replication than female gametes, eggs. Although observed in mammals, birds, fish, 
and even plants, estimates of the magnitude of male mutation bias vary substantially 
across species. There are two explanations for this. First, many genomic factors (e.g. 
repetitive elements, GC content, recombination rate) influence mutation rates 
regionally across the genome and, when not accounted for, can skew estimates of 
male mutation bias. Second, variations observed across species may be influenced 
by differences in life history traits, specifically metabolic rate, sexual selection, and 
generation time. Male mutation bias is expected to be influenced by metabolic rate 
because sperm not only live in a more reactive oxygen species rich environment, 
they are also more susceptible to mutations through oxidative stress than eggs. Male 
mutation bias might become elevated with stronger post-copulatory sexual selection; 
males in species where sperm from multiple males compete to fertilize eggs produce 
more sperm, potentially at the expense of a higher mutation rate, than males in 
species without competition. Additionally, species with shorter generation times 
might experience less male mutation bias because their sperm undergo fewer rounds 
of replication before conception.  
 
Few studies have examined the factors that influence variation in the magnitude of 
male mutation bias across multiple species using more than a subset of any genome. 
Utilizing the 32 eutherian mammal genome sequences we are able to investigate 
male mutation bias on a genome-wide scale across mammalian taxa with diverse life 
history traits. We ask which life history traits affect the magnitude of male mutation 
bias observed in mammals. To answer this question we collected literature on life 
history traits for all 32 mammals, filtered whole-genome alignments of factors 
known to influence substitution rates regionally, and computed global and context-
dependent substitution rates. Then, after accounting for phylogenetic dependence, 
we developed a model to describe how variations in life history traits affect 
variations in the magnitude of male mutation bias. We found that representatives of 
three major life history traits (metabolic rate, generation time, and sexual selection) 
all affect the magnitude of male mutation bias, explaining at least 70% of the 
variation observed across these diverse mammals. Our results corroborate and 
expand upon previous research, and suggest the significant influence of life history 
traits on genome evolution. 
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Much of the human genome exists in the nucleus as DNA wrapped around 
histones to form nucleosomes which are further compacted into higher-
order structure. However, in any given cell line, certain stretches are more 
loosely arranged and accessible to binding factors. DNase Hypersensitivity 
(DHS) can be exploited to reveal these “open chromatin” and identify 
functional elements that are actively involved in transcriptional regulation – 
such as promoters, enhancers, insulators, suppressors, and locus control 
regions. From the results of our genome-wide assay, known as DNase-seq, 
we are able to study the locations of open sites with respect to the nearest 
gene. Moreover, using microarray data, we can compare the prevalence of 
DHS sites across different cell-lines with their expression values. We 
observe some genes where the DHS signal at the promoter increases with 
expression as expected; while other promoters are open in all cell-lines 
regardless of expression. In these cases, control of transcription appears to 
be more complex, suggesting the participation of additional binding factors 
and/or distal elements. We further analyzed these regions in the context of 
transcription start site (TSS) usage. These alternate gene architectures may 
reflect different methods of transcriptional regulation. 
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Development of the millichip provides researchers with a straightforward, 
economical method for monitoring the transcription of the entire genome of 
simple organisms under varying sets of conditions. The millichip is a 1 mm2 
glass chip containing up to 4489 unique 70mers on its surface with the 
ability to be hybridized with 5 μL solutions. These millichips are fabricated 
using the maskless array synthesizer developed in the Sussman lab and later 
commercialized by NimbleGen Systems, Inc. An array of covalently 
attached oligonucleotides is synthesized in situ on a pre-scored glass 
microscope slide. The surface of the glass on which the oligonucleotides are 
attached is then subdivided along the pre-scored grid into 62 separate chips, 
each ~1 mm2 and 1 mm thick. These millichips can then be placed in 
microfuge tubes and used for hybridization to fluorescently labeled RNA. 
The fluorescence intensity of the 16 μm sized fluorescent features is then 
determined by measurement under a fluorescent microscope and quantified 
with software developed in our lab. The advantages of this approach 
include: (1) Each millichip costs ~1% of the typical DNA chip (~$10) so 
that many more experiments can be performed. Each millichip currently 
contains 4489 70mers, but additional improvements to the technology will 
increase this number dramatically. (2) The hybridization is done in the 
bottom of a microfuge tube, rather than in larger volume flatbed chambers, 
minimizing the amount of reagents. (3) The entire procedure can be 
performed at the bench top, rather than at a core facility. The goal of this 
work is to create a method for performing whole genome transcriptome 
analysis at the price and ease of an agarose gel, to allow scientists to more 
readily explore the full spectrum of changes in RNA expression that occur 
in biological systems. The millichip is being utilized to compare 
transcription levels of protein kinases in Arabidopsis thaliana grown under 
varying conditions. The ability to perform numerous chip experiments at a 
low cost allows for the comparison of hundreds of combinations of growth 
conditions, whereas previously only one or two changes have been 
evaluated in a single experiment.  
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The recent advances in sequencing technologies have allowed large 
amounts of additional sequence data to be generated for relatively little cost 
to improve existing genome assemblies. Extracting information from these 
data for good genome assembly requires meticulous and effective 
methodologies and tools. We present a tool, Atlas-Link, that can produce a 
de novo scaffold structure, or upgrade an existing scaffold structure of a 
draft assembly using mate pair sequencing data.  
 
The Atlas-Link software implements a greedy algorithm and uses graph 
theory to link and orient assembled existing contigs quickly and accurately 
using mapped mate pair information and an AGP file describing the contig 
locations in the existing assembly. Atlas-Link can also be applied to an 
ACE file from an assembler. The program has versatile and flexible features 
that provide users freedom to tune to different data. The algorithms 
associated with Atlas-Link are designed for high sequence coverage. But, 
based on simulated and benchmark data analyses, Atlas-Link achieves 
highly accurate and continuous scaffold structures representing the actual 
genome from both high and low coverage sequencing data. This new 
module of the Atlas assembly suite has been applied and significantly 
improved the previously released draft genome assemblies of the Tammar 
wallaby, the sea urchin and the honeybee using SOLiD and/or 454 
sequencing data. 
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High-throughput next-generation sequencing technology enables detection 
of DNA copy number variations (CNVs) with higher accuracy than 
microarray based approaches. The 1000 Genomes Poject Pilot 3 capture 
sequencing data targeted more than eight thousand exon regions of the 
human genome, in nearly 697 individual samples from 7 populations. We 
developed computational and statistical methods for CNV detection that can 
deal effectively with the high-level of inherent sequence coverage 
fluctuation usually seen in capture sequencing data. 
 
As the primary measured quantity, our method utilizes the number of reads 
mapped to a given capture target region within a given individual. The 
expected read count is modeled as a linear function of the overall read 
coverage of that sample, multiplied by a target-specific proportionality 
constant that accounts for target probe affinity and possible target specific 
PCR biases. CNV candidates are detected as low p-value outliers to the null 
model fit of the expected read count distribution. Sensitivity and selectivity 
were estimated using “simulated” CNV events (e.g. heterozygous or 
homozygous deletions, or amplifications) mixed in with the measured data.  
 
We first applied our methods for 107 samples in a dataset produced by the 
Wellcome Trust Sanger Institute with paired-end Illumina sequencing. We 
identified a total of 164 exonic heterozygous-deletion events, of which 
55.5% overlaps with CNV events in the Database Of Genomic Variants 
(DGV). Experimental validation of these events, as well as the analysis of 
the remaining ~600 samples, sequenced in three other data producing 
centers within the 1000 Genome Project, are underway. 
 
Currently, multiple large medical sequencing projects generate whole-
exome capture data from thousands of individual samples. Our study 
demonstrates that such datasets are a useful substrate for detecting copy 
number changes in the coding regions of genes. Our methods, trained on the 
1000 Genomes Project pilot data, form a turn-key pipeline that can be 
readily applied for CNV detection in capture sequencing projects. 
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Next-generation sequencing (NGS) technologies have revolutionized 
genome sequencing by coupling extremely high throughput with low cost, 
thereby providing researchers with unprecedented opportunities to address 
many important biomedical problems efficiently. Large-scale resequencing 
projects, e.g. 1000 Genomes, TCGA, and TSP, have been initiated to extend 
our knowledge of single nucleotide polymorphisms (SNPs), short 
insertions/deletions (INDELs) and structural variations (SVs) and relate 
these variants to human diseases. The amount of NGS data submitted to 
public repositories such as the Short Read Archives (SRA) at the NIH 
National Center of Biotechnology Information (NCBI) is growing 
exponentially and submissions represent a wide array of technology 
platforms and sequence collection strategies. To process and analyze these 
data for variation detection in a uniform manner is a challenge requiring a 
standard modular pipeline. In collaboration with investigators at Boston 
College and the University of Michigan, NCBI is developing a framework 
Variation Discovery and Annotation Pipeline (Gpipe). The pipeline 
generates quality input sequence data from the Short Read Archives, checks 
sample identities, aligns the read data with the human reference genome 
sequences, refines the mapping of placed reads (duplicate removal and base 
quality recalibration etc), and calls SNPs, INDELs, and SVs according to 
data availability and project-specific policies. A centrally implemented 
pipeline streamlines the data processing workflow for the data generated by 
next-generation sequencing technologies. 
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DNA methylation plays an important role in genome organization and 
function. However, little is known about the evolutionary conservation of 
DNA methylation patterns in mammalian genomes. Here we investigate 
whole-genome DNA methylation profiles in the central nervous system, and 
present the first large-scale comparative DNA methylation study in human 
and mouse genomes. The methylation data were generated using a novel 
method, methylation mapping analysis by paired-end sequencing (Methyl-
MAPS). Genomic DNA from postmortem tissue was fractionated into 
methylated and unmethylated compartments and subsequent sequencing 
performed via the ultra high-throughput SOLiD sequencing platform.  
 
In this large-scale DNA methylation profiling study, we have mapped DNA 
methylation states of over 36% and 89% of CpG sites in human and mouse 
brains. The human brain metholome data covers 10,262,160 CpGs across 10 
normal brain samples from cerebral cortex. The mouse data represents 5 
mouse brain specimens from the 129S6/SvEv inbred strain. These data 
revealed that DNA methylation patterns are not conserved in evolutionary 
conserved regions of the human and mouse genomes (r=0.25). Intriguingly, 
the extent of human-mouse DNA methylation is not driven by sequence 
conservation, rather it is driven by CpG dinucleotide density. DNA 
methylation conservation increases with increasing CpG density, showing 
>80% correlation for regions containing >5 CpG dinucleotides in 100bp 
window. These highly conserved regions are enriched in gene promoters 
and first exons, with conserved methylation patterns representing both 
unmethylated and methylated states. In addition, these data show distinct 
methylation signatures that are characteristic of specific genomic features 
(e.g, promoters and internal exons) that are highly conserved within human 
and mouse genomes. This study underscores the impact of DNA 
methylation in mammalian genome evolution. 
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DNA methylation may play an important role in the etiology of 
neuropsychiatric disorders, perhaps as equally important as genetics and the 
environment. However, In order to better understand both the wild type 
genomic DNA methylation patterns and aberrant methylation events that 
occur in disease states, we first examined DNA methylation profiles within 
the normal human brain. We have developed a cost-effective, unbiased, 
whole-genome methylation profiling technique that can assay the 
methylation state of more than 80% of the CpG sites in the human genome. 
This method, methylation mapping analysis by paired-end sequencing 
(Methyl-MAPS) couples advances in next generation sequencing with 
enzymatic fractionation of DNA by methylation state. In this large-scale 
study we have mapped the methylation state of 36% of CpG sites in the 
human cerebral cortex of 10 normal non-psychiatric subjects (including 6 
prefrontal and 4auditory cortical samples). We focused on the prefrontal 
cortex (PFC) due to converging evidence from neuroimaging and functional 
studies implicating this region in both depression and schizophrenia. 
Secondarily, we also examined the auditory cortex, because schizophrenia 
disorder includes defects in sensory perception and processing. With these 
data we are for the first time able to explore DNA methylation profiles 
within two distinct brain regions with differing neurodevelopmental 
trajectories; the evolutionarily conserved auditory temporal cortex 
developing early as compared to the prefrontal cortex which undergoes 
maturation well into early adulthood. Our data reveal that DNA methylation 
is significantly more conserved in the auditory cortex then the PFC (P<10-
15). Despite this significant difference, DNA methylation signatures in the 
cortex are highly conserved, with >25% of the total CpG sites in cortex 
showing less than 20% difference in methylation state across the 10 samples 
examined. Cross-species analysis of DNA methylation conservation 
between human and mouse brains show that DNA methylation is not 
correlated with sequence conservation. Instead, increase in cross-species 
DNA methylation conservation is correlated with increasing CpG density. 
Genomic regions with significant human-mouse DNA methylation 
conservation (correlation >80%) typically have greater than 5 CpG 
dinucleotide in 100bp window. Although enriched in gene promoters, these 
regions also cover gene bodies, as well as repeat sequences that represent 
both methylated and unmethylated states. These data provide insight in 
studies of neuropsychiatric disorders, in identifying genomic regions that 
are developmentally and evolutionarily conserved that when aberrantly 
methylated may confer increase risk for disease.  
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DNA methylation plays a vital role in genome dynamics and, in the human 
genome, occurs predominantly at cytosine guanine dinucleotide (CpG) 
sites1. The unique part of haploid human genome2 analysed here contains 
around 20 million CpG sites (methylome) where DNA methylation can 
vary, affecting many biological processes in health and disease3. Using 
whole-genome bisulfite sequencing4-6, we report the essentially complete 
(92.62%) methylome of human peripheral blood mononuclear cells 
(PBMC) which constitute an important source for clinical blood tests world-
wide. We find the majority of CpG sites (68.4% at false positive rate of 
0.46%) and only <0.2% of non-CpG sites to be methylated, demonstrating 
that non-CpG cytosine methylation is negligible in human PBMC. Analysis 
of the PBMC methylome revealed a rich landscape of epigenomic data for 
20 distinct features including regulatory, protein-coding, RNA gene coding, 
non-coding and repeat sequences. Alu element mobility, for instance, was 
found to negatively correlate with their methylation levels, emphasizing the 
critical role of DNA methylation in genome stability. Integration of our 
methylome data with the previously determined genome sequence2 of the 
same Asian individual analysed here, enabled a first assessment of allele-
specific methylation (ASM) differences between the two haploid 
methylomes of any individual. Using a conservative cut-off (p <0.001), we 
identified 599 haploid differentially methylated regions (hDMRs) covering 
287 genes. Of these, 76 genes had hDMRs within 2kb of their 
transcriptional start sites of which >80% displayed allele-specific 
expression (ASE) after random testing using TA clone sequencing of the 
same PBMC sample. These data show, that ASM is a recurrent 
phenomenon and highly correlated with ASE, suggesting that imprinting 
may be more common than previously thought. Our study not only provides 
a comprehensive resource for future epigenomic research but also 
demonstrates a paradigm for large-scale epigenomics studies through new 
sequencing technology. 
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There is a strong demand in the genomic community to develop effective 
algorithms to identify INDELs and structural variants from multiple 
samples, in order to investigate disease-related variants and genetic survey 
of large populations. We developed a so-called Pindel [1] method to 
identify breakpoints of large deletions (1bp-50kb) and medium sized 
insertion (1-60bp) at base level precision from paired-end short reads. From 
those one-end mapped paired-end reads, our Pindel program uses the 
mapped read to determine the anchor point on the reference genome and the 
direction of unmapped read. Knowing the anchor point, the direction to 
search for the unmapped read and the user defined Maximum Deletion Size, 
a sub-region in the reference genome can be located, where Pindel will 
break the unmapped reads into 2 (deletion) or 3 (short insertion) fragments 
and map the two terminal fragments separately.  
 
In this study we developed a novel procedure based on Pindel algorithm to 
process multiple samples. We add tags to the reads to indicate their sources. 
Then we run Pindel using the entire pool of reads as the input. We modified 
our Pindel program to report the sample sources of the supporting reads for 
each identified indel event. With such information we are able to discern 
which samples have what indels. We also adapted the algorithm to include 
detection of deletions with small insertions of non-templated sequences at 
the breakpoint, and to report a confidence score that is monotonically 
related to false discovery rate.  
 
We demonstrated our method with the low coverage data of human chr1 
from 170 individuals in the 1000 genomes project and with the high 
coverage sequence data of COLO-829 cancer cell lines from both normal 
and tumor tissues of the same individual [2].  
 
[1] Ye, K. et al. Bioinformatics 2009 25(21):2865-2871 
[2] Pleasance, E. et al. Nature 2010, 463, 191-196  
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Genetic studies of populations from the Indian subcontinent are of great 
interest for many reasons, including India’s large population size, its 
complex demographic history, and its unique social structure. Despite 
recent large-scale efforts in discovering human genetic variation (e.g., 
ENCODE, HapMap, and PopRes), India’s vast reservoir of genetic diversity 
remains largely unexplored. To address this issue and to provide a 
supplement to the ENCODE resequencing project, we resequenced one of 
the 100Kb ENCODE regions in 94 South Indian samples collected from 
five populations – representing four castes and one tribal population – from 
the state of Andhra Pradesh in South India. By examining the unbiased 
distribution of common and rare (MAF<5%) variants in these non-HapMap 
populations, we sought to assess the additional information that can be 
gained by sampling more diverse populations, especially in geographic 
regions with little or no current coverage. 
 
By comparing the five Indian populations with eight HapMap III 
populations that are resequenced in the same region, we found that more 
than 15% of the total SNPs are Indian-specific. Nine percent of the total 
were found only in the five South Indian populations. Several Indian 
population samples have nucleotide and haplotype diversity as high as 
HapMap African populations (nucleotide diversity estimates of 0.089 in 
middle-caste Yadava, 0.085 in lower-caste Mala/Madiga, and 0.083 in tribal 
Irula, compared to 0.082 and 0.083 in YRI and LWK). Unlike HapMap 
populations, whose sequence diversity decreases in proportion to their 
distances from Africa, some Indian populations (Yadava, Mala, and Irula) 
have significantly elevated sequence diversity relative to their geographic 
distance from Africa. Our study highlights the need to further study Indian 
genetic variation. 
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The recent availability of a growing number of sequenced eukaryotic 
genomes allowed us to examine gene genealogies along the most sampled 
lineages of vertebrates, arthropods, and fungi in unprecedented detail. We 
classified about 86% of 1.36M protein-coding genes from 95 annotated 
genomes into hierarchical orthologous groups, with over 90% of these 
groups having Gene Ontology (GO) or InterPro functional annotation. 
Using these data, we explored the links between gene essentiality, 
functionality, and accumulated numbers of homologs with constrained by 
selection ortholog sequence divergence, gene copy-number, and phyletic 
distribution. 
We find a clear enrichment of essentiality among universal orthologs, with 
surprising consistency of the universal fraction across vertebrates, 
arthropods, and fungi. Essential genes consistently exhibit greater 
conservation of sequence identity, and are enriched among the majority of 
biological processes in animals, but not in yeast. Single-copy orthologs are 
characterized by markedly higher sequence identities, and the strength of 
purifying selection also vary substantially among different functional gene 
classes. The othology data are available from OrthoDB at 
http://cegg.unige.ch/orthodb. 
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Unitary pseudogenes are class of unprocessed pseudogenes without 
functioning (i.e. genic) counterparts in the genome. Numerically, they 
constitute only a small fraction of tens of thousands of annotated 
pseudogenes in the human genome. However, as they represent distinct 
functional losses over time, they shed particular light on the unique features 
of humans in primate evolution. Here, we develop a pipeline to detect 
human unitary pseudogenes through analyzing the global inventory of 
orthologs between the human genome and its mammalian relatives. We 
apply conservative cutoffs meant to filter out false positives and focus on 
gene losses along the human lineage after the divergence from rodents ~75 
million years ago. In total, we identify 76 unitary pseudogenes, including 
previously annotated ones, such as ψGULO and ψUOX, and many novel 
ones. By comparing each of these to its functioning ortholog in other 
mammals, we can approximately date the creation of each unitary 
pseudogene (i.e. the gene ‘death date’) and show that for our group of 76, 
the functional genes appear to be disabled at a fairly uniform rate 
throughout primate evolution—and not all at once, correlated, for instance, 
with the ‘Alu burst’. Furthermore, we identify 11 ‘polymorphic’ 
pseudogenes that have both nonfunctional and functional alleles currently 
segregating in the human population. Comparing them with their orthologs 
in other primates, we find that two of them are in fact pseudogenes in non-
human primates suggesting that they actually represent cases of a gene that 
is in the process of being resurrected in the human lineage. 
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The incorporation of histone H3 variants has been implicated in the 
epigenetic memory of cellular state. Using genome editing with zinc finger 
nucleases to tag endogenous H3.3, we report genome-wide profiles of H3 
variants in mammalian embryonic stem (ES) cells and neuronal precursor 
cells. Genome-wide patterns of H3.3 are dependent on amino acid 
sequence, and change with cellular differentiation at developmentally 
regulated loci. The H3.3 chaperone Hira is required for H3.3 enrichment at 
active and repressed genes. Strikingly, Hira is not essential for localization 
of H3.3 at telomeres and many transcription factor binding sites. 
Immunoaffinity purification and mass spectrometry reveal that the proteins 
Atrx and Daxx associate with H3.3 in a Hira-independent manner. Atrx is 
required for Hira-independent localization of H3.3 at telomeres, and for the 
repression of telomeric RNA. Our data demonstrate that multiple and 
distinct factors are responsible for H3.3 localization at specific genomic 
locations in mammalian cells. 
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The main goal of the 1000 genomes project is to establish a comprehensive 
and detailed catalogue of human genome variations; which in turn will 
empower association studies to identify disease-causing genes. The pilot 
studies for the 1000 genomes project are complete and the main project of 
sequencing 1000 additional whole genomes is underway. This is generating 
unprecedented amount of data everyday. A joint Data Coordination Center 
(DCC) between EBI and NCBI is responsible for maintaining the data.  
 
The DCC manages the data flow for the project, which starts from getting 
sequence data from the sequencing centers via Sequence Read Archive 
(SRA) and ends at placing both the raw data and analysis results on publicly 
visible ftp sites. DCC data QA pipelines are integrated into the workflow to 
ensure data integrity and consistency. After retrieving the sequence data 
from the SRA, the DCC checks the data to make sure the reads are of high 
quality (Fastq QA) and are labelled correctly as appropriate samples and 
individuals (Sample QA), and then make the Fastq files available on the ftp 
sites. Data processing teams at the Sanger institute and the Translational 
Genomics Research institute subsequently align the high quality Fastq files 
to the reference genome and recalibrate base qualities. The alignments are 
returned to DCC as BAM files, which have to pass a BAM QA process 
before they can be released on the ftp sites. Analysis group uses the 
alignments to make variant calls, which are also distributed to public in 
Variant Call Format (VCF) through the DCC ftp sites. The variant calls can 
also be browsed in an Ensembl style browser.  
 
The ftp sites and browser site are: 
ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/ 
ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/release/ 
http://browser.1000genomes.org/ 
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Reconstructing the evolutionary history at genomic loci where there is a 
high frequency of recombination can be difficult because the exchange of 
discrete blocks of genetic information (mosaic recombination) can obscure 
a clear signal of a bifurcating, tree-like history. This problem may be 
particularly pronounced when examining gene families because there can be 
non-allelic homologous recombination among gene copies (paralogs), in 
addition to allelic recombination. Using a new statistical method we are 
able to detect recent and ancestral recombination in gene families and 
among the paralogs. We apply this method to two gene families with 
unusually high levels of diversity, each with thousands of alleles: the 
variant antigen (var) genes that code for cell-surface proteins in the human 
malaria parasite P. falciparum, and the Human Leukocyte Antigen (HLA) 
Class I loci, which code for proteins that present pathogen antigens to the 
immune system. Here we show how mosaic recombination is generating 
diversity at these loci over evolutionary time, and how detecting blocks of 
exchanged genetic material may resolve outstanding issues in the evolution 
of these gene families. In the case of the hyper-variable var genes, we show 
how this family has a surprising old structure, with recombination blocks 
dating from before speciation, whereas many HLA alleles that may appear 
to be ancient are in fact recently evolved mosaics of old sequences 
recombined with newer ones. 
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Behavior arises from the interplay between genes, the environment, and 
experience, as interpreted and integrated by the nervous system. Interesting 
behavioral differences between individuals can be heritable, but attempts to 
map "behavioral genes" typically result in the identification of many QTLs 
with small effects, and only a few of these genes have been followed to the 
molecular level. We are studying the genetic architecture of foraging and 
social behaviors in the nematode worm Caenorhabditis elegans, a simple 
model animal with interesting but tractable behaviors. Our experimental 
approach combines neuroscience, molecular genetics, and an analysis of 
recombinant inbred advanced intercross lines (RIAILs) generated from a 
cross between two wild-type C. elegans strains. We find that multiple QTLs 
with epistatic interactions affect single behaviors. These genes intersect by 
regulating a common neuronal circuit. Comparing these results with results 
in flies and mice suggests that G protein-coupled receptor signaling may be 
a common target for natural genetic variation in very different systems. 
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Metagenomics - shotgun sequencing a microbial community directly from its 
environment - enables studies of the unseen world and its impacts on humanity and 
the planet. Our goal is to develop phylogenetic methods to study microbial diversity 
using metagenomic data. However, it is not clear a priori that meaningful trees 
relating short, fragmentary metagenomic sequence reads can be constructed.  
We approach this problem with two insights. First, we focus on gene trees in which 
the leaves are individual metagenomic reads, rather than species trees. Second, we 
leverage “reference” gene sequences from fully sequenced microbial genomes and 
probabilistic profiles of their evolution to classify metagenomic reads, construct 
alignments, and guide phylogeny construction (from which reference sequences can 
be pruned). We constructed a metagenomic simulation pipeline and evaluated how 
well this method resolves phylogenies of metagenomic reads compared to using full-
length rRNA or protein sequences. Performance is reasonable as long as the number 
and phylogenetic breadth of reference sequences is fairly large. We therefore 
generated trees for a collection of taxonomically informative genes and used these in 
several novel ways. 
First, we developed a method to define operational taxonomic units (OTUs), a 
microbial surrogate for species. Typical OTU methods cluster sequences using pair-
wise sequence identity. To enable clustering of non-overlapping metagenomic reads, 
we utilize branch lengths in our SSU-rRNA tree to derive a phylogenetic distance 
measure. We applied this method to human distal gut, human saliva, and global open 
ocean metagenomes. Deeply sequenced metagenomic libraries recover most OTUs 
found using traditional PCR methods, plus additional OTUs including previously 
unknown bacterial taxa. Our second method estimates geometric characteristics of 
OTU ranges by comparing sets of OTUs found at sites separated by different 
distances (i.e. distance-decay). We found great variability in geographic ranges, 
potentially reflecting different dispersal processes and environmental requirements. 
 
We also developed taxonomy-free methods to quantify bacterial diversity within and 
between metagenomic samples. Our statistics are based on mean branch-lengths 
separating pairs of reads in protein-coding gene phylogenies. Applying this method 
to an ocean depth gradient, we found high community diversity at intermediate 
depths compared to shallow and very deep samples, a pattern that is not revealed 
using OTUs based on pair-wise sequence identity. 
 
Phylogenetic approaches to metagenomics shed light on the rare biosphere and the 
mechanisms structuring microbial communities. 
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Gene expression varies within and between species and is an important 
source of phenotypic differences. The potential for evolutionary changes in 
gene expression depend on the properties of regulatory mutations, but no 
quantitative description of the characteristics of these mutations exists. For 
a single focal gene’s expression, we empirically determine the regulatory 
mutation rate (i.e., the proportion of new mutations that affect its 
expression), the distribution of mutational effects, the prevalence of 
dominance, and the relative frequency of cis- and trans-acting mutants. To 
address these issues, we collected ~250 novel genotypes of a 
Saccharomyces cerevisiae strain expressing Yellow Fluorescent Protein 
(YFP) regulated by the promoter sequence of the TDH3 gene. Briefly, EMS 
mutagenesis was used to elevate the mutation rate, and 1728 candidate 
mutants were isolated by Fluorescence Assisted Cell Sorting (FACS). In a 
secondary screen, a clonal population of each of these candidate mutant 
genotypes was cultured and analyzed by FACS to estimate the mean and 
variance of YFP fluorescence for each novel genotype. Nonsynonymous 
YFP coding sequence changes or YFP gene duplications were found in 43 
candidates; we noted that these genotypes have the most-extreme 
phenotypes but otherwise excluded them from further analysis. Using the 
remaining mutants, our data suggest that mutations causing statistically 
significant changes in YFP expression should occur spontaneously at rate of 
approximately 6 x 10-7 /genome/generation. Mutations with small effects on 
expression are more common than those with large effects, but intriguingly 
we found that the mutations that increase expression is were approximately 
twice as common as those that decrease expression. Mutant genotypes were 
also crossed to a wildtype strain that enabled us to assess dominance and 
distinguish between cis- and trans-action. We found that 85.3% of mutant 
alleles were recessive to the wildtype allele in a diploid background. Of the 
28 genotypes harboring a dominant regulatory mutation, we observed that 9 
affected YFP expression in an allele-specific manner (i.e., in cis), while the 
rest show trans-acting effects. 
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To address the genotype to phenotype problem we developed a relevant but 
simple comparative model system for the budding yeast, Saccharomyces 
cerevisiae. Our system enables a comprehensive assessment of the genetic 
mechanisms that lead to different phenotypes for the same mutation in two 
different genetic backgrounds. We focused on a strain called Σ1278b 
because it mates and forms viable meiotic progeny with the reference strain, 
S288C, but it is separated from S288C by the same level of genetic 
variation typical of two human individuals.  
 
As a first step we sequenced and assembled the 12 Mb Σ1278b genome. By 
computational and tiling array analysis, we annotated a total of 6923 open 
reading frames (ORFs) in Σ1278b, of which 6848 have orthologs within 
S288c. Differences between the strains were largely caused by small indels 
or SNPs, with an average SNP density of 3.2 per kilobase, which is similar 
to the divergence between two humans.  
 
We deleted all ~5500 genes within Σ1278b to enable a systematic 
comparison of its deletion mutant phenotypes to those of S288c. In 
particular, we identified genes that are required uniquely for viability in 
either Σ1278b or S288c, a phenotype termed "conditional essentiality". We 
expected such conditional essential genes to be rare because the genomes of 
Σ1278b and S288c are nearly identical.  
 
Although 894 genes were essential in both S288c and Σ1278b, 44 genes 
were essential only in Σ1278b and 13 genes were essential only in S288c. 
Our analysis showed that conditional essentiality is almost always a 
consequence of complex genetic interactions involving multiple modifiers.  
 
The ability to identify these conditional essential phenotypes in yeast 
provides the framework to unravel the fundamental principles of genetic 
networks based upon natural variation, including those that underlie human 
disease.  
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Transcriptional profiling in the nematode Caenorhabditis elegans has so far 
been performed on large-scale harvests of stably differentiated embryonic 
or postembryonic cells, yet key events in development rely on individual 
cells that migrate and invade tissues dynamically. Male gonadal 
development in C. elegans requires that the linker cell trace an arced 
pathway through the posterior body; during this, the linker cell both 
migrates and changes shape in a highly reproducible way, and this program 
partially requires the nuclear hormone receptor NHR-67 (Kato and 
Sternberg [2009], Development, 136, 3907-3915). We have thus adapted 
laser microsurgery, patch-clamp pipettes, and 3'-tailed RT-PCR to enable 
RNAseq of individually dissected migrating linker cells from wild-type L3- 
and L4-stage male larvae, and from nhr-67(RNAi) L4 larvae. We have 
detected expression of 7,439 genes in wild-type L3 or L4 linker cells, 
versus 13,136 genes in bulk RNA from wild-type larvae (out of 20,252 
genes in the C. elegans genome). 853 genes (~11% of 7,439) are robustly 
expressed in L3 or L4 linker cells (with an RPKM of at least 1), but have at 
least 20-fold lower expression in bulk larvae; this subset of linker-cell-
specific genes includes nhr-67, along with over 40 other transcription 
factors such as the bZIP atf-5, three Hox genes, three HLH genes, and the 
heterochronic gene lin-29. We are currently assaying particularly interesting 
genes for function by GFP expression patterns and RNAi phenotypes. This 
analysis should provide the first transcriptional portrait of a migrating cell 
in C. elegans. 
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Dictyostelium discoideum is a eukaryotic microbial model system for 
multicellular development, cell-cell signaling and social behaviour. Key 
models of social evolution require an understanding of genetic relatedness 
between individuals across the genome or possibly at specific genes, but the 
nature of variation within D. discoideum is largely unknown. We conducted 
the first molecular population genomic study in this species, examining the 
levels and patterns of nucleotide variation in this social microbial species as 
well as phenotyping wild strains for levels of kin discrimination, social 
dominance and mating type. We find surprisingly low levels of nucleotide 
variation in D. discoideum across these strains, with a mean π = 0.0008, and 
there is no strong population stratification within North American strains. 
Contrary to expectations of kin selection theory on the evolution of social 
cooperation, we do not find any clear relationship between nucleotide 
divergence and levels of social dominance and kin discrimination in D. 
discoideum. We do, however, observe a significant negative correlation of 
kin discrimination between strains with geographic distance. Finally, 
despite the fact that sex has been rarely observed in this species, we 
document a rapid distance decay of linkage disequilibrium between SNPs, 
the presence of recombinant genotypes among natural strains, and high 
levels of the population recombination parameter ρ. Our results indicate that 
greater levels of self/non-self recognition may arise within D. discoideum 
populations, possibly to mitigate against the evolution of cheating 
behaviours in the spatially unstructured populations of this species. Our 
SNP data also indicates that recombination is widespread within D. 
discoideum, and that sex as a form of social interaction is likely to be an 
important aspect of this model organism’s life cycle. These results suggest 
that genetic studies in this species should be possible, and would potentially 
expand the molecular toolkit available for this model organism. 
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Phenotypic variation results from a combination of genetic and epigenetic 
differences. With the advent of deep sequencing, it is possible to examine 
the consequences of genetic polymorphisms genome-wide. Arabidopsis 
thaliana provides an excellent model for such a study as it exists in the wild 
as a collection of naturally occurring inbred populations with significant 
phenotypic differences. Using 454 mate-pair and XLR reads, we generated 
a de novo assembly of a Cape Verde Island (Cvi-0) accession. Comparison 
to the Columbia (Col-0) reference identifies SNPs, indel, and structural 
variations constituting a 3% sequence difference between these accessions. 
Using the Cvi-0 assembly as a reference, we have mapped the Cvi-0 
transcriptome, methylome and smRNAome. A comparison of methylomes 
between Cvi-0, Col-0 and the Landsberg Erecta (Ler-0) accession reveals 
that Cvi-0 lacks half the methylation of the other accessions due to a 
decrease in the methylated cytosines at CG dinucleotides. The highest 
conservation of CG methylation between the accessions occurs in a region 
upstream of the transcription start site suggesting a possible role for 
retention of mCG at specific regulatory regions. While there is significant 
conservation of smRNA loci between the accessions, hundreds of 
accession–specific epialleles have been identified. Additionally, the 
relationship of structural, genetic and epigenetic variation is also presented. 
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Statistical analysis of sequence variation data has enabled the construction 
of a fine-scale genome-wide map of recombination rates in humans. These 
maps revealed a landscape dominated by recombination hotspots and led to 
the discovery of a 13-bp motif associated with the activity of 40% of human 
hotspots. Recently, we showed that the rapidly evolving zinc-finger protein 
PRDM9 binds this motif and that the motif is being lost from the human 
genome through a self-destructive drive. These observations, and the fact 
that humans and chimpanzees show low, if any, sharing of hotspots, suggest 
a scenario in which the evolution of PRDM9 and the hotspot motif are 
coupled. However, many questions remain about whether there exist classes 
of hotspot that are conserved and whether recombination rates are 
conserved at broader scales between species. To address these questions we 
have sequenced 10 Pan troglodytes verus to 6-10X coverage using paired 
end sequencing with 50-bp reads. This project increases the amount of 
chimpanzee variation data by nearly 10-fold and provides a comparative 
map of genetic variation between humans and their closest living relatives. 
From these data we intend to construct a high-resolution genome-wide 
recombination map using coalescent methods that incorporate genotype 
uncertainty. This will enable four innovations: (1) locating chimpanzee 
hotspots and observing their properties, (2) determining whether hotspot 
classes predicted by PRDM9 are enriched in chimpanzee, (3) identifying 
shared hotspot classes between chimpanzee and human, (4) exploring the 
scales at which recombination factors operate in chimpanzee. 
*Equal contributors 
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Changes in gene regulation have been proposed as critical in the evolution 
of phenotypic diversity of primates. However, the lack of high-quality 
reference genomes for most species and the limited number of 
independently derived transcripts for non-human primates has made it 
difficult to study gene regulation across multiple primates. To overcome 
these problems, we used massively-parallel sequencing to 
interrogate mRNA samples extracted from the livers of 16 species (12 
primates including human, and 4 non-primate out groups; 4 samples per 
species). Of the 12 primate species, 8 do not have currently available 
reference genome sequences (vervet, galago, slow loris, and 5 lemur 
species), which means that we had to assemble the transcriptomes de novo 
for these species. This study design results in nucleotide sequence, 
quantitative expression, and gene structure data from thousands of genes, 
providing insight into gene regulation and sequence evolution across a 
broad spectrum of primate species. 
 
Our analysis has revealed sets of genes whose expression level patterns are 
consistent with the action of natural selection along individual or ancestral 
primate lineages. We also investigated the relationship between alternative 
splicing within species and complete exon gains and losses between 
species. Interestingly, we also identified a large number of genes, highly 
conserved at the sequence level, that are expressed in the livers of some 
taxa, but that are unexpressed in others. Further, we have identified genes 
whose function and expression pattern we hypothesize may underlie 
specific adaptive processes. For example, PRKAA2, which inactivates 
enzymes that regulate the synthesis of fatty acids and is targeted by drugs 
that treat diabetes, is lowly expressed in primates but highly expressed in 
non-primate out groups.  
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DNA Sequencing Flowgram: Each
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VISITOR INFORMATION 
 
EMERGENCY                CSHL                          BANBURY 
Fire (9) 742-3300 (9) 692-4747 
Ambulance (9) 742-3300 (9) 692-4747 
Poison (9) 542-2323 (9) 542-2323 
Police (9) 911 (9) 549-8800 
Safety-Security Extension 8870  
 
Emergency Room 
Huntington Hospital 
270 Park Avenue, Huntington 
631-351-2300 
(1037)  
Dentists 
Dr. William Berg 
Dr. Robert Zeman 
 
631-271-2310 
631-271-8090 
Doctor 
MediCenter 
234 W. Jericho Tpke., Huntington Station 
631-423-5400 
(1034) 
Drugs - 24 hours, 7 days 
Rite-Aid 
391 W. Main Street, Huntington 
631-549-9400 
(1039) 
Free Speed Dial 
Dial the four numbers (****) from any tan house phone to place a 
free call. 
GENERAL INFORMATION 
 
Books, Gifts, Snacks, Clothing, Newspapers 
 BOOKSTORE   367-8837 (hours posted on door) 
 Located in Grace Auditorium, lower level. 
 
Photocopiers, Journals, Periodicals, Books, Newspapers 
 Photocopying – Main Library 
 Hours:  8:00 a.m. – 9:00 p.m. Mon-Fri 
             10:00 a.m. – 6:00 p.m. Saturday 
Helpful tips - Obtain PIN from Meetings & Courses Office  
to enter Library after hours.  See Library staff for photocopier 
code. 
 
Computers, E-mail, Internet access 
 Grace Auditorium 
 Upper level: E-mail only 
 Lower level: Word processing and printing. 
 STMP server address: mail.optonline.net 
 To access your E-mail, you must know the name of your  
 home server.    
 
Dining, Bar 
 Blackford Hall 
  Breakfast  7:30–9:00, Lunch 11:30–1:30, Dinner  5:30–7:00 
  Bar  5:00 p.m. until late  
 Helpful tip - If there is a line at the upper dining area, try the  
 lower dining room 
 
 
 
Messages, Mail, Faxes 
 Message Board, Grace, lower level 
 
Swimming, Tennis, Jogging, Hiking 
June–Sept. Lifeguard on duty at the beach. 12:00 noon–6:00 p.m.  
Two tennis courts open daily. 
 
Russell Fitness Center 
 Dolan Hall, west wing, lower level 
 PIN#:  Press 64350 (then enter #) 
 
Concierge 
 On duty daily at Meetings & Courses Office. 
After hours – From tan house phones, dial x8870 for 
assistance 
  
Pay Phones, House Phones 
Grace, lower level; Cabin Complex; Blackford Hall; Dolan Hall, 
foyer  
 
CSHL’s Green Campus 
 
Cold Spring Harbor Laboratory is pledged to operate in an 
environmentally responsible fashion wherever possible.  In the past, 
we have removed underground oil tanks, remediated asbestos in 
historic buildings, and taken substantial measures to ensure the 
pristine quality of the waters of the harbor. Water used for irrigation 
comes from natural springs and wells on the property itself.  Lawns, 
trees, and planting beds are managed organically whenever possible.  
And trees are planted to replace those felled for construction 
projects.   
 
Two areas in which the Laboratory has focused recent efforts have 
been those of waste management and energy conservation.  The 
Laboratory currently recycles most waste.  Scrap metal, electronics, 
construction debris, batteries, fluorescent light bulbs, toner cartridges, 
and waste oil are all recycled.  For general waste, the Laboratory uses 
a “single stream waste management” system, removing recyclable 
materials and sending the remaining combustible trash to a 
cogeneration plant where it is burned to provide electricity, an 
approach considered among the most energy efficient, while providing 
a high yield of recyclable materials. 
 
Equal attention has been paid to energy conservation.  Most lighting 
fixtures have been replaced with high efficiency fluorescent fixtures, 
and thousands of incandescent bulbs throughout campus have been 
replaced with compact fluorescents.  The Laboratory has also 
embarked on a project that will replace all building management 
systems on campus, reducing heating and cooling costs by as much 
as twenty-five per cent. 
 
Cold Spring Harbor Laboratory continues to explore new ways in 
which we can reduce our environmental footprint, including 
encouraging our visitors and employees to use reusable containers, 
conserve energy, and suggest areas in which the Laboratory’s efforts 
can be improved. This book, for example, is printed on recycled 
paper. 
                       1-800 Access Numbers 
 
 AT&T  9-1-800-321-0288 
 MCI  9-1-800-674-7000 
 
Local Interest 
 Fish Hatchery   631-692-6768 
 Sagamore Hill   516-922-4447 
 Whaling Museum   631-367-3418 
 Heckscher Museum  631-351-3250 
 CSHL DNA Learning  x 5170 
   Center 
 
New York City 
 Helpful tip - 
 Take Syosset Taxi to Syosset Train Station 
 ($8.00 per person, 15 minute ride), then catch Long Island  
 Railroad to Penn Station (33rd Street & 7th Avenue).   
 Train ride about one hour. 
 
   TRANSPORTATION 
Limo, Taxi 
 Syosset Limousine  516-364-9681  (1031) 
 Super Shuttle  800-957-4533  (1033) 
  To head west of CSHL - Syosset train station 
  Syosset Taxi  516-921-2141  (1030) 
 To head east of CSHL - Huntington Village  
  Orange & White Taxi 631-271-3600  (1032) 
Executive Limo  631-696-8000  (1047) 
 
Trains 
 Long Island Rail Road   822-LIRR  
 Schedules available from the Meetings & Courses Office. 
 Amtrak   800-872-7245 
 MetroNorth   800-638-7646 
 New Jersey Transit  201-762-5100 
 
Ferries 
 Bridgeport / Port Jefferson 631-473-0286 (1036) 
 Orient Point/ New London 631-323-2525 (1038) 
 
Car Rentals 
 Avis   631-271-9300 
 Enterprise   631-424-8300 
 Hertz   631-427-6106 
  
Airlines 
 American   800-433-7300 
 America West  800-237-9292 
 British Airways  800-247-9297 
 Continental   800-525-0280 
 Delta   800-221-1212 
 Japan Airlines  800-525-3663 
 Jet Blue   800-538-2583 
 KLM   800-374-7747 
 Lufthansa   800-645-3880 
 Northwest   800-225-2525 
 United   800-241-6522 
 US Airways   800-428-4322 
